Renal dysfunction associated with infrarenal cross clamping of the aorta during major vascular surgery by Van der Merwe, Wynand Louw
RENAL DYSFUNCTION ASSOCIATED WITH
INFRARENAL CROSS CLAMPING OF THE AORTA
DURING MAJOR VASCULAR SURGERY
WYNAND LOUW VAN DER MERWE
MB,ChB, MMed (Anes), FFA (SA)
Dissertation presented for the degree of
Doctor of Medicine
in the Faculty of Medicine
University of Stellenbosch
Promotor: Prof. AR Coetzee March 2000
MB,ChB, MMed (Anes), PhD, FFA (SA), FFARCS, MD, PhD
I, the undersigned, hereby declare that the work contained in this thesis is my own
original work and that I have not previously in its entirety or in part submitted it at any
university for a degree.
WL van der Merwe
Stellenbosch University http://scholar.sun.ac.za
Acute renal failure still is, with the exception of cardiac deaths, the most important
pathological process associated with perioperative mortality in patients operated for
abdominal aortic aneurysms. The intraoperative change in renal blood flow (RBF) and
glomerular function have been investigated in human and animal models, particularly
over the past 15 years. Despite large variation in study populations, measurement
techniques and study designs in general, a significant body of evidence has developed
which suggests infrarenal aortic clamp-induced renal ischemia to be the cause of
postoperative acute renal failure when this complication does occur.
It is rather surprizing then that, despite some recent studies which have reported on
various pharmacological interventions to prevent intraoperative renal ischemia (with
variable success), very little has apparently been done to unravel the pathogenesis
and exact pathophysiology of this potentially lethal complication. Although a number of
investigators suggest the possibility of hormonal involvement (particularly renin-
angiotensin, antidiuretic hormone (ADH) and catecholamines) in the process, the exact
role of these mediators have not been explored (or reported) in a structured fashion.
In an initial human study, renal hemodynamics and function were measured from the
preoperative period, during the intraoperative phase and at least until 4 hours after
aortic unclamping. To investigate the possibility of a temporal relationship between
renal changes and fluctuations in hormonal concentrations, plasma concentrations of
relevant hormones were determined at every sampling period where renal parameters
were measured.
The decrease in RBF and glomerular filtration rate (GFR) which we demonstrated to
coincide with infrarenal aortic cross clamping, is consistent with results previously
published. We demonstrated persistence of the impairment of these parameters as
long as 4 hours into the postoperative phase; which has previously only been reported
for the period until immediately after aortic unclamping with the abdomen still open.
The persistence of a depressed GFR until the time of discharge of patients is cause for
concern, particularly in patients with compromised renal function prior to surgery.
Stellenbosch University http://scholar.sun.ac.za
Of the measured hormones with a potential influence on RBF and nephron function,
renin was the only mediator where changes in plasma concentrations coincided with
the depression of RBF and GFR after aortic cross clamping. The design of our study
did not allow us to conclude whether the concomitant increase in angiotensin II was
primarily responsible for the change in renal hemodynamics, or whether the raised
renin (and angiotensin) levels were stimulated by the decrease in RBF induced by
another mechanism.
In another patient group, we demonstrated that the combination of mannitol and
dopamine provided no protection against the deleterious effects of aortic cross
clamping. In fact, the high urine volumes produced under the influence of these
agents (which did not correlate with RBF at the corresponding periods), is likely to
prompt a false sense of security. Given the lack of any objective benefit afforded by
these agents, their use in these clinical circumstances should be discouraged.
The animal studies were aimed at elucidation of the exact role of angiotensin in the
pathogenesis and pathophysiology of the renal changes associated with infrarenal
aortic clamping, as well as the interaction of angiotensin with other modulators for
which an interactive relationship had been described previously under other
experimental and/or clinical circumstances.
The first study showed that, although renin (and thus angiotensin) concentrations were
high after aortic unclamping, the hormone had no pathogenic or pathophysiological
role of significance in the observed renal changes during this period (since blocking
angiotensin II activation by the prevention of renin release, or by inhibiting the
conversion enzyme, did not prevent a substantial decrease in RBF or GFR during that
period). Preventing angiotensin II activation did, however, prevent renal changes
during aortic clamping. This beneficial effect did not establish a primary role for
angiotensin during that period, since the favourable influence could also (at least
partially) be explained by prevention of the permissive influence of angiotensin on
other vasoconstrictors and/or other vasodilatory influences of ACE inhibition and [1-
blockade which are unrelated to angiotensin. This study did indicate that (at least
partially) different mechanisms are responsible for the renal changes seen during
aortic clamping, and after aortic unclamping.
Stellenbosch University http://scholar.sun.ac.za
The second study explored the role of calcium in the renal pathophysiological changes
during aortic clamping and after unclamping. The protective influence effected by
the administration of a Ca2+ -blocker suggest the dependence of the renal
vasoconstrictive and glomerular pathophysiological process( es) on the cellular influx of
Ca2+ through voltage-gated channels. It unfortunately provides no definitive insight
into the primary instigators of these processes. However, it does offer a clinically
useful method of preventing these changes and protecting the kidney against ischemic
injury during abdominal aortic surgery.
The third component of the animal studies demonstrates the importance of the
protective effect of renal prostaglandins during the specific experimental (and probably
also the clinical) circumstances. Again, it does not provide definitive information on the
mediators responsible for the renal changes, since the deleterious effects of numerous
endogenous substances have previously been shown to be counterbalanced by
intrarenal synthesis of prostaglandins under various experimental and clinical
circumstances. The extent of the pathophysiological and ultrastructural changes which
occurred under the influence of a NSAID does, however, suggest that these drugs
should not be used under these clinical circumstances.
The last component of the study provides evidence that angiotensin only plays a
secondary/supplementary role in the renal pathophysiological process even during
aortic clamping. This may explain the contradictory evidence regarding the potential
beneficial effect of ACE inhibition (on renal hemodynamics and glomerular function)
during abdominal aortic surgery (Licker et al. 1996, Colson et al. 1992a). Based on
our studies, ACE inhibition can not be supported for this purpose.
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Akute nierversaking is met die uitsondering van kardiale sterftes, steeds die
belangrikste patologiese proses wat geassosieer is met perioperatiewe mortaliteit in
pasiënte wat opereer word vir abdominale aorta aneurismes. Die intraoperatiewe
veranderinge in renale bloedvloei (NBV) en glomerulêre funksie is die afgelope 15 jaar
ondersoek en gerapporteer in pasiënte- sowel as diere-modelle. Ten spyte van groot
variasies in studie-populasies, meettegnieke en ontwerp van studies in die algemeen,
dui 'n wesenlike hoeveelheid getuienis daarop dat infrarenale klemming van die aorta
renale isgemie induseer, wat die oorsaak is van postoperatiewe akute nierversaking
wanneer hierdie komplikasie voorkom.
Dit is verbasend dat, ten spyte van sommige onlangse studies wat rapporteer oor 'n
verskeidenheid farmakologiese ingrepe om intraoperatiewe renale isgemie te voorkom
(met wisselende sukses), baie min oënskynlik gedoen is om die patogenese en die
presiese patofisiologie van hierdie potensieel dodelike komplikasie te ontrafel. Hoewel
verskeie outeurs die moontlikheid van hormonale betrokkenheid (veral renien-
angiotensien, antidiuretiese hormoon en katekolamiene) in hierdie proses suggereer, is
die presiese rol van hierdie mediators nog nie op 'n gestruktureerde wyse ondersoek
(of rapporteer) nie.
In ons aanvanklike pasiënte-studie is renale hemodinamika en -funksie gemeet vanaf
die preoperatiewe periode, gedurende die intra-operatiewe fase en tot minstens vier
uur na ontklemming van die aorta. Serumkonsentrasies van relevante hormone is
bepaal tydens elke metingsperiode waar renale parameters gemeet is, ten einde die
moontlikheid van 'n temporale verwantskap tussen renale veranderinge en variasies in
hormoonkonsentrasies te ondersoek.
Die vermindering in NBV en glomerulêre filtrasiespoed (GFS) wat ons aangetoon het
om saam te val met infrarenale aortaklemming, stem ooreen met resultate wat tevore
deur ander navorsers publiseer is. Ons het aangetoon dat die inkorting van hierdie
parameters voortduur tot minstens vier uur na aorta-ontklemming. Hierdie
veranderinge is tevore slegs rapporteer vir periodes tot kort na aorta-ontklemming voor
sluiting van die buikwond. Die feit dat die GFS steeds verlaag is met ontslag van
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hierdie pasiënte, skep rede tot kommer, veral in pasiënte wat alreeds ingekorte
nierfunksie het voor die chirurgiese prosedure.
Van die gemete hormone wat moontlik 'n invloed sou kon uitoefen op NBV eh
nefronfunksie, was renien die enigste waarvan verandering in plasmakonsentrasies
saamgeval het met die onderdrukking van NBV en GFS na aortaklemming. Die
ontwerp van ons studie het ons nie toegelaat om 'n besliste uitspraak te maak of die
geassosieerde verhoging in angiotensien II primêr verantwoordelik was vir die
verandering in renale hemodinamika, of dat die verhoogde renien (en angiotensien)
bloedvlakke moontlik sekondêr stimuleer is deur die verandering in NBV wat deur 'n
ander meganisme induseer is.
In 'n ander pasiëntegroep het ons aangetoon dat die kombinasie van mannitol en
dopamien geen beskerming verleen het teen die nadelige effekte van aorta-klemming
nie. Die groot volumes uriene wat uitgeskei is onder die invloed van hierdie middels
(wat nie korreleer het met NBV tydens ooreenstemmende periodes nie), het
inderwaarheid 'n ontoepaslike gerustheid uitgelok. Weens die ooglopende gebrek aan
objektiewe voordeel wat verleen word deur hierdie middels, behoort hulle gebruik
tydens hierdie kliniese omstandighede ontmoedig te word.
Die doel van die diere studies was die identifisering van die presiese rol van
angiotensien in die patogenese en patofisiologie van die renale veranderinge
geassosieer met infrarenale aortaklemming, sowel as die interaksie van angiotensien
met ander modulators waarvoor 'n interaktiewe verwantskap voorheen beskryf is onder
eksperimentele en/of kliniese omstandighede.
Die eerste studie het getoon dat alhoewel renien (en dus angiotensien) konsentrasies
hoog was na aorta-ontklemming, die hormone geen betekenisvolle patogenetiese of
patofisiologiese rol in die waargenome renale veranderinge gedurende hierdie
periode het nie (aangesien blokkade van angiotensien aktivering deur voorkoming van
renien vrystelling, of deur inhibisie van angiotensien omsettingsensiem (AOE), nie 'n
daling in NBV of GFS kon voorkom nie). Voorkoming van angiotensien II aktivering het
egter wel renale verandering voorkom gedurende aortaklemming. Dié voordelige
effek het nie 'n primêre rol vir angiotensien gedurende die periode bevestig nie,
aangesien die gunstige invloed ook (ten minste gedeeltelik) verduidelik kon word deur
die voorkoming van die fassiliterende invloed van angiotensien op ander
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vasokonstriktore en/of ander vasodilator-invloede van die onderdrukking van AOE en
ïs-blokkers (wat geen verband het met angiotensien of die blokkade daarvan nie). Die
studie het aangetoon dat (ten minste gedeeltelik) verskillende meganismes
verantwoordelik is vir renale veranderinge wat gesien is gedurende aortaklemming
en na -ontklemming.
Die tweede studie het die rol van kalsium in die renale patofisiologiese veranderinge
gedurende aortaklemming en na ontklemming ondersoek. Die beskermende
invloed wat deur die toediening van Ca2+ -blokkers bewerkstellig is, het bevestig dat die
renale vasokonstriktoriese en glomerulêre patofisiologiese prosesse afhanklik is van
sellulêre influks van kalsium deur spannings-afhanklike kannale. Dit het ongelukkig
geen definitiewe insig verleen ten opsigte van die primêre inisieerders van die proses
nie. Dit verskaf nogtans 'n bruikbare kliniese metode om daardie veranderinge te
voorkom en die niere teen isgemiese besering gedurende abdominale aorta-chirurgie
te beskerm.
Die derde komponent van die diere-studies demonstreer die belangrikheid van die
beskermende effek van renale prostaglandiene tydens die spesifieke eksperimentele
(en waarskynlik ook die kliniese) omstandighede. Weereens gee dit nie definitiewe
inligting oor die bemiddelaars wat verantwoordelik is vir die renale veranderinge nie,
aangesien die skadelike effekte van verskeie endogene stowwe voorheen aangetoon
is om beperk of voorkom te word deur die intrarenale vrystelling van prostaglandiene.
Die omvang van die patofisiologiese en ultrastrukturele veranderinge wat ontstaan het
onder die invloed van nie-steroïed anti-inflammatoriese middels (wat gebruik is om
prostaglandien sintese te inhibeer), dui aan dat hierdie middels vermy moet word
onder soortelyke kliniese omstandighede.
Die laaste komponent van die studie verskaf 'n sterk aanduiding dat angiotensien slegs
'n sekondêre/aanvullende rol speel in die renale patofisiologiese proses, selfs
gedurende aortaklemming. Dit mag die weersprekende getuienis oor die potensiële
voordeel van AOE onderdrukking (op renale hemodinamika en glomerulêre funksie)
gedurende abdominale aortachirurgie (Licker et al. 1996, Colson et al. 1992a) verklaar.
Gebaseer op ons studies, kan AOE onderdrukking nie ondersteun word vir hierdie doel
nie.
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1.1 RENAL DYSFUNCTION AND/OR FAILURE ASSOCIATED WITH
INFRARENAL CROSS CLAMPING OF THE AORTA DURING ABDO-
MINAL AORTIC SURGERY
With the exception of cardiac deaths, acute renal failure (ARF) remains the most important
pathological process associated with mortality in the immediate postoperative period
subsequent to abdominal aortic surgery since Dubast et al. (1952) described the first
successful resection and graft replacement of an atherosclerotic abdominal aortic
aneurysm (Wantz et al. 1964; Hicks et al. 1975; Crawford et al. 1981; Fielding et al. 1984;
Szilagi et al. 1986; Breckwoldt et al. 1992). When renal failure occurs postoperatively, it
carries a poor prognosis with a mortality in excess of 50% which has not improved over
the past decades (Wantz et al. 1964; Abbott et al. 1971; Chawla et al. 1975; McCombs et
al. 1979; Wakefield et al. 1982; Nachbur et al. 1987; Johnston et al. 1988; Sullivan et al.
1990).
The incidence of renal failure after abdominal aortic surgery has not changed substantially
with reported figures varying between 7% and 27% in the 1960's (Wantz et al. 1964; Porter
et al. 1966; Graham et al. 1968), 4% and 39% in the 1970's (Van Heeckeren 1970, Couch
et al. 1970; Thompson et al. 1975; Powis et al. 1975; Hicks et al. 1975; Chawla et al. 1975;
Young et al. 1977; Baird et al. 1978; McCombs et al. 1979; Lawrie et al. 1979) and 7% and
45% in the 1980's (Whittemore et al. 1980; Wakefield et al. 1982; Diehl et al. 1983; Alpert
et al. 1984; Fielding et al. 1984; Serrano-Hernando et al. 1985; Ostri et al. 1986;
Cohen et al. 1986; Szilagi et al. 1986; Nachbur et al. 1987; Johnston et al. 1988). These
figures are dependent on the population studied, with groups with ruptured aortic
aneurysms demonstrating a much higher incidence of renal failure than patients operated
electively.
It is uncertain why neither a reduction in the incidence of renal failure or an improvement in
outcome, has been recorded when renal failure does occur. It is conceivable that this
could be due partly to the fact that improved monitoring, management technology and
regimen has allowed more critically ill and older patients to be accepted for surgery
(Lazarus 1986). However, this speculation has not been explored in the literature in this
population group. Critical analysis of the literature indicates that population groups, with
the associated risk factors for the development of ARF, vary significantly between studies.
It is not possible to ascertain to what extent this contributes to a lack of improvement in the
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2reported incidence of ARF and adverse outcome. A vast variation in definition of renal
insufficiency and/or ARF compromises interpretation of the literature and the comparison
of studies. The fact that stricter criteria that defined renal dysfunction at a lesser degree of
renal insufficiency had been applied in studies published more recently may contribute to
the apparent continued high incidence of renal insufficiency (Porter et al. 1966;
Sturm et al. 1987). Strict and appropriate criteria recently applied does, however, not
explain the continued high mortality associated with renal dysfunction and ARF. On the
contrary, similar mortality rates in association with stricter criteria for renal dysfunction
would indicate deterioration in outcome.
Initial studies suggesting that early dialysis improved prognosis in patients with ARF, have
not been confirmed (Brady et al. 1996). There is, however, some evidence that the
maintenance phase of acute tubular necrosis in a diverse population of patients is
significantly shorter with the use of biocompatable dialysis membranes (Hakin et al. 1994).
Very little information is available on the influence of dialysis in patients with ARF after
aortic surgery. Early hemodialysis was suggested to improve outcome in patients who
develop ARF after abdominal aortic surgery (Chawla et al. 1975). This recommendation is
based on a 66% survival in 9 patients who developed ARF perioperatively versus a 100%
mortality rate in 5 other patients with ARF who were not dialised because it was either
considered to be too late to be effective or was thought to be contraindicated in the face of
other complications. Clearly the design of this study, including the patient numbers, is
inadequate to make such a suggestion. In a similar population of patients without prior
renal disease who developed ARF after ruptured aortic aneurysms, Abbot et al. (1975)
employed an intravenous nutritional program plus aggressive early dialysis. They could
only achieve a 12,5% survival in 32 patients. In another study by Cohen et al. (1986), from
a group of 6 patients with preoperative serum creatinine values in excess of 4mg.dl-1 (353
urnol.l") 4 patients showed increased renal dysfunction postoperatively, which was treated
with early hemodialysis. Although only one of the four patients died within 30 days of
surgery, the mean duration of hospital stay was 30 days and the one year survival of the
group was only 33%. Other studies (Wakefield et al. 1982) also failed to show benefit in
terms of survival with employment of hemodialysis and reported a 68% mortality in
patients with a blood urea nitrogen in excess of 50mg.dr1 (17,85 mmol.l').
If one accepts that ARF is still a major predictor of morbidity and mortality in abdominal
aortic aneurysm (AAA) repair despite significant improvements in perioperative care of
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3patients, it should be clear that an approach aimed at the prevention of renal dysfunction
and ARF may prove to be of benefit in improving (renal) outcome. Such an approach
could include the following:
1. Defining preoperative, intraoperative and postoperative risk factors.
1.1 Preoperative risk factors: The delineation of preoperative risk factors that would
predict postoperative renal dysfunction and subsequent identification of such risk
factor(s) in an individual patient, could result in one of two major management
approaches. If quantitative information from the literature indicates that the degree
of risk for the development of ARF is such that is exceeds the risk of adopting a
conservative non-surgical approach with regular assessment of increase in
aneurysm size (Christenson et al. 1977), the latter method could be adopted. If, on
the other hand, the preoperative risk factor(s) is quantitatively of a lesser
magnitude or cannot be quantified from the literature, an approach of optimalizing
those parameters perioperatively would be more appropriate (Pollock and John-
son 1973; Bush et al. 1981).
1.2 Intraoperative and postoperative risk factors: The occurrence of unforeseen
intraoperative and postoperative incidents (such as hypotension, long cross clamp
time and significant blood loss) which the literature may define as risk factors are
less easily predicted in any individual patient. Awareness of such risk factors
demands an approach of constant optimalisation of these variables (Wakefield et
al. 1982; Ostri et al. 1986).
2. Defining the major cause(s) of ARF associated with abdominal aortic surgery.
The most common renal causes of ARF reported in earlier studies of major vascular
surgery were nephrotoxins (particularly radiographic contrast dyes and aminoglycoside
antibiotics) and atheromatous emboli or thrombosis of the renal arteries (Thurlbeck and
Castleman 1957; Hardin 1964; Wantz et al. 1964). Delaying surgery for at least 24 hours
after the use of radiographic contrast media and specific surgical precautions including
renal artery bypass grafting in patients at risk of thromboembolic occlusion of the renal
arteries have minimized the risk of ARF due to renal causes (Novick et al. 1977).
Prerenal ARF is by far the most common cause of perioperative renal failure in the broad
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4surgical population, with renal ischemia almost invariably the underlying etiology (Wilkes
and Mailloux 1986). Although disputed by some investigators (Mowlem et al. 1960), there
was already a growing body of evidence in the early 1960's to support renal ischemia as
the most significant cause of ARF subsequent to abdominal aortic surgery. This
conclusion was based on collateral facts such as the histological changes in the kidneys
(Nanson et al. 1959), the benefit of renal neural blockade (Porter et al. 1966) and
adequate intravascular volume replacement (Beall et al. 1963), as well as direct evidence
provided by renographic investigations (Whitley et al. 1961). Renal ischemia is now
generally accepted to be the major cause of both temporary renal dysfunction (Gamulin et
al. 1984; Gelman 1995) and ARF (McCombs et al. 1979) after infrarenal cross clamping of
the aorta. The exact pathogenic and pathophysiological mechanisms involved in the
decrease in renal blood flow remain elusive (Myers et al. 1996).
3. The cause of reduced renal blood flow associated with AAA surgery.
Despite the knowledge of the importance of renal ischemia in the pathophysiology of ARF
and attempts at manipulating RBF perioperatively, renal dysfunction continues to be a
frequent complication of abdominal aortic surgery (Szilagi et al. 1986, Breckwoldt et al.
1992). Theoretically, at least, elucidation of the mechanism(s) or cause(s) of the reduction
in RBF will provide therapeutic option(s), which, by addressing the primary cause of the
problem, may have a distinct chance of preventing renal ischemia and adverse outcome.
Although a number of possible mechanisms such as renin release (Berkowitz and
Shetty 1974), angiotensin" (Colson et al. 1992a; Licker et al. 1996) calcium flux (Colson
et al. 1992a) and renal prostanoids (Myers et al. 1996) have been manipulated
pharmacologically with varying degrees of success, the primary mechanism(s) remains to
be established. In addition, the relative degree of success in manipulating potential
causative factors remains in dispute (Colson et al. 1992a; Licker et al. 1996;
Myers et al. 1996), largely because of the lack of a common experimental or clinical model
in the various studies. Possible interaction of various potential causative factors in a
sequence of pathophysiological events also remains to be explored.
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51.2 CHANGES IN RBF AND KIDNEY FUNCTION ASSOCIATED WITH INFRA-
RENAL CROSS CLAMPING OF THE AORTA
1.2.1 Human studies
Human studies of significance where RBF was measured perioperatively together with
some form of assessment of nephron function at the same measurement times, were only
reported since 1984 (Gamulin et al. 1984; Myers et al. 1984; Gamulin et al. 1986; Colson
et al. 1992a; Colson et al. 1992b; Licker et al. 1996) (Table 1.1). Although attempts were
made to influence RBF pharmacologically in some studies (Gamulin et al. 1986; Colson et
al. 1992a; Licker et al. 1996), these attempts were either unsuccessful (Gamulin et al.
1986) or a control group (where no manipulation was attempted) was not included so that
comparison of RBF and nephron function at various measurement times is not possible
between these studies.
All these studies, with the exception of the reports by Myers et al. (1984) and Colson et al.
(1992b), demonstrated a significant decrease in RBF subsequent to infrarenal cross
clamping of the aorta when compared to intraoperative preelamp values. Colson et al.
(1992a) and Licker et al. (1996) reported a return of RBF towards preelamp values after
release of the cross clamp, while Gamulin et al. (1984 and 1986) demonstrated a
continued reduction in RBF after clamp removal in the intraoperative period. It is unclear
why Colson et al. (1992a) showed a reduction in RBF with an associated decrease in GFR
during aortic cross clamping, while the same investigators (Colson et al. 1992b) were
unable to show similar changes in a subgroup where the anaesthetic technique and
experimental method were comparable to the former study. Small numbers (n = 8) and
the fact that some patients received drugs such as angiotensin converting enzyme
inhibitors (ACE inhibitors) and calcium entry blockers preoperatively, may have had an
influence in the latter study (Colson et al. 1992b).
Gamulin et al. (1984 and 1986) demonstrated an increase in the 1131-hippuran extraction
fraction subsequent to aortic cross clamping, which is suggestive of a redistribution of RBF
towards the renal cortex. This is contrary to studies of ARF in humans (Hollenberg et al.
1968) and experimental animals (Parekh and Veith 1981) where renal ischemia was
associated with a redistribution of RBF towards the deeper cortical and medullary regions.
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Table 1.1 Human studies where both renal blood flow and nephron function were measured in infrarenal abdominal
aortic surgery
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7However, Gamulin et al. (1984 and 1986) used a constant infusion of mannitol intra-
operatively in an attempt to maintain adequate volumes of urine production for accurate
clearance measurements, which may have been responsible for the increase in cortical
blood flow (Velasques et al. 1973; Abbott et al. 1974). Licker et al. (1996) were unable to
demonstrate redistribution of RBF after aortic cross clamping.
All four studies where aortic cross clamping was shown to induce a reduction in RBF, also
demonstrated a concomitant decrease in GFR which persisted after clamp removal. In the
studies by Colson et al. (1992a) and Licker et al. (1996), this occurred despite
normalisation of RBF. In the Myers et al. study (1984) a reduction of between 20% and
35% in GFR was demonstrated, but intragroup statistical analysis was not reported as this
study primarily compared a group where the cross clamp was applied infrarenally with
another group where clamping was done above the renal arteries.
Only Gamulin et al. (1984 and 1986) investigated the possibility of proximal tubular
damage, which, together with the thick ascending limb of the loop of Henle in the
medullary region (mTAL), is the most vulnerable part of the kidney during ischemic injury
(Brezis et al. 1984). They were unable to demonstrate liganduria or Iysozymuria, which
would have been indicative of ischemic dysfunction of the proximal tubules.
Gamulin et al. (1984 and 1986) were unable to demonstrate distal nephron dysfunction by
sequential measurement of free water clearance (CH20), a sensitive index of early
ischaemie functional impairment (Baek et al. 1973). Colson et al. (1992a) and Licker et al.
(1996) measured fractional excretion of sodium (FENa) for the same purpose (Steiner
1984). Both groups demonstrated increased FENa after aortic cross clamping with
extension into the postoperative period in the latter study, suggesting distal nephron
dysfunction. However, this change could also be due to an increased sodium load through
intravascular fluid loading, volume depletion with pre-existing chronic renal disease, or
osmotic or chemical diuresis (Steiner 1984).
In summary, these studies suggest a reduction in RBF after infrarenal cross clamping of
the aorta with a concomitant decrease in GFR which remains depressed even after
recovery of RBF. The integrity of tubular function apparently remains intact. A few
important issues remain unanswered by these studies. Firstly, because renal venous
samples could only be obtained directly from the renal vein after laparotomy, none of the
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8studies could measure preoperative awake control values of RBF or GFR. The effect of
anaesthesia and surgery (prior to cross clamping of the aorta) on these parameters in this
particular population group remains unclear, although Colson et al. (1992c) showed lower
intraoperative control values for RBF and GFR in a halothane subgroup in comparison to
an isoflurane group, suggesting a detrimental effect of the former drug. Secondly,
although GFR remained decreased in comparison to preelamp values after release of the
clamp intraoperatively, only one study where intraoperative reduction in RBF and GFR
was demonstrated also reported postoperative GFR measurements (Licker et al. 1996).
This group reported creatinine clearances (Cereal)12 hours postoperatively that were less
than preoperative and intraoperative preclamp measurements. Subsequent follow up was
not reported.
A number of studies report perioperative changes in renal function without measurement
of RBF in abdominal aortic surgery (Table 1.2). These studies are almost invariably
retrospective and the majority suffers from other design defects which compromise
interpretation of results. Powis et al. (1975) is the only group to report on both glomerular
and tubular function. They report Iysozymuria indicative of proximal tubular dysfunction in
65% (n=34) of aortic surgery patients in the postoperative period while stating that Cereal
was decreased postoperatively in 21 patients (62% of their sample). The extent and
duration of this abnormality is not reported. Cohn et al. (1970) and Pollock et al. (1973)
also report on peri operative changes in Cereal. In a patient group where relatively small
volumes of intravenous fluids were given, postoperative Cerealwas shown to be depressed
in a graph, but statistical analysis was not reported (Pollock et al. 1973). Cohn et al.
(1970) showed Cerealto be increased one hour postoperatively with a return to control
values on the seventh postoperative day, but again no statistical analysis was given. Bush
et al. (1981), Wakefield et al. (1982), Ostri et al. (1986) and Breckwoldt et al. (1992)
reported increases in peak serum creatinine levels in the postoperative period when
compared with preoperative controls. Ostri et al. (1986) and Breckwoldt et al. (1992)
claimed a return to control values at the time of discharge. Wakefield et al. (1982) did not
report on discharge creatine levels and Bush et al. (1981) indicated that creatinine levels
were still more than o.ërnq.ot' (44~mol.r1) above preoperative control values in 4 out of 9
patients where intraoperative fluid administration was titrated against central venous
pressure measurements. Alpert et al. (1984) claimed that serum creatinine levels did not
increase perioperatively in aortic surgery patients who became oliguric, but no data or
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9Table 1.2 Human studies where preoperative renal function were reported
without measurement of renal blood flow in infrarenal aortic surgery
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statistics were given to support this claim. All studies reporting on serum creatinine levels
must be evaluated with the knowledge that serum creatinine levels demonstrate a poor
correlation with changes in glomerular or renal function (Kim et al. 1969), with elevation of
serum creatinine only becoming evident when 60% of the functional renal mass has been
(irreversibly) injured (Tobias et al. 1962). Clearly, the human studies reporting only on
perioperative changes in kidney function with abdominal aortic surgery, provides
inconclusive information on the change in function. In addition, it suffers from the
disadvantage that absence of concurrent RBF data makes it impossible to ascertain to
which extent renal ischemia contributed to whatever functional changes were shown.
1.2.2 Animal studies
Early studies, using a number of different measurement techniques, demonstrated a
decrease in total RBF when the aorta was clamped infrarenally in various dog models
(Gagnon et al. 1960; Whitley et al. 1961; Stein et al. 1972). Gagnon et al. (1960) reported
a gradual improvement during a 2-hour clamping period with restoration of normal renal
blood flow within the first hour after release of the clamp, while RBF was still significantly
reduced after clamp removal in the study by Stein et al. (1972). Nanson et al. (1959)
injected India ink into the renal artery after infrarenal cross clamping and demonstrated
redistribution of blood flow away from the cortex towards the medulla. They also
demonstrated proximal and distal tubular necrosis consistent with severe ischemic injury.
More recently Abbot et al. (1973) and Berkowitz et al. (1974), using Xenon 133 washout
techniques and Gelman et al. (1984a), measuring regional blood flow with labeled
microspheres, were unable to demonstrate a decrease in total RBF after infrarenal aortic
clamping. However, all three studies reported a redistribution of blood flow away from the
superficial cortex to the deeper corticomedullary region that was maintained in the two
studies that continued measurement after unclamping (Abbot et al. 1973; Berkowitz et al.
1974). These changes are similar to the response described in other models of early renal
ischemia (Hollenberg et al. 1968; Parekh and Veith 1981).
Although the decrease in RBF towards the end of a 60 minute clamping period was
statistically insignificant, it decreased further subsequent to clamp removal to be
significantly reduced 60 minutes after unclamping in the most recent report where mean
transmittable doppler flowmeters were used to measure RBF in a rat model
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(Myers et al. 1996).
Animal studies (Table 1.3) contrast sharply with those done in humans where a reduction
in total RBF associated with decreased GFR after infrarenal aortic cross clamping is
reported in the majority of publications. No clear tendency emerges from animal studies
however, with reports ranging from decreases in total RBF (Stein et al. 1972);
redistribution of RBF without reduction of total RBF (Gelman et al. 1984a) and studies
reporting no change (Cronenwett and Lindenauer 1977). Reasons for both the difference
between conclusions in human and animal studies, as well as the widely divergent findings
between various animal studies, could possibly be elucidated further if a clinically relevant
animal model is used and subjected to similar pharmacological manipulation as occurs in
humans.
Species differences could be a contributing factor for different results, although mongrel
dogs were used in the majority of animal studies. However, even within the same species,
differences in size of the animals (frequently not specified) and particularly age (invariably
not specified) could have contributed to divergent outcomes. Differences in experimental
design and particularly the lack of universal technique of RBF measurement with the
reported use of microspheres (Gelman et al. 1984a), xenon washout (Abbot et al. 1973),
electromagnetic flow probe (Stein et al. 1972), external renograms (Whitley et al. 1961),
PAH clearance (Gagnon et al. 1960) and doppler flowmeters (Myers et al. 1996) could
also have contributed.
More important, however, are the differences in outcome between human and animal
studies. Clearly, species differences could again playa role. Differences in measurement
techniques could also have had an influence with radio-isotope labeled hippuran or PAH
clearance almost invariably used in human studies. Less obvious, but perhaps much more
important, are two other differences:
1. The age of animals used in experimental studies is never mentioned (and probably
not known to the investigators) except for referring to them as "adult" (Abbot et al.
1974). One may speculate that these animals were probably not old and therefore
not subject to the physiological and sometimes pathophysiological changes of
ageing. This contrasts with human studies where patients presenting for
abdominal aortic surgery are almost invariably from the elderly age group (Cohen
et al. 1986; Colson et al. 1992a, 1992b; Licker et al. 1996). The fact that advanced
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Table 1.3 Measurement of renal blood flow and glomerular function in experimental animals subjected to infrarenal aortic
cross clamping
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age was demonstrated to be predictive of adverse renal outcomes in some studies
on vascular surgery patients (Svensson et al. 1989; Bergqvist et al. 1983), is
probably related to the fact that preoperative renal dysfunction is much more
common in this population group (Novis et al. 1994). Indeed, 74% to 84% of
patients with abdominal aortic aneurysms have other pre-existing disease
(Thompson et al. 1975; Scobie et al. 1977, Crawford et al. 1981) with hypertension,
general atherosclerosis and diabetes mellitus being extremely prevalent; all of
which cause pathological changes in the kidney. Porter et al. (1966) demonstrated
a preponderance of severe chronic renal disease in all patients who died
subsequent to aortic surgery, irrespective of whether renal failure contributed to the
mortality. Renal vascular changes, particularly arteriolosclerosis (McLachlan 1978)
and progressive histopathological abnormalities of the nephron (reduction in the
number of glomeruli (Kaplan et al. 1975) and thickening of the glomerular and
tubular basement membrane (McLachlan 1978)) occurs with ageing even in the
absence of disease. This explains the functional changes in the kidney, which
occurs with age. These changes are not reflected by the usual preoperative
measurements such as serum creatinine and blood urea nitrogen (BUN) (Kim et al.
1969). The structural changes are also accompanied by altered tubular responses
to hormones (Epstein and Hollenberg 1976) and a variable degree of dependence
on renal prostaglandins for the maintenance of renal blood flow (Gurwitz et al.
1990) which is absent in normal adults (Donker et al. 1976). Although it may be
difficult to find an animal model with comparable preoperative renal changes, it
should be clear that published differences between human and animal models in
response to aortic cross clamping may at least partially be contributed to this fact.
2. Although stabilization (no surgical stimuli) during perclamp measurement times is
only mentioned in some animal studies (Gagnon et al. 1960; Berkowitz and Shetty
1974), it is clear from the description of methodology in the other studies that
surgical stimulation was minimal after initial preparation of the models. This
contrasts with human studies where significant intra-abdominal surgical stimulation
associated with resection and bypass grafting of abdominal aortic aneurysms were
invariably present at the times of perelamp measurement of renal hemodynamics.
The hormonal changes associated with such surgical stimulation alone (Kataja et
al. 1989), could quite conceivably have contributed to any changes in RBF and
Stellenbosch University http://scholar.sun.ac.za
14
kidney function which occurred during aortic cross clamping. Simulating such
surgical stimulation in animal models is likely to influence the results.
1.3 ETIOLOGY OF CHANGES IN RBF AND KIDNEY FUNCTION WITH ABDOMINAL
AORTIC SURGERY
There is probably general agreement that the renal failure and, less dramatically, the more
frequent changes in renal function associated with infrarenal cross clamping of the aorta
during abdominal aortic surgery, is of ischemic origin (Stein et al. 1972; Bush et al. 1983;
Gamulin et al. 1984, 1986; Myers et al. 1996). An understanding of the etiology and
pathophysiology involved in this particular population may help to identify beneficial
pharmacological manipulation(s) that could be applied prophylactically, since the use of
pharmacologic agents is of questionable benefit in patients with established or early ARF
(Lazarus 1986). A number of potential endocrine and autonomic nervous system
mediators have been reported in the literature; to date without exact clarification of the
pathogenic role of any of these factors.
1.3.1. Renal sympathetic nerves and circulating catecholamines
1.3.1.1 Relevant physiology
The kidney demonstrates the ability to autoregulate its blood flow independent of extrinsic
modulation (Waugh et al. 1960), primarily through varying resistance of the preglomerular
afferent arteriole. However, unlike the cardiac and cerebral circulations, sympathomimetic
effects may override the intrinsic control of RBF (Hermansson et al. 1981). Although the
exact physiological role of the renal adrenergic nerves is still unclear, the renal
sympathetics, as well as circulating catecholamines, have been demonstrated to influence
RBF significantly under pathological conditions. Under conditions of stress, renal
sympathetic mediated release of noradrenaline causes renal vasoconstriction through an
alpha-adrenergic receptor mechanism (Schrier 1974). Circulating catecholamines have a
similar effect (Rector et al. 1972). Although both renal nerve stimulation and circulating
catecholamines exert a significant direct effect on renal vascular tone, a considerable
portion of vascular resistance changes seems to be mediated additionally via angiotensin
II production through renin release (Pelayo et al. 1984). Despite the fact that both afferent
and efferent arterioles have adrenergic innervation and receptors (Ljungqvist and
Wagermark 1970), adrenergic effects are much more prominent on the efferent arteriole
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(Pelayo et al. 1984). This is probably due to adrenergically mediated angiotensin II
production, the effect of the latter hormone being more prominent on the efferent than on
the afferent arteriole. This leads to an increased glomerular ultrafiltration fraction
(Hermansson et al. 1981) which can be blocked by angiotensin converting enzyme (ACE)
inhibition (Anderson RJ et al. 1975; Anderson WP et al. 1981).
1.3.1.2 The role of the renal sympathetic nerves and circulating catechol a-
mines in renal changes with aortic surgery
The involvement of the renal sympathetic nerves in the changed renal hemodynamics with
infrarenal aortic clamping has been explored in a number of animal and human studies. In
animal studies in which the aortic cross clamp was applied, infiltration of the renal vascular
pedicle with a local anaesthetic agent or the administration of ganglion blockers have been
successful in preventing the change in renal hemodynamics (Nanson et al. 1959; Whitley
et al. 1961) and reduced the extent of histological change in the kidney (Nanson et al.
1959). However, other studies have been unable to demonstrate similar benefit with
ganglion blockade (Stein et al. 1972). While Powers et al. (1957) found both infiltration of
the renal pedicle and ganglion blockade to be capable of preventing oliguria in patients,
Porter et al. (1966) were unable to show prevention of postoperative changes in BUN with
pedicle infiltration in a similar population. Neither of these groups measured changes in
RBF. Gamulin et al. (1986) failed to show any improvement in changed renal
hemodynamics with aortic clamping when blocking the renal sympathetic outflow with
thoracolumbar epidural block in patients. All the above studies, other than being
inconclusive in terms of the possible etiological role of the renal sympathetic nerves, fail to
examine the potential contribution of increased plasma concentrations of catecholamines
during aortic surgery (Kataja et al. 1989) in the changed renal hemodynamics.
Both stimulation of the renal sympathetic nerves and increased levels of circulating
catecholamines may stimulate renin release from the kidney (Schrier 1974) through an
agonist effect on r.wreceptors (Osborn et al. 1981). The release of renin leads to an
increase in angiotensin " levels in the presence of angiotensin converting enzyme
(Margolis and Stein 1984). Increased levels of circulating catecholamines and stimulation
of the renal sympathetic nerves could therefore influence renal hemodynamics indirectly
by increasing systemic and renal concentrations of angiotensin ll, a potent renal
vasoconstrictor (Pelayo et al. 1984). Renin release that has been shown to occur in
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abdominal aortic surgery (Berkowitz and Shetty 1974; Grindlinger et al. 1981; Grant et al.
1983), can be prevented by the administration of r.,-blockers to humans (Grant et al. 1983)
and to experimental animals (Berkowitz and Shetty 1974). RBF was only measured in the
study by Berkowitz and Shetty (1974), who showed prevention of the redistribution of
blood flow to the corticomedullary region (which occurred in animals not treated with r.,-
blockade). Because intra-abdominal surgical stimulation probably did not occur during
measurement of RBF in the Berkowitz study, the potential direct effects of increased renal
sympathetic tone (Schrier 1974) and circulating catecholamines (Kataja et al. 1989) are
again obscured, which limits the conclusions, which could be drawn from this study.
The exact nature of the interaction between catecholamine blood levels and the changes
in RBF during abdominal aortic surgery remains to be established.
1.3.2. The renin angiotensin system
1.3.2.1 Relevant physiology
Although a comprehensive review of the physiology of the renin-angiotensin system is
beyond the scope of this thesis, the most relevant aspects of its physiology in the context
of the clinical and experimental studies presented in this thesis will be discussed briefly.
The renal as well as systemic effects of renin are almost exclusively a consequence of
angiotensin II (Gillies and Morgan 1982) which is produced by the effect of converting
enzyme on angiotensin I (Margolis and Stein 1984). Renin release is controlled by a
number of factors which can be classified as intrarenal (including the renal vascular
receptor and the macula densa), sympathetic (including the renal nerves and circulating
catecholamines) and humoral factors (including ADH, angiotensin II, prostaglandins and
electrolytes) (Davis and Freeman 1976). The inhibibitory effect of angiotensin II on renin
release establishes a homeostatic regulatory loop for the system (Haber 1976).
Angiotensin II has significant effects on RBF and GFR. Through a vasoconstrictor effect
on both the afferent (Mitchell and Navar 1987) and the efferent (Edwards 1983) arterioles,
it can cause a variable, concentration dependant reduction in RBF (Edwards 1983; Blantz
et al. 1976). Because the effect of angiotensin lion the efferent arteriole usually
predominates (Edwards 1983), intraglomerular capillary hydrostatic pressure is increased,
with maintenance or even an increase in GFR despite a decrease in RBF
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(Kastner et al. 1984). Filtration fraction is therefore increased. However, angiotensin II
also causes contraction of the mesangial cells in the glomerulus, which reduces the
ultrafiltration coefficient (Blantz et al. 1976) and would tend to decrease GFR despite the
increase in intraglomerular capillary hydrostatic pressure. Although the latter effect is
probably of lesser importance in physiologic conditions, it may contribute significantly to
regulation of GFR in pathologic conditions (Ichikawa and Harris 1991). Because of these
variable effects of angiotensin II, blockade of angiotensin II action has been demonstrated
to lead to an increase (Ichikawa and Brenner 1984; Navar et al. 1982), a decrease (Hall et
al. 1979) or to an unchanged GFR (Clappison et al. 1981; Yoshioka et al. 1986).
Angiotensin II also exerts effects on the renal tubular system where it increases the
reabsorption of sodium and water in the proximal tubule (Hall et al. 1977) independent of
its stimulatory effect on the secretion of aldosterone, which increases sodium reabsorption
largely in the distal tubule and collecting duct (Biron et al. 1961). Despite the identification
of a substantial number of additional transport systems in the renal tubule, the renin-
angiotensin-aldosterone system is still considered to be the most important regulator of
sodium transport in this part of the nephron (Berry et al. 1996). The importance of the
direct effect of angiotensin II is illustrated by the fact that ACE inhibition produces sodium
loss even when aldosterone is infused concomitantly (Hall et al. 1979).
Several studies have shown angiotensin II to also be a local regulatory hormone in the
kidney (Hall et al. 1977; Mendelsohn 1982) and many other tissues (Dzau 1987). The
local production of angiotensin II has been identified in all regions of the kidney where
physiological effects of the hormone have been demonstrated (Mendelsohn 1982; Blantz
and Gabbai 1987). Consequently, measurement of plasma renin or angiotensin levels
may not give an accurate indication of the extent of tissue angiotensin effects at any
specific time (Waeber et al. 1989). Similarly, indication of complete systemic blockade of
angiotensin II production may not necessarily reflect adequate blockade at tissue level
(Dzau 1987). This may explain why larger doses of ACE inhibitors exert more significant
clinical effects than what is possible to achieve with doses that provide complete
suppression of systemic renin or angiotensin II levels (Dzau 1987; Brunner et al. 1987).
Finally, angiotensin interacts with other mediators and ions that may influence its effects,
particularly in the kidney. The effect of angiotensin II is markedly increased in the
presence of physiological concentrations of calcium in both the rat (Douglas et al. 1982)
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and human (Chansel et al. 1982) kidney. Angiotensin" increases the prejunctional
release of noradrenaline when the sympathetic nervous system is stimulated (Zimmerman
1978) and will therefore enhance vascular and other effects of increased sympathetic tone.
This interaction explains the reduction in circulating noradrenaline concentrations
observed during ACE inhibition (Maslowski et al. 1981). Angiotensin" activates
phospholipase A in the vascular smooth muscle and mesangial cells in the kidney
(Zusman et al. 1977; Ardaillou et al. 1987). Prostaglandins, resulting from phospholipase
A activation, modulate the renal effects of angiotensin" significantly (Zusman and Keiser
1977; Schnerman et al. 1984). Although this interaction is probably unimportant in normal
physiological conditions, it is of great significance under pathophysiological circumstances
(Henrich et al. 1978a, 1978b).
1.3.2.2 The role of angiotensin II in ischemic ARF
From the physiological background it is clear that angiotensin " has the potential to
produce significant decreases in RBF with concomitant changes in nephron function.
Impaired RBF may initiate ARF firstly by reducing glomerular capillary pressure to a level
at which filtration is severely impaired or ceases and secondly by causing ischemic
damage to the functional components of the nephron (De Torrente, 1984). Reduced RBF
has also been demonstrated during the maintenance phase of postischemic ARF after
termination of the initiating event (intrarenal noradrenaline or clamping of the renal artery)
in animal models (Cronin et al. 1978a, 1978b; Venkatachalam et al. 1978) and humans
(Reubi 1974). Extreme elevation of plasma renin levels during this phase and its
subsequent fall in the recovery phase (Brown et al. 1970; Moran and Myers 1985) have
led to suggestions that angiotensin " may be the mediator responsible for the reduction in
RBF. Indeed, blocking the effect of angiotensin" has been shown to be of prophylactic
benefit in some models of ARF (Falk et al. 1980). However, a number of studies have
failed to establish such a pathogenic role for angiotensin " (Arendshorst et al. 1976;
Mason et al. 1979; Bidani et al. 1979) although some of this evidence is circumstantial and
the possible role of local intrarenal angiotensin " has not been adequately explored in
various models of ischemic ARF. Based on current evidence it is suggested that
hyperangiotensinemia during ARF is more likely a result of postischemie tubular injury than
a primary pathogenic phenomenon (Myers and Moran 1986). The same authors and
others (Badr and Ichikawa 1988) conclude however, that high angiotensin " concen-
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trations do contribute to the pathophysiological and biochemical changes and that
normalization of angiotensin blood levels could be important in facilitating the onset of
recovery.
1.3.2.3 The role of the renin-angiotensin system in renal changes with aortic
surgery
There is a lack of consistency with regard to changes demonstrated in renin concentration
subsequent to aortic cross clamping in experimental models (Table 1.4), with some studies
showing an increase (Berkowitz and Shetty 1974) and others no significant change
(Cronenwett and Lindenauer 1977).
A number of studies have reported on changes in plasma renin concentrations during
abdominal aortic surgery in humans (Table 1.5). Gal et al. (1974) observed increased
intraoperative renin concentrations, even before aortic clamping, when compared with
preoperative control values. In other studies preclamp intraoperative renin concentrations
were not significantly increased when compared with preoperative controls (Grindlinger
et al. 1981; Grant et al. 1983; Kataja et al. 1989). All of the above studies demonstrated
an increase in plasma renin concentrations after infrarenal cross clamping the aorta. In
studies by Gal et al. (1974) and Grant et al. (1983) plasma renin levels continued to rise
after unclamping the aorta, reaching a peak 30 minutes after unclamping in the former
study while peaking only 30 minutes after arrival in the recovery ward in the latter study. In
the studies by Grindlinger et al. (1981) and Kataja et al. (1989) renin levels after
unclamping were similar to values during the clamping period. Salem et al. (1988)
observed increased renin concentrations after infrarenal aortic cross clamping compared
with intraoperative preelamp controls in patients receiving intravenous dopamine in a dose
of 2)lg.kg-1.min-1. In a non-dopamine control group, increased renin concentrations did not
reach statistical significance because of wide scatter, despite a mean renin level which
was even higher than in the dopamine group. Renin concentrations were not determined
after unclamping of the aorta in this study.
While patients receiving ïs-btockers preoperatively (for various indications) did not
demonstrate an increase in perioperative renin levels in the study by Grant et al. (1983),
there was no difference in renin concentration-change between patients on ~-blockers
preoperatively and those not receiving ïs-blockers in the Grindlinger et al. (1981) study.
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Table 1.4 Studies in animals (dogs) in which plasma renin levels were measured with infrarenal cross clamping of the
aorta
a. :I:a. EE nl 0
Authors nl Y ;;:Y , "0Publication cD I: iii , iii 0l!! 0 l!!a. Oa. 0 CommentsYear ... 0 jja.,_ a. a. a.E a.EI:t) I: I: ,5..!!! I: nl iii,- ::l '2 '2 '2 i31:"0 I: CJ I:
~,5
Cl) Cl) Cl) I: Cl) I: Cl)
Il:: Il:: Il::::l Il::::l Il::
Stein et al. 0 C ? ? ? ®(see · Poor study; no measurement results given; comments that "renin varied from animal to animal and showed1972 comments) no consistent pattem that could be related to changes in any other parameter"
Berkowitz et al. ± (60 min ® (see · fl.-blockade prevented renin increase1974 0 C t it after comments)unclamp) · fl.-blockade also prevented redistribution of renal blood fiow away from cortex
Cronenwett et al. ® (see · Mean renin levels doubled after clamp, but statistically nol significant (n=6)0 C ± 0 ±1977 comments) · No change in renal blood fiow I'\)o
C = control measurement; ± = no change relative to control; t = increased relative to control; tt = highest levels measured; ® = not
measured/reported; EB= measured; ? = unclear whether measured/no results given
Stellenbosch University http://scholar.sun.ac.za
Table 1.5 Human studies in which plasma renin was measured in abdominal aorta surgery
a. ~a. EE ca 0
Authors ca "9 I;::C;; . "C
Publication e e iii ~c. iii 0~ 0 Oa. 0 CommentsYear as a. a. a.E a.E jjco e c e ca e ca ca.- ::I ï: ·ë ï: li ·ë lic"C c~.= III III III C III C III0:: 0:: 0::::1 0::::1 0::
Gal et al. C t t ® tt e Renin levels in patients with renal (lumbar) sympathectomy not different fnom those without sympathectomy1974 ·
Grindlinger et Renin ± Renin and Renin and · Renin levels also increased in patients on l1-blockers preoperatively
al. 1981
C
angiotensin t angiotensin t ® angiotensin t ® · No correlation between postop hypertension and renin levels
Grant et al. · Highest levels 30 minutes after arrival in recovery ward
1983
C ± ± t +r ® · Renin not increased in patients on ('!a-blockers preoperatively
Salem et al. e C r ® e ® · Renin levels increased irrespective of whether dopamine (2J,.l9.kg-1.min-1) was administered or not1988
Kataja et al. C ± ± i i ® · No correlation between postop hypertension and renin levels1989 ~. ~.
N_.
C = control measurement; ± = no change relative to control; t = increased relative to control; tt
measured/reported
highest levels measured; ® = not
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The reason for this difference between the two study outcomes is unclear, but may relate
to different doses of ts-blockers received or to the possibility that patients in the latter study
did not receive l1-blockers in the immediate preoperative period (not specified). RBF was
not measured in any of the above human studies, despite reference to the possibility of
involvement of the renin-angiotensin mechanism in the etiology of reduced RBF during
abdominal aortic surgery (Gal et al. 1974; Grant et al. 1983; Salem et al. 1988; Kataja
et al. 1989). The relationship, if any, between renal hemodynamics and increases in renin
or angiotensin concentrations in aortic surgery are consequently not elucidated by the
above studies.
The existence of such a relationship could also be shown indirectly by demonstrating
prevention of changes in renal hemodynamics subsequent to blockade of angiotensin
receptors or inhibiting the synthesis of angiotensin by the administration of ACE inhibitors.
A beneficial effect of ACE inhibition on RBF may not necessarily resolve the question
whether increases of renin or angiotensin concentrations (if shown to be correlated with
reduced RBF during abdominal aortic surgery), is in fact the cause or the result of
decreases in RBF. A decrease in RBF due to other mechanisms has been shown to
induce secondary release of renin and therefore also increased angiotensin II
concentrations (Badr and Ichikawa 1988). This secondary increase in angiotensin II
concentrations does however contribute to the maintenance of increased renal vascular
resistance (Hostetter and Brenner 1988). Only two recently published studies have
explored this therapeutic option (Colson et al. 1992a; Licker et al. 1996). Colson et al.
(1992a) demonstrated a reduction in RBF after infrarenal aortic clamping in patients
despite the administration of enalapril 10mg orally twice daily for two days prior to surgery.
A similar reduction in RBF and GFR in a placebo group suggests no benefit derived from
the administration of the ACE inhibitor. In contrast, Licker et al. (1996) reported
maintenance of RBF after aortic clamping in patients who received a single intravenous
dose of enalapril (50f.!g.kg-1) preoperatively, while clamping induced a significant decrease
in RBF in a saline control group. They suggest differences in dose regimen, anaesthetic
management and measurement methods as possible reasons for the contradictory results.
No reference could be found to assist in comparing the two dose regimen in terms of
possible plasma concentrations or biological efficacy. The two preparations used for the
measurement of RBF, 1131-hippuran and para-aminohippuric acid respectively, have been
shown to be handled identically by the kidney with a direct correlation between the
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clearances (correlation coefficient = 0.993) of the two substances (Ram et al. 1967). This
makes divergent results due to different measurement techniques unlikely. The fact that 5
of the 11 enalapril patients in the Licker study received calcium channel blockers as part of
their preoperative therapy, could have influenced their results. Patients on preoperative
calcium blockers were excluded from the Colson (1992a) study. The latter group of
investigators also demonstrated that the intraoperative administration of the calcium
channel blocker, nicardipine, prevented changes in RBF after aortic clamping in one of the
subgroups of their study.
Kataja et al. (1989) in a study of patients during abdominal aortic surgery where RBF was
unfortunately not measured, reports intraoperative urine output in patients receiving
preoperative captopril to be almost twice the volume achieved in a non-captopril control
group. It is possible, but not yet proven that the ACE inhibitor may have been responsible
for the improved urine flow, although no further parameters of renal function were
assessed.
The indirect evidence to suggest an etiological role for the renin-angiotensin system in the
reduction of RBF induced by infrarenal aortic cross clamping in humans is therefore also
inconclusive.
Conclusions from studies performed during other surgical procedures suggest a role for
the renin-angiotensin system in the pathophysiology of reduced RBF and therefore
potential benefit from interrupting the angiotensin activation pathway. Plasma renin levels
were shown to be increased with suprarenal cross clamping of the aorta (Symbas et al.
1983; Joob et al. 1986), even when adjuncts (shunt or bypass) were used to increase RBF
during clamping (Symbas et al. 1983). While RBF remained depressed 30 minutes after
release of the suprarenal cross clamp (± 50% of preclamp control values) in control
animals, RBF returned to preclamp control levels after release of the clamp in animals
pretreated with an ACE inhibitor (Joob et al. 1986). Angiotensin was also suggested to
playa significant role in the hypertension associated with suprarenal cross clamping of the
aorta (Hong et al. 1992). While Taylor et al. (1977) observed a substantial increase in
plasma angiotensin concentrations during cardiopulmonary bypass (CPB) which remained
elevated for several hours, Colson et al. (1990) reported prevention of the decrease in
RBF during CPB with the preoperative administration of an ACE inhibitor.
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The indiscriminate use of ACE inhibitors in patients scheduled for abdominal aortic surgery
without proof of benefit in terms of renal hemodynamics or improved clinical outcome
cannot be recommended. Recovery of blood pressure and renal perfusion after
hemorrhagic hypotension, which is relatively common during aortic surgery, is significantly
impaired in the presence of ACE inhibition (Yamashita et al. 1977; Zerbe et al. 1981).
Patients with renal artery stenosis, which occurs not infrequently in the presence of aortic
aneurysms (Novick et al. 1977), and especially bilateral stenosis, may suffer a dramatic
decrease in GFR and renal function subsequent to ACE inhibitor therapy (Hricik et al.
1983; Lakhani et al. 1985). The absence of renal artery stenosis on angiography was a
noted exclusion criterion in the studies of Colson et al. (1992a) and Licker et al. (1996).
1.3.3. Arginine vasopressin (AVP)/antidiuretic hormone (ADH)
1.3.3.1 Relevant physiology
Factors responsible for the release of ADH during anaesthesia and surgery (Ishihara et al.
1978) are stimulation of hypothalamic osmoreceptors by increased serum osmolality
(Schrier et al. 1979), stimulation of carotid baroreceptors by decreased arterial blood
pressure (Woods et al. 1983) and of volume receptors located in the left atrium, which are
sensitive to reduced circulating blood volume (Yared et al. 1985). Surgical (visceral)
stimulation and stress (Knight et al. 1986) and increased concentrations of catecholamines
and angiotensin II (Schrier et al. 1975; Stella and Zanchetti 1987) also contribute
significantly to stimulation of ADH secretion.
ADH is a potent systemic vasoconstrictor (McNeil et al. 1970; Boyle et al. 1983), but its
effect on vascular smooth muscle is probably unimportant under normal physiological
conditions (Padfield et al. 1981).
ADH has been shown to exert vasoconstrictive effects in the kidneys of experimental
animals (Yared et al. 1985), reducing glomerular perfusion. ADH also evokes the release
of vasodilatory prostaglandin E (Zipser et al. 1981), balancing the renal vasoconstrictive
effects of ADH and other vasoactive substances under pathophysiological conditions
(Patrono and Dunn 1987). Glomerular function is further modulated by ADH through
stimulation of mesangial cell contraction (Schor et al. 1981) which decreases the
glomerular ultrafiltration coefficient and GFR independent of a pathway involving
angiotensin II. This effect of ADH is also attenuated by prostaglandin E2, which is
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synthetized by mesangial cells (Scharschmidt et al. 1983). The prostaglandin stimulatory
effect of ADH is suggested to be dependent on the pressor, not the antidiuretic, activity of
this hormone (Sawyer et al. 1977).
ADH exerts its tubular effects mainly on the distal tubule and collecting duct where it
promotes water reabsorption, as well as on the thick ascending limb of the loop of Henle
where it stimulates active reabsorption of sodium (Amiel et al. 1987). Because of
predominance of the former effect, varying degrees of hyponatremia are a common
feature of high plasma concentrations of ADH. In addition, particularly in the presence of
normovolemia, high ADH concentrations would lead to oliguria and a high urinary sodium
concentration (Zaloga and Hughes 1990). Such circumstances would obviate the use of
urinary sodium concentration or FENa in the diagnosis of ARF.
1.3.3.2 The role of ADH in ischemic ARF
The presence of ADH has been suggested to be necessary for the full nephrotoxic effect
of cyclosporine in the rat kidney (Barros et al. 1987). The pathophysiological role of ADH
is postulated to be either its renal vasoconstrictor effect or its action on mesangial cells
leading to reduced glomerular ultrafiltration independent of angiotensin II (Schor et al.
1981).
Elevated concentrations of angiotensin II and ADH often circulate in all forms of ARF,
including renal failure of ischemic origin (Hostetter and Brenner 1988). It is suggested that
under such circumstances the reductions in ultrafiltration coefficient may be brought about,
at least in part, through the actions of these agents rather than by direct glomerular injury.
Although ADH is therefore not suggested to be a primary pathogenic instigator of injury in
ischemic ARF, it does participate in the pathophysiological process.
1.3.3.3 The role of ADH in renal changes with aortic surgery
Plasma ADH concentrations are not increased by anaesthesia as such or by anaesthetic
agents such as fentanyl or halothane (Ishihara et al. 1978). Morphine has been reported
to stimulate (Lightman and Forsling 1980) and inhibit (Woods et al. 1983) the release of
ADH. Changes in ADH concentrations seen with intravenous morphine administration are
likely to be induced by its effect on vascular smooth muscle leading to a state of relative
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hypovolemia, a known stimulus for ADH release (Yared et al. 1985), rather than a direct
effect of the drug.
The trauma and stress of surgery causes dramatic increases in ADH secretion
(Sinnatamby et al. 1974), the magnitude and duration of the hormonal response being in
proportion with the severity of the surgical procedure (Haas and Glick 1978). ADH
concentrations consistently rise far in excess of levels necessary for maximum antidiuresis
(Field man et al. 1985) and are therefore responsible for the significantly negative free
water clearance (CH20) seen in the perioperative period. Excessive ADH levels are also
responsible for the high FENa seen after major surgery and in critically ill patients in the
absence of ARF (Zaloga and Hughes 1990).
Although ADH contributes to changes in systemic vascular resistance during surgery
(Boyle et al. 1983), its potential effect on the renal vasculature has not been studied under
these circumstances. In the only study of abdominal aortic surgery to report on changes in
ADH concentrations perioperatively, Kataja et al. (1989) report concentrations to be
increased even before cross clamping of the aorta, reaching a peak in the recovery ward
and remaining increased on the first postoperative morning. Changes in RBF and renal
function were not reported in this study.
The presence or absence of a temporal relationship between ADH concentrations and
altered kidney function and RBF in aortic surgery therefore remains to be elucidated.
1.3.4. The role of other substances in altered renal hemodynamics and function in
ischemic ARF and during aortic surgery
A number of other non-hormonal substances have been suggested to playa role in the
changes in RBF and kidney function associated with abdominal aortic surgery
(Gamulin et al. 1986). A few studies where the potential benefit of blocking the release or
the biological effect of these substances were investigated in clinical or experimental
models during infrarenal clamping of the aorta, have been published recently. These
studies, as well as the possible pathogenic role of these substances in inducing the
changes seen in aortic surgery, will be briefly reviewed.
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1.3.4.1 Calcium (Ca2+)
The effects of Ca2+ on renal hemodynamics and kidney function have been investigated
predominantly by using calcium channel blockers or physiological antagonists of Ca2+ in
various clinical and experimental models.
Ca2+ does not influence RBF (Wallia et al. 1985) or GFR (Leonetti et al. 1982;
Wallia et al. 1985) in normal humans indicating minimal effect of Ca2+ on resting renal
vascular tone. In contrast to the lack of effect in normal subjects, hypertensive patients
exhibit a significant renal hemodynamic effect with sustained increases in RBF and GFR
under the influence of calcium channel blockers (Ca2+-blockers) (Reams and Bauer 1990).
Although Ca2+-blockers do not affect renal hemodynamics under normal resting conditions,
they dramatically alter the response of the kidney to vasoconstrictor agents. The renal
vasoconstrictive effects of noradrenaline (Loutzenhiser and Epstein 1987), angiotensin II
(Ichikawa et al. 1979), thromboxane (Loutzenhiser et al. 1986) and endothelin
(Loutzenhiser et al. 1990) are significantly attenuated by Ca2+-blockers. The predominant
effect of Ca2+-channel blockade is on the afferent arteriole (Flemming et al. 1987), thereby
decreasing preglomerular vascular tone. The nett result is an increase in intracapillary
hydrostatic pressure in the glomerulus with a modest improvement in renal blood flow, but
a marked augmentation of GFR when Ca2+-blockers are administered in the presence of
renal vasoconstrictors (Loutzenhiser et al. 1985).
1.3.4.1.1 The role of Ca2+ in ARF
Although Ca2+ has been demonstrated to playa specific role in renal tubular damage in
ARF (Wilson et al. 1984; Arnold et al. 1986), this brief review will, in the context of this
thesis, focus predominantly on the effect of Ca2+ in changed renal hemodynamics and
glomerular function as well as its interaction with other vasoactive substances in ischemic
ARF.
Ca2+-blockers protect the kidney more effectively against noradrenaline induced ischemia
than against ARF induced by total renal artery clamping (Malis et al. 1983). This is
proposed to be due to verapamil preventing total cessation of RBF during intrarenal
noradrenaline infusion. Moreover, Ca2+-blockers have been shown to inhibit the renal
vasoconstrictive effects of noradrenaline, angiotensin II, thromboxane, ADH and
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endothelin (Ichikawa et al. 1979; Loutzenhiser et al. 1986; Loutzenhiser and Epstein 1987;
Loutzenhiser et al. 1990), and the plasma concentrations of these vasoconstrictors are
generally increased during ischemic episodes associated with clinical ARF. Use of in vitro
cell culture techniques has also demonstrated that vasoconstrictors most probably mediate
their effects on vascular smooth muscle and the mesangial cells in the glomerulus by
increasing intracellular Ca2+ (Takeda et al. 1986; 1988; Bonventre et al. 1986). The initial
increase in cytosolic Ca2+ occurs secondary to intracellular Ca2+-mobilisation as it occurs
even in the presence of Ca2+-free media or a Ca2+-blocker (Takeda et al. 1986; 1988).
However, the sustained (minutes) vascular effects of ADH on vascular smooth muscle
(Takeda et al. 1988) and of angiotensin II on glomerular mesangial cells (Takeda et al.
1986) involve replenishment of intracellular Ca2+ stores by enhanced Ca2+ influx, an effect
which can be partially blocked by Ca2+-blockers (Takeda et al. 1986; 1988).
It is well known that autoregulation of RBF is abolished for days to weeks after an ischemic
insult known to cause ARF (Adams et al. 1980). This effect is detrimental as it
predisposes the kidney to subsequent ischemic damage if fluctuation in renal perfusion
pressure occurs. Verapamil and diltiazem have been shown to prevent this loss of
autoregulation of RBF subsequent to an intrarenal noradrenaline insult known to cause
reversible ischemic ARF (Robinette et al. 1987), this despite the fact that Ca2+-blockers
have been demonstrated to block the renal autoregulatory capability in a non-ischemic
kidney model in vitro (Cohen and Fray 1982).
Inhibition of the physiological and pathophysiological role of Ca2+ in glomerular function
may also be beneficial in ARF. The reduction of glomerular filtration coefficient mediated
at least partly by vasoactive substances is blocked by the administration of verapamil
(Ichikawa et al. 1979). Indeed, filtration fraction has been demonstrated to be increased or
unchanged under the influence of Ca2+-blockers (Dietz et al. 1983; Roy et al. 1983; Bell
and Lindner 1984). This maintenance of glomerular capillary permeability is suggested to
be secondary to the prevention of mesangial cell contraction. Ca2+-blockers also
predominantly reduce the vascular tone of preglomerular blood vessels (Flemming et al.
1987), thus assisting the maintenance of intracapillary hydrostatic pressure in the
presence of a decrease in renal artery perfusion pressure.
The combination of maintenance of glomerular permeability and capillary hydrostatic
pressure is responsible for the increase in GFR subsequent to the administration of Ca2+-
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blockers in ARF (Wait et al. 1983; Woolley et al. 1988). Maintenance of GFR may be
beneficial in ARF by assisting in the washout of necrotic cellular debris and thus
preventing or attenuating tubular obstruction, the primary maintenance factor in ARF
(Burke et al. 1980). Maintenance of GFR may not be universally beneficial, as a decrease
in GFR may be associated with a decrease in tubular reabsorption, thereby decreasing
renal energy and oxygen requirements (Brezis et al. 1984a, 1989).
The detrimental effects of cellular and mitochondrial Ca2+ overload as well as the potential
beneficial effects of Ca2+ -blockers have been well described and reviewed (Schrier et al.
1987; Weinberg 1991). It will not be described here as it falls out of the scope of this
thesis.
1.3.4.1.2 The role of Ca2+ in renal changes with aortic surgery
Only one published study (Colson et al. 1992a) has explored the possible role of Ca2+ in
the changed renal hemodynamics and glomerular function indirectly by investigating the
potential benefit of prophylactic administration of a Ca2+-blocker. They reported
maintenance of RBF and GFR in patients who received nicardipine, while RBF and GFR
were decreased after aortic cross clamping in both a control group and in another group of
patients who received an ACE inhibitor. The calculated filtration fraction was significantly
higher in the nicardipine group than in any of the other groups, which is consistent with the
predominantly preglomerular vascular effect and maintenance of glomerular filtration
coefficient described for Ca2+ -blockade (Ichikawa et al. 1979; Flemming et al. 1987).
A beneficial effect of Ca2+ -blockade does not establish a primary pathogenic role for Ca2+
in the renal changes, which occur with infrarenal aortic cross clamping. In fact, it is much
more likely that the benefit is derived from blocking the effect of Ca2+ much lower down the
pathophysiological pathway induced by other mediators known to exert their effects
through a Ca2+-modulated mechanism (Ichikawa et al. 1979; Loutzenhiser et al. 1986,
Loutzenhiser and Epstein 1987, Loutzenhiser et al. 1990).
1.3.4.2 Endothelin
Endothelin has been postulated to playa local regulatory role in renal function, particularly
in respect of the control of RBF and glomerular function, together with other vasoactive
substances (Luscher et al. 1991). Endothelin has been shown to be synthetised in
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mesangial cells (Zoja et al. 1991), glomerular epithelial cells (Kasinath et al. 1992) and
endothelial cells of the renal microvasculature (Marsden et al. 1991). Endothelin
(receptor) binding sites have been shown to be distributed through the kidney, with higher
densities in the glomeruli, inner medulla and vasa recta (Power et al. 1989). The effects of
endothelin on the renal vasculature produces significant decreases in RBF and GFR in
association with a decrease in sodium excretion and an increase in plasma renin activity
(Miller et al. 1989) in concentrations low enough not to elicit changes in arterial blood
pressure (Badr et al. 1989). Endothelin produces a renovascular effect of long duration,
with renal vasoconstriction persisting up to 40 minutes after cessation of an intravenous
infusion of endothelin (Goetz et al. 1989).
A wide range of interactions have been described between endothelin and other
vasoactive substances, which modulate the actions of endothelin and may even be
responsible for a major part of its primary actions in vivo. The renal actions of endothelin
are associated with activation of the renin-angiotensin system, suggesting that the renal
vasoconstrictor response to endothelin may involve a contribution from angiotensin II
(Miller et al. 1989). In addition, endothelin has been shown to promote angiotensin II
production by enhancing the activity of the ACE (Kawaguchi et al. 1990). Angiotensin II on
the other hand, enhances the effect of endothelin by stimulating endothelin synthesis and
release (Kohno et al. 1991), as well as increasing vascular responsiveness to endothelin
(Dohi et al. 1992). The biological significance of the above interactions is demonstrated by
the marked inhibition of the renal effects of endothelin when angiotensin II synthesis is
blocked by the administration of an ACE inhibitor (Chan et al. 1994).
Calcium and calcium ionophores also playa role in the synthesis and release of endothelin
(Boulanger and Luscher 1990; Luscher et al. 1991). Through binding with its receptor on
vascular smooth muscle, endothelin increases intracellular Ca2+ via activation of
phospholipase C and phosphoinositol metabolism (Simonson et al. 1989). The resultant
increase in renal vascular tone can be inhibited by Ca2+-blockers (Loutzenhiser et al.
1990). Endothelin enhancement of the effect of other vasoconstrictors such as
noradrenaline also involves activation of voltage-operated Ca2+-channels, which can be
inhibited by Ca2+-blockade (Yang et al. 1990).
Endothelin also interacts intrarenally with two important vasodilatory substances. Similar
to other vasoconstrictors, endothelin stimulates the release of the vasodilatory
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prostaglandins E2 and 12from the kidney (Rae et al. 1989; Chou et al. 1990). Endothelium-
derived relaxing factor (or nitric oxide) has effects opposing those of endothelin in the
kidney (Tollins et al. 1990) and also inhibits the angiotensin II induced contraction of
mesangial cells (Shultz et al. 1990). Renal vasoconstriction induced by low concentrations
of endothelin is also markedly potentiated in the presence of an inhibitor of nitric oxide
production (Lerman et al. 1992). The above findings thus demonstrate the importance of a
balance between endothelium derived vasoconstricting and vasodilating substances as a
local regulatory system of kidney function and suggest that this balance may be important
in disease states in which these factors are excessively stimulated or absent.
1.3.4.2.1 The role of endothelin in ischemic acute renal failure
In patients with ARF, plasma endothelin levels are elevated and they decline during
recovery from the disease (Tomita et al. 1989). It is suggested that ischemia may
stimulate endothelin production (Yanagisawa et al. 1988) although decreased clearance
may also be partly responsible for the increased concentration. In ischemic ARF of the rat,
infusion of an antibody against endothelin ameliorates the vasoconstriction characteristics
of postischemie nephrons and markedly increases renal plasma flow and single nephron
GFR (Kon et al. 1989). In another model of ischemie ARF, endothelin antibodies protected
the kidney from acute tubular necrosis after renal artery occlusion (Shibouta et al. 1990),
suggesting that endothelin may be one of the important deleterious mediators in the
pathogenesis of ischemic ARF.
Endothelin is also suggested to playa pathogenic role in ARF induced by cyclosporin.
Similar to the ischemic ARF model, increased systemic concentrations of endothelin have
been observed in patients treated with cyclosporin (Deray et al. 1991) and treatment with
endothelin antibody was found to improve the immunosuppressant-induced decrease in
RBF and GFR (Kon et al. 1990).
1.3.4.2.2 The role of endothelin in renal changes with aortic surgery
Changes in endothelin concentrations with infrarenal aortic cross clamping have only been
investigated in one study (Antonucci et al. 1990). This group reported a significant
increase in endothelin plasma levels after aortic clamping. They suggested that infusion of
nifedipine was responsible for the maintenance of GFR demonstrated in the presence of
increased endothelin levels. Unfortunately, RBF was not measured and a non-nifedipine
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control group was not included in the study to substantiate their claim for the beneficial
effect of the Ca2+ -blocker.
Based on evidence from other studies where changed renal hemodynamics induced by
endothelin was reversed by the administration of an ACE inhibitor (Chan et al. 1994), ACE
inhibition may also be expected to be of benefit with aortic cross clamping if endothelin
does prove to be an important pathogenic factor in the renal dysfunction associated with
this procedure.
1.3.4.3. Adenosine
Adenosine has been postulated to link control of RBF and GFR with changes in renal
metabolism (Osswald et al. 1980; Spielman and Thompson 1982). However, it is
questionable whether renal blood flow has a metabolic control component since complete
renal autoregulation is retained in the non-filtering kidney (Ofstad and Aukland 1985). The
quantitative importance of adenosine as a physiological regulator of renal hemodynamics
is still poorly understood.
Acute administration of adenosine causes significant renal vasoconstriction with
concomitant decreases in filtration fraction and GFR (Hester et al. 1983; Hall et al. 1985).
It appears that adenosine needs a functioning angiotensin II receptor system for its renal
vasoconstrictor action (Dietrich et al. 1991). The combined renal vasoconstrictive effect of
adenosine and angiotensin II is predominantly on preglomerular vessels (Tagawa and
Vander 1970; Hall et al. 1985), which is in contrast with the more prominent influence of
angiotensin II alone on the efferent arteriolar tone (Edwards 1983). With continued
infusion of adenosine, renal vascular resistance and RBF return toward normal (Tagawa
and Vander 1970; Hall et al. 1985). This is at least partly due to the suppression of renin
secretion (and subsequent reduced angiotensin II production) caused by adenosine
(Tagawa and Vander 1970). If renin or angiotensin II levels remain increased despite the
suppressive effect of adenosine on renin secretion, the secondary renal vasodilation will
be attenuated (Hall et al. 1985). Increased sodium intake also decreases the renal
vasoconstrictive effect of adenosine probably due to its inhibitory effect on the renin-
angiotensin system, but it may also be in response to other effects of increased sodium.
Even when the renal vasoconstrictive effect of adenosine is inhibited by the administration
of an ACE inhibitor, GFR still decreases (Hall et al. 1985). This is at least partly due to the
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vasodilator effect of adenosine on efferent arterioles through the Aradenosine receptor,
which is independent of the presence of angiotensin II (Holz and Steinhausen 1987). GFR
also remains decreased despite recovery of RBF with continued (chronic) administration of
adenosine (Hall et al. 1985). The cause of the continued reduction in GFR is partly due to
the efferent vasodilator effect of adenosine and partly because adenosine-induced
reduction of renin and angiotensin concentrations would also reduce efferent arteriolar
tone which decreases intraglomerular hydrostatic pressure and filtration fraction. An
increase in renal prostaglandin synthesis (Hall et al. 1985) and a decrease in
noradrenaline sensitivity (Hashimoto and Kokobun 1971) may also playa contributory role.
1.3.4.3.1. The role of adenosine in ischemic acute renal failure
It is possible that the adenosine-angiotensin II interaction may playa role in causing renal
vasoconstriction and ischemic renal failure during certain pathological conditions such as
severe renal artery stenosis or hypoxia since tissue, urine and blood concentrations of
adenosine have been shown to increase markedly during renal artery occlusion (Miller et
al. 1978). In such circumstances angiotensin II levels have also been demonstrated to be
elevated (Brown et al. 1970; Moran and Myers 1985) and adenosine has been
demonstrated to cause sustained renal vasoconstriction of preglomerular vessels when
angiotensin II is maintained at high concentrations (Hall et al. 1985). The magnitude and
time course of adenosine-induced renal vasoconstriction is nevertheless such that is it
unlikely to be the primary pathogenic mediator responsible for acute renal failure (Firth et
al. 1988).
1.3.4.3.2. The role of adenosine in renal changes with aortic surgery
Adenosine has been suggested as the mediator of changes in renal hemodynamics with
infrarenal aortic cross clamping in a study on dogs (Frank et al. 1988). In this study RBF
decreased and renal vascular resistance increased only after release of the aortic cross
clamp and was associated with an increase in adenosine levels in the systemic circulation.
The increase in adenosine concentrations is suggested to be due to tissue ischemia distal
to the aortic cross clamp. If adenosine is the only or primary mediator involved in renal
hemodynamic changes with aortic surgery, it would be difficult to explain the renal
changes, which occur immediately after clamping of the aorta (Gamulin et al. 1984, 1986;
Colson et al. 1992a). Patients with well developed collateral circulation such as individuals
with occlusive arterial disease would then also be unlikely to suffer the same renal
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hemodynamic upsets as patients without adequate collateral blood flow. Patients with
aorto-iliac occlusive disease were included in renal hemodynamic studies during aortic
surgery and were not reported to behave differently in terms of reported renal changes
(Gamulin et al. 1984, 1986; Colson et al. 1992a; Licker et al. 1996).
If adenosine does playa role in renal hemodynamic changes with aortic surgery, ACE
inhibition is likely to be beneficial in preventing these changes based on the evidence of
the adenosine-angiotensin interaction in the renal circulation (Hall et al. 1985; Dietrich
et al. 1991).
1.4 HYPOTHESIS
From the preceding literature survey, it is clear that a number of important aspects relating
to renal changes with infrarenal cross clamping of the aorta still need to be elucidated.
Although the majority of human studies suggest a decrease in RBF and GFR associated
with infrarenal aortic cross clamping, the exact duration of these changes, particularly the
decreased GFR, is still unclear. A significant decrease in GFR would introduce a
significant risk and would, by decreasing functional renal reserve, increase the possibility
of frank renal failure with subsequent (future) ischemic (or other) insults, or even through
the progressive deterioration of renal function with ageing (Kaplan et al. 1975;
McLachlan 1978).
Published human studies also employ intraoperative preelamp measurement of RBF as
control against which subsequent changes are compared for significance. Such an
approach ignores the possibility that anaesthesia and surgery may decrease RBF from
awake values, hence obscuring decreases in RBF, which may be even more significant in
a statistical and clinical context.
Hormones involved in the normal physiological control of RBF and kidney function are
known to be present in higher concentrations in ischemic ARF (Badr and Ichikawa 1988).
Although their roles in the pathogenesis of ischemic ARF is in dispute, it is accepted that
they playa role in the pathophysiology of this condition (Myers and Moran 1986; Badr and
Ichikawa 1988).
With the exception of renin measurements, plasma levels of the above hormones have
only rarely been determined in abdominal aortic surgery. None of the human studies
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where renin (or any other hormone) levels were measured, report on concomitant
measurement of RBF. The association between increased levels of hormones and
changes in renal hemodynamics therefore also remains to be explored.
There is significant interaction between hormonal vasoconstrictors. In addition, the final
intracellular vasocontrictive mechanisms invariably overlap. Inhibition of one vasoactive
mediator could therefore attenuate the vasoconstrictive response induced by another.
This is supported by the apparent success of different pharmacological agents in
maintaining RBF and GFR with infrarenal aortic cross clamping (Colson et al. 1992a;
Licker et al. 1996). Although results are conflicting, it may be argued that any agent that
increases RBF during aortic surgery would suffice. However, different substances
influence some intrarenal vascular beds more than others, so that improved global renal
blood flow may not reflect adequate regional perfusion and function. In addition, specific
vasoconstrictive substances initiate specific homeostatic and pathophysiological
sequences (Margolis and Stein 1984) so that non-selective vasodilatation may not
necessarily inhibit other concurrent harmful pathophysiological effects.
If hormones therefore play a pathophysiological, if not pathogenic, role in altered renal
hemodynamics and function with abdominal aortic surgery, identification of those
substances would assist in the selection of the most appropriate pharmacological agents
to maintain renal homeostasis for the duration of the renal insult.
ARF remains an important cause of morbidity and contributes to mortality after abdominal
aortic surgery (Nachbur et al. 1987; Johnston et al. 1988) and renal ischemia is suggested
to be the cause (Gamulin et al. 1984; Gelman 1995). Since pharmacological treatment of
early and established ARF is notoriously unsuccessful (Lazarus 1986), a preventative
approach aimed at inhibition of endogenous agents involved in the etiology of ARF in this
particular population, may be expected to be more successful in improving outcome.
Based on the above, the hypothesis for this thesis is that infrarenal aortic cross
clamping induces a reduction in RBF and kidney function, which is associated with
changes in plasma hormone concentrations that play a pathogenic or
pathophysiological role in the changed renal hemodynamics.
Stellenbosch University http://scholar.sun.ac.za
36
The aim of this thesis is therefore to:
1. Confirm or reject this hypothesis;
2. Demonstrate whether pharmacological manipulation of pathophysiological
hormonal factors inhibits the adverse renal effects of aortic cross clamping.
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2.1 HUMAN STUDY
The human study was approved by the Ethics Committee of the Faculty of Medicine,
University of Stellenbosch (Project number 88/036).
Patients scheduled for elective abdominal aortic grafting surgery were used for this
study. Thirty-three patients were operated electively for non-ruptured aortic aneurysms
and twelve for atherosclerotic aortoiliac occlusive disease. Informed consent was
obtained from all patients. Preoperative assessment included measurement of serum
urea, creatinine, electrolytes, glucose, full blood count, blood gasses, and clotting
profile. A twelve lead ECG and erect antero-posterior chest X-ray was performed.
Creatinine clearance was done preoperatively, using a 24-hour urine collection period.
Creatinine clearance was repeated postoperatively on day 6 or 7. Twenty four hour
urine samples for the measurement of creatinine clearance 1 day peroperatively and 7
days postoperatively were collected under strict supervision with the patients voiding
voluntarily. Patients emptied their bladders immediately before the commencement of
the sampling period and again at the end of 24 hours. The latter sample and others
voided in the course of the sampling period were kept in a refrigerator until a collective
sample was taken for measurement of creatinine concentration. Adequacy of urine
collection was assessed with the measurement of 24 hour total creatinine excretion.
Additional cardiac assessment included a stress ECG and an assessment of
ventricular function (echo-cardiography or radio-isotope cardiography), the latter in
cases with a clinical history indicative of compromised ventricular function. Patients
with a positive stress ECG were considered for coronary angiography by a cardiologist
and aortic surgery postponed if considered necessary.
Patients with preoperative renal dysfunction (creatinine clearance less than
50 rnl.minute' and/or serum creatinine in excess of 120l-lmol/liter), cardiac failure, or
renal artery stenosis detected on the preoperative aortic angiogram, were not included
in the study. Patients on ACE inhibitor therapy were also excluded from the study and
in patients receiving diuretics, therapy was stopped three days prior to surgery. Other
preoperative therapy (methyldopa, n = 9; digoxin, n = 5; nifedipine, n = 2; Is-adrenerqic
receptor blockers, n = 7; nitrates, n = 11) was maintained up to and including the
morning of surgery.
On the morning of surgery patients were premedicated with diazepam 10 mg orally one
hour before transportation to the radiology theatre. A radio-opaque catheter was
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advanced into the renal vein under x-ray screening control and its tip positioned as
close as possible to the renal pelvis. Placement was done under local anaesthesia
(lignocaine 2%) from the right femoral vein (n = 37) except in cases where the
preoperative angiogram indicated the probability of distal anastomoses of a bifurcation
graft on the femoral arteries. In these patients (n = 8) the renal venous catheter was
placed from the right internal jugular vein. Where technically possible the catheter tip
was placed in the right renal vein (n = 38), with the others advanced into the left renal
vein (n = 7). Correct placement of the catheter was confirmed with a hard copy x-ray
and the catheter secured in position with a skin suture. All renal venous catheter
placements were performed by the same radiologist.
After securing the renal venous catheter, the patients were taken directly to the
anaesthetic induction room. In the induction room a peripheral venous cannula, a
radial arterial and a thermodilution pulmonary artery catheter (Edwards labs. Size 7F)
were placed under local anaesthesia (lignocaine 2%). A Foley (12g) urinary bladder
catheter was inserted under cover of local anaesthetic jelly (lignocaine 0.02%). During
placement of the intravascular lines and urinary catheter, midazolam was administered
if deemed necessary for additional anxiolysis in 1mg increments (maximum dose =
7mg). A lumbar epidural catheter was placed via the L2-L3 or L3-L4 interspace. After
returning the patient to the prone position, a test dose of 3ml 0.5% bupivacaine with
1:200 000 adrenaline was injected through the catheter. Ringers lactate was given
intravenously according to a regimen of 1.5ml per kilogram bodyweight for each hour
the patient had been nil per mouth prior to induction of anaesthesia. This volume was
supplemented when necessary to obtain a left ventricular filling pressure of at least
6 mmHg at the time of induction.
Anaesthesia was induced after a 3 minute period of preoxygenation with 100% oxygen.
Alfentanil was infused at a rate of 10j..lg.kg-1.min-1 for ten minutes, followed by a
continuous infusion of 1j..lg.kg-1.min-1 for the duration of the procedure and terminated
30 minutes prior to the expected completion of surgery. After 4 minutes of the priming
infusion of alfentanil, thiopentone (2-4mg.kg-1) was administered until loss of eyelid
reflex. Endotracheal intubation was facilitated with the injection of pancuronium
0.1 mq.kq'. Muscle relaxation was maintained with additional bolus administration of
pancuronium (0.01 mq.kq') whenever the fourth twitch returned clinically with train of
four ulnar nerve stimulation. After intubation, patients were ventilated (Ohmeda 7000,
BOC) with oxygen in air (Fi02 = 0.5). Minute volume of ventilation was adjusted to
maintain the end-expired partial pressure of carbon dioxide (PETC02) at 4 - 4.5kPa as
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measured with a capnograph (Datex Cardiocap CCI 104-23-01, Finland). Concurrence
between expiratory CO2 values and blood gasses were verified and ventilation adjusted
in accordance with arterial carbon dioxide partial pressures (PaC02) if a gradient
existed. Anaesthesia was maintained with halothane (0.8-1.0%) from a calibrated
vaporizer and the alfentanil infusion (1llg.kg-1.min-1), supplemented with additional
bolusses of 10Il9.kg-1 if deemed necessary. No patient received more than two
additional bolusses during the procedure. Preservative free morphine (3 - 5mg) was
administered epidurally as soon as the patient stabilized after induction to provide
postoperative analgesia and facilitate extubation as soon as possible after completion
of surgery.
Mean arterial blood pressure (MAP) was maintained within 20% of resting preoperative
control values throughout the procedure. An intravenous infusion of nitroglycerine
(TridilR, Boots Pharmaceuticals) was instituted after induction of anaesthesia and the
dosage adjusted to maintain the blood pressure within the above limits throughout the
procedure. Nitroglycerine was continued in the postoperative period at a dose of
0.5Ilg.kg-1. The maximum dosages during each of the measurement periods were
noted. Intravenous fluid (isotonic crystalloid, colloid or packed red cells) was infused to
maintain pulmonary artery wedge pressure (PAWP) above 9 mmHg, hematocrit above
29% and MAP within the designated limits. Total volumes of each fluid type for the
immediate preoperative period and the duration of the surgical procedure was noted for
each patient. Body temperature as measured with the pulmonary artery thermistor was
maintained above 35°C with the use of a warm water humidifier (Fisher & Paegel
MR300, Fisher & Paegel, New Zealand) attached to the inspiratory limb of the
anaesthetic circle system, by employing an under-table warming blanket, by warming
all intravenous fluids with an in-line warming device (FenwaII, Model 4R4303, Fenwall,
USA) and by warming all fluids used for intra-abdominal lavage as well as wet swabs to
37°C.
The aorta was approached by means of a median laparotomy in all patients.
Depending on the vascular pathology, a tube or bifurcation graft was used. The aorta
was clamped 2 - 3cm below the renal arteries and the proximal clamp was maintained
in position until completion of the distal anastomoses. Total aortic clamping time was
noted.
Heart rate (HR) (recorded from standard lead II), systolic and diastolic arterial pressure,
central venous pressure (CVP) and PAWP were recorded. The filling pressures were
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recorded at end-expiration from a monitor hard copy printout (Datex DR-104-23-00,
Datex, The Netherlands) using the mid-axillary line as zero reference point. Standard
pressure transducers were used (Statham P23, Statham, Puerto Rico) and transducers
were calibrated before each recording. MAP was calculated and recorded from the
area under the radial artery pressure recording. Cardiac output was determined in
triplicate with the thermodilution method by injection of 5ml of a 5% dextrose solution at
4°C into the proximal port of the pulmonary artery catheter over a 5 seconds period.
The injections were spaced throughout the respiratory cycle and the mean of the three
computed values (Spectramed Starcom, Spectramed, USA) was calculated and
recorded for this study. Systemic vascular resistance was calculated with the following
formula:
SVR (dynes.sec.ern") = (MAP - CVP). 80/CO
All hemodynamic parameters were measured in the middle and at the end of each
measurement period and the mean of the two measurements was calculated and noted
as the value for that particular measurement period.
Renal plasma flow and glomerular filtration rate were measured using clearances of 1125
hippuran (CHIP)and Cr51EDTA (CEDTA) respectively (Gamulin et al. 1984; Mimran et al.
1983). The labeled compounds were injected as soon as intravenous access was
established in the awake patient in the induction room as a bolus of 1,1MBq 1125
hippuran and 2,2MBq Cr51 EDTA. In addition, a continuous infusion of 2,7MBq 1125
hippuran and 5,3MBq C~1 EDTA in 1 litre 0.9% sodium chloride was initiated and
continued throughout the study to maintain stable blood levels of the labeled
compounds. The infusion rate was started at 150ml.h(1 and decreased by 'l Oml.hr'
every 5 minutes down to 1Oornl.hr', which was continued as the maintenance infusion
rate. The first clearance measurements were started 60 - 70 minutes after initiating the
infusion of labeled compounds. Cr51EDTA was supplied by Amersham (UK) and 1125
hippuran by the National Accelleration Centre (Faure, RSA). For clearance
measurements urine was collected through the indwelling intravesical Foleys catheter
for periods of either 20 or 30 minutes and arterial blood samples were taken in the
middle and at the end of each sampling period. To ensure that the bladder was
properly emptied at the commencement and at the end of each measurement period,
200ml air was injected into the bladder just before the beginning, and again at the end
of each sampling period. Activity of the marker isotopes were measured in a counter
(Canberra Well) linked to a multichannel analyzer (Canberra Series 20). Arterial
activity was expressed as the mean of the two samples taken during each
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measurement period and the percentage difference between these two measurements
was also calculated. In order to calculate the extraction fraction of 1125hippuran (EHlP)
across the kidney, renal venous blood was sampled with a mechanical pump for the
5 minutes preceding the middle, as well as the 5 minutes preceding the end of the
measurement period at a rate of 1ml.min". Renal venous isotope activity was
calculated in the same manner as arterial activity. CHIP,CEDTA,EHIP,filtration fraction
(FF), RBF and renal vascular resistance (RVR) were calculated by using the following
equations:
(where UHIP= urinary concentration of 1125hippuran; Uvol =urinary volume in rnl.min";
and aHIP= arterial plasma concentration of 1125hippuran)
(where UEDTA=urinary concentration of Cr51 EDTA; and aEDTA= arterial plasma
concentration of Cr51EDTA
(where RVHIP= renal venous plasma concentration of 1125hippuran)
RBF (ml.min") = CHIP/EHIPx 100/(1 OO-Hct)
(where Hct = hematocrit)
RVR (dyne.sec.ern") = 80 X (MAP-CVP)/RBF
In order to calculate creatinine clearance (Cereat)and the two indices of renal tubular
function, fractional excretion of sodium (FENa) and free water clearance (CH20), the
following measurements were made on arterial blood samples taken in the middle of
each sampling period, as well as a sample from the urine collected during the whole
sampling period:
1. Plasma and urine sodium (Na+) concentrations were determined with a
Technikon SMAC automated analyzer (Technikon, New York, USA) by use of
an ion-selective glass electrode.
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2. Plasma and urine creatinine concentrations were determined with the
Technikon SMAC automated analyzer (Technikon, New York, USA), using the
colorimetric measurement of the reaction between creatinine and saturated
pipric acid as automated by Chasson et al. (1961).
3. Serum and urine osmolality were determined using the freezing point method
(Ganotec Osmomat 030, Ganotec).
The calculated indices were determined with the following equations:
Ccreat(ml.min-1)= UcreatXUvol/Pcreat
(where Uereat= urine creatinine concentration; Pereat= plasma creatinine
concentration; Uvol = urine volume)
TUNa(mEq.min) = UNa/WOOX Uvol
(where TUNa= total urinary Na+; UNa= urinary sodium concentration; Uvol =
urine volume per minute)
(where UNa= urinary Na+concentration; PNa=plasma Na+concentration)
CH20(rnl.rnin') = Uvol- (Uvol x Uosm/Posm)
(where Uosm= urine osmolality; Posm= plasma osmolality).
Functional integrity of proximal tubular cells was tested with the measurement
of urinary r.,2-microglobulin (Schardijn and Van Eps, 1987). Urine samples were
taken during every measurement period and kept at 4°C before and after pH
adjustment to values of 6-8 with 1 M NaOH. Quantitative determinations of r.,r
microglobulin levels were done the day after surgery, using a double antibody
radioimmunoassay technique (Pharmacia f1rmicro RIA, Pharmacia Diagnostics
AB).
A range of hormone levels were measured in arterial blood samples taken at
the midpoint of each measurement period. Arginine vasopressin was measured
with a double disequilibrium radioimmunoassay technique (Robertson et al.
1970; Robertson et al. 1973) after extraction with bonded phase (C2 Ethyl) solid
phase collumns (Anatech Instruments). Plasma renin activity on arterial and
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renal venous blood samples taken at the midpoint of each measurement period
were determined by radioimmunoassay of generated Angiotensin I with a
Gamma Coat (1125) technique (Incstar, USA). Aldosterone concentrations of
arterial blood samples were measured using a "no extraction" Coat-a-Count
radioimmunoassay test kit (Diagnostic Products Corporation, USA). An
immunoradiometric assay (Incstar, USA) was used to determine ACTH
concentrations in arterial blood samples taken at the middle of each sampling
period. Plasma catecholamine (adrenaline, noradrenaline and dopamine)
concentrations were measured on arterial blood samples taken only at two
occasions per patient; the first after induction of anaesthesia and
commencement of surgery but before mannitol and dopamine administration
was started and the second immediately after aortic cross clamping. The
catecholamine concentrations were determined (after acidic extraction) by
injection of a plasma extract into a high performance liquid chromatograph-
electrochemical detection system (Model LC-304, Bioanalytical Systems) as
previously described by Russell et al. (1985).
Patients were randomly allocated to one of two study groups:
1. Control (n = 22)
These patients were managed as described above and no additional
pharmacological manipulation was done.
2. Mannitol + dopamine (n = 23)
These patients received the same basic anaesthetic regimen as previously
described. They also received mannitol as a single dose of O.5g.kg-1 over a
10 minute period, which was completed 5 minutes before application of the
aortic cross clamp. A constant infusion of dopamine (2J.lg.kg-1.min-1) was
initiated immediately after completion of the preelamp measurement period and
continued until 24 hours postoperatively.
Co-workers responsible for conducting the anaesthetic, taking blood and urine
samples, as well as those responsible for analysis of those samples were
blinded to the group allocation of patients.
Measurements were taken at the following times:
1. Before induction of anaesthesia with the patient breathing room air.
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2. After induction of anaesthesia with surgery in progress before cross clamping of
the aorta (this measurement period ended within 10 minutes of aortic cross
clamping in all patients).
3. Immediately after cross clamping of the aorta.
4. Just before unclamping of the aorta.
5. Immediately after unclamping of the aorta.
6. Four hours after unclamping of the aorta.
7. Twenty four hours after unclamping of the aorta (only I1rmicroglobulin).
On completion of surgery, patients were ventilated until they were adequately awake;
had a core temperature of at least 36°C; were hemodynamically stable and had a
hematocrit of at least 30%; and had an oximeter saturation in excess of 95% with an
Fi02 of 0.4, before they were extubated. Nine patients were still being ventilated at the
time of the sixth measurement period 4 hours after aortic unclamping (control group
n = 5; mannitol + dopamine group n = 4).
2.2 ANIMAL STUDIES
The animal studies were approved by the Ethics Committee of the Faculty of Medicine
of the University of Stellenbosch (Project number 88/036).
2.2.1 The influence of the renin-angiotensin system on changes in renal
hemodynamics and kidney function with infrarenal cross clamping of the
aorta
Twenty four pigs were used in this part of the study. All animals received food and
water ad libitum until experimentation. Their weights varied between 19k9 and 29kg.
The animals were initially sedated with ketamine 1Omq.kq' intramuscularly and brought
to the operating theatre where intravenous access was secured with a 18g cannula into
a vein of the pinna. Anaesthesia was subsequently induced with thiopentone
(5 rnq.kq'). A tracheostomy was performed and the trachea intubated with a cuffed
tracheostomy tube. On initiation of intermittent positive pressure ventilation, muscle
paralysis was obtained by injecting a bolus of pancuronium (0,1 rnq.kq'), followed by a
constant infusion of 0,1mg.kg -1.h(1. Animals were ventilated with oxygen and nitrogen
with an inspiratory oxygen concentration of 50%. A ventilation frequency of 14 breaths
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per minute was used and tidal volume was adjusted to maintain the end expiratory CO2
concentration between 4 and 5 volumes percent, using a circle system with CO2
absorption. If subsequent blood gas analysis showed a PaC02 value in excess of
5kPa or below 4kPa, ventilation was adjusted to obtain PaC02 levels between those
limits. Anaesthesia was maintained with halothane 1,2%, vaporized from a calibrated
vaporizer (Draqerwerk, Germany).
An under-table-heating device and an in-line intravenous fluid warmer was used to
maintain blood temperature of the animals above 35°C. The laparotomy incision and
bowels of the animals were covered with plastic and surgical drapes as far as possible
during and after the surgical preparation, for the same purpose. Blood temperature
was measured with the pulmonary artery catheter and recorded at each measurement
period. Normal saline was infused at a variable rate to maintain left ventricular filling
pressure (PAWP) between 10 and 15 mmHg.
Cr51 EDTA (Amersham, UK) and 1123 hippuran (National Acceleration Centre, Faure,
RSA) were used for the determination of GFR and RBF respectively. Bolus doses of
1,1 M Bq (Cr51 EDTA) and 0,55 M Bq (1123 hippuran) were administered intravenously
immediately after placement of the intravenous cannula. This was followed by a
continuous infusion of the isotopes; 2,65 M Bq Cr51 EDTA and 1,35 M Bq 1123 hippuran
in 200ml saline given at a rate of trnl.kql.hr" (13,25 K Bq and 6,75 K Bq per kilogram
per hour respectively) for the duration of the study protocol. Arterial and renal venous
plasma as well as urinary isotope activity was counted in a Canberra Well (Canberra)
counter linked to a multichannel analyzer (Canberra Series 20, Canberra). CEDTA, CHIP,
EHIP, FF and RBF were calculated for each measurement period, using the same
formulae as applied in the human study.
Arterial pressure was transduced (Statham P23, Statham) from a cannula inserted into
the left carotid artery. Mean arterial pressure (MAP) was computed from the area
under the arterial pressure recording. A pulmonary artery catheter (Edwards Labs.
Size 5F) was inserted from the left internal jugular vein to obtain PAWP recordings and
for thermodilution cardiac output (CO) determination with a CO computer (Mansfield
9530, Mansfield). Pressure transducers were calibrated before each recording. CO
determinations were done in triplicate at each measurement time and the means of
these values are reported. Measurements of CO were done by injecting 5ml of 5%
dextrose and water at 4°C by hand into the proximal injection port, spacing injections
throughout the respiratory cycle.
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A laparotomy was performed through a median incision. The retroperitoneal space
was opened and both ureters identified. The ureters were sequentially tied off
approximately 5cm proximal to the bladder, the ureteral lumen opened and a thin bore
catheter with total internal volume of O.Bml advanced proximally to between 2 and 3cm
from the renal calyx. A ligature was tied around the ureter and catheter to secure the
catheter position and to ensure free drainage of all urine produced by each kidney
through its ureteral catheter for accurate urine volume measurements.
The retroperitoneal space was opened over the left renal pelvis and carefully dissected
onto the renal vein without disturbing the renal nerves. A 20 gauge cannula was then
inserted into the renal vein approximately 3cm from the renal pelvis with its tip directed
towards the kidney and secured with a suture.
The aorta was dissected 2cm distal to the origin of the renal arteries to allow for
placement of an aortic cross clamp. Circumferential dissection invariably led to
drainage of lymphatic fluid from the para-aortic tissue, the loss of which was
compensated with intravenous saline as already described.
All sampling periods were of 20 minutes duration. Hemodynamic measurements
(MAP, PAWP, heart rate, CO) were taken in the middle of each renal venous blood
sampling described below (i.e. 5 and 15 minutes into each sampling period).
Hemodynamic results are given as the mean of these two measurements for each
period.
Plasma renin activity on renal venous and arterial blood samples were determined by
radioimmunoassay of generated angiotensin I with a 1125 Gamma Coat technique
(Incstar, USA) for each measurement period. Arterial blood samples were taken to
enable calculation of FENa and CH20 with the same formulae as given in the human
studies. Renal venous blood samples were taken manually from a 3-way tap on an
extension tube (dead space volume = 1ml) attached to the renal venous cannula. Two
samples of 5ml each were taken for the isotope studies after discarding the saline
withdrawn from the extension tube. Each sample was drawn over a 5 minute period
(starting from the end of the third and twelfth minute of the measurement period
respectively) to ensure a sample representative of renal venous isotope concentrations
for the 20 minute sampling period and to prevent contamination with inferior vena cava
blood. Arterial blood samples for isotope measurements were taken at the middle of
the two renal venous sampling periods. Arterial and renal venous isotope activities
were expressed as the mean of the counts done on the two samples per measurement
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period. The percentage difference in counts done on arterial samples were calculated
and noted for each measurement period. Extensions and cannulae were flushed with a
heparin/saline solution (500 IU heparin/100ml saline) after sampling, to prevent clotting.
All urine investigations were done on samples taken from the combined urine
production of both kidneys over the full 20 minute sampling period (differences in urine
volumes between kidneys were always less than 10% for all sampling periods in all
animals).
Animals were randomly allocated to one of three study groups:
1. Animals where only the radio-isotopes were administered as a constant infusion
(n = 8).
2. Animals where esmolol was infused at a dose of 3001l9.kg-1.min-1together with
the radio-isotopes from the time of securing the intravenous infusion (n = 8).
3. Animals where enalaprilat was infused at 15J.lg.kg.-1.h(1with the radio-isotopes,
together with an initial bolus of 1,25mg over 10 minutes immediately after
establishing intravenous access (n = 8). The enalaprilat dose was established
in a dose finding study in two pigs. The aim of this study was to identify a dose
which would not induce decreases in MAP below 80% of pre-enalaprilat control
values for the full experimental period, and at or above the dose recommended
for comprehensive ACE inhibition (Rutledge et al. 1988).
Assistants and co-workers who were responsible for sampling and
measurement of any parameter were blinded to the group allocation of
individual animals. A minimum of 90 minutes from initiation of radio-isotope and
study drug infusion was allowed before any sampling or other measurements
were commenced. After surgical preparation of the animals, infrarenal para-
aortic manual pinching of tissues at a rate of 5 pinches per minute were
continued during the experimental period to simulate clinical conditions during
aortic aneurysm surgery.
Sampling and measurements were done over 20 minute periods at the following times:
1. Control preclamp: After completion of surgical preparation with a minimum of
90 minutes from commencing the isotope infusion, ± study drug.
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2. Postclamp: Immediately after cross-clamping the aorta 2cm below the renal
arteries.
3. Pre-unclamp: The last 20 minutes of an one hour clamping period.
4. Post-unclamp: This period commenced 30 minutes after release of the aortic
cross clamp.
After completion of the last sampling period, the capsule of the left kidney was opened,
the kidney extricated from the capsule and the renal pedicle was clamped. The kidney
was immediately removed, a full length sagittal incision made and full thickness (cortex
and medulla) biopsies were taken for light and electron microscopy and fixed in 10%
formaline and 2,5% phosphate buffered glutharaldehyde respectively. Removal and
biopsies of the right kidney were done in a similar fashion. Total time elapsed between
unclamping of the aorta and nephrectomy/biopsies varied between 55 and 60 minute
for all animals.
Standard Light Microscopy:
After fixation of the specimens overnight at 4°C in 2.5% phosphate buffered
glutaraldehyde or 10% formalin, sections thereof preferably representing both cortex
and medulla were imbedded in wax (paraffin). Microtome sections three microns thick
were cut from the wax blocks, dewaxed in xylol and rehydrated in decreasing
concentrations ethanol down to water. Staining with Mayer's haematoxylin for 10
minutes was followed by thorough rinsing in running water and thereafter 5 to 10
seconds of differentiation in 1% acid-alcohol (1% HCI in 70% ethanol). The sections
were rinsed again in water followed by staining in 1% eosine Y for 3 minutes,
sequential dehydration in increasing concentrations of ethanol and clarification with
xylol. The stained sections were then mounted on glass slides under a cover slip with
DPX.
Electron Microscopy:
Following fixation overnight in 2.5% phosphate buffered glutaraldehyde (pH7.4) the
specimens were further dissected with the aid of a dissecting microscope in order to
obtain areas of cortex as near as possible to the cortico-medullary junction. The
samples thus obtained were rinsed in phosphate buffer followed by 60 minutes of post
fixation in 1.5% buffered osmium tetroxide. After double rinsing in distilled water the
tissue was placed in 2% uranyl acetate in 70% ethanol for 20 minutes. The specimens
were sequentially dehydrated for 5 minutes in each of 70% and 96% ethanol and then
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placed in 2% uranyl nitrate in 96% ethanol for 10 minutes. After thrice placing the
specimens in 100% ethanol/sodium sulphate for a total of 45 minutes it was embedded
in Spurr's epoxy resin and left overnight at 60°C. Sections were then cut with a glass
knife using a LKB Bromma Ultratome. One micron thick sections were stained with 1%
toluidine blue and used for light microscopic orientation and selection of deep cortical
areas containing proximal convoluted tubules (pars convaluta), the proximal straight
tubule (pars recta) and the cortical thick ascending limb of the distal tubule. Ultrathin
sections of 80-100 nm representative of these 3 nephron segments were mounted on
copper grids and stained with 2% uranyl acetate in 50% ethanol followed by lead citrate
staining. The sections were then examined with a Hitachi-H600 transmission electron
microscope at a voltage of 50kV.
The presence and extent of morphologic change indicative of cellular injury was
assessed in blinded fashion. Reliable parameters were identified after comparison with
a control group of 5 animals where kidney biopsies were taken after induction of
anaesthesia and without surgical stimulation other than surgical exposure of the kidney
through a laparotomy similar to the procedure for the experimental animals. The four
ultrastructural parameters assessed in this manner were changes in brush border
microvilli, the granular endoplasmic reticulum, the structure (and particularly swelling)
of the mitochondria, and changes in nuclear chromatin. Each of these parameters
were further graded, a score of 0 representing absence of change and a score of 3 the
most extreme degree of alteration. After grading for each of the above parameters
were done for a particular animal, such an animal was designated to one of two
possible groups in accordance with the assessment and grading. Those with at least 2
parameters with change (regardless of the grading ~ 1) or 1 parameter given a grading
of 3 were designated "clearly abnormal", whereas those falling short of these criteria
were regarded as "minimally altered to normal".
After the bilateral nephrectomies and biopsies, the animals were killed with the
administration of potassium chloride intravenously while still under anaesthesia.
One of the animals in the enalaprilat group developed malignant hyperpyrexia during
the experiment and had to be excluded from the group.
Stellenbosch University http://scholar.sun.ac.za
50
2.2.2 The comparative influences of angiotensin converting enzyme (ACE)
inhibition and Ca2+ -blockade on renal hemodynamics and function with
infrarenal aortic cross clamping
Animals were randomly assigned to one of two groups:
1. A group of pigs where verapamil was administered in a dose of O.25mg.kg-1
over 10 minutes after placement of the intravenous cannula, followed by a
continuous intravenous infusion of verapamil at a dose of 2!lg.kg-1.min-1 for the
duration of the experiment (n = 8).
2. A group of animals where enalaprilat was administered intravenously in the
same manner as described in group 3 of 2.2.1 (n = 8). This group was included
mainly for three reasons. Firstly, it prevented the possibility of bias, which
would have been relevant if only a verapamil group of pigs were studied on their
own in this part of the study. Secondly, if comparisons between results in this
group and the enalaprilat group of the first part of the study (2.2.1)
demonstrated no significant differences between the groups, it would indicate
lack of methodological and other differences between these two studies. This
would provide justification for inclusion of the control group of pigs of the first
part of the study (2.2.1), into comparative analysis of animal groups in this
section of the study. Thirdly, it provides the opportunity of comparing the
potential benefits of ACE-inhibition and Ca2+ -channel blockade in these
experimental circumstances.
The general preparation and experimental design was as described in section 2.2.1.
Two animals in the enalaprilat group and one in the verapamil group developed
malignant hyperpyrexia in the course of the experiment and had to be excluded from
the study.
Statistical analysis includes comparisons between the above two groups and control
animals from section 2.2.1. This was considered to be justifiable due to the fact that
the experimental design was exactly the same and because statistical comparisons
between the two enalaprilat groups from section 2.2.1 and 2.2.2 demonstrated no
differences in any of the measured or calculated parameters at any of the
measurement periods.
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2.2.3 The influence of prostaglandins in the changed renal hemodynamics and
glomerular function associated with infrarenal cross clamping of the aorta
and the effect of prostaglandin inhibition on the potential beneficial
influence of ACE inhibition
Animals were randomly assigned to one of two groups:
1. A group of pigs where diclofenac was administered in a dose of 2mg.kg-1
together with the radio-isotope bolus immediately after establishing the
intravenous infusion (n = 8). This was to investigate (through an indirect
method) the role of renal prostaglandins in balancing the effect of
vasoconstrictors previously described for different experimental conditions
(Henrich et al. 1978a, Schnermann et al. 1984, Rae et al. 1989, Chou et al.
1990), under our experimental and clinical circumstances.
2. A group of pigs where diclofenac (2mg.kg-1) was administered together with the
radio-isotope bolus after establishing the intravenous infusion. In addition,
enalaprilat was administered as described in group 3 of section 2.2.1 (n = 8).
The general preparation and experimental design was as described in section 2.2.1.
One animal in the diclofenac plus enalaprilat group developed malignant hyperthermia
in the course of the experiment. In one pig in the diclofenac group it was discovered
after 20 minutes of aortic clamping that sterile water rather than normal saline had
been administered as intravenous fluid. A further two pigs in the diclofenac group
developed persistent anuria soon after application of the aortic cross clamp so that
clearance measurements for the calculation of RBF and GFR could no longer be
performed. The above animals (one in the diclofenac plus enalaprilat group and three
in the diclofenac group) were therefore excluded from the study.
Separate statistical analyses were done firstly between the diclofenac and control
groups, and secondly between the diclofenac plus enalaprilat and the enalaprilat (from
section 2.2.2) groups. This was considered justifiable as argued in section 2.2.2.
2.3.1 Statistical analysis
Statistical analysis was performed in collaboration with Dr. S. Maritz of the Institute for
Biomedical Statistics of the Medical Research Council.
For the analysis of all data in the human study and for the analysis of intragroup
changes in the animal studies, a standard computer software package (Sigmastat
version 5.0 for DOS; Jandel Scientific Software, San Rafael, California, USA) was
used. Within-group measurements were evaluated using analysis of variance
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(ANOVA) for repeated measurements and between-group comparisons were made
using one-way ANOV A. If the data were not normally distributed (Kolmogorov-Smirnov
test, p < 0.05) and/or did not have equal variances (Levene Median test, p < 0.05),
equivalent non parametric tests were performed. These were the Friedman two-way
repeated measures ANOVA on ranks and the Kruskal-Wallis ANOVA on ranks (Siegel
1953a). Post-hoc multiple comparison procedures were performed using the Student-
Newman-Keuls test. Paired and unpaired t-tests were done as appropriate when
comparing two groups and if these did not meet the criteria for normality of distribution
and equality of variances, the equivalent non-parametric tests were performed
(Wilcoxon signed rank test and rank sum test [Mann-Whitney]) (Siegel 1953b).
Nominal and proportional data were analysed using Chi-squared tests and Fisher's
exact test where expected values were less than five (Siegel 1953c). An alpha value
equal to or less than 0.05 was regarded as indicating a significant result.
For comparisons of intergroup data in the animal studies, analyses of changes from
one measurement period to the next were performed between the relevant animal
groups for reasons discussed in section 4.4. The MINITAB computer software
package (MINITAB Inc., State College, Pennsylvania, USA) was used for this purpose.
Comparisons between groups were made using one-way ANOV A. In cases of non-
homogeneous standard deviations, and where p-values were marginally close to the
0.05 cut-of for statistical significance, the Welch test (the approach of the MINITAB
program to the Behrens-Fisher problem) was performed to confirm the conclusions
suggested by the p-values. In the cases where the test on single variables did not
demonstrate significant differences, a global test of equality of the profiles of the
relevant animal groups were performed for confirmation. The Wilks statistic
(MANOVA) was used for this purpose.
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3.1 PATIENT STUDY
3.1.1 Intra-group changes at various measurement times in humans
3.1.1.1 Intra-group changes in 22 control patients
Timing of measurement steps:
Step 1:
Step 2:
Step 3:
Step 4:
Step 5:
Step 6:
Step 7:
awake control
post-induction before aortic clamping
immediately after aortic clamPing} Iperc amp
just before unclamping of aorta
immediately after aortic unclamping
4 hours after unclamping of aorta
24 hours after aortic unclamping (only ~rmicroglobulin)
RBF and the RBF/CO ratio were not influenced by the induction of anaesthesia and
surgery prior to aortic cross clamping (steps 1-2; Table 3.1). RBF decreased signifi-
cantly relative to awake control and intraoperative preclamp values subsequent to
application of the aortic cross clamp (50.4% and 48.2% reduction respectively). RBF
remained depressed throughout the period of clamping and immediately after release
of the clamp, relative to the two preelamp measurements. Four hours after unclamping
RBF was still decreased in comparison with the two preclamp measurements although
it had improved relative to the perelamp (during clamping: steps 3 and 4) and initial
postclamp values (Table 3.1). The RBF/CO ratio demonstrated the same patterns of
change as RBF, except that RBF/CO had not recovered relative to the two preelamp
measurements even 4 hours after aortic unclamping (Table 3.1).
Considering the changes in RBF, RVR predictably increased upon aortic cross
clamping and remained raised until after unclamping (Table 3.1). However, 4 hours
after unclamping RVR returned to values similar to the two sets of preelamp
calculations.
Hippuran extraction 4 hours after unclamping was lower than the 2 sets of preelamp
values, but the maximum change was less than 9% (Table 3.1).
GFR as measured by Cr51 EDTA clearance was not influenced by the induction and
maintenance of anaesthesia and surgery prior to clamping the aorta (Table 3.2). GFR
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decreased significantly after infrarenal cross clamping (54% lower that the preclamp
measurement) and remained low throughout the clamping period. It improved relative
to the two perelamp measurements subsequent to release of the clamp, but was still
significantly reduced in comparison with the two preelamp measurements. GFR
measurement 4 hours after unclamping demonstrated a further improvement relative to
the first measurement after unclamping, but was still significantly less than the
preelamp values. When using calculated Cerealas a measure of GFR, mean values and
changes concurred with Cr51 EDTA clearances, except that improvement in Cerealwas
delayed until 4 hours after aortic unclamping relative to perelamp and immediate post-
unclamp values (Table 3.2). FF remained unchanged throughout the experimental
period (Table 3.2).
Urine production decreased significantly after application of the aortic cross clamp
(Table 3.4) and remained depressed relative to preclamp urine volumes throughout the
experimental period. Although mean urine volume 4 hours after unclamping was more
than double volumes measured immediately after aortic cross clamping (statistically
non-significant), it was still significantly less than mean volumes measured during the
two preelamp measurement periods.
Fractional excretion of sodium (FENa)was significantly greater during the awake control
measurement period than any of the subsequent measurement periods (Table 3.4).
Total urinary sodium excretion (TUNa) demonstrated the same pattern, while the post-
induction measurement was also greater than the two perelamp measurements
(Table 3.4). Free water clearance (CH20) became more positive during the two
perclamp (during application of the cross clamp) measurement periods relative to the
awake control value (Table 3.4). Subsequent to release of the aortic cross clamp,
urinary concentration of I1rmicroglobulin increased relative to all previous
measurements. The mean values continued to rise in the urine samples collected 4
hours and 24 hours after aortic unclamping respectively, although these increases
were not significantly different from the measurements immediately after unclamping
(Table 3.4).
Systemic hemodynamic parameters remained relatively stable throughout the
experimental period. Heart rate remained unchanged until after unclamping, when it
increased relative to the two perclamp measurements (Table 3.3). Four hours after
unclamping the heart rate was greater than any of the previous measurement periods.
The two CVP measurements after unclamping were greater than the awake control
value (Table 3.3). CO and PAWP were unchanged throughout the experimental period
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(Table 3.3). Calculated SVR was greater in the awake control period than any of the
other measurement times (Table 3.3). Immediately before unclamping the aorta, SVR
was increased relative to the values in the two measurement periods after aortic
unclamping.
Both arterial and renal venous renin activity were uninfluenced by anaesthesia and the
initial surgical stimulus prior to aortic clamping, but increased significantly immediately
after clamping and remained elevated (relative to the first two measurements)
throughout the experimental period (Table 3.5). The serum aldosterone concentrations
remained unchanged until the second perelamp measurement. Thereafter they
increased relative to the two preclamp concentrations whence they continued to rise so
that the 4 hour post-unclamp measurement was higher than the first four measurement
periods (Table 3.5). ACTH concentrations only increased relative to awake control
values at the pre-unclamp (step 4) measurement period (Table 3.5). The highest
concentrations were obtained after unclamping with values immediately after
unclamping greater than all previous measurement periods and the 4 hour post-
unclamp concentrations higher than both preclamp measurements and the first
measurement after aortic clamping. ADH concentrations increased significantly on
commencement of surgery relative to the awake values (Table 3.5). A further increase
occurred after aortic unclamping, with both post-unclamp concentrations (steps 5 and
6) being greater than all measurement steps prior to unclamping.
All intraoperative and the 4 hours post-unelamp measurements of hematocrit were
lower than the preoperative control value (Table 3.6). The 4 hours post-unci amp mean
value was significantly greater than the postclamp (step 3) mean.
Body core temperature decreased intraoperatively relative to awake control
measurement, but recovered relative to intraoperative temperatures at 4 hours after
unclamping (Table 3.6).
All intraoperative nitroglycerine infusion rates were greater than the dose administered
4 hours postoperatively (Table 3.6). The preelamp and postclamp (steps 2 and 3)
infusion rates were also significantly greater than the dose immediately after
unclamping.
Cr51 EDTA and 1125 hippuran concentrations were relatively constant within
measurement periods with no significant differences between the measurement steps
(Table 3.7).
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Table 3,1 Renal hemodynamic variables in 22 control patients
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
RBF 1 22 1258.3 342.1 72.9 c,d,e,f
(ml.min") 2 19 1204.5 349.8 80.2 c,d,e,f
3 18 623.4 158.2 37.3 a.b.f
4 19 687.2 269.4 61.8 a,b,f
5 19 727.2 315.1 72.3 a,b,f
6 15 994.9 316.5 81.7 a,b,c,d,e
RBFICO 1 22 0.244 0.067 0.014 c,d,e,f
2 19 0.206 0.113 0.024 c,d,e,f
3 18 0.112 0.071 0.015 a,b
4 19 0.132 0.081 0.017 a,b
5 19 0.112 0.067 0.014 a,b
6 15 0.124 0.099 0.021 a,b
RVR 1 22 6.69 1.78 0.38 6.52 5.38 7.66 c,d,e
(dyn.s.crn") 2 19 5.75 1.92 0.44 5.39 4.88 7.03 c,d,e
3 18 10.28 2.94 0.69 9.43 7.74 13.01 a,b,f
4 19 10.38 4.41 1.01 9.74 7.56 11.94 a,b,f
5 19 10.59 5.50 1.26 9.56 6.88 12.22 a,b,f
6 15 6.65 1.85 0.48 6.82 5.33 7.38 c,d,e
EH1P 1 22 0.67 0.102 0.022 f
2 19 0.66 0.090 0.021 f
3 18 0.64 0.062 0.014
4 19 0.65 0.072 0.016
5 19 0.63 0.071 0.016
6 15 0.61 0.050 0.013 a,b
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05);
e = significantly different from step 5 (p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (RBF, RBFlCO, EH1P).
Friedman ANOVA on ranks; Student-Newman-Keuls (RVR).
RBF = renal blood flow; RBFICO = renal blood flow as a fraction of cardiac output; RVR = renal vascular resistance;
EH1P = Hippuran extraction fraction.
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Table 3.2 Glomerular function variables in 22 control patients
Variable Step N Mean 50 SE Median 25 75 InterstepPerc Perc differences
GFR 1 22 97.8 22.82 4.87 c,d,e,f
(ml.rnin.") 2 22 98.5 31.88 6.8 c.d.e.f
3 22 45.3 13.64 2.98 a,b,e,f
4 22 50.7 27.74 5.91 a,b,e,f
5 22 61.7 24.5 5.22 a,b,e,f
6 22 76.1 21.73 4.63 a,b,c,d,e
C creat 1 22 92.2 17.05 3.63 89.6 77 110.4 c.d.e.f
(rnl.rnin.") 2 22 90.7 17.66 3.77 92.5 74.8 105 c,d,e,f
3 22 48.9 21.12 4.5 46.4 38.8 53.1 a,b,f
4 22 48.7 18.9 4.03 44.3 36 59 a.b.f
5 22 57.7 20.04 4.27 54 43.9 64.8 a,b,f
6 22 72.3 17.26 3.68 59.8 48 84.3 a.b.c.d,e
FF 1 22 0.2 0.039 0.008
2 22 0.21 0.057 0.012
3 22 0.19 0.063 0.014
4 22 0.18 0.067 0.014
5 22 0.22 0.063 0.013
6 22 0.22 0.06 0.013
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (GFR, FF).
Friedman ANOVA on ranks; Student-Newman-Keuls (Cereat).
GFR = glomerular filtration rate (measured by clearance of Crs, EDTA); C creat= calculated creatinine clearance;
FF = filtration fraction.
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Table 3.3 Systemic hemodynamic variables in 22 control patients
Variable Step N Mean SO SE Interstepdifferences
HR 1 22 74.45 12.48 2.66 f
(beats.rnin') 2 22 75.82 14.85 3.17 f
3 22 69.41 16.05 3.42 e,f
4 22 71.32 17.03 3.63 e,f
5 22 80.41 16.30 3.48 c,d,f
6 22 92.36 19.71 4.20 a,b,c,d,e
MAP 1 22 107 14.89 3.17 b,c,d,e,f
(mmHg) 2 22 91.23 15.03 3.20 a
3 22 85.79 10.38 2.21 a
4 22 88.76 15.54 3.31 a
5 22 91.23 12.97 2.76 a
6 22 88.86 13.95 2.98 a
CVP 1 22 7.14 2.21 0.47 e,f
(mmHg) 2 22 9.36 3.51 0.75
3 22 9.73 3.62 0.77
4 22 9.82 3.53 0.75
5 22 10.18 2.36 0.50 a
6 22 10.82 4.44 0.95 a
PAWP 1 22 11.27 3.77 0.80
(mmHg) 2 22 11.00 3.30 0.70
3 22 12.41 4.06 0.87
4 22 12.23 2.89 0.62
5 22 12.05 3.87 0.83
6 22 13.36 4.72 1.01
CO 1 22 5.27 0.97 0.21
(l.rnin") 2 22 5.42 1.37 0.29
3 22 5.02 1.32 0.28
4 22 4.80 1.24 0.27
5 22 5.78 1.43 0.31
6 22 5.97 1.45 0.31
SVR 1 22 1540.3 280.6 59.6 b,c,d,e,f
(dyn.s.crn") 2 22 1242.6 262.5 55.6 a
3 22 1255.6 249.4 52.8 a
4 22 1360.2 322.1 68.1 a,e,f
5 22 1160.2 254.5 53.9 a,d
6 22 1098.8 316.4 69.8 a,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; CVP = central venous pressure; PAWP = pulmonary artery
occlusion pressure; CO = cardiac output; SVR = systemic vascular resistance.
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Table 3.4 Parameters of renal tubular function in 22 control patients
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
Uvol 1 22 5.32 4.12 0.88 3.75 2.95 6.25 c,d,e,f
(rnl.min') 2 22 4.24 2.29 0.49 4.14 2.03 5.40 c,d,e,f
3 22 1.54 0.76 0.16 1.68 0.87 2.25 a,b
4 22 1.69 0.85 0.18 1.53 1.00 2.25 a,b
5 22 2.19 1.11 0.24 2.48 1.10 3.0 a,b
6 22 3.17 3.00 0.64 2.20 1.17 3.3 a,b
FEN. 1 22 0.04 0.019 0.004 0.030 0.03 0.05 b,c,d,e,f
2 22 0.03 0.020 0.004 0.030 0.014 0.04 a
3 22 0.02 0.013 0.003 0.012 0.01 0.03 a
4 22 0.02 0.019 0.004 0.015 0.01 0.04 a
5 22 0.03 0.020 0.004 0.020 0.01 0.04 a
6 22 0.03 0.039 0.008 0.020 0.01 0.03 a
TUNa 1 22 0.544 0.227 0.048 0.512 0.392 0.641 b,c,d,e,f
(rnêq.min") 2 22 0.353 0.200 0.042 0.317 0.197 0.486 a,c,d
3 22 0.116 0.072 0.015 0.097 0.066 0.178 a,b
4 22 0.138 0.096 0.020 0.106 0.065 0.186 a,b
5 22 0.201 0.143 0.030 0.176 0.101 0.321 a
6 22 0.338 0.395 0.084 0.203 0.115 0.360 a
CH20 1 22 -0.82 3.04 0.65 -1.62 -0.87 -2.69
(rnl.rnin") 2 22 -0.53 1.88 0.40 -0.99 -0.38 -1.63
3 22 -0.52 0.43 0.09 -0.45 -0.32 -0.77
4 22 -0.63 0.58 0.13 -0.61 -0.38 -0.95
5 22 -0.70 0.61 0.13 -0.79 -0.54 -1.00
6 22 -1.24 1.74 0.37 -0.81 -0.55 -1.27
[l,2-micro 1 22 0.35 0.51 0.11 0.2 0.16 0.35 e,f,g
(nq.rnl') 2 22 0.28 0.24 0.05 0.2 0.20 0.36 e,f,g
3 22 0.65 1.26 0.27 0.2 0.13 0.40 e,f,g
4 22 0.87 1.30 0.28 0.31 0.28 0.90 e,f,g
5 22 2.10 2.03 0.43 1.63 0.70 2.81 a,b,c,d
6 22 6.37 5.64 1.20 5.18 1.80 10.40 a.b.c.d
7 21 10.28 8.92 1.95 9.0 1.93 15.59 a,b,c,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly different from
step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5 (p< 0.05); f = significantly
different from step 6 (p < 0.05); g = significantly different from step 7 (p < 0.05).
Friedman ANOVA on ranks; Student-Newman-Keuls.
Uvol = urine volume; FEN. = fractional excretion of sodium; TUNa = total urinary excretion of sodium; CH20 = free water
clearance; [l,2-micro = f),2-microglobulin.
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Table 3.5 Hormonal changes in 22 control patients
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
Pren 1 22 1.45 1.45 0.31 0.90 0.5 2.1 c,d,e,f
(lig.r'.h(') 2 22 1.80 1.40 0.30 1.34 0.77 2.6 c,d,e,f
3 22 4.47 3.33 0.71 3.41 2.4 5.84 a,b
4 22 5.82 10.04 2.14 3.62 2.5 5.0 a,b
5 22 3.86 2.80 0.60 2.51 2.1 4.37 a,b
6 22 5.93 10.37 2.21 2.90 2.28 4.9 a,b
RVren 1 22 1.94 1.59 0.34 1.84 0.6 2.4 c,d,e,f
(lig.r'.h(') 2 22 2.14 1.58 0.34 1.71 1.02 3.2 c,d,e,f
3 22 7.09 5.11 1.09 5.23 3.6 8.56 a,b
4 22 8.44 9.34 1.99 5.61 3.5 7.74 a,b
5 22 5.97 3.84 0.82 4.51 3.39 8.6 a,b
6 22 7.39 10.15 2.16 4.16 2.9 7.52 a,b
ACTH 1 21 13.41 8.05 1.76 13.1 7.6 15.63 d,e,f
(rnq.l") 2 22 95.14 163.79 34.92 12.2 7.3 99.60 e,f
3 22 76.27 105.32 22.46 21.3 5.0 79.70 e,f
4 22 141.72 199.88 42.61 19.5 7.2 204.7 a,e
5 22 250.80 263.96 56.28 145.05 8.9 526.7 a,b,c,d
6 22 222.68 214.08 45.64 156.75 27.7 405.9 a,b,c
Aldosterone 1 21 107.09 77.99 17.02 138.0 41.9 139.0 d,e,f
(pmol.l') 2 22 112 66.00 14.07 138.5 41.6 139.0 d,e,f
3 22 168.8 122.66 26.15 139.0 115.0 191.0 e,f '"
4 22 248.64 129.98 27.71 226.5 164.0 308.0 a,b
5 22 343.86 251.96 53.72 282.5 161.0 476.0 a,b,c
6 22 400.68 308.74 65.82 304.0 192.0 511.0 a,b,c,d
ADH 1 21 1.30 0.93 0.20 1.15 0.7 1.83 b,c,d,e,f
(pq.rnl') 2 22 9.77 9.12 1.94 6.43 1.7 19.24 a.e.f
3 22 9.66 8.76 1.87 8.62 1.32 14.06 a,e,f
4 22 10.23 8.99 1.92 9.65 1.2 18.5 a,e,f
5 22 15.23 9.78 2.08 18.34 5.26 24.5 a.b.c.d
6 22 17.42 8.16 1.74 20.55 11.21 24.5 a,b,c,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05).
Friedman ANOVA on ranks; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity; ACTH = adrenocorticotrophic hormone;
DH = antidiuretic hormone
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Table 3.6 Diverse parameters, which may influence renal hemodynamics in 22 control
patients
Variable Step N Mean SO SE Median 25 Perc 75 Perc Interstepdifferences
Hct 1 22 38.8 4.00 0.85 b,c,d,e,f
(%) 2 22 33.3 5.05 1.08 a
3 22 32.8 4.26 0.91 a,f
4 22 34.4 4.86 1.04 a
5 22 35.3 4.76 1.02 a
6 22 35.9 4.22 0.90 a,c
Temp 1 22 36.2 0.60 0.13 36.2 35.8 36.7 b,c,d,e
(OC) 2 22 35.6 0.35 0.08 35.6 35.3 35.8 a,f
3 22 35.3 0.48 0.10 35.4 34.9 35.6 a,f
4 22 35.4 0.58 0.12 35.3 34.9 35.7 a,f
5 22 35.4 0.56 0.12 35.3 35.0 35.8 a,f
6 22 36.9 1.12 0.24 36.5 36.0 37.8 b,c,d,e
TNT 1 22 0
(~g.kg·lmin·l) 2 22 1.55 0.64 0.14 e,f
3 22 1.55 0.80 0.17 e,f
4 22 1.32 0.57 0.12 f
5 22 1.07 0.44 0.10 b,c,f
6 22 0.52 0.11 0.02 b,c,d,e
a = significantly different from step 1(p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (Hct, TNT).
Friedman ANOVA on ranks; Student-Newman-Keuls (Temp).
Hct = hematocrit; Temp = blood temperature; TNT = maximum intravenous infusion rate of nitroclycerine.
Table 3.7 Differences in arterial isotope counts between two samples per
measurement time in 22 control patients
Variable Step N Mean SO SE Median 25 75Perc Perc
% Cr51 1 22 3.87 3.08 0.66 3.5 1.3 5.6
2 22 4.15 3.55 0.76 3.7 1.3 6.4
3 22 4.85 3.50 0.75 4.05 1.9 6.6
4 22 4.65 4.02 0.86 2.95 1.7 7.1
5 22 3.14 2.96 0.63 2.75 0.9 4.5
6 21 2.98 3.03 0.66 1.5 0.93 4.45
% 1125 1 22 8.86 5.15 1.10 9.35 4.9 10.8
2 22 7.07 5.79 1.23 5.50 2.4 9.6
3 22 6.18 4.35 0.93 5.20 3.7 8.3
4 22 5.95 6.48 1.38 3.95 1.2 7.9
5 22 5.40 5.29 1.13 4.65 1.1 6.7
6 21 6.55 6.55 1.43 3.20 1.88 11.1
No interstep differences
ANOVA; Student-Newman-Keuls
% Cr51 = % difference in arterial Cr51 concentrations between 1st and 2nd blood sample per measurement step;
% 1125 = % difference in arterial I'" concentrations between 1st and 2nd blood sample per measurement step.
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3.1.1.2 Intra-group changes in 23 patients who received mannitol and
dopamine
Step 3:
Step 4:
Step 5:
Step 6:
Step 7:
immediately after aortic clamPing}
perclamp
just before unclamping of aorta
immediately after aortic unclamping
4 hours after unclamping of aorta
24 hours after aortic unclamping (only f1rmicroglobulin)
Timing of measurement steps:
Step 1: awake control
Step 2: post-induction before aortic clamping
RBF and the RBF/CO ratio were uninfluenced by anaesthesia and surgery prior to
infrarenal aortic cross clamping (steps 1-2; Table 3.8). Both parameters decreased
significantly immediately after application of the cross clamp (49.5% and 40.8%
respectively, relative to the preelamp values). RBF and RBF/CO remained depressed
throughout the rest of the experimental period relative to the two preclamp
measurements. Four hours after unclamping, both parameters were still significantly
depressed relative to preclamp values (34% reduction in RBF and 45.2% decrease in
RBF/CO ratio).
All calculated RVR values after aortic cross clamping were significantly greater than the
preelamp value (Table 3.8). The two perclamp and immediately post-unelamp RVR
calculations were also increased relative to the awake control RVR, but 4 hours after
unclamping RVR had returned to values similar to the awake control calculations.
Although the hippuran extraction 4 hours after aortic unclamping was only 12% less
than the awake control measurement, this difference was nevertheless statistically
significant due to little scatter of the data (Table 3.8).
GFR as measured by Cr51 EDTA clearance decreased subsequent to induction of
anaesthesia and commencement of surgery relative to the awake control measure-
ment, (Table 3.9). The two perclamp measurements and immediately post-unelamp
value were significantly less than the two preclamp measurements. Although GFR 4
hours after unclamping had increased relative to the perelamp and immediately post-
unclamp measurements, it was still significantly less than the awake control value
(28.6% difference). When using calculated Cereal as a measure of GFR, mean values
and changes concurred with Cr1 EDTA clearances except that the 4 hour post-
unclamp value was still decreased relative to both preelamp measurement times
(Table 3.9).
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FF during the perelamp period decreased significantly relative to awake controls, but
was again comparable to control values subsequent to release of the aortic cross
clamp (Table 3.9).
Although urine production immediately after aortic cross clamping decreased relative to
both preclamp measurements, none of the subsequent volumes differed significantly
from any of the preelamp measurements (Table 3.11). FENa and TUNa remained
unchanged throughout the experimental period (Table 3.11). CH20 was more negative
4 hours after unclamping than any of the calculated values in earlier measurement
periods (Table 3.11). Subsequent to release of the aortic cross clamp, urinary 11z-
microglobulin concentration increased relative to all previous measurements
(Table 3.11). Mean l1z-microglobulin concentrations continued to rise in urine samples
collected 4 hours and 24 hours after unclamping, although these values were not
significantly different from the measurement immediately after unclamping due to large
scatter of data.
Systemic hemodynamic parameters were relatively stable throughout the experimental
period. Heart rate increased after induction of anaesthesia during the initial surgical
phase, but returned to awake control values after aortic clamping (Table 3.10). Four
hours after unclamping, heart rate was increased relative to all previous measurement
periods. MAP decreased after induction of anaesthesia and after aortic cross clamping
it decreased further, to values less than both preelamp measurements (steps 1 and 2)
as well as both post-unelamp measurements (steps 5 and 6) (Table 3.10). The
measurement immediately prior to unclamping increased to the extent that it did not
differ from other measurements except for being lower than awake control and 4 hours
post-unelamp measurements. Awake control CVP measurement was less than the
value just before aortic unclamping and the two post-unelamp measurements (Table
3.10). The first postclamp PAWP measurement was statistically significantly lower
than the measurements in the subsequent three measurement periods (Table 3.10).
Cardiac output decreased upon aortic cross clamping in comparison to the
measurement immediately prior to clamping (Table 3.10). The first CO after aortic
clamping was also significantly less than the two post-unelamp measurements.
Induction of anaesthesia and aortic unclamping (steps 2 and 5 respectively) produced
a reduction in SVR relative to the awake control calculation (Table 3.10).
Arterial and renal venous renin activity were uninfluenced by anaesthesia and the initial
surgical period, but increased significantly immediately after aortic clamping and
remained elevated relative to the two preelamp measurements throughout the rest of
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the experimental period (Table 3.12). The serum aldosterone concentrations
demonstrated the same trends (Table 3.12). Serum ADH concentrations increased
subsequent to anaesthetic induction and commencement of surgery and showed no
additional response to aortic clamping, but both measurements after unclamping were
increased relative to all previous concentrations (Table 3.12). All post-induction ACTH
concentrations were greater than awake the control concentrations (Table 3.12). The
two post-unclamp measurements were also raised in comparison with the two
preelamp and first postclamp concentrations.
All intra-operative hematocrit values were less than awake control measurements, with
return to control values 4 hours post-unelamp (Table 3.13). The 4 hours post-unclamp
measurement was also greater than the two perelamp measurements and the
immediate post-unclamp value already showed an improvement on the first perclamp
concentration.
Body core temperature decreased intraoperatively relative to awake control
measurement, but recovered relative to intraoperative temperatures at 4 hours after
unclamping (Table 3.13). The first perelamp measurement was also significantly lower
than the intraoperative preclamp temperature, but mean temperatures never decreased
below 35°C.
All intraoperative nitroglycerine infusion rates were comparable and greater than the
dose administered 4 hours after unclamping (Table 3.13).
Cr51 EDTA and 1125 hippuran concentrations were relatively constant within measure-
ment periods throughout the experimental period with only the awake control and first
postclamp measurements of 1125 hippuran demonstrating differences of significance
(Table 3.14).
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Table 3.8 Renal hemodynamic variables in 23 patients who received mannitol and dopamine.
Variable Step N Mean SO SE Median 25 Perc 75 Perc
Interstep
differences
RBF 1 19 1255.4 271.3 62.2 c.d.e.t
(rnl.rnin' ) 2 19 1404.8 436.2 100.1 c,d,e,f
3 19 709.8 313.9 76.1 a,b
4 17 831.3 289.7 66.5 a,b
5 16 781.9 267.9 71.6 a,b
6 12 925.6 247.2 87.4 a,b
"or/co 1 19 0.239 0.066 0.015 c,d,e,f
2 19 0.250 0.108 0.024 c,d,e,f
3 19 0.148 0.058 0.014 a,b
4 17 0.160 0.071 0.016 a,b
5 16 0.132 0.058 0.016 a,b
6 12 0.137 0.064 0.021 a,b
RVR 1 19 6.67 2.05 0.47 c,d,e
(dyn.s.cm") 2 19 5.57 2.16 0.50 c,d,e,f
3 19 11.04 5.22 1.27 a,b
4 17 9.31 4.13 0.95 a,b
5 16 10.25 4.10 1.10 a,b
6 12 8.72 3.07 1.09 b
EH1P 1 19 0.72 0.073 0.017 0.74 0.68 0.76 f
2 19 0.66 0.076 0.017 0.66 0.61 0.71
3 19 0.67 0.072 0.018 0.68 0.61 0.71
4 17 0.64 0.076 0.017 0.63 0.58 0.68
5 16 0.63 0.073 0.019 0.61 0.59 0.67
6 12 0.63 0.080 0.028 0.62 0.57 0.67 a
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly different from
step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5 (p < 0.05);
f = significantly different from step 6 (p < 0.05).
AN OVA, Student-Newman-Keuls (RBF, RBF/CO, RVR).
Friedman ANOVA on ranks; Student-Newman-Keuls (EHlP)'
RBF = renal blood flow; RBF/CO = renal blood flow as a fraction of cardiac output; RVR = renal vascular resistance;
EH1P = hippuran extraction fraction.
Table 3.9 Glomerular function variables in 23 patients who received mannitol and dopamine
Variable Step N Mean SO SE
Interstep
differences
GFR 1 23 103.4 31.6 6.59 b,c,d,e,f
(ml.min' ) 2 23 86.2 22.29 4.65 a,c,d,e
3 23 40.5 15.49 3.23 a,b,f
4 23 48.4 20.56 4.29 a,b,f
5 23 48.1 24.93 5.2 a,b,f
6 19 73.5 26.63 6.11 a,c,d,e
Cereat 1 23 97.7 16.36 3.41 c,d,e,f
(rnl.rnin ) 2 22 93.7 17.51 3.73 c,d,e,f
3 22 43.7 13.20 2.81 a,b,f
4 22 50.9 15.91 3.39 a,b,f
5 22 50.2 19.12 4.08 a,b,f
6 22 72.5 20.09 4.28 a,b,c,d,e
FF 1 23 0.20 0.04 0.009 c,d
2 23 0.17 0.06 0.012
3 23 0.16 0.04 0.009 a,e,f
4 23 0.15 0.04 0.009 a,e,f
5 23 0.19 0.06 0.013 c,d
6 19 0.20 0.06 0.014 c,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls.
GFR = glomerular filtration rate (measured by clearance of Cr51 EDTA); Ccreat= calculated creatinine clearance;
FF = filtration fraction.
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Table 3.10 Systemic hemodynamic variables in 23 patients who received mannitol and dopamine
Variable Step N Mean SO SE Median 25 Perc 75 Perc Interstepdifferences
HR 1 23 75.96 14.4 3.0 b,f
(beats.min' ) 2 23 84.09 16.65 3.47 a,c,d,f
3 23 74.78 15.77 3.29 b,f
4 23 73.96 15.86 3.31 b,f
5 23 81.04 12.31 2.57 f
6 23 91.43 16.42 3.42 a.b.c.d.e
MAP 1 23 107.48 16.76 3.49 109.0 101.0 117.5 b,c,d
(mmHg) 2 23 95.65 17.61 3.67 94.5 82.0 106.0 a,c
3 23 88.39 12.78 2.66 87.5 79.5 94.75 a,b,e,f
4 23 92.87 13.66 2.85 92.0 81.25 98.75 a,f
5 23 99.26 15.71 3.28 100.0 89.0 112.0 c
6 23 103.22 17.81 3.71 102.5 88.25 119.25 c,f
CVP 1 23 6.52 4.23 0.88 6.0 3.0 10.0 d,e,f
(mmHg) 2 23 7.83 3.82 0.80 8.0 4.0 10.5
3 23 7.96 3.52 0.73 8.0 4.5 10.75
4 23 8.54 3.38 0.71 9.0 5.5 10.75 a
5 23 9.09 4.16 0.87 9.0 6.0 11.75 a
6 23 9.22 3.45 0.72 9.0 7.0 11.0 a
PAWP 1 23 9.61 5.23 1.09 9.0 6.0 13.25
(mmHg) 2 23 10.43 5.16 1.08 10.0 6.5 13.50
3 23 9.65 5.39 1.24 8.5 6.0 13.50 d,e,f
4 23 11.26 5.06 1.05 10.0 8.0 14.00 c
5 23 12.13 5.14 1.07 11.0 8.25 14.75 c
6 23 12.43 4.73 0.99 12.0 10.0 14.75 c
CO 1 23 5.54 1.17 0.25
(l.min' ) 2 23 5.93 1.46 0.30 c
3 23 4.97 1.10 0.23 b,e,f
4 23 5.37 1.55 0.32
5 23 6.25 1.32 0.28 c
6 23 5.95 2.09 0.44 c
SVR 1 23 1508.5 455.6 94.8 b,e
(dyn.s.crn") 2 23 1214.2 322.1 67.0 a
3 23 1351.7 453.4 94.3
4 23 1313.6 378.9 78.9
5 23 1205.6 408.5 85.2 a
6 23 1404.5 601.7 125.0
a = signigicantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05);
e = significantly different from step 5 (p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (CO, HR, SVR).
Friedman ANOVA on ranks; Student-Newman-Keuls (PAWP, MAP, CVP).
CO = cardiac output; HR = heart rate; PAWP = pulmonary artery occlusion pressure; MAP = mean arterial pressure;
CVP = central venous pressure; SVR = systemic vascular resistance.
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Table 3.11 Parameters of renal tubular function in 23 patients who received mannitol and dopamine
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
Uvol 1 23 6.51 3.64 0.76 6.5 3.68 9.34 c
(ml.min ) 2 23 7.01 4.25 0.89 7.0 2.75 9.94 c
3 23 4.07 2.41 0.5 3.53 2.81 4.19 a,b
4 23 4.85 3.07 0.64 3.9 3.00 6.21
5 23 4.34 2.42 0.50 4.25 2.78 5.86
6 23 5.35 3.10 0.65 5.5 2.33 7.60
FENa 1 23 0.05 0.035 0.007
2 22 0.06 0.039 0.008
3 22 0.09 0.061 0.013
4 22 0.08 0.053 0.011
5 22 0.08 0.038 0.008
6 22 0.08 0.044 0.009
TUNa 1 23 0.671 0.401 0.083
(rnêq.rnln' ) 2 22 0.778 0.443 0.094
3 22 0.487 0.367 0.078
4 22 0.516 0.328 0.070
5 22 0.530 0.295 0.063
6 22 0.718 0.455 0.097
CH20 1 23 -0.13 2.32 0.48 -0.36 1.20 -1.79 f
(rnl.mln' ) 2 22 -0.70 1.78 0.38 -1.13 -0.48 -1.55 f
3 22 -0.88 1.38 0.30 -0.50 -0.35 -0.89 f
4 22 -0.73 0.87 0.19 -0.55 -0.29 -1.18 f
5 22 -0.78 0.69 0.15 -0.71 -0.32 -1.25 f
6 22 -1.82 1.43 0.3 -1.67 -0.8 -2.38 a,b,c,d,e
f:l.rmicro 1 23 0.33 0.49 0.10 0.20 0.16 0.22 e,f,g
(nq.rnl') 2 23 0.44 0.42 0.09 0.26 0.2 0.48 e,f,g
3 23 0.93 1.81 0.38 0.31 0.2 0.87 e,f,g
4 23 1.97 3.99 0.83 1.00 0.21 1.69 e,f,g
5 22 3.38 3.47 0.74 2.11 1.37 3.33 a,b,c,d
6 23 9.92 13.92 2.90 5.00 1.3 10.5 a,b,c,d
7 21 16.26 12.08 2.64 15.95 6.5 26.9 a,b,c,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5
(p < 0.05); f = significantly different from step 6 (p < 0.05); g = significantly different from step 7 (p < 0.05).
AN OVA; Student-Newman-Keuls (FENa,TUNa).
Friedman ANOVA on ranks; Student-Newman-Keuls (Uvol, CH20. f:l.2-micro)
Uvol = urine volume; FENa = fractional excretion of sodium; TUNa = total urinary excretion of sodium; CH20 = free
water clearance; f:l.2-micro = f:l.2-microglobulin.
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Table 3.12 Hormonal changes in 23 patients who received mannitol and dopamine
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
Pren 1 23 1.11 0.75 0.16 c,d,e,f
().lg.!" .hr') 2 22 1.43 1.33 0.28 c,d,e,f
3 23 6.60 11.15 2.33 a,b
4 23 7.10 10.83 2.26 a,b
5 23 7.24 9.86 2.06 a,b
6 23 6.00 11.52 2.40 a,b
RVren 1 23 1.39 11.15 0.24 c,d,e,f
().lg.r1.h(1) 2 22 2.05 2.02 0.43 c,d,e,f
3 23 8.06 11.45 2.39 a,b
4 23 8.83 10.78 2.25 a,b
5 23 10.8 11.49 2.40 a,b
6 23 7.20 11.90 2.48 a,b
ACTH 1 22 15.31 20.60 4.39 8.00 5.0 15.8 b,c,d,e,f
(mq.l") 2 22 52.36 85.77 18.29 21.55 8.3 65.8 a,e,f
3 22 55.77 81.4 17.35 27.05 10.8 50.7 a,e,f
4 22 79.52 97.19 20.72 39.6 11.1 107.2 a
5 22 190.32 222.83 47.51 88.8 17.3 380.2 a,b,c
6 22 220.55 216.65 46.19 167.5 19.7 360.6 a,b,c
Aldosterone 1 22 112.5 114.81 24.47 139.0 50.0 139.0 c,d,e,f
(pmol.l") 2 22 102.53 97.92 20.88 139.0 40.2 124.0 c,d,e,f
3 22 163.18 57.22 12.02 139.0 108.0 188.0 a,b
4 22 230.7 138.22 29.43 182.5 139.0 294.0 a,b
5 22 240.97 140.92 30.04 179.0 139.0 334.0 a,b
6 22 274.48 263.74 56.23 227.5 143.0 441.0 a,b
ADH 1 22 1.36 1.17 0.25 b,c,d,e,f
(pq.rnl') 2 22 12.45 8.71 1.86 a,e,f
3 22 10.23 8.29 1.77 a,e,f
4 22 10.47 8.58 1.83 a,e,f
5 22 16.92 8.97 1.91 a,b,c,d
6 22 17.51 8.56 1.83 a,b,c,d
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05);
e = significantly different from step 5 (p < 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (Pren, RVren, ADH).
Friedman ANOVA on ranks; Student-Newman-Keuls (ACTH, Aldosterone).
Pren = arterial renin activity; RVren = renal venous renin activity; ACTH = adrenocorticotrophic hormone; ADH = antidiuretic
hormone.
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Table 3.13 Diverse variables which may influence renal hemodynamics in 23 patients who
received mannitol and dopamine
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
Hct 1 23 39.91 4.48 0.93 b.c.d,e
(%) 2 23 34.96 5.62 1.17 a
3 23 32.78 4.45 0.93 a.e.f
4 23 33.48 3.75 0.78 a,f
5 23 36.57 5.22 1.09 a,c
6 23 38.39 5.59 1.17 c,d
Temp 1 23 36.00 0.69 0.14 36.0 35.70 36.48 b,c,d,e
(OC) 2 23 35.40 0.85 0.18 35.5 34.73 36.00 a,c
3 23 35.06 0.89 0.19 35.3 34.43 35.70 a.b.f
4 23 35.25 0.91 0.19 35.4 34.70 35.88 a,f
5 23 35.23 0.88 0.18 35.4 34.73 35.93 a,f
6 23 36.43 1.08 0.22 36.0 36.00 36.85 c,d,e
TNT 1 23 0
(j.lg.kg- min- ) 2 23 1.7 1.24 0.26 f
3 23 1.83 1.74 0.36 f
4 23 1.96 1.78 0.37 f
5 23 1.52 0.85 0.18 f
6 23 0.52 0.10 0.02 b.c.d,e
a = significantly different from step 1(p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05); e = significantly different from step 5 (p
< 0.05); f = significantly different from step 6 (p < 0.05).
ANOVA; Student-Newman-Keuls (Hct, TNT).
Friedman AN OVA on ranks; Student-Newman-Keuls (Temp).
Hct = hematocrit; Temp = blood temperature; TNT = maximum intravenous infusion rate of nitroclycerine.
Table 3.14 Differences in arterial isotope counts between two samples per measure-
ment time in 23 patients who received mannitol and dopamine
Variable Step N Mean SO SE Median 25 75 InterstepPerc Perc differences
% Cr51 1 23 4.85 4.13 0.86
2 23 5.97 4.29 0.89
3 23 4.35 2.76 0.58
4 23 4.08 2.19 0.46
5 23 5.26 4.08 0.85
6 20 3.44 2.78 0.62
% 1125 1 23 8.71 7.14 1.49 7.8 4.55 11.55 c
2 23 6.57 5.25 1.10 6.4 1.80 9.92
3 23 4.13 3.70 0.77 2.9 1.95 5.52 a
4 23 4.97 3.38 0.71 5.3 2.18 6.77
5 23 4.50 3.55 0.74 2.8 2.08 7.57
6 20 5.16 5.19 1.16 2.9 1.70 8.15
a = significantly different from step 1 (p < 0.05); c = significantly different from step 3 (p < .05).
AN OVA; Student-Newman-Keuls (% C~1).
Friedman ANOVA on ranks; Student-Newman-Keuls (% 1125).
% Cr51 = % difference in arterial Cr51 concentrations between 1st and 2nd blood sample per measurement step;
% 1125= % difference in arterial1125 concentrations between 1st and 2nd blood sample per measurement step.
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3.1.2 Inter-group differences between control and mannitol plus dopamine
groups of patients
There were no differences in the preoperative demographic parameters of age, length,
body mass, body surface area (BSA), male: female ratio, the presence of diabetes,
hypertension or ischemic heart disease, or preoperative medication between the
control patients and the mannitol plus dopamine group of patients (Table 3.15)
Aortic cross clamp times were similar in the two patient groups (Table 3.16). Patients
in the mannitol plus dopamine group received significantly more intravenous
crystalloids in the immediate perioperative period (1 hour preoperatively until the end of
surgery) than control patients, but there were no differences between the two groups in
volumes of colloid and blood infused (Table 3.16).
In both groups of patients the creatinine clearance done on a 24 hour urine sample one
week postoperatively was significantly reduced relative to the Cereal done prior to
surgery (after admission to the ward) (Table 3.16). There were, however, no
differences between the control and mannitol plus dopamine groups in either the pre-
or postoperative Cereal values. Total 24 hour urinary creatinine excretion was 12210.8
(± 1052 (SO)) urnol and 12683.5 (± 1281 (SO)) urnol in control and mannitol plus
dopamine patient groups respectively.
Six patients (3 in the control group and 3 in the mannitol and dopamine group) had
serum creatinine concentrations greater than the upper limit of normal (120l-lmol. r1)
7 days postoperatively. These patients are grouped together and compared with all
patients with postoperative serum creatinine levels of less than 120l-lmol.r1 in
Table 3.16a. Although the preoperative serum creatinine concentrations were
significantly higher in the former group, both group means were still well within normal
limits. The preoperative as well as postoperative Cereal values in the patient group with
abnormal postoperative creatinine concentrations were significantly lower than the
patients with normal postoperative creatinine concentrations. While the postoperative
Cereal values were significantly lower than their respective preoperative values in both
groups, the preoperative-postoperative differences were substantially greater in the
patients with abnormal postoperative creatinine concentrations (f êml.rnin' vs
6.5 ml.rnin').
There were no differences in RBF (Figure 3.1 and Tables 3.1 and 3.8 respectively) or
the RBF/CO ratio (Figure 3.2 and Tables 3.1 and 3.8 respectively) between the control
group and the mannitol plus dopamine group of patients at any of the measurement
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times in the perioperative period. Similarly, calculated RVR did not differ between the
two groups at any of the sampling times (Figure 3.3 and Tables 3.1 and 3.8
respectively). Although there was a numerical difference of 7.5% in awake control EH1P
values between the control and mannitol plus dopamine groups (Tables 3.1 and 3.8
respectively), this difference was not statistically significant and the other perioperative
values were almost identical with significant overlap of SEM's (Figure 3.4).
Table 3.15 Preoperative demographic data of control patients and patients who
received mannitol and dopamine during infrarenal aortic aneurysm repair
Control patients Patients who received mannitol and
(n = 22) dopamine (n = 23)
Mean SO SE Mean SO SE
Age (years) 66.5 7.49 1.6 63.13 10.16 2.12
Length (centimetre) 167.36 8.96 1.91 168 9.22 1.92
Mass (kilogram) 68.27 15.32 3.27 66.06 15.35 3.2
BSA (rn") 1.76 0.2 0.04 1.74 0.22 0.05
Male: Female 16:6 16:7
Diabetics 4 3
Presence of ischemic heart disease 15 13
Presence of (controlled) hypertension 12 10
Preoperative medication 5 Diuretics • 7
5 a-methyldopa 4
3 rs-brockers 4
5 Glyceryltrinitrate 6
3 Digitalis 2
0 Prazosin 1
1 Nifedipine 1
No significant differences between groups (t-test).
Diuretics were stopped 2 days before surgery.
BSA = body surface area. Presence of ischemic heart disease based on previous myocardial infarct on resting ECG
and/or history of previous infarct and/or taking medication for angina and/or a positive stress ECG with coronary artery
disease demonstrated on coronary angiography. Serum electrolytes were within normal limits in all patients.
Table 3.16 Perioperative demographic and other relevant data in control patients and patients
who received mannitol and dopamine in the intra- and postoperative periods
Control patients Patients who received mannitol and
(n = 22) dopamine (n = 23)
Mean SO SE Mean SO SE
Cereat(ml.mln"):
1 day preoperatively. t [89.05 16.32 3.48 t [93.27 17.69 3.77
7 days post-operatively 80.47 19.48 4.47 83.57 18.25 3.98
Aortic cross clamp time (minutes) 73.0 14.13 3.01 75.91 15.45 3.22
Intravenous fluids (mi):
Crystalloid 5350.0* 991.7 211.4 6233.5* 1218.4 254.0
Colloid 1090.9 382.2 81.5 1130.4 438.6 91.5
Packed Red Cells (ml): 1323.9 408.1 85.1 1336.4 478.6 102.0
t = intra-group difference (p < 0.01)
* = intergroup difference (p < 0.05)
t - test
cereat= creatinine clearance (24 hour urine sample collection)
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Table 3.16a Creatinine clearance and serum creatinine values 1 day preoperatively
and 7 days postoperatively in both patient groups
Cr pre-op Cr post-op Ccrpre-op Ccrpost-op
Mean SO 95% Mean SO 95% Mean SO 95% Mean SO 95%
Postop Cr
88.5 t<12Ollmol.r1 83.7 11.5 79.7-87.7 83.8 11.2 81.8-86.7 95.0 13.4 92.7-97.4 14.9 85.8-91.1
(n = 34) r-;-
** ** **
Postop Cr
155.8 t 43.2 t>120 urnol.l' 96.7 9.0 92.2-101.2 13.2 149.3-162.4 61.2 3.8 59.3-63.1 4.7 40.8-45.5
(n = 6)
p < 0.05 }
differences between groups
p < 0.001
t p < 0.01 differences between postop and preop values within a group
differences between groups: unpaired t-test
differences within groups (between pre- and postop values): paired t-test
Cr = serum creatinine (urnol.l"): Cer = creatinine clearance (ml.min"): 95% = 95% confidence limits
Figure 3.1 Perioperative changes in renal blood flow in control patients and patients
who received mannitol and dopamine
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M4 = pre-unclamp
M5 = post-unclamp
M6 = 4 hours post-unclamp
No significant differences between
control and mannitol + dopamine groups
at the various measurement periods
Stellenbosch University http://scholar.sun.ac.za
Figure 3.2
Figure 3.3
73
Perioperative changes in renal blood flow as a fraction of cardiac output
(RBF/CO) in control patiens and patients who received mannitol and
dopamine
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No slgnlftcant differences between
control and mannitol + dopamine groups
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Perioperative changes in renal vascular resistance (RVR) in control
patients and patients who received mannitol and dopamine
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Figure 3.4 Perioperative changes in hippuran extraction fraction (EHlP) in control
patients and patients who received mannitol and dopamine
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Despite the 16.6% decrease in GFR induced by anaesthesia and exploratory surgery in
the mannitol plus dopamine group (versus maintenance of preoperative GFR in the
initial surgical period in the control group), none of the GFR values differed significantly
between the two patient groups (Figure 3.5 and Tables 3.2 and 3.9 respectively).
Calculated Cerealdid not differ between the control and drug manipulated groups at any
of the measurement periods (Figure 3.6 and Tables 3.2 and 3.9 respectively). Filtration
fractions were identical in the two groups preoperatively, but the mannitol plus
dopamine group demonstrated significantly reduced values just before application of
the aortic clamp and during the perclamp period relative to the control patients
(Figure 3.7 and Tables 3.2 and 3.9).
Volumes of urine production were similar between the two patient groups before
induction of anaesthesia (Figure 3.8 and Tables 3.4 and 3.11). Mannitol and dopamine
infusion had not been commenced at this stage (in that group of patients). Mannitol
plus dopamine infusion induced increased urine production relative to the control group
during the preelamp measurement period (p < 0.05). This difference was maintained
throughout the rest of the experimental period at an even more significant level
(p < 0.01). Predictably, as urinary sodium concentration (not shown in tables or
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figures) was consistently increased after commencement of the mannitol and dopamine
infusions, the TUNawas much greater throughout the rest of the experimental period in
the latter group in comparison to control patients (p < 0.001; Figure 3.9, Tables 3.4 and
3.11). Similarly, FENawas also greater in the mannitol plus dopamine patients than in
the control group for the duration of surgery and into the postoperative period (p < 0.01;
Figure 3.10, Tables 3.4 and 3.11). There were no differences in CH20 values between
the two groups of patients at any of the measurement times (Figure 3.11, Tables 3.4
and 3.11 respectively). Urinary l1z-microglobulin concentrations demonstrated identical
rising trends from the post-unclamp period onwards in the two patient groups with no
significant differences between them at any of the measurement periods (Figure 3.12,
Tables 3.4 and 3.11).
Figure 3.5 Peri operative changes in glomerular filtration rate in control patients and
patients who received mannitol and dopamine
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Perioperative changes in creatinine clearance in control patients and
patients who received mannitol and dopamine
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Perioperative changes in urine volume (Uvol) in control patients and
patients who received mannitol and dopamine
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Comparison of total urinary sodium excretion (TUNa) at different
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received mannitol and dopamine
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Perioperative changes in fractional excretion of sodium (FENA)in control
patients and patients who received mannitol and dopamine
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Figure 3.12 Perioperative changes in urinary B2-microglobulin concentrations in
control patients and patients who received mannitol and dopamine
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Figures were produced only for those hemodynamic variables, which may influence
renal hemodynamics and kidney function. The mean value for MAP in mannitol plus
dopamine patients was significantly greater than in control patients 4 hours after aortic
unclamping (Figure 3.13, Tables 3.3 and 3.10), without any significant differences at
the other measurement times. The PAWP immediately after aortic cross clamping was
higher in the control group than in mannitol plus dopamine patients (p < 0.05), with no
inter-group differences at any of the other measurement times (Figure 3.14, Tables 3.3
and 3.10). CVP measurements (Tables 3.3. and 3.10, no figure) were comparable
between the two groups at all measurement periods. There were no significant
differences in measured CO between the two groups of patients at any of the
measurement periods (Figure 3.15, Tables 3.3 and 3.10).
Other measured and calculated hemodynamic parameters (heart rate and SVR) were
not different between the two patient groups with the exception of the SVR 4 hours
after aortic unclamping which was significantly higher (p < 0.05) in the mannitol plus
dopamine group (Tables 3.3. and 3.10, no figures).
None of the measured hormonal concentrations (with the exception of the cate-
cholamine concentrations) demonstrated any differences between groups at any of the
measurement periods (Pren: Figure 3.16, Tables 3.5 and 3.12; RVren: Figure 3.17,
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Tables 3.5 and 3.12; ACTH: Figure 3.18, Tables 3.5 and 3.12; Aldosterone:
Figure 3.19, Tables 3.5 and 3.12; ADH: Figure 3.20, Tables 3.5 and 3.12). The plasma
noradrenaline and dopamine concentrations were both significantly greater in mannitol
plus dopamine patients than in control patients after application of the aortic cross
clamp while no differences were apparent prior to cross clamping (Table 3.17).
Table 3.17 Plasma catecholamine concentrations before and after aortic cross clamping in control
patients and patients who received mannitol and dopamine
Control (n = 11) Mannitol + Dopamine (n - 14)
Mean Median 25 Perc 75 Perc Mean Median 25
75
Perc Perc
Preclamp Noradrenaline 0.265 0.25 0.15 0.35 0.307 .[ 0.27 0.16 0.35
Postclamp Noradrenaline 0.360 0.29 0.21 0.41 t 0.753 0.37 0.990.55
Preclamp Adrenaline 0.128 0 0 0.23 0.062 0 0 0.11
Postclamp Adrenaline 0.132 0 0 0 0.088 0 0 0.20
Preclamp Dopamine 0 0 0 0 0.029
• [5:.0
0 0
Postclamp Dopamine 0 0 0 0 t 59.99 48.32 56.40
Wilcoxon signed rank test
• significant difference between preclamp and postclamp concentration within the group (p < 0.05)
t significant difference between patient groups at the same measurement time (p < 0.05)
Catecholamine concentrations in ng.mr' plasma
Figure 3.13 Perioperative changes in mean arterial pressure (MAP) in control patients
and patients who received mannitol and dopamine
MAP
(mm Hg)
M1 M2 M3 M4 M5 M6
Measurement Periods
o = control patients
o = mannitol + dopamine patients
** Significant difference between control
and mannitol + dopamine groups
(p < 0.01)
M2 = Intra-operative preclamp
M3 = postclamp
M4 = pre-unclamp
M5 = post-unclamp
M6 = 4 hours post-unclamp
M1 = awake control
Values are given as means, ± 1 SEM
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Perioperative changes in pulmonary artery wedge pressure (PAWP) in
control patients and patients who received mannitol and dopamine
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Perioperative changes in cardiac output (CO) in control patients and
patients who received mannitol and dopamine
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Perioperative changes in arterial plasma renin concentrations (Pren) in
control patients and patients who received mannitol and dopamine
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Perioperative changes in renal venous renin (RVren)concentrations in
control patients and patients who received mannitol and dopamine
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Perioperative changes in plasma adrenocorticotrophic hormone (ACTH)
concentrations in control patients and patients who received mannitol
and dopamine
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Perioperative changes in plasma aldosterone concentrations in control
patients and patients who received mannitol and dopamine
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Perioperative changes in plasma ADH concentrations in control patients
and patients who received mannitol and dopamine
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Measurements of other parameters which may influence renal hemodynamics and
kidney function were also similar at all measurement times (Het: Figure 3.21,
Tables 3.6 and 3.13; Temp: Figure 3.22, Tables 3.6 and 3.13; TNT: Figure 3.23,
Tables 3.6 and 3.13).
The differences in arterial isotope counts per measurement period (both er51 and 1125)
did not differ between the two patient groups at any of the measurement periods
(Table 3.7 and 3.14, no figures).
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Perioperative changes in hematocrit in control patients and patients who
received mannitol and dopamine
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Perioperative changes in nitroglycerin (TNT) infusion rate in control
patients and patients who received mannitol and dopamine
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3.2 ANIMAL STUDIES
3.2.1
M2 = Intra-operative preclamp
M3 = postclamp
M4 = pre-unclamp
M5 = post-unclamp
M6 = 4 hours post-unclamp
INTRA-GROUP CHANGES AT VARIOUS MEASUREMENT TIMES IN
EXPERIMENTAL ANIMALS
3.2.1.1 Control group (no pharmacological manipulation)
Timing of measurement steps
Step 1: preclamp
Step 2: immediately post-clamp (postclamp ) }
perelamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
There were no differences in the hemodynamic variables of heart rate, mean arterial
pressure, pulmonary artery occlusion pressure or cardiac output between the four
measurement steps. The hematocrit was similar in the four experimental steps
(Table 3.18).
Both RBF and GFR decreased after application of the aortic cross clamp and remained
significantly reduced relative to preclamp control values immediately before
unclamping, as well as 30 minutes after release of the clamp (Table 3.19). Similarly,
RBF expressed as a fraction of CO, was decreased in the postclamp stages relative to
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preclamp control values. Extraction of hippuran was marginally greater after release of
the cross clamp than immediately prior to unclamping, but nevertheless statistically
significant because of very little scatter of data.
Urine volume was significantly reduced in all three postclamp measurement periods
relative to preelamp control values (Table 3.20). Free water clearance was more
positive immediately after aortic clamping than both preelamp and post-unelamp
measurements.
Both arterial and renal venous measurements of renin activity increased significantly
after aortic cross clamping and remained raised relative to preclamp values for the rest
of the experimental period (Table 3.21).
Table 3.18 Systemic hemodynamic parameters and hematocrit in 8 control animals
Variable Step N Mean SO SE Median 25 Pere 75 Pere
HR 1 8 130.13 7.74 2.73 125.5 135
(beats.rnin') 2 8 126.25 10.9 3.85 123 134
3 8 127.63 14.93 5.28 117.5 136.5
4 8 129.38 13.97 4.94 122.5 138.5
MAP 1 8 82.06 6.33 2.24 77.5 86
(mmHg) 2 8 83.38 10.51 3.72 74 95.5
3 8 86.00 11.53 4.08 76.5 93.5
4 8 80.19 7.5 2.65 74.5 86.25
PAWP 1 8 11.81 3.34 1.18 13 9.25 14.5
(mmHg) 2 8 12.75 3.12 1.10 13.25 10.25 15
3 8 13.19 3.05 1.08 14 11 15.5
4 8 11.81 2.12 0.75 12 10 13.5
CO 1 8 4.05 0.70 0.25 3.87 3.53 4.65
(t.rnln') 2 8 3.91 0.96 0.34 3.78 3.0 4.78
3 8 3.69 1.05 0.37 3.33 2.78 4.73
4 8 3.73 0.90 0.32 3.6 2.95 4.6
Het 1 8 32.50 2.78 0.98
(%) 2 8 31.25 2.66 0.94
3 8 31.25 2.49 0.88
4 8 32.56 2.38 0.84
No interstep differences
ANOVA; Student-Newman-Keuls (HR. MAP, Het).
Friedman ANOVA on ranks; Student-Newman-Keuls (PAWP,CO).
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Het = hematocrit.
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Table 3.19 Renal hemodynamic and glomerular function data in 8 control animals
Variable Step N Mean SO SE Median 25 Perc 75 Perc
RBF 1 7 551.29b.c,d 182.8 68.86 560 420 578.25
(ml.rnin') 2 7 260.14- 134.31 50.77 243 152 311.25
3 7 348.57" 155.17 58.65 342 220.5 409.5
4 7 276' 113.13 42.76 274 198.25 309.5
GFR 1 8 80.63b.C.d 20.16 7.13
(rnl.rnin') 2 8 38.63" 12.22 4.32
3 8 49.88- 11.97 4.23
4 8 53.88" 21.64 7.65
FF 1 8 0.33 0.06 0.02
2 8 0.33 0.08 0.03
3 8 0.33 0.05 0.02
4 8 0.37 0.06 0.02
EH1P 1 7 0.72 0.05 0.02 0.73 0.68 0.76
2 7 0.70 0.09 0.04 0.73 0.68 0.77
3 7 0.70d 0.05 0.02 0.68 0.66 0.75
4 7 0.72c 0.04 0.02 0.73 0.70 0.75
RBF/CO 1 7 0.138b,c.d 0.024 0.009
2 7 0.074" 0.041 0.015
3 7 0.097- 0.028 0.011
4 7 0.076· 0.023 0.009
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05) c = significantly different
from step 3 (p< 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls (GFR, FF, RBF/CO)
Friedman ANOVA on ranks; Student-Newman-Keuls (RBF,EH1p).
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EH1P = Hippuran extraction; RBF/CO =
renal blood flow as a fraction of cardiac output.
Table 3.20 Urine volumes and indices of renal tubular function in control animals
Variable Step N Mean SO SE
Uvol 1 8 138.38b,c,d 69.91 24.72
(ml) 2 8 85.25' 46.44 16.42
3 8 79.88" 44.63 15.78
4 8 63.0" 38.51 13.62
FEN" 1 8 0.13 0.08 0.03
2 8 0.13 0.06 0.02
3 8 0.11 0.05 0.02
4 8 0.06 0.03 0.02
CH20 1 8 -21.3b 18.77 6.64
(rnl.min') 2 8 -9.99-d 12.75 4.51
3 8 -12.44 9.11 3.22
4 8 -22.58b 10.5 3.71
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls
Uvol = urine volume / 20 minutes; FEN" = fractional excretion of sodium; CH20 = free water clearance.
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Arterial and renal venous measurements of renin activity in control
animals
Variable Step N Mean SO SE
Pren 1 8 0.55bC.d 0.26 0.09
(llg.r1.h(1) 2 8 3.29· 2.17 0.77
3 8 3.41· 2.0 0.71
4 8 5.26· 3.11 1.1
RVren 1 8 0.79b.C.d 0.4 0.14
(llg.r1.h(1) 2 8 4.5' 2.98 1.05
3 8 5.07· 3.15 1.11
4 8 7.47a 4.12 1.46
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity.
Table 3.22 Differences in arterial isotope counts between two samples per measure-
ment time in 8 control pigs
Variable Step N Mean SO SE Median 25 75Perc Perc
%Cr1 1 8 8.1 5.26 1.86 6.8 4.15 10.15
2 8 12.24 16.34 5.78 7.2 3.05 11.6
3 8 3.31 2.19 0.77 3.5 1.4 5.1
4 8 6.06 4.7 1.66 5.55 2.05 9.85
% 1123 1 8 7.39 8.42 2.98 4.7 2.35 7.8
2 8 10.46 16.39 5.79 5.65 1.6 9.45
3 8 3.54 3.83 1.35 2.05 1.1 4.75
4 8 3.21 3.6 1.27 1.4 0.3 6.8
No interstep differences
Friedman ANOVA on ranks; Student-Newman-Keuls
% Cr51 = % difference in arterial Cr51 concentrations between 1st and 2 nd blood sample per measurement step;
% 1123 = % difference in arterial 1123 concentrations between 1st and 2nd blood sample per measurement step.
3.2.1.2 Intra-group changes in pigs which received esmolol prior to aortic
cross clamping
Timing of measurement steps
Step 1: preclamp
Step 2: immediately post-clamp (postclamp ) }
perclamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
Although RBF decreased significantly in the perclamp period (steps 2 and 3) in
ïs-blocked pigs, this decrease was quantitatively less significant than in control animals
(13% and 19% reduction in postclamp and pre-unclamp values respectively in
Is-blocked animals versus 52% and 36% reductions in control animals during the same
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periods) (Table 3.23). After removal of the aortic cross clamp, RBF decreased further
relative to control preelamp values and both perelamp measurements. RBF as a
fraction of CO did not decrease upon application of the aortic cross clamp, but
decreased significantly in comparison to preelamp and both perelamp measurements
when the cross clamp was released (Table 3.23). GFR was maintained in the
perclamp period in r.,-blocked pigs, but decreased significantly relative to control and
both perelamp measurement steps subsequent to release of the cross clamp Table
3.23). FF was increased relative to control and post-unelamp values immediately
before removal of the cross clamp (Table 3.23). EH1P remained constant throughout the
experimental period (Table 3.23).
MAP was significantly greater before aortic unclamping in comparison to all other
measurement periods (Table 3.24), although this difference was never more than 14%.
All other hemodynamic measurements (HR, PAWP and CO) and the hematocrit
remained constant throughout the experimental period (Table 3.24).
The volume of urine production was not influenced by aortic cross clamping in r.,-
blocked pigs, but urine production decreased significantly relative to control and
perelamp values upon removal of the aortic clamp (Table 3.25). Indices of renal
tubular function (FENa, CH20) remained unchanged by aortic manipulation in the r.,-
blocked animals (Table 3.25).
Both Prenand RVrenmeasurements were uninfluenced by clamping and unclamping of
the aorta (Table 3.26).
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Table 3.23 Renal hemodynamic and glomerular function data in 8 B-blocked pigs
Variable Step N Mean SO SE Median 25 Perc 75 Perc
RBF 1 8 524.0b.c.d 130.54 46.15
(rnl.rnln') 2 8 453.88a.d 139.67 49.38
3 8 423.0a.d 129.38 45.74
4 8 327.5a,b.C 83.3 29.45
GFR 1 8 101.63d 30.38 10.74
(ml.min") 2 8 81.88d 10.6 3.75
3 8 88.38d 27.08 9.57
4 8 58.63,·b.e 9.57 3.31
FF 1 8 0.37c 0.06 0.02 0.36 0.31 0.43
2 8 0.39 0.06 0.02 0.41 0.31 0.44
3 8 0.46a.d 0.06 0.02 0.47 0.39 0.51
4 8 0.34c 0.09 0.03 0.39 0.25 0.41
EHIP 1 8 0.73 0.04 0.002
2 8 0.72 0.04 0.002
3 8 0.73 0.03 0.002
4 8 0.72 0.06 0.002
RBF/CO 1 8 0.146d 0.045 0.016
2 8 0.153d 0.068 0,024
3 8 0.147d 0.063 0.022
4 8 0.106a.b 0.030 0.011
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05) c = significantly different from
step 3 (p< 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls (RBF, GFR, E HIP, RBF/CO )
Friedman ANOVA on ranks; Student-Newman-Keuls (FF)
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EHIP = Hippuran extraction; RBF/CO = renal
blood flow as a fraction of cardiac output.
Table 3.24 Systemic hemodynamic parameters and hematocrit in 8 B-blocked pigs
Variable Step N Mean SO SE
HR 1 8 102.19 3,05 1.08
(beats.mln") 2 8 98.38 6.67 2.36
3 8 97.63 9.09 3.21
4 8 96.25 5.83 2.06
MAP 1 8 84.06c 11.38 4.02
(mmHg) 2 8 87.63 15.81 5.59
3 8 93.81a.b.d 15.66 5.54
4 8 81.38 c 9.66 3.42
PAWP 1 8 12.56 2.24 0.79
(mmHg) 2 8 12.63 1.9 0.67
3 8 12.25 2.75 0.97
4 8 11.69 2.72 0,96
CO 1 8 3.65 0.43 0.15
(I.min") 2 8 3.12 0.55 0.19
3 8 3.02 0,64 0.23
4 8 3.14 0.62 0.22
Het 1 8 31.13 3.44 1.22
(%) 2 8 31.25 3.01 1.06
3 8 31.38 3.25 1.15
4 8 31.50 2.51 0.89
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Het = hematocrit.
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Table 3.25 Urine volumes and indices of renal tubular function in 8 B-blocked pigs
Variable Step N Mean SO SE Median 25 75Perc Perc
Uvol 1 8 162.38" 88.63 31.33
(ml) 2 8 185.38" 95.01 33.59
3 8 164.0" 81.99 28.99
4 8 96.38 a,0• 58.98 20.85
FEN. 1 8 0.12 0.08 0.03
2 8 0.15 0.07 0.02
3 8 0.15 0.07 0.02
4 8 0.09 0.03 0.003
CH20 1 8 -34.83 21.98 7.77 -26.9 -33.89 -22.74
(ml.min ) 2 8 -20.2 17.99 6.36 -14.51 -30.77 -8.26
3 8 -15.67 12.70 4.49 -19.53 -23.69 -8.42
4 8 -39.89 25.06 8.86 -32.82 -57.41 -20.99
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls
Uvol = urine volume / 20 minutes; FEN. = fractional excretion of sodium; CH20 = free water clearance
Table 3.26 Arterial and renal venous measurements of renin activity in 8 B-blocked pigs
Variable Step N Mean SO SE
Pren 1 8 0.64 0.62 0.22
(f.lg.l".h(') 2 8 0.48 0.2 0.07
3 8 0.33 0.2 0.07
4 8 0.42 0.27 0.10
RVren 1 8 0.86 0.8 0.28
(j.lg.r'.h(') 2 8 0.75 0.33 0.12
3 8 0.60 0.32 0.11
4 8 0.69 0.54 0.19
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity
Table 3.27 Differences in arterial isotope counts between two samples per measure-
ment time in 8 B-blocked pigs
Variable Step N Mean SO SE
% Cr5' 1 8 5.88 3.35 1.18
2 8 3.18 1.90 0.67
3 8 3.52 2.25 0.80
4 8 5.21 3.84 1.36
% I'"' 1 8 5.51 4.95 1.75
2 8 2.48 1.55 0.55
3 8 3.29 2.97 1.05
4 8 4.03 3.38 1.20
No interstep differences
Friedman ANOVA on ranks; Student-Newman-Keuls
% Cr5' = % difference in arterial C~' concentrations between 1st and 2 nd blood sample per measurement step;
% 1'23= % difference in arteriall'23 concentrations between 1st and 2nd blood sample per measurement step.
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3.2.1.3 Intra-group changes in 2 groups of pigs which received enalaprilat
prior to aortic cross clamping
Timing of measurement steps
Step 1: preelamp
Step 2: immediately post-clamp (postclamp ) }
perclamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
The intragroup changes of the two enalaprilat groups of pigs described in sections
2.2.1 and 2.2.2 of the methods chapter, are described together in this section of the
results chapter, for reasons elaborated upon in section 2.2.2. The group of 7 pigs
refers to the animals described in section 2.2.1 and the group of 6 pigs refers to the
animals of section 2.2.2 (see methodology section for reasons why both these groups
were reduced from their original numbers of 8 each).
In the first group of 7 pigs which received enalaprilat, RBF only decreased relative to
the control value when the aortic cross clamp was released (Table 3.28). This also
occurred in the second group of 6 animals that received enalaprilat, but in this case the
post-unelamp value was also significantly less than the two perclamp measurements
(Table 3.33). In both enalaprilat groups RBF as a fraction of CO decreased
subsequent to aortic unclamping relative to control and both perelamp measurements
(Tables 3.28 and 3.33). In both groups of pigs where enalaprilat was administered,
GFR decreased after aortic unclamping in comparison to preclamp control and the two
perelamp measurements (Tables 3.28 and 3.33). FF and EH1P remained unchanged
throughout the experimental period in the first and second groups of enalaprilat animals
(Tables 3.28 and 3.33).
MAP was increased relative to preelamp and post-unclamp measurements during the
perelamp period, although this difference did not exceed 15% in either of the two
groups of pigs which received enalaprilat (Tables 3.29 and 3.34). In the first group of
pigs that received enalaprilat, the mean PAWP in the post-unclamp period was
2 mmHg greater than the preclamp control measurement (Table 3.29), while the PAWP
was unchanged throughout in the second group of enalaprilat animals (Table 3.34).
CO was significantly reduced in the perclamp measurement periods relative to
preelamp and post-unelamp measurements, albeit that the maximum difference was no
more than 11.6% in the first group of enalaprilat pigs (Table 3.29). The same trend did
not reach statistical significance in the second group of animals which received the
ACE-inhibitor (Table 3.34). HR and hematocrit were unchanged throughout the
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experimental periods in both groups of pigs which received enalaprilat (Tables 3.29
and 3.34).
Urine volume decreased after removal of the aortic cross clamp relative to the
perelamp measurement periods in the second group of pigs, which received enalaprilat
(Table 3.35). The same trend did not reach statistical significance in the first
enalaprilat group of animals (Table 3.30). In the first enalaprilat group, CH20 was
positive in the period immediately after application of the aortic cross clamp relative to
post-unclamp calculated values (Table 3.30). Again, a similar trend did not reach
statistical significance in the second group of animals, which received enalaprilat
(Table 3.35). FENa remained unchanged throughout experimentation in both groups of
pigs subjected to intravenous enalaprilat administration (Tables 3.30 and 3.35).
Pren and RVren measurements remained high, but unchanged throughout the
experimental period, in all four measurement periods in both enalaprilat groups of pigs
(Tables 3.31 and 3.36).
Percentage differences in arterial Cr51 and 1123 concentrations between the first and
second blood samples per measurement step remained unaltered throughout the
experimental period in both groups of enalaprilat animals (Tables 3.32 and 3.37).
Comparisons of all parameters at all measurement steps between the two
enalaprilat groups of animals, demonstrated no statistically significant
differences.
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Table 3.28 Renal hemodynamic and glomerular function data in 7 pigs which
received intravenous enalaprilat
Variable Step N Mean 50 SE
RBF 1 7 402.29" 56.45 21.34
(ml.min") 2 7 345.57 84.93 32.1
3 7 361.71 37.81 14.29
4 7 311.43" 32.64 12.34
GFR 1 7 75.43" 12.91 4.88
(ml.min") 2 7 69.57d 15.88 6.0
3 7 78.29" 10.26 3.88
4 7 52.29a.b,e 10.97 4.14
FF 1 7 0.37 0.03 0.002
2 7 0.4 0.08 0.03
3 7 0.4 0.07 0.03
4 7 0.36 0.07 0.03
EH1P 1 7 0.74 0.05 0.002
2 7 0.71 0.03 0.002
3 7 0.72 0.03 0.002
4 7 0.72 0.05 0.002
RBF/CO 1 7 0.101" 0.022 0.008
2 7 0.096" 0.026 0.01
3 7 0.103d 0.017 0.006
4 7 0.078a.be 0.01 0.004
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05)
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EH1P = Hippuran extraction; RBF/CO = renal
blood flow as a fraction of cardiac output.
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Table 3.29 Systemic hemodynamic parameters and hematocrit in 7 pigs which
received intravenous enalaprilat
Variable Step N Mean SO SE
HR 1 7 117.93 8.58 3.24
(beats.min") 2 7 116.79 10.68 4.04
3 7 123.00 17.66 6.67
4 7 128.64 16.62 6.28
MAP 1 7 75.5b•C 8.43 3.18
(mmHg) 2 7 83.57a.d 4.67 1.76
3 7 88.43a.d 9.2 3.48
4 7 76.86b•c 5.67 2.14
PAWP 1 7 13.07d 2.88 1.09
(mmHg) 2 7 13.79 2.53 0.96
3 7 14.29 1.93 0.73
4 7 15.29a 2.21 0.84
CO 1 7 4.06b,c 0.7 0.26
(I.min") 2 7 3.65a.d 0.68 0.26
3 7 3.59a,d 0.66 0.25
4 7 4.06b,c 0.67 0.26
Hct 1 7 31.43 3.1 1.17
(%) 2 7 31.0 2.16 0.82
3 7 31.57 2.23 0.84
4 7 32.0 2.45 0.93
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Hct = hematocrit.
Table 3.30 Urine volumes and indices of renal tubular function in pigs which received
intravenous enalaprilat
Variable Step N Mean SO SE Median 25 75Perc Perc
Uvol 1 7 191.14 60.6 22.9 185.0 146.75 223.5
(ml) 2 7 233.29 53.66 20.28 228.0 206.5 245.0
3 7 197.0 53.09 20.07 212.0 145.0 238.75
4 7 168.29 93.84 35.47 131.0 97.25 216.0
FENa 1 7 0.15 0.08 0.03 0.14 0.08 0.21
2 7 0.20 0.09 0.03 0.16 0.13 0.28
3 7 0.42 0.72 0.27 0.18 0.09 0.20
4 7 0.13 0.10 0.04 0.08 0.06 0.17
CH20 1 7 -5.69 19.32 7.3
(ml.min") 2 7 2.63d 16.3 6.16
3 7 -24.09 19.68 7.44
4 7 -32.26b 28.61 10.84
b = significantly different from step 2 (p < 0.05); d = significantly different from step 4 (p < 0.05)
AN OVA; Student-Newman-Keuls (CH20)
Friedman AN OVA on ranks; Student-Newman-Keuls (Uvol, FENa)
Uvol = urine volume I 20 minutes; FENa = fractional excretion of sodium; CH20 = free water clearance.
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Table 3.31 Arterial and renal venous measurements of plasma renin activity in pigs
which received intravenous enalaprilat
Variable Step N Mean SO SE
Pren 1 7 5.02 1.12 0.42
(>L9·r1.h(l) 2 7 4.16 1.7 0.64
3 7 4.04 0.94 0.35
4 7 4.63 1.17 0.44
RVren 1 7 6.96 1.86 0.7
(>L9.r1.h(l) 2 7 5.58 2.66 1.01
3 7 5.83 1.75 0.66
4 7 6.68 1.46 0.55
No interstep differences.
ANOVA; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity.
Table 3.32 Differences in arterial isotope counts between two samples per
measurement time in 7 pigs which received intravenous enalaprilat
Variable Step N Mean SO SE
% erS1 1 7 4.8 4.46 1.68
2 7 7.5 7.94 3.0
3 7 5.54 4.42 1.67
4 7 4.96 6.26 2.37
% 1123 1 7 5.43 3.3 1.25
2 7 7.64 3.38 1.28
3 7 6.09 4.13 1.56
4 7 4.04 3.64 1.38
No interstep differences
ANOVA; Student-Newman-Keuls
% erS1 = % difference in arterial erS1 concentrations between 15t and 2nd blood sample per measurement step;
% 1123 = % difference in arterial 1123 concentrations between 15t and 2nd blood sample per measurement step.
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Table 3.33 Renal hemodynamic and glomerular function data in 6 pigs which
received enalaprilat
Variable Step N Mean SO SE
RBF 1 6 413.67d 156.14 63.75
(rnl.rnln') 2 6 380.83<1 129.67 52.94
3 6 393.5d 159.83 65.25
4 6 291.17"·b.C 102.73 41.94
GFR 1 6 65.5d 16.88 6.89
(rnl.rnin") 2 6 67.33d 20.6 8.41
3 6 68.33d 17.52 7.15
4 6 44.5,·b.C 10.29 4.2
FF 1 6 0.36 0.06 0.020
2 6 0.39 0.04 0.002
3 6 0.38 0.04 0.002
4 6 0.36 0.03 0.002
EH1P 1 6 0.72 0.08 0.03
2 6 0.71 0.04 0.002
3 6 0.69 0.05 0.02
4 6 0.70 0.06 0.02
RBF/CO 1 6 0.11d 0.029 0.012
2 6 0.105d 0.02 0.008
3 6 0.113d 0.035 0.014
4 6 0.079a.b.c 0.024 0.01
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EH1P = Hippuran extraction;
RBF/CO = renal blood flow as a fraction of cardiac output.
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Table 3.34 Systemic hemodynamic parameters and hematocrit in 6 pigs which received enalaprilat
Variable Step N Mean SO SE
HR 1 6 117.0 5.78 2.36
(beats.min") 2 6 115.83 9.15 3.73
3 6 118.67 8.62 3.52
4 6 123.92 15.64 6.39
MAP 1 6 70.67bC 2.16 0.88
(mmHg) 2 6 79.83a.d 5.79 2.36
3 6 84.58··d 3.6 1.47
4 6 71.83b.c 2.82 1.15
PAWP 1 6 11.0 2.0 0.82
(mmHg) 2 6 11.67 2.77 1.13
3 6 10.92 3.22 1.31
4 6 11.25 3.06 1.25
CO 1 6 3.69 0.45 0.18
(l.rnin") 2 6 3.54 0.57 0.23
3 6 3.4 0.49 0.2
4 6 3.67 0.56 0.23
Hct 1 6 27.0 2.0 0.82
("lo) 2 6 27.33 2.16 0.88
3 6 26.83 3.25 1.33
4 6 26.5 3.08 1.26
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Hct = hematocrit.
Table 3.35 Urine volumes and indices of renal tubular function in 6 pigs which received enalaprilat
Variable Step N Mean SO SE
Uvol 1 6 163.17 68.44 27.94
(ml) 2 6 232.33d 89.37 36.49
3 6 237.33d 49.56 20.23
4 6 115.17b.c 65.18 26.61
FENa 1 6 0.32 0.19 0.08
2 6 0.36 0.3 0.12
3 6 0.22 0.08 0.03
4 6 0.19 0.11 0.04
CH20 1 6 -0.98 25.8 10.53
(rnl.min') 2 6 2.8 27.23 11.11
3 6 -38.91 62.28 25.43
4 6 -21.07 23.84 9.73
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05) d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls
Uvol = urine volume / 20 minutes; FEN. = fractional excretion of sodium; CH20 = free water clearance.
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Table 3.36 Arterial and renal venous measurements of renin activity in 6 pigs
which received enalaprilat
Variable Step N Mean SO SE
Pren 1 6 5.8 1.26 0.51
(1!9X'.h(') 2 6 5.71 1.3 0.53
3 6 5.66 1.48 0.6
4 6 5.17 1.36 0.55
RV,en 1 6 6.76 1.22 0.5
(1!9X'.h(') 2 6 6.76 1.22 0.5
3 6 7.45 1.59 0.65
4 6 8.98 4.67 1.91
No interstep differences
ANOVA; Student-Newman-Keuls (Pren)
Friedman ANOVA on ranks; Student-Newman-Keuls (RV,en)
P,en= arterial renin activity; RV,en= renal venous renin activity.
Table 3.37 Differences in arterial isotope counts between two samples per measurement
time in 6 pigs which received enalaprilat
Variable Step N Mean SO SE
% Cr5' 1 6 4.57 2.49 1.02
2 6 4.8 4.02 1.64
3 6 3.63 3.08 1.26
4 6 4.15 2.5 1.02
% 1'23 1 6 7.27 3.78 1.54
2 6 4.35 4.84 1.98
3 6 4.6 3.07 1.25
4 6 5.27 4.26 1.74
No interstep differences
ANOVA; Student-Newman-Keuls
% Cr5' = % difference in arterial Cr5' concentrations between 1s' and 2nd blood sample per measurement step;
% 1'23 = % difference in arterial I '23 concentrations between 1st and 2nd blood sample per measurement step.
3.2.1.4 Intra-group changes in 7 pigs which received intravenous verapamil
Timing of measurement steps
Step 1: preelamp
Step 2: immediately post-clamp (postclamp ) }
perclamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
Left ventricular filling pressures and cardiac output remained uninfluenced by aortic
cross clamping and unclamping (Table 3.38). Heart rate increased significantly relative
to all previous measurements subsequent to release of the aortic clamp. MAP was
greater in the perelamp period than measurements prior to application of the cross
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clamp. Although MAP decreased upon clamp release (7.5% reduction), it remained
significantly higher than the preclamp control measurement, albeit a difference of only
6%. Hematocrit was unchanged by the experimental procedure (Table 3.38).
In contrast to changes in all other experimental groups, RBF, the RBF : CO ratio, as
well as GFR were uninfluenced by aortic clamping and unclamping (Table 3.39).
Filtration fraction and hippuran extraction also remained unchanged throughout the
experimental period.
The volumes of urine production during the two perclamp measurement periods were
significantly more than preelamp measurements (Table 3.40). Unclamping of the aorta
reduced urine production relative to perclamp volumes, to values which were similar to
preclamp control measurements. Free water clearance and fractional excretion of
sodium were uninfluenced by aortic clamping and unclamping (Table 3.40).
Arterial and renal venous renin concentrations remained similar to control measure-
ments throughout the aortic clamping periods (Table 3.41). However, in both
instances, renin concentrations after unclamping were significantly higher than
preelamp and perclamp measurements.
Similar to the other experimental groups, percentage differences in arterial Cr51 and
1123 concentrations between the first and second blood samples per measurement
period remained unchanged throughout the experimental period (Table 3.42).
Stellenbosch University http://scholar.sun.ac.za
102
Table 3.38 Systemic hemodynamic parameters and hematocrit in 7 pigs which received
verapamil
Variable Step N Mean SO SE
HR 1 7 104.43d 6.12 2.31
(beats.min") 2 7 104.79d 8.84 3.34
3 7 109.21d 6.36 2.4
4 7 121.36a.b.c 7.10 2.69
MAP 1 7 73.64b•c.d 5.24 1.98
(mmHg) 2 7 83.86a.d 5.73 2.16
3 7 84.79a.d 10.86 4.1
4 7 78.43a.b•c 6.69 2.53
PAWP 1 7 12.14 2.39 0.9
(mmHg) 2 7 12.79 3.07 1.16
3 7 11.64 2.06 0.78
4 7 11.14 2.38 0.9
CO 1 7 3.8 0.38 0.14
(l.rnin") 2 7 3.56 0.46 0.17
3 7 3.5 0.56 0,21
4 7 3.87 0.60 0.23
Het 1 7 28.86 2.97 1.12
(%) 2 7 27.43 2.76 1.04
3 7 29.71 2.93 1.11
4 7 30.0 3.56 1.35
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); e = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Het = hematocrit.
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Table 3.39 Renal hemodynamic and glomerular function data in 7 pigs which
received verapamil
Variable Step N Mean SO SE
RBF 1 7 417.86 89.15 33.69
(ml.min") 2 7 466.33 154.23 62.96
3 7 396.83 83.32 34.02
4 7 424.86 129.33 48.88
GFR 1 7 79.43 19.16 7.24
(ml.min") 2 7 82.43 21.73 8.21
3 7 81.00 21.47 8.12
4 7 88.57 25.11 9.49
FF 1 7 0.39 0.05 0.002
2 7 0.38 0.03 0.002
3 7 0.37 0.04 0.002
4 7 0.39 0.08 0.030
EH1P 1 7 0.68 0.08 0.030
2 7 0.69 0.05 0.002
3 7 0.70 0.05 0.002
4 7 0.67 0.04 0.002
RBF/CO 1 7 0.110 0.023 0.009
2 7 0.135 0.043 0.017
3 7 0.119 0.031 0.013
4 7 0.112 0.037 0.014
No interstep differences
ANOVA; Student-Newman-Keuls
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EH1P = Hippuran extraction;
RBF/CO = renal blood flow as a fraction of cardiac output.
Table 3.40 Urine volumes and indices of renal tubular function in 7 pigs which
received verapamil
Variable Step N Mean SO SE
Uvol 1 7 99.0b,c 49.03 18.53
(ml) 2 7 172.0·,d 91.25 34.49
3 7 167.43 a.0 72.53 27.41
4 7 106.14b,c 62.14 23,75
FEN. 1 7 0,12 0.08 0.03
2 7 0.14 0.06 0.02
3 7 0.13 0.04 0.002
4 7 0.08 0,04 0.002
CH20 1 7 -27.3 11.12 4.2
(ml.min") 2 7 -23.68 16.64 6.29
3 7 -22.32 15,21 5,75
4 7 -34.21 18.98 7.17
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05);
c = significantly different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0,05)
AN OVA; Student-Newman-Keuls
Uvol = urine volume / 20 minutes; FE N. = fractional excretion of sodium; CH20 = free water clearance.
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Table 3.41 Arterial and renal venous measurements of renin activity in 7 pigs
which received verapamil
Variable Step N Mean SO SE
Prell 1 7 1.63d 1.09 0.41
(J.1g.r'.h(') 2 7 1.19d 0.57 0.21
3 7 1.16d 0.72 0.27
4 7 3.07a.b.c 1.52 0.58
RVren 1 7 2.32d 1.53 0.58
(J.1g.r'.h(') 2 7 1.72d 0.91 0.34
3 7 1.70d 1.07 0.40
4 7 6.45a.h.c 6.43 2.43
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly different
from step 3 (p < 0.05); d = significantly different from step 4 (p < .05).
ANOVA; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity.
TABLE 3.42 Differences in arterial isotope counts between two samples per
measurement time in 7 pigs which received verapamil
Variable Step N Mean SO SE
% Crs, 1 7 8.49 5.50 2.08
2 7 6.57 5.13 1.94
3 7 7.89 7.26 2.75
4 7 3.0 1.99 0.75
% 1'23 1 7 4.91 4.83 1.83
2 7 9.8 19.18 7.25
3 7 4.5 4.59 1.73
4 7 3.79 3.32 1.25
No interstep differences
ANOVA; Student-Newman-Keuls
% Cr' = % difference in arterial Crs, concentrations between 1st and 2nd blood sample per measurement step;
% 1'23= % difference in arteriall'23 concentrations between t" and 2nd blood sample per measurement step.
3.2.1.5 Intra-group changes in 5 pigs which received intravenous diclofenac
Timing of measurement steps
Step 1: preelamp
Step 2: immediately post-clamp (postclamp ) )
perelamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
Although the mean heart rate of this group of pigs was significantly increased after
unclamping of the aorta when compared with the preelamp and first postclamp
measurements, these differences were only 7.5% in both cases (Table 3.43). Both
perelamp MAP measurements were greater than preelamp measurements, as well as
the post-unclamp measurements. PAWP was unchanged throughout the experimental
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period. Cardiac output was decreased during both perclamp measurement periods
relative to the preclamp control value with recovery to control measurement after aortic
unclamping. The hematocrit remained unchanged in the four experimental periods
(Table 3.43).
RBF decreased by 50% from the control measurement upon application of the
infrarenal cross clamp and was only 33% of control value prior to aortic unclamping
(Table 3.44). Although RBF improved after unclamping (relative to the pre-unclamp
measurements), it remained significantly lower than the control measurements. RBF
expressed as a fraction of CO was less than 50% of control values during both
perclamp measurements and after release of the aortic clamp. GFR was reduced to
40% of control measurements upon aortic cross clamping and remained at similar
decreased levels throughout the experimental period without recovery during the
unclamping phase. Both filtration fraction and hippuran extraction remained
unchanged at all measurement times (Table 3.44).
Urine production was significantly reduced in both perclamp as well as the post-
unclamp measurement periods relative to control values (Table 3.45). Although mean
values of fractional excretion of sodium and free water clearance changed substantially
after aortic cross clamping, it never reached statistical significance because of large
scatter of the data (Table 3.45). Two animals developed anuria after aortic cross
clamping which persisted for the rest of the study period. Because this prevented the
radio-isotope clearance measurements and thus the calculation of RBF, GFR and other
derived parameters, these animals were excluded from the study.
Scatter of data also prevented raised mean arterial renin concentrations from reaching
statistical significance after aortic cross clamping (Table 3.46). All postclamp renal
venous renin levels, however, were significantly greater than the preelamp control
concentration.
Percentage differences in arterial Cr51 and 1123 concentrations between the first and
second blood samples per measurement period remained unaltered for the duration of
the experiments (Table 3.41).
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Table 3.43 Systemic hemodynamic parameters and hematocrit in 5 pigs which received
diclofenac intravenously
Variable Step N Mean SO SE
HR 1 5 119.7d 3.87 1.73
(beats.min") 2 5 119.7d 2.22 0.99
3 5 125.0 4.17 1.86
4 5 128.7a.b 7.22 3.23
MAP 1 5 82.0b•c 3.26 1.46
(mmHg) 2 5 92.7a.d 3.4 1.52
3 5 95.2a.d 4.91 2.19
4 5 80.1 b.c 2.16 0.97
PAWP 1 5 10.6 2.07 0.93
(mmHg) 2 5 12.3 1.57 0.7
3 5 12.4 2.1 0.94
4 5 11.9 1.78 0.8
CO 1 5 3.59b.C 0.37 0.17
(l.rnin") 2 5 3.13a,d 0.2 0.09
3 5 2.96a.d 0,2 0.09
4 5 s.e= 0,56 0.25
Het 1 5 28.2 3.56 1,59
(%) 2 5 28.4 2,88 1.29
3 5 29.2 2.95 1.32
4 5 30.2 2.49 1.11
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Het = hematocrit.
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Table 3.44 Renal hemodynamic and glomerular function data in 5 pigs which
received diclofenac intravenously
Variable Step N Mean SO SE 95%CI
RBF 1 5 363.0b,c,d 61.83 27.65 71,08
(ml.mln") 2 5 152,4· 39.79 17,79 45.74
3 5 120.0a.d 33.77 15.10 37.82
4 5 170.4a.e 34.05 15.23 39.14
GFR 1 5 79.6b,c.d 7.33 3.28 8.43
(rnl.rnin') 2 5 32.0" 7.28 3.26 8.37
3 5 28.6· 7.09 3.17 8.15
4 5 33.0a 5.24 2.35 6.03
FF 1 5 0.41 0.07 0.03 0.09
2 5 0.42 0.09 0.04 0.11
3 5 0.47 0.10 0.04 0.11
4 5 0.42 0.09 0.04 0.10
EH1P 1 5 0.75 0.03 0.002 0.04
2 5 0.72 0.06 0.03 0.07
3 5 0.72 0.07 0.03 0.08
4 5 0.70 0.06 0.03 0.07
RBF/CO 1 5 0.101b,c,d 0.012 0.005 0.014
2 5 0.048a 0.011 0.005 0.013
3 5 0.040· 0.011 0.005 0.012
4 5 0.047· 0.003 0.001 0.004
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = siqnificantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EH1P = Hippuran extraction;
RBF/CO = renal blood flow as a fraction of cardiac output.
Table 3.45 Urine volumes and indices of renal tubular function in 5 pigs which
received diclofenac intravenously
Variable Step N Mean SO SE
Uvol 1 5 260.8b,c,d 78.81 35.25
(ml) 2 5 124.4",d 28.01 12.52
3 5 79.2· 38.61 17.27
4 5 67.0··b 28.52 12.76
FEN. 1 5 0.46 0.6 0.27
2 5 1.41 0.99 0.49
3 5 1.52 1.12 0.5
4 5 1.36 0.91 0.41
CH20 1 5 -16.69 23.1 10.33
(ml.min') 2 5 -0.37 11.15 4.99
3 5 -3.58 11.15 4.99
4 5 -4.32 12.75 5.7
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); d = significantly different
from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls
Uvol = urine volume / 20 minutes; FENa = fractional excretion of sodium; CH20 = free water clearance.
Stellenbosch University http://scholar.sun.ac.za
108
Table 3.46 Arterial and renal venous measurements of renin activity in 5 pigs which
received diclofenac intravenously
Variable Step N Mean SO SE
Pren 1 5 1.79 2.67 1.2
(llg.r1.h(1) 2 5 3.77 1.60 0.71
3 5 3.91 0.39 0.17
4 5 4.69 1.42 0.67
RVren 1 5 1.1b,c,d 0.44 0.2
(llg.r1.h(1) 2 5 5.05" 1.71 0.77
3 5 7.97' 2.96 1.33
4 5 6.59" 1.55 0.69
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly different
from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05),
ANOVA; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity.
Table 3.47 Differences in arterial isotope counts between two samples per
measurement time in 5 pigs which received diclofenac
Variable Step N Mean SD SE
% Cr51 1 5 7.16 5.92 2.65
2 5 6.2 6.54 2.93
3 5 4.82 3.55 1.59
4 5 3.22 2.76 1.24
% 1123 1 5 3.34 3.25 1.45
2 5 4.28 4.48 2.01
3 5 2.46 2.59 1.16
4 5 2.96 3.31 1.48
No interstep differences
ANOVA; Student-Newman-Keuls
% Cr51 = % difference in arterial C~l concentrations between 151and 2nd blood sample per measurement step;
% 1123 = % difference in arterial 1123concentrations between 1st and 2nd blood sample per measurement step.
3.2.1.6 Intra-group changes in 7 pigs which received both enalaprilat and
diclofenac intravenously
Timing of measurement steps
Step 1: preclamp
Step 2: immediately post-clamp (postelamp ) } perclamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
Similar to other experimental groups, PAWP was maintained at constant levels
throughout the experimental procedure (Table 3.48). MAP was also uninfluenced by
aortic clamping and unclamping. Heart rate accelerated after aortic unclamping when
compared with all three previous measurement periods. Cardiac output decreased
upon aortic cross clamping (8% reduction). During the second perclamp measurement
period, CO returned to levels similar to control measurements, a recovery, which
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persisted after aortic unclamping. Hematocrit remained similar in all four experimental
periods (Table 3.48).
RBF was decreased by aortic cross clamping, a reduction which persisted after
removal of the clamp (Table 3.49). The RBF : CO ratio demonstrated similar changes.
The GFR decreased significantly upon application of the aortic clamp and remained at
virtually unchanged (reduced) levels throughout the rest of the experimental period.
Filtration fraction and hippuran extraction remained unchanged by aortic clamping and
unclamping (Table 3.49).
Urine volumes decreased significantly after aortic clamping and remained at similar
reduced levels for the duration of the experiment (Table 3.50). Large scatter prevented
mean changes in free water clearance in excess of 60% (becoming less negative)
during clamping, from reaching statistical significance. Fractional excretion of sodium
was unchanged by aortic manipulation (Table 3.50).
Both arterial and renal venous concentrations of renin were greater than accepted
normal values during the control period and remained at similar concentrations during
the other three measurement periods (Table 3.51).
Again, percentage differences in arterial Cr51 and 1123concentrations between the first
and second blood samples per measurement step, remained unaltered for the duration
of the experiments (Table 3.52).
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Table 3.48 Systemic hemodynamic parameters and hematocrit in 7 pigs which
received enalaprilat and diclofenac
Variable Step N Mean SO SE
HR 1 7 115.29d 12.72 4.81
(beats.mln") 2 7 110.64d 11.85 4.48
3 7 116.0d 11.99 4.53
4 7 136.36··b.C 14.21 5.37
MAP 1 7 77.07 5.85 2.21
(mmHg) 2 7 85.43 5.02 1.9
3 7 86.79 6.29 2.38
4 7 77.0 4.28 1.62
PAWP 1 7 11.64 1.91 0.72
(mmHg) 2 7 12.79 2.34 0.89
3 7 13.07 1.88 0.71
4 7 12.64 2.35 0.9
CO 1 7 3.86b 0.32 0.12
(l.rnin') 2 7 3.54·d 0.37 0.14
3 7 3.71 0.48 0.18
4 7 4.0b 0.5 0.19
Het 1 7 28.71 4.23 1.60
(%) 2 7 28.57 4.28 1.62
3 7 27.43 4.83 1.82
4 7 28.14 5.15 1.94
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly different
from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls.
HR = heart rate; MAP = mean arterial pressure; PAWP = pulmonary artery occlusion pressure; CO = cardiac output;
Het = hematocrit.
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Table 3.49 Renal hemodynamic and glomerular function data in 7 pigs which
received enalaprilat and diclofenac
Variable Step N Mean SO SE Median 25 Perc 75 Perc
RBF 1 7 542.14 o.c.c 154.55 58.42
(rnl.rnin") 2 7 335.57" 217.24 82.11
3 7 316.0" 164.31 62.1
4 7 282.0· 140.1 52.95
GFR 1 7 97.0b.Cd 27.87 10.54 103.0 74.75 120.50
(rnl.rnin') 2 7 58.0· 28.76 10.87 48.0 34.75 76.50
3 7 57.86" 29.61 11.19 49.0 38.5 60.25
4 7 58.86" 48.39 18.29 49.0 25.75 63.25
FF 1 7 0.42 0.04 0.002
2 7 0.41 0.05 0.002
3 7 0.42 0.06 0.02
4 7 0.41 0.03 0.002
EHIP 1 7 0.66 0.10 0.04
2 7 0.66 0.08 0.03
3 7 0.66 0.09 0.03
4 7 0.62 0.08 0.03
RaF/co 1 7 0.141O.Cd 0.046 0.017
2 7 0.093" 0.056 0.021
3 7 0.083" 0.034 0.013
4 7 0.07· 0.034 0.013
a = significantly different from step 1 (p < 0005); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3(p < 0.05); d = significantly different from step 4 (p < 0.05).
ANOVA; Student-Newman-Keuls (RBF, FF, E HIP, RaF/co )
Friedman ANOVA on ranks; Student-Newman-Keuls (GFR)
RBF = renal blood flow; GFR = glomerular filtration rate; FF = filtration fraction; EHIP = Hippuran extraction;
RaF/co = renal blood flow as a fraction of cardiac output.
Table 3.50 Urine volumes and indices of renal tubular function in 7 pigs which received
enalaprilat and diclofenac
Variable Step N Mean SO SE Median 25 75Perc Perc
Uvol 1 7 141.86b.Cd 90.82 34.33
(ml) 2 7 67.71a 35.33 13.35
3 7 62.0· 37.56 14.2
4 7 49.29" 29.03 10.97
FENs 1 7 0.12 0.07 0.03
2 7 0.15 0.08 0.03
3 "7 0.12 0.08 0.03
4 7 0.11 0.1 0.04
CH20 1 7 -35.64 70.35 26.59 -9.07 -2.74 -32.05
(ml.min") 2 7 -13.87 9.61 3.63 -11.65 -5.78 -21.66
3 7 -8.60 17.70 6.69 -7.96 0.96 -13.74
4 7 -22.84 19.76 7.47 -16.95 -13.98 -28.69
a = significantly different from step 1 (p < 0.05); b = significantly different from step 2 (p < 0.05); c = significantly
different from step 3 (p < 0.05); d = significantly different from step 4 (p < 0.05)
ANOVA; Student-Newman-Keuls (Uvol, FENs)
Friedman ANOVA on ranks; Student-Newman-Keuls (CH20)
Uvol = urine volume / 20 minutes; FEN. = fractional excretion of sodium; CH20 = free water clearance.
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Table 3.51 Arterial and renal venous measurements of renin activity in 7 pigs which
received enalaprilat and diclofenac
Variable Step N Mean SO SE Median 25 Perc 75 Perc
Pren 1 7 5.10 0.92 0.35 5.04 4.57 5.55
(1!9.r1.h(l) 2 7 5.06 1.44 0.54 4.46 4.16 6.52
3 7 4.53 1.91 0.72 4.86 2.74 5.82
4 7 6.39 4.62 1.75 4.64 3.90 6.91
RVren 1 7 6.63 1.27 0.48 6.42 5.98 7.04
(1!9.r1.h(') 2 7 6.80 2.02 0.76 6.50 5.54 7.92
3 7 6.79 1.98 0.75 6.48 4.98 8.70
4 7 10.4 7.38 2.79 7.47 6.63 10.14
No interstep differences
Friedman ANOVA on ranks; Student-Newman-Keuls.
Pren = arterial renin activity; RVren = renal venous renin activity.
Table 3.52 Differences in arterial isotope counts between two samples per measurement
time in 7 pigs which received enalaprilat and diclofenac
Variable Step N Mean SO SE
% CrS1 1 7 4.46 2.47 0.94
2 7 6.84 7.29 2.76
3 7 4.44 3.09 1.17
4 7 5.8 5.49 2.08
% 1123 1 7 9.17 8.31 3.14
2 7 5.3 2.17 0.82
3 7 5.8 3.55 1.34
4 7 5.17 7.51 2.84
No interstep differences
ANOVA; Student-Newman-Keuls
% CrS1 = % difference in arterial CrI concentrations between 1st and 2nd blood sample per measurement step;
% 1123 = % difference in arterial 1123 concentrations between 1st and 2nd blood sample per measurement step.
3.2.2 INTER-GROUP COMPARISONS OF CHANGES BETWEEN MEASURE-
MENT TIMES IN VARIOUS GROUPS OF EXPERIMENTAL ANIMALS
3.2.2.1 Comparison of inter-measurement changes in control animals,
animals pretreated with esmolol and animals pretreated with enala-
prilat respectively, as well as comparison of renal electron-
microscopic changes in the same groups
Timing of measurement steps
Step 1: preclamp
Step 2: immediately post-clamp (postclamp ) } perelamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
There were no significant differences in changes of systemic hemodynamic parameters
(MAP, PAWP and CO) with a potential influence on renal hemodynamics or function in
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successive measurement periods (or between the first and last measurement periods)
between any of the three groups (Table 3.53).
The decrease in RBF upon aortic cross clamping (x1-2) was greater in the control
group of animals than in both the esmolol and enalaprilat groups with no difference
between the latter two groups (Figure 3.24, Table 3.54). The total decrease in RBF
over the duration of the experiment (from M1 to M4) was significantly greater in the
control animals than the enalaprilat group, but the esmolol group did not differ from any
of the other two groups. RBF as a fraction of CO demonstrated significant changes
that were similar to the changes in RBF (Table 3.54).
The reduction in GFR due to aortic clamping was significantly greater in the control
group than in the enalaprilat group, but the changes in these two groups did not differ
significantly from the esmolol group (Figure 3.25, Table 3.54). In both the esmolol and
the enalaprilat groups, the GFR decreased significantly more than the control group
(which demonstrated a small, non-significant increase) upon release of the cross
clamp. This reversal of the direction of change was responsible for the fact that there
were no differences in the total change (from M1 to M4) in GFR between the preclamp
and the post-unelamp measurements when the three groups of pigs were compared
(x1-4; Figure 3.25, Table 3.54).
The changes in FF between the control and esmolol groups were significantly different
between the postclamp and pre-unclamp measurements due to a decrease in the
former group and a small increase in the latter group (Table 3.54). These changes
were significantly reversed between the pre-unclamp and post-unclamp (x3-4)
measurements.
There were no significant differences in changes of EH1P values in successive
measurement periods or over the duration of the experiments between any of the
groups (Table 3.54).
Clamping the aorta in the control group led to a mean decrease (x1-2) in urine volume
production (Tables 3.20, 3.55) that was significantly different from the non-significant
step-change in the enalaprilat group (Tables 3.30, 3.55). Due to a progressive, non-
significant decline in urine output in the enalaprilat group (Tables 3.30, 3.55), there
were no differences in the total urine output decrease over the duration of the
experiment (x1-4) between any of the groups (Table 3.55).
Between the postclamp and pre-unclamp measurements (x2-3), the CH20 in the
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enalaprilat group decreased significantly relative to the control and esmolol groups
(Table 3.55). However, the initial (preclamp and postclamp) absolute CH20 values in
the enalaprilat group were positive relative to the other two groups, so that the
absolute CH20 values at the pre-unclamp measurement period are similar (means of
-12.44, -15.67 and -24.08 for the control, esmolol and enalaprilat groups respectively).
There were no significant differences in changes of FENa values in successive
measurement periods or in first-to-Iast measurement period (x1-4) changes between
any of the experimental groups (Table 3.55).
Plasma renin measurements increased significantly between preclamp and postclamp
measurements (x1-2) in control animals relative to the other two groups (Figure 3.26,
Table 3.56). Due to this cross clamp induced increase in renin measurements in
control animals, the change from preclamp to post-unelamp (x1-4) values were also
significantly different in control animals (increase) in comparison to the esmolol and
enalaprilat groups (Table 3.56). Although plasma renin did not change significantly
during the entire experimental period in either the esmolol or the enalaprilat groups, all
measurement period values were low in the esmolol group (0.63, 0.47, 0.33 and 0.42
at the respective measurement periods) and much higher (5.02, 4.16, 4.04 and 4.62) in
the enalaprilat group (due to the inhibited negative feedback on renin release caused
by the ACE-inhibitory effect of enalaprilat).
The renal electronmicroscopic changes in proximal tubular cells are shown for each
individual animal in Table 3.57. Because there were no significant differences in any of
the renal hemodynamic or renal function parameters between the two ACEI groups,
these two groups were combined for the comparisons of ultrastructural changes with
other animal groups. The severity grading for changes in each subcellular structure
(microvilli of the brush border, granular endoplasmic reticulum (gER), mitochondria and
nuclear chromatin) demonstrates great variation within and also between animal
groups.
Changes ascribable to immersion fixation in glutaraldehyde were present in all
specimens, including the five animals used as controls for all experimental groups
where renal biopsies were taken under anaesthesia though a laparotomy without
aortic clamping or other potential insult. These changes entailed varying degrees of
cellular swelling with protrusion of apical cytoplasm and associated collapse of tubular
lumina (Photographs 3.1, 3.2 and 3.3). Varying degrees of cytoplasmic vacuolization
were also seen in non-experimental control biopsies and in all experimental groups.
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Since these changes may (at least in part) constitute fixation related artefact, it would
be unreliable to consider them as indicators of cellular injury and were therefore not
taken into account. Despite the above shortcomings, other significant subcellular
structural changes indicating degrees of cellular injury could be clearly observed.
Comparisons of structural abnormality severity scores and numbers of changed
parameters between the control (no drug), enalaprilat and esmolol animal groups are
shown in Table 3.58. A spectrum of ultrastructural changes suggestive of ischemic
injury was observed in control (photograph 3.4), enalaprilat (photograph 3.5) and
esmolol (photograph 3.6) animals.
Table 3.59 shows the numbers of animals in each group classified as demonstrating
clearly abnormal histology and those with normal histology or only minimal change.
Although the enalaprilat and esmolol animals invariably demonstrated better mean and
median severity scores, a lesser number of abnormal parameters, as well as a smaller
percentage of biopsies classified as clearly abnormal when compared with control
animals, these differences never reached statistical significance.
Table 3.53 Comparisons of absolute changes in relevant systemic hemodynamic parameters between
measurement times in control, esmolol and enalaprilat groups of pigs
MAP x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Control -1.3 7.4 -2.6 9.6 5.8 7.7 1.8 9.7
Esmolol -3.5 5.4 -6.1 6.6 12.4 8.4 2.6 6.4
Enalaprilat -8.0 5.0 -4.8 5.6 11.5 8.5 -1.3 10.6
PAWP
Control -0.93 2.16 -0.43 1.65 1.37 3.19 0 3.09
Esmolol -0.06 1.61 0.37 1.66 0.56 1.26 0.87 1.86
Enalaprilat -0.7 1.82 -0.5 2.04 -1.0 1.52 -2.21 1.31
CO
Control 0.13 0.45 0.22 0.30 -0.03 0.57 0.32 0.66
Esmolol 0.53 0.32 0.10 0.23 -0.11 0.17 0.51 0.44
Enalaprilat 0.4 0.29 0.06 0.08 -0.47 0.08 -0.01 0.23
No differences in changes between groups.
AN OVA
MAP = mean arterial pressure (mmHg); PAWP = pulmonary artery wedge pressure (mmHg); CO = cardiac output (l.rnin"):
x1-2 = mean difference between 1st and 2nd measurement periods; x2-3 = mean difference between 2nd and 3m measurement
periods; x3-4 = mean difference between 3m and 4th measurement periods; x1-4 = mean difference between 1st and 4th
measurement periods.
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Table 3.54 Comparisons of absolute changes in renal hemodynamic and glomerular function parameters
between measurement times in control, esmolol and enalaprilat groups of pigs
RBF x1-2 SO x2-3 SO x34 SO x1-4 SO
Control 291.14bc 239.7 -88.43 193.3 72.57 158.9 275.29c 117.5
Esmolol 70.1a 111.7 30.88 68.9 95.50 99.3 196.5 72.5
Enalaprilat 56.7" 41.6 -16.14 68.8 50.29 40.9 90.86a 69.1
GFR
Control 42.0c 27.9 -11.25 16.1 4.0bc 24.2 26.75 26.9
Esmolol 19.75 26.0 -6.5 25.17 29.75a 26.16 43.0 27.15
Enalaprilat 5.86a 14.6 -8.71 16.93 26.0a 15.37 23.14 17.45
FF
Control 0.0009 0.059 0.006b 0.066 -0.047b 0.055 -0.0404 0.075
Esmolol -0.016 0.024 -0.0698a 0.041 0.119a 0.074 0.034 0.061
Enalaprilat -0.028 0.057 -0.0024 0.07 0.041 0.136 0.0101 0.094
EH1P
Control 0.019 0.086 0.0005 0.077 -0.02 0.035 -0.0007 0.056
Esmolol 0.012 0.022 -0.017 0.031 0.015 0.044 0.01 0.043
Enalaprilat 0.021 0.043 -0.004 0.013 0.001 0.048 0.019 0.062
RBF,CO
Control 0.063b, 0.052 -0.022 0,04 0.02 0,041 0.061c 0.021
Esmolol -0.006a 0.051 0.005 0.018 0.04 0.049 0,039 0.025
Enalaprilat 0.005a 0.01 -0.006 0.021 0.025 0.012 0.023a 0,021
a :: significantly different from control animals (p < 0,05); b:: significantly different from esmolol animals (p < 0.05);
c :: significantly different from enalaprilat animals (p < 0.05).
AN OVA
RBF :: renal blood flow (mi.min'): GFR:: glomerular filtration rate (ml.mm"): FF:: filtration fraction; EH1P:: hippuran
extraction fraction; RBF/CO:: renal blood flow as a fraction of cardiac output; x1-2:: mean difference between t" and 2nd
measurement periods; x2-3:: mean difference between 2nd and 3rd measurement periods; x3-4:: mean difference
between 3'" and 4th measurement periods; x1-4:: mean difference between 1SI and 4th measurement periods.
Table 3.55 Comparisons of absolute changes in urine volumes and indices of renal
tubular function between measurement times in control, esmolol and
enalaprilat groups of pigs
Uvol x1-2 SO x2-3 SO x34 SO x14 SO
Control 53.12c 27.17 5.37 9.75 16.88 23.14 75.38 46.33
Esmolol -23.00 83.67 21.37 36.0 67.62 79.20 66.0 46,28
Enalaprilat -42.14a 51.50 36.28 44.7 28.71 62.72 22.0 64.75
FEN.
Control 0.001 0.045 0.014 0.029 0.055 0.042 0.071 0.075
Esmolol -0.024 0.094 -0,005 0.072 0,064 0.062 0.033 0.079
Enalaprilat -0.043 0.052 -0.219 0.656 0.29 0.637 0.027 0.059
CH20
Control -11.31 8,92 2.45c 8.4 10.14 11.27 1.28 14,79
Esmolol -14,62 32.21 -4.53c 21.86 24.21 30.66 5.06 10.75
Enalaprilat -8.33 14.63 26.72a,b 27.93 8.17 18,32 26.57 43.81
a :: significantly different from control animals (p < 0.05); b:: significantly different from esmolol animals (p < 0.05);
c= significantly different from enalaprilat animals (p < 0.05).
AN OVA
Uvol :: urine volume (ml in 20 min); FENa:: fractional excretion of sodium; CH2o:: free water clearance (rnl.rnln'):
x1-2 :: mean difference between 1st and 2nd measurement periods; x2-3:: mean difference between 2nd and 3'"
measurement periods; x3-4:: mean difference between 3rd and 41h measurement periods; x1-4:: mean difference
between 1st and 4th measurement periods.
Stellenbosch University http://scholar.sun.ac.za
117
Table 3.56 Comparisons of absolute changes in plasma renin levels between
measurement times in control, esmolol and enalaprilat groups of pigs
Pr." x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Control _2.74b.C 2.25 -0.12 1.81 -1.86 2.43 -4.71b•C 3.05
Esmolol 0.16a 0.47 0.14 0.11 -0.09 0.18 0.21a 0.42
Enalaprilat 0.86a 1.79 0.12 1.52 -0.59 1.26 0.39a 0.85
a = significantly different from control animals (p < 0.05); b = significantly different from esmolol animals (p < 0.05);
c = significantly different from enalaprilat animals (p < 0.05).
ANOVA
Pren = plasma renin levels (j.ig.r'.hr"\ x1-2 = mean difference between 1s, and 2nd measurement periods; x2-3 = mean
difference between 2nd and 3rd measurement periods; x3-4 = mean difference between 3rd and 4'h measurement periods;
x1-4 = mean difference between 1" and 4thmeasurement periods.
Figure 3.24 Comparisons of changes in renal blood flow between measurement times
in control, esmolol and enalaprilat animals
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Figure 3.26
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Comparisons of changes in glomerular filtration rate between measure-
ment times in control, esmolol and enaparilat animals
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Comparisons of changes in plasma renin concentrations between
measurement times in control, esmolol and enaparilat animals
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Table 3.57 Electronmicroscopic ultrastructural change: severity grading in control
animals, animals which received enalaprilat (ACEI) and animals which
received esmolol (B-blocker)
Group &
Total No. abnormal
Villi gER Mitochondria Chromatin Severityanimal No.
Score
parameters
Control
1 2 1 2 0 5 3
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 1 0 0 0 1 1
5 1 1 1 0 3 3
6 2 2 0 0 4 2
7 0 1 2 0 3 2
8 1 0 1 0 2 2
ACEI
1 0 0 0 0 0 0
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 2 1 2 0 5 3
5 0 0 0 0 0 0
6 0 0 0 0 0 0
7 3 0 0 0 3 1
8 0 0 0 0 0 0
9 2 0 0 0 2 1
10 2 1 1 0 4 3
11 3 0 0 0 3
-
1
12 0 2 1 0 3 2
fs-blocker
1 1 1 1 0 3 3
2 2 1 1 0 4 3
3 0 0 0 0 0 0
4 0 2 1 0 3 2
5 0 0 0 0 0 0
6 0 0 0 0 0 0
7 1 1 0 0 2 2
Severity grading per parameter: 0 - 3
Total severity score: Sum of parameter severity gradings (maximum = 12)
No. abnormal parameters: Number of parameters with grading> 0 (maximum = 4)
Table 3.58 Comparison of electronmicroscopic structural abnormalities between
control animals, animals which received enalaprilat (ACEI) and animals
which received esmolol (B-block)
Severity Score No. Abnormal parameters
Mean Median 25 Perc 75 Perc Mean Median 25 Perc 75 Perc
Control (n = 8) 2.75 2.5 2.0 3.5 1.8 2.0 1.0 2.5
ACEI (n = 12) 2.0 2.0 0.25 3.0 1.0 1.0 0.25 1.5
ïs-block (n= 7) 1.7 2.0 0.25 3.0 1.4 2.0 0.25 2.75
No significant differences between groups
Kruskal-Wallace
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Table 3.59 Comparison of numbers of animals which had clearly abnormal
ultrastructure vs those with minimal change or normal ultrastructure
between control, ACEI and B-blocked animals
Minimal change - normal animals Clearly abnormal animals
Control (n = 8) 3 5
ACEI (n = 12) 8 4
r.,-block (n = 7) 3 4
No significant differences between any groups: Chi Square
Clearly abnormal: Severity score = 3 for at least one parameter and/or 2: 2 parameters with any
degree of abnormality
Photograph 3.1 Proximal convoluted tubule (non-experimental animal without aortic
clamping) showing a normal appearance with an intact brush border (arrow).
Protrusion of apical cytoplasm is present with luminal occlusion (asterisk).
Scale bar, 1cm = 211m.
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Photograph 3.2 Proximal straight tubule (non-experimental animal without aortic
clamping) showing apical cytoplasmic swelling and protrusion
with luminal obliteration (asterisk) and mild vacuolization.
Normal brush border (arrow). Scale bar, 1cm = tBum.
I\)_...
Photograph 3.3 Thick ascending limb (non-experimental animal without
aortic clamping) showing mild apical protrusion with
luminal narrowing (asterisk). The chromatin shows a
normal distribution. No organellar swelling apparent.
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Photograph 3.4 Proximal convoluted tubule (control group, no drugs
administered) showing irregularity of the brush border with
clubbing and loss of microvilli (arrows). Cytoplasmic
vacuolization is also apparent. Scale bar, 1cm = 1,8Ilm.
.....
N
N
Photograph 3.5 Proximal straight tubule (ACEI group) showing brush
border irregularity with loss of microvilli (arrows). Scale
bar, 1cm = 1,8Ilm.
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Photograph 3.6
123
Thick ascending limb (r..-blocker group) showing mitochondrial swelling (arrowheads)
and dilatation of the granular endoplasmic reticulum (arrows). Scale bar, 1cm = 1.4llm.
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3.2.2.2 Comparison of inter-measurement changes in control animals,
animals pretreated with verapamil and animals pretreated with
enalaprilat, as well as comparison of renal electron microscopic
changes in the same groups
Timing of measurement steps
Step 1: preclamp
Step 2: immediately post-clamp (postclamp ) } perelamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
Systemic hemodynamic parameters relevant to renal hemodynamics and function
(MAP, PAWP, CO) demonstrated comparable changes between measurement periods
with the exception of the x1-2 change in MAP where, surprisingly, a greater increase
was recorded in the verapamil group than in the control group due to aortic cross
clamping (Table 3.60). The actual mean MAP measurements after aortic clamping
were, however, almost identical (verapamil group MAP = 83.85 mmHg; Control group
MAP = 83.37 mmHg).
The clamp-induced (x1-2) decrease in RBF was significantly greater in the control
animals than in the two drug manipulated groups, with the verapamil group even
demonstrating a small increase, although this change was not significantly different
from the enalaprilat animals (Figure 3.27, Table 3.61). Due to the decrease in RBF
subsequent to release of the aortic clamp (x3-4) in the enalaprilat group and a further
decrease in the control group in the same period (the former being significantly
different from the verapamil group), the x1-4 changes (decrease) in these two groups
were significantly different relative to the verapamil animals (Figure 3.27, Table 3.61).
The extent of the x3-4 decrease in RBF in the enaparilat group was responsible for the
significant x1-4 change (decrease) relative to verapamil animals, although the x1-4
change in enalaprilat pigs was still significantly less than the control group (Figure 3.27,
Table 3.61). The RBF as a fraction of CO showed the same significant changes as
RBF as independent parameter between the three groups of animals (Table 3.61).
The x1-2 change in GFR in control animals (decrease) was significantly different from
the verapamil and enalaprilat groups with no difference between the latter two groups
of animals (Figure 3.28, Table 3.61). A GFR decrease in the enalaprilat group between
the pre-unclamp and post-unelamp periods (x3-4) induced a change which was
significantly different from the verapamil group. The extent of this x3-4 decrease in the
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enalaprilat group deemed the difference in the x1-4 change between the latter group
and control animals insignificant despite the significant x1-2 difference between the
groups. It was also responsible for a significantly different x1-4 change (decrease)
relative to verapamil animals, the latter also being significantly different from the control
group (Figure 3.28, Table 3.61).
There were no significant changes in either the FF or EH1P in successive measurement
periods or over the duration of the experimental period (x1-4) between any of the
animal groups (Table 3.61).
There was a significantly different change (decrease) in urine volume produced
between the preclamp and postclamp measurements (x1-2) in the control animals
relative to the other two groups (Table 3.62). The x3-4 decrease in urine volume in the
enalaprilat group was significantly different from control animals. This reversal of the
x1-2 change between these two groups made the x1-4 change similar, while the x1-4
change between control and verapamil animals was significantly different (Table 3.62).
The urine volume change (decrease) from the first to the last measurement period in
control animals was thus significantly different from verapamil animals.
Neither CH20 nor FENa changes demonstrated any significant differences between any
of the three groups (Table 3.62).
Plasma renin measurements changed (increased) significantly between preelamp and
postclamp values in control animals relative to both other experimental groups
(Figure 3.29, Table 3.63). Changes (increases) in Prenin both control and verapamil
animals were significantly different from the enalaprilat group between the pre-unclamp
and post-unelamp periods. Due to the progressive increase in Prenin control animals,
the change from x1-4 values in the latter group was significantly different from both the
verapamil and the enalaprilat groups. Again, changes during the whole experimental
period was minimal in the enalaprilat group with high absolute values at all
measurement periods (5.8, 5.7, 5.66 and 5.16 respectively) due to inhibition of the
negative feedback on renin release.
The renal electronmicroscopic changes in proximal tubular cells for each individual
animal in the three relevant groups are shown in Table 3.64. The two ACE inhibitor
animal groups are again combined for comparison with the control and verapamil
groups. The severity grading for changes in each subcellular structure demonstrates
substantial variation both within and between animal groups. It is conspicuous that
mitochondrial swelling was the only abnormality which occurred in (some) verapamil
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animals (photograph 3.7, 3.8, 3.9, 3.10), while gER and microvillous changes were also
noted in animals in the control (photograph 3.4) and enalaprilat (photograph 3.5)
groups.
Structural abnormality severity scores and numbers of changed parameters in the
control, enalaprilat and verapamil groups are compared in Table 3.65. Although both
these cumulative indices demonstrate a severity trend of control > enalaprilat >
verapamil, these differences do not reach statistical significance (control vs verapamil :
p = 0.059).
Table 3.66 shows the number of animals in each group classified as demonstrating
clearly abnormal histology, versus those with normal histology or minimal change in
accordance with previously defined criteria. None of the animals in the verapamil
group was classified as "clearly abnormal" which was significantly different from both
the other two groups.
Table 3.60 Comparisons of absolute changes in relevant hemodynamic parameters
between measurement times in control, verapamil and enalaprilat groups
of pigs
MAP x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Control _1.3b 7.4 -2.6 9.6 5.8 7.7 1.8 9.7
Verapamil -10.2" 2.2 -0.9 6.1 6.3 5.7 -4.7 4.3
Enalaprilat -9.1 5.0 -4.7 4.5 12.7 3.5 -1.1 2.7
PAWP
Control -0.93 2.16 -0.43 1.65 1.37 3.19 0 3.09
Verapamil -0.06 1.61 0.37 1.66 0.56 1.26 0.87 1.86
Enalaprilat -0.66 2.01 0.75 0.82 -0.33 1.60 -0.25 2.36
CO
Control 0.13 0.45 0.22 0.3 -0.03 0.57 0.32 0.66
Verapamil 0.23 0.42 0.06 0.34 -0.37 0.30 -0.07 0.44
Enalaprilat 0.1'5 0.15 0.14 0.22 -0.26 0.26 0.02 0.30
a = significantly different from control animals (p < 0.05); b = significantly different from verapamil animals (p < 0.05)
ANOVA
MAP = mean arterial pressure (mmHg); PAWP = pulmonary artery wedge pressure (mmHg) CO = cardiac output
(l.rnin'): x1-2 = mean difference between 1s, and 2nd measurement periods; x2-3 = mean difference between 2nd and 3'"
measurement periods; x3-4 = mean difference between 3'" and 4,h measurement periods; x1-4 = mean difference
between 1st and 4th measurement periods.
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Table 3.61 Comparisons of absolute changes in renal hemodynamics and glomerular
function parameters between measurement times in control, verapamil
and enalaprilat groups of pigs
RBF x1-2 so x2-3 so x3-4 so x1-4 so
Control 291.14b,c 239.7 -88.43 193.3 72.57 158.9 275.29b,c 117.5
Verapamil -38.17' 93.6 69.5 83.9 -64.83c 77.3 _7.0"c 106.4
Enalaprilat 32.83' 50.4 -12.67 84.9 102.33b 96.6 122.5·,b 94.6
GFR
Control 42.0b,c 27.9 -11.25 16.10 -4.0 24.20 26.75b 26.90
Verapamil _3.0' 18.57 1.43 12.22 -7.57c 21.59 -9.14"c 31.73
Enalaprilat -1.83' 6.15 -1.0 10.79 23.83b 17.72 21.0b 16.80
FF
Control 0.0009 0.059 0.006 0.066 -0.0473 0.055 -0.0404 0.075
Verapamil 0.0008 0.034 0.0071 0.033 0.0086 0.045 0.0032 0.061
Enalaprilat -0.0241 0.028 0.0035 0.043 0.0246 0.052 0.004 0.044
EH1P
Control 0.019 0.086 0.0005 0.077 -0.02 0.035 -0.0007 0.056
Verapamil 0.021 0.046 -0.0135 0.013 0.0358 0.035 0.0105 0.092
Enalaprilat 0.002 0.073 -0.0116 0.042 -0.0031 0.015 -0.0124 0.046
RBF/CO
Control 0.063b,c 0.052 -0.022 0.04 0.02 0.041 0.061 b.c 0.021
Verapamil -0.021 a 0.027 0.016 0.022 -0.004c 0.021 -0.008"c 0.027
Enalaprilat 0.005' 0.015 -0.008 0.026 0.034b 0.025 0.031··b 0.025
•a = significantly different from control animals (p < 0.05); b = significantly different from verapamil animals (p < 0.05);
c = significantly different from enalaprilat animals (p < 0.05).
ANOVA
RBF = renal blood flow (rnl.rnin"): GFR = glomerular filtration rate (ml.min"): FF = filtration fraction; EH1P = hippuran
extraction fraction; RBF/CO = renal blood flow as a fraction of cardiac output; x1-2 = mean difference between 1s1and 2nd
measurement periods; x2-3 = mean difference between 2nd and 3rd measurement periods; x3-4 = mean difference
between 3rd and 4th measurement periods; x1-4 = mean difference between 1st and 4th measurement periods.
Table 3.62 Comparisons of absolute changes in urine volumes and indices of renal
tubular function between measurement times in control, verapamil and
enalaprilat groups of pigs
Uvol x1-2 so x2-3 so x3-4 so x1-4 so
Control 53.12b,c 27.17 5.37 9.75 16.88c 23.14 75.38b 46.33
Verapamil -73.0' 66.06 4.57 90.49 61.29 73.16 -7.14' 41.58
Enalaprilat -69,17' 42.48 -5.0 64.98 122.17' 69.04 48.0 75.03
FEN.
Control 0.001 0.045 0.014 0.029 0.055 0.042 0.071 0.076
Verapamil -0.027 0.066 0.013 0.059 0.047 0.05 0.033 0.084
Enalaprilat -0.043 0.139 0.136 0.338 0.032 0.053 0.125 0.246
CH20
Control -11.31 8.92 2.45 8.4 10.14 11.27 1.28 14.79
Verapamil -3.62 12.18 -1.36 25.97 11.89 15.98 6.91 20.27
Enalaprilat -3.78 12.76 41.71 39.11 -17.84 42.94 20,09 28.01
a = significantly different from control animals (p < 0.05); b = significantly different from verapamil animals (p < 0,05); c
= significantly different from enalaprilat animals (p < 0.05).
ANOVA
Uvol = urine volume (ml in 20 min); FEN. = fractional excretion of sodium; CH20 = free water clearance (rnl.rnin'):
x1-2 = mean difference between 1st and 2nd measurement periods; x2-3 = mean difference between 2nd and 3rd
measurement periods; x3-4 = mean difference between 3rd and 4th measurement periods; x1-4 = mean difference
between t" and 4th measurement periods.
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Table 3.63 Comparisons of absolute changes in plasma renin levels between
measurement times in control, verapamil and enalaprilat groups of pigs.
Pren x1-2 SO x2-3 SO x34 SO x14 SO
Control _2.74b,c 2.25 -0.12 1.81 -1.86c 2.43 _4.71b•C 3.05
Verapamil 0.44a 0.66 0.03 0.42 -1.91c 1.33 _1.43a 1.04
Enalaprilat 0.09a 1.48 0.05 1.94 _0.49a.b 1.17 0.63a 1.61
a = significantly different from control animals (p < 0.05); b = significantly different from verapamil animals (p < 0.05);
c = significantly different from enalaprilat animals (p < 0.05).
ANOVA
Pren= plasma renin levels (~g.rl.h(\ x1-2 = mean difference between 1st and 2nd measurement periods; x2-3 = mean
difference between 2nd and 3m measurement periods; x3-4 = mean difference between 3m and 4th measurement periods;
x14 = mean difference between 151 and 4th measurement periods.
Figure 3.27 Comparisons of changes in renal blood flow between measurement times
in control, verapamil and enalaprilat animals
~~----.:.:.:.: -B----.:.:--~
600 : ----------~-------:
,,,
M1 M2 M3 M4
Measurement Periods
o = control animals
o = verapamil animals Ml = preclamp control
6 = enalaprilat animals M2 _ poaIclamp
Values are given as absolute means, ± 1 SEM at M3= pre-unclamp
the individual measurement periods M4 = 30 min.post-unclamp
a = change between measurement times
significantly different from control group }
b = change between measurement times
significantly different from verapamil group p < 0.05
c = change between measurement times
significantly different from enalaprilat group
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Figure 3.28
Figure 3.29
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Comparisons of changes in glomerular filtration rate between measure-
ment times in control, verapamil and enalaprilat animals
--------------~-------------------~------_:-_-- __ - ~ _ -,J_, ', :
90
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70
GFR
(ml.min-1) 60
50
40
M1 M3 M4M2
Measurement Periods
o = control animals
o = verapamIl animals
6 = enalaprilat animals
M1 - preclamp control
M2 - postclamp
M3 - pre-unclamp
M4 = 30 mln. post-unclampValues are given as absolute means, ± 1 SEM at
the individual measurement periods
a = change between measurement times
significantly different from control group }
b = change between measurement times
significantly different from verapamil group
c = change between measurement times
significantly different from enalaprilat group
p < 0.05
Comparisons of changes in plasma renin concentrations between
measurement times in control, verapamil and enalaprilat animals
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4
renin
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3
2
M1 M2 M4M3
Measurement Periods
o = control animals
o = verapamil animals M1 = preclamp control
6 = enalaprilat animals M2 = postclamp
Values are given as absolute means, ± 1 SEM at M3 = pr....unclamp
the individual measurement periods M4 = 30 min. post-unclamp
a = change between measurement times }
significantly different from control group
b = change between measurement times
significantly different from verapamil group P < 0.05
c = change between measurement times
significantly different from enalaprllat group
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Table 3.64 Electronmicroscopie ultrastructural change: severity grading in control
animals, animals which received enalaprilat (ACEI) and animals which
received verapamil (Ca2+ -blocker)
Group &
Total No. abnormal
Villi gER Mitochondria Chromatin Severityanimal No.
Score
parameters
Control
1 2 1 2 0 5 3
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 1 0 0 0 1 1
5 1 1 1 0 3 3
6 2 2 0 0 4 2
7 0 1 2 0 3 2
8 1 0 1 0 2 2
ACEI
1 0 0 0 0 0 0
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 2 1 2 0 5 3
5 0 0 0 0 0 0
6 0 0 0 0 0 0
7 3 0 0 0 3 1
8 0 0 0 0 0 0
9 2 0 0 0 2 1
10 2 1 1 0 4 3
11 3 0 0 0 3 1
12 0 2 1 0 3 2
Ca" -blocker
1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 0 0 2 0 2 1
4 0 0 2 0 2 1
5 0 0 1 0 1 1
6 0 0 1 0 1 1
7 0 0 1 0 1 1
Severity grading per parameter: 0 - 3
Total severity score: Sum of parameter severity gradings (maximum = 12)
No. abnormal parameters: Number of parameters with grading> 0 (maximum = 4)
Table 3.65 Comparison of electronmicroscopie structural abnormalities between
control animals, animals which received enalaprilat (ACEI) and animals
which received verapamil (Ca2+-block)
Severity Score No. Abnormal parameters
Mean Median 25 Perc 75 Perc Mean Median 25 Perc 75 Perc
Control (n = 8) 2.75 2.5 2.0 3.5 1.8 2.0 1.0 2.5
ACEI (n = 12) 2.0 2.0 0.25 3.0 1.0 1.0 0.25 1.5
Ca2+-block (n= 7) 1.0 1.0 0.25 1.75 0.7 1.0 0.25 1.0
No significant differences between groups
(Severity Score: Control vs Ca2+ -block: p = 0.06)
Kruskal-Wallace
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Table 3.66 Comparison of numbers of animals which had clearly abnormal
ultrastructure vs those with minimal change or normal ultrastructure
between control, ACEI and Ca2+-block animals
Minimal change - normal animals Clearly abnormal animals
Control (n = 8) 3 5
ACEI (n = 12) 8 4
Ca2+-block (n = 7) 7 0
Control vs ACEI: NS
Control vs Ca2+-block: p < 0.05
ACEI vs Ca2+-block: p < 0.05 } Chi Square
Clearly abnormal: Severity score = 3 for at least one parameter and/or ~ 2 parameters with any
degree of abnormality
Photograph 3.7 Proximal convoluted tubule (Ca2+-blocker group) showing an appearance similar to
that of normal, non-experimental animals. Scale bar, 1cm = 1, turn.
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Photograph 3.8 Proximal straight tubule (Ca
2+-blocker group) showing an
appearance similar to that of normal, non-experimental animals.
Scale bar, 1cm = 1,3I!m.
W
N
Photograph 3.9 Thick ascending limb (Ca-blocker group) showing an
appearance similar to that of normal, non-experimental
animals. Scale bar, 1cm = 1,3I!m.
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Photograph 3.10
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Proximal convoluted tubule (Ca-blocker group) showing an intact brush border with
slight mitochondrial swelling (arrows). Scale bar, 1cm = 1,3~m.
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3.2.2.3 Comparison of inter-measurement changes in control animals and
animals pretreated with diclofenac, as well as comparison of renal
electronmicroscopic changes in the same groups
Timing of measurement steps
Step 1: preelamp
Step 2: immediately post-clamp (postclamp ) } perelamp
Step 3: immediately before release of clamp (pre-unclamp)
Step 4: starts 30 minutes after release of clamp (post-unclamp)
There were no significant differences in changes of hemodynamic parameters (HR,
MAP, PAWP and CO) in successive measurement periods (or between the first and
fourth measurement periods) between the two groups of pigs. The most relevant of
these parameters in the context of renal hemodynamics and glomerular function are
given in Table 3.67.
Although the changes in RBF between measurement times were not different between
the two groups of animals (Table 3.68, Figure 3.30), the absolute RBF measurements
in diclofenac animals were invariably in excess of 40% lower than control animals at
the same measurement periods (Figure 3.30). RBF as a fraction of CO demonstrated
similar trends (Table 3.68).
Due to some degree of recovery of GFR just before release of the aortic clamp in
control animals, there was a significant difference in the change between the two
groups of animals in this period (x2-3), as the GFR in the diclofenac pigs continued to
decrease (Table 3.68, Figure 3.31). Similar to RBF, the absolute GFR values
immediately before and again 30 minutes after release of the aortic clamp, were> 40%
lower in the diclofenac than control animals (Figure 3.31).
There were no differences in changes of either EH1P or FF in sequential measurement
periods or from preelamp to post-unelamp (x1-4) between the two groups of pigs
(Table 3.31).
Differences in changes in the volume of urine production were in sharp contrast to the
relative lack of significant differences in changes in RBF and GFR between the two
groups. There were much more significant reductions in urine production in diclofenac
pigs (relative to controls) in both the pre- to postclamp periods (x1-2) and the
postclamp to pre-unclamp periods (x2-3) (Table 3.69). These changes were
responsible for the fact that the x1-4 change was also significantly different between
the two groups of animals (Table 3.69).
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The diclofenac animals were the only group in which FENa consistently exceeded a
value of 1.0 subsequent to aortic cross clamping (Table 3.45). The changes (increase)
from postclamp to pre-unclamp (x2-3) and over the duration of the experiment (x1-4)
were significantly different between the two groups of animals (Table 3.69). Although
the absolute CH20 value at the end of the experimental period were more positive in the
diclofenac pigs than any of the other experimental groups (Table 3.45), there were no
statistically significant differences in changes between measurement periods between
control and diclofenac animals (Table 3.69).
Changes in plasma renin concentrations between measurement periods were similar in
control and diclofenac animals (Table 3.70, Figure 3.32).
Because the difference in RBF between the two animal groups at the control
(preclamp) measurement was statistically significant (unlike comparisons of RBF
control measurements between any of the other animal groups reported in this thesis),
comparisons of values at the specific measurement periods are also shown for RBF,
GFR, FF and renin concentrations (Figures 3.30,3.31, 3.31a and 3.32 respectively).
The renal ultrastructural changes for individual animals in the control and diclofenac
animals are listed in Table 3.71. While the control animals demonstrate a range of
abnormalities (Table 3.71, photograph 3.4), substantial structural abnormalities
involving at least 3 of the 4 cellular structures were evident in all animals in the diclo-
fenac animals (Table 3.71; photographs 3.11, 3.12, 3.13). While nuclear chromatin
abnormalities manifested in 4 of the 5 NSAID animals (photograph 3.13), such changes
were absent in control animals (and all other experimental groups).
Comparison of both structural abnormality severity score and mean number of
abnormal parameters, demonstrate significant differences between the groups, with the
diclofenac animals more severely affected (Table 3.72). Comparison of numbers of
animals classified as either clearly abnormal or normal to minimal abnormality, shows
no difference between the groups (p = 0.057). It is likely that, had the 2 animals which
were excluded because of anuria (and which presumably had not only substantial
functional, but also ultrastructural abnormalities) also been biopsied, a statistically
significant difference would also have been achieved with this comparison.
The diclofenac group was the only experimental group where structural abnormalities
could be detected with light microscopy. The toluidine blue stained semithin sections
demonstrated shortening of the proximal tubular brush borders in this group.
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Table 3.67 Comparisons of absolute changes in relevant hemodynamic parameters
between measurement times in control and diclofenac groups of pigs
MAP x1-2 SO x2-3 SO X3-4 SO x1-4 SO
Control -1.3 7.4 -2.6 9.6 5.8 7.7 1.8 9.7
Diclofenac -10.7 2.9 -2.5 3.0 15.1 5.4 1.9 4.6
PAWP
Control -0.93 2.16 -0.43 1.65 1.37 3.19 0 3.09
Diclofenac -1.7 1.09 -0.10 1.91 0.5 3.10 -1.3 1.98
CO
Control 0.13 0.45 0.22 0.30 -0.03 0.57 0.32 0.66
Diclofenac 0.46 0.21 0.17 0.07 -0.63 0.41 0 0.20
No differences in changes between groups.
ANOVA
MAP = mean arterial pressure (mmHg); PAWP = pulmonary artery wedge pressure (mmHg); CO = cardiac output
(l.min'): x1-2 = mean difference between 1st and 2nd measurement periods; x2-3 = mean difference between 2nd and 3rd
measurement periods; x3-4 = mean difference between 3rd and 4th measurement periods; x1-4 = mean difference
between 1st and 4th measurement periods.
Table 3.68 Comparisons of absolute changes in renal hemodynamic and glomerular
function parameters between measurement times in control and
diclofenac groups of pigs
RBF x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Control 291.14 239.7 -88.43 193.3 72.57 158.9 275.29 117.5
Diclofenac 210.6 33.8 32.4 25.8 -50.4 41.8 192.6 39.37
GFR
Control 42.0 27.9 -11.25b 16.1 -4.0 24.20 26.75 26.90
Diclofenac 47.6 9.07 3.4a 7.8 -4.4 11.84 46.6 11.55
FF
Control 0.0009 0.059 0.006 0.066 -0.0473 0.055 -0.0404 0.075
Diclofenac -0.0094 0.062 -0.055 0.071 0.049 0.035 -0.015 0.063
EH1P
Control 0.019 0.086 0.0005 0.077 -0.02 0.035 -0.0007 0.056
Diclofenac 0.033 0.07 -0.0004 0.049 0.022 0.041 0.055 0.071
RBF/CO
Control 0.063 0_052 -0_022 0.040 0.02 0.041 0.061 0.021
Diclofenac 0.052 0.009 0.007 0.007 -0.006 0.009 0.053 0.009
a = significantly different from control animals (p < 0.05); b = significantly different from diclofenac animals (p < 0.05).
ANOVA
RBF = renal blood flow (rnl.rnln'): GFR = glomerular filtration rate (rnt.rnin"): FF = filtration fraction; EH1P = hippuran
extraction fraction; RBF/CO = renal blood flow as a fraction of cardiac output; x1-2 = mean difference between 1s1 and 2nd
measurement periods; x2-3 = mean difference between 2nd and 3rd measurement periods; x3-4 = mean difference
between 3rd and 41h measurement periods; x1-4 = mean difference between 151 and 41h measurement periods.
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Table 3.69 Comparisons of changes in urine volumes and indices of renal tubular
function between measurement times in control and diclofenac groups of
pigs
Uvol x1-2 so x2-3 so x3-4 so x1-4 so
Control 53.12b 27.17 5.37b 9.75 16.88 23.14 75.38b 46.33
Diclofenac 136.4· 63.75 45.2· 24.32 12.2 13.2 193.8· 66.17
FEN.
Control 0.001 0.045 0.014 0.029 0.055 0.042 0.071b 0.076
Diclofenac -0.874 1.226 -0.219 0.303 0.163 0.575 -0.9· 0.94
CH20
Control -11.31 8.92 2.45 8.40 10.14 11.26 1.28 14.79
Diclofenac -16.32 14.34 3.21 7.14 0.74 6.26 -12.37 21.84
a = significantly different from control animals (p < 0.05); b = significantly different from diclofenac animals (p < 0.05).
ANOVA
Uvol = urine volume (ml in 20 min); FEN. = fractional excretion of sodium; CH20 = free water clearance (rnl.min');
x1-2 = mean difference between 1s' and 2nd measurement periods; x2-3 = mean difference between 2nd and 3"'
measurement periods; x3-4 = mean difference between 3"' and 4'h measurement periods; x1-4 = mean difference
between 1s' and 4'h measurement periods.
Table 3.70 Comparisons of absolute changes in plasma renin levels between
measurement times in control and diclofenac groups of pigs
Pren x1-2 so x2-3 so x3-4 so x1-4 so
Control -2.74 2.25 -0.12 1.81 -1.86 2.43 -4.71 3.05
Diclofenac -1.98 3.30 -0.14 1.51 -0.77 1.76 -2.9 2.82
No significant differences between groups.
ANOVA
Pren= plasma renin levels (~g.I.·'.h('); x1-2 = mean difference between 1s' and 2nd measurement periods; x2-3 = mean
difference between 2nd and 3"' measurement periods; x3-4 = mean difference between 3"' and 4'h measurement periods;
x1-4 = mean difference between t" and 4'h measurement periods.
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Figure 3.30 Comparisons of changes in renal blood flow between measurement
times and differences in absolute values at measurement times in
control and diclofenac animals
RBF
(ml.mln")
M1 M2 M3 M4
Measurement Periods
o = control animals
o = diclofenac animals
Differences in absolute values at
measurement times:
Values are given as means, ± 1 SEM
at the individual measurement periods
M1 = preclamp control
M2 = postclamp
M3 = pre-unclamp
M4 = 30 mln. post·unclamp
p < 0.05
P < 0.01
P < 0.001
No significant differences in changes
between measurement times between
the two groups of animals
Figure 3.31 Comparisons of changes in glomerular filtration rate between measurement
times and differences in absolute values at measurement times in control
and diclofenac animals
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M1 M2 M3 M4
Measurement Periods
o = control animals
o = diclofenac animals
• p < 0.05
Values are given as means, ± 1 SEM
at the individual measurement periods
M1 _ preetemp control
M2 _ postelamp
M3 "'"pre-unclamp
M4 - 30 mln. post-unclamp
Differences in absolute values at
measurement times:
a = change between measurement
times significantly different from
control group
b = change between measurement
times significantly different from
diclofenac group
} p < 0.05
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Figure 3.31a Comparisons of changes in filtration fraction (FF) between measurement
times and differences in absolute values at measurement times in control
and diclofenac animals
0.55
0.50
Filtration
0.45
fraction
0.40
0.35
0.30
*
0.25
Values are given as means, ± 1 SEM
at the individual measurement periods
o = control aniinals
o = diclofenac animals
M1 M2 M3 M4
Measurement periods
Differences in absolute values at
measurement times:
• p < 0.05
M1 = preclamp control
M2 = postclamp
M3 = pre-unclamp
M4 = 30 min.post-unclamp
No significant differences in changes
between measurement times between
the two groups of animals
Figure 3.32 Comparisons of changes in plasma renin concentrations between
measurement times and differences in absolute values at measurement
times in control and diclofenac animals
o = control animals
o = diclofenac animals
7
6
5
renin 4
( )Jg.I" .hr·')
3
2
M1 M2 M4M3
Measurement Periods
Values are given as means, ± 1 SEM
at the individual measurement periods
No differences in absolute values at any
measurement time
No significant differences in changes
between the two groups of animals
M' = preclamp control
M2 = postclamp
M3 = pre-unclamp
M4 = 30 mln. poat·unclamp
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Table 3.71 Electronmicroscopic ultrastructural change: severity grading in control
animals and animals which received diclofenac (NSAID)
Group & Total No. abnormal
animal No. Villi gER Mitochondria Chromatin Severity parameters
Score
NSAID
1 2 2 2 3 9 4
2 2 3 3 3 11 4
3 2 2 2 3 9 4
4 1 2 3 3 9 4
5 1 2 2 0 5 3
Control
1 2 1 2 0 5 3
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 1 0 0 0 1 1
5 1 1 1 0 3 3
6 2 2 0 0 4 2
7 0 1 2 0 3 2
8 1 0 1 0 2 2
Severity grading per parameter: 0 - 3
Total severity score: Sum of parameter severity gradings (maximum = 12)
No. abnormal parameters: Number of parameters with grading> 0 (maximum = 4)
Table 3.72 Comparison of electronmicroscopic structural abnormalities between
control animals and animals which received diclofenac (NSAID)
Severity Score Number of abnormal parameters
Clearly
75
Minimal change - abnormal
Mean Median 25 75 Mean Median
25 normal animals animalsPerc Perc Perc Perc
Control (n = 8) 2.75 2.5 2.0 3.5 1.8 2.0 1.0 2.5 3 5
* * NS
NSAID (n = 5) 8.6 9.0 8.0 9.5 3.8 4.0 3.75 4.0 0 5
* Significant difference between control and NSAID groups (p < 0.005)
Mann-Whitney: Severity Score and number of abnormal parameters
Fisher exact: Minimal change - normal/clearly abnormal comparisons
Clearly abnormal: Severity score = 3 for at least one parameter and/or z 2 parameters with any
degree of abnormality
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Photograph 3.11
141
Proximal convoluted tubule (NSAID group) showing irregularity of the brush border with
shortened, abnormal microvilli (asterisk). Scale bar, 1cm = 1,3f..Lm.
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Photograph 3.12 Proximal straight tubule (NSAID group) showing brush border
disarray with villous clubbing (asterisk), mitochondrial swelling
(arrows) and dilatation of the granular endoplasmic reticulum
(arrowheads). Scale bar, 1cm = 1,3~m.
_.
~
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Photograph 3.13 Thick ascending limb (NSAID group) showing
mitochondrial swelling (arrows), dilatation of the
granular endoplasmic reticulum (arrowheads) and
slight peripheral nuclear chromatin condensation. Scale
bar, 1cm = 1,4~m.
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3.2.2.4 Comparison of inter-measurement changes in animals pretreated with
enalaprilat or enalaprilat plus diclofenac, as well as comparison of
renal electron microscopic changes in the same groups
Step 1:
Step 2:
Step 3:
preclamp
immediately post-clamp (postclamp ) } perclamp
immediately before release of clamp (pre-unclamp)
Timing of measurement steps
Step 4: starts 30 minutes after release of clamp (post-unclamp)
The systemic hemodynamic parameters, which could potentially influence renal
hemodynamics and function (MAP, PAWP and CO) demonstrated no significant
differences between the two animal groups in changes between successive or in first-
to-last (x1-4) measurement periods (Table 3.73).
The RBF change induced by aortic cross clamping (x1-2) was significantly more
pronounced in the enalaprilat plus diclofenac group, although the same change in
RBF/CO did not reach statistical significance (Figure 3.33, Table 3.74). By comparison,
both RBF and RBF/CO decreased significantly subsequent to aortic cross clamping in the
enalaprilat plus diclofenac group with intragroup comparisons (Table 3.74), without
significant changes in the same parameters in the enalaprilat group (Table 3.74).
The x1-2 GFR change in the enalaprilat plus diclofenac group (decrease) was
significantly different from the enalaprilat animals (Figure 3.34, Table 3.74). Although
the x3-4 change in GFR was not significantly different between the two groups of
animals (p = 0.054), the extent of the GFR decrease from the pre-unclamp to post-
unclamp measurements in the enalaprilat group, rendered the x1-4 change not
significantly different between the two groups.
There were no significant differences in changes between consecutive measurement
periods or first-ta-last (x1-4) changes of either FF or EH1P between the two experimental
groups (Table 3.74).
The change in urine volume between the preclamp and postclamp measurement
periods were significantly different between the two animal groups (x1-2, Table 3.75)
due to a doubling of urine production in the enalaprilat group (Table 3.35) and a
reduction in excess of 50% in the enalaprilat plus diclofenac group (Table 3.50).
Another change (x3-4) was significantly different between the two experimental groups,
predominantly as a result of a 50% decrease in the volume of urine produced in the
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enalaprilat group subsequent to release of the aortic cross clamp (Table 3.35). Again,
this reversal in change relative to the x1-2 change, rendered the x1-4 change not
significantly different between the two groups of animals.
There was a significantly different x2-3 change between the two experimental groups in
CH20 (Table 3.75), primarily due to the fact that CH20 became significantly more
negative between the postclamp and pre-unclamp measurement periods in the
enalaprilat animals (Table 3.35). Just focussing on the change, obscures the fact that
the initial (preclamp control) value of CH20 in the enalaprilat group was much less
negative than any of the other experimental groups (Table 3.35).
There were no significant differences in changes of plasma renin concentrations
between the two animal groups with Pren sustained at high levels throughout the
experimental periods in both groups (Figure 3.35, Table 3.76).
Table 3.77 lists the extent of renal electronmicroscopic changes in individual animals in
the enalaprilat and enalaprilat plus diclofenac animals. A spectrum of subcellular
structural changes was apparent in both enalaprilat (photograph 3.5) and enalaprilat
plus diclofenac animals, with the latter group seemingly more prone to microvillous
changes and dilatation of the granular endoplasmic reticulum (Table 3.77, photo-
graphs 3.14, 3.15).
Comparisons of structural abnormality scores and numbers of abnormal structures
between the two animal groups are shown in Table 3.78. Although a tendency towards
more severe ischemic changes is apparent in the diclofenac plus enalaprilat group,
statistical significance is not achieved in either comparison. Numbers of animals
classified as demonstrating clearly abnormal histology versus those with normal
histology or minimal change were not significantly different between the two groups
(Table 3.78).
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Table 3.73 Comparisons of absolute changes in relevant systemic hemodynamic parameters between
measurement times in pigs which received either enalaprilat or enalaprilat plus diclofenac
MAP x1-2 SO. x2-3 SO x3-4 sn x1-4 so
Enalaprilat -9.1 5.0 -4.7 4.5 12.7 3.5 -1.1 2.7
Enalaprilat & -8.3 2.2 -1.3 2.3 9.7 4.6 0.1 5.2
Diclofenac
PAWP
Enalaprilat -0.66 2.01 0.75 0.82 -0.33 1.60 -0.25 2.36
Enalaprilat & -1.14 2.40 -0.28 1.31 0.42 1.59 -1.0 1.47
Diclofenac
CO
Enalaprilat 0.15 0.15 0.14 0.22 -0.26 0.26 0.02 0.30
Enalaprilat & 0.32 0.30 -0.16 0.30 -0.29 0.18 -0.13 0.32
Diclofenac
No differences in changes between groups.
ANOVA
MAP = mean arterial pressure (mmHg); PAWP = pulmonary artery wedge pressure (mmHg); CO = cardiac output
(I.min"): x1-2 = mean difference between 151 and 2nd measurement periods; x2-3 = mean difference between 2nd and 3'"
measurement periods; x3-4 = mean difference between 3'" and 41h measurement periods; x1-4 = mean difference
between 151 and 41h measurement periods.
Table 3.74 Comparisons of absolute changes in renal hemodynamic and glomerular
function parameters between measurement times in enalaprilat and
enalaprilat plus diclofenac groups of pigs
RBF x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Enalaprilat 32.8- 50.4 -12.67 84.86 102.3 116.6 122.5 94.6
Enalaprilat & 206.6b 186.7 19.57 105.54 34.0 157.6 260.1 199.7
Diclofenac
GFR
Enalaprilat -1.83- 6.15 -1.0 10.79 23.83 17.72 21.0 16.8
Enalaprilat & 39.29b 19.61 0.14 12.81 -1.0 22.88 38.43 47.78
Diclofenac
FF
Enalaprilat -0.024 0.028 0.0035 0.043 0.0246 0.052 0.004 0.044
Enalaprilat & 0.011 0.052 -0.0095 0.073 0.0124 0.065 0.0145 0.054
Diclofenac
EH1P
Enalaprilat 0.0023 0.073 -0.0116 0.041 -0.0031 0.015 -0.012 0.046
Enalaprilat & -0.0045 0.038 0.0064 0.09 0.037 0.069 0.0388 0.071
Diclofenac
r<Dr Ico
Enalaprilat 0.004 0.015 -0.007 0.026 0.034 0.035 0.03 0.025
Enalaprilat & 0.048 0.056 0.01 0.032 0.012 0.037 0.071 0.057
Diclofenac
a = significantly different from enalaprilat animals (p < 0.05); b = significantly different from enalaprilat plus diclofenac
animals (p < 0.05).
ANOVA
RBF = renal blood flow (rnl.rnin'): GFR = glomerular filtration rate (ml.min"): FF = filtration fraction; EHIP = hippuran
extraction fraction; RBF/CO = renal blood flow as a fraction of cardiac output; x1-2 = mean difference between 151 and 2nd
measurement periods; x2-3 = mean difference between 2nd and 3'" measurement periods; x3-4 = mean difference
between 3'" and 41h measurement periods; x1-4 = mean difference between 151 and 41h measurement periods,
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Table 3.75 Comparisons of absolute changes in urine volumes and indices of renal tubular function
between measurement times in pigs which received either enalaprilat or enalaprilat plus
diclofenac
Uvol x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Enalaprilat -69.17b 42.48 -5.0 64.98 122.17b 69.04 48.0 75.03
Enalaprilat & 74.14a 88.21 5.71 20.63 12.71a 24.84 92.57 69.01
Diclofenac
FEN.
Enalaprilat -0.043 0.139 0.136 0.338 0.032 0.053 0.125 0.246
Enalaprilat & -0.025 0.094 0.031 0.028 0.011 0.052 0.018 0.067
Diclofenac
CH20
Enalaprilat -3.78 12.76 41.71 b 39.11 -17.84 42.94 20.09 28.01
Enalaprilat & -21.77 69.15 -5.26a 13.74 14.24 31.69 -12.79 81.62
Diclofenac
a :: significantly different from enalaprilat animals (p < 0.05); b= significantly different from enalaprilat plus diclofenac
animals (p < 0.05).
AN OVA
Uvol :: urine volume (ml in 20 min); FENa:: fractional excretion of sodium; CH20 :: free water clearance (rnl.rnin");
x1-2 :: mean difference between 1st and 2nd measurement periods; x2-3:: mean difference between 2nd and 3m
measurement periods; x3-4:: mean difference between 3m and 4th measurement periods; x1-4:: mean difference
between 1st and 4th measurement periods.
Table 3.76 Comparisons of absolute changes in plasma renin levels between
measurement times in pigs which received either enalaprilat or enalaprilat
plus diclofenac
Pren x1-2 SO x2-3 SO x3-4 SO x1-4 SO
Enalaprilat 0.09 1.48 0.05 1.94 0.49 1.17 0.63 1.61
Enalaprilat & 0.05 0.87 0.53 2.39 -1.86 5.39 -1.28 4.65
Diclofenac
No significant differences between groups.
ANOVA
Pren:: plasma renin levels (f.1g.r1.hr"'); x1-2:: mean difference between 1st and 2nd measurement periods; x2-3:: mean
difference between 2nd and 3m measurement periods; x3-4:: mean difference between 3m and 4th measurement periods;
x1-4 :: mean difference between 1st and 4th measurement periods.
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Comparisons of changes in renal blood flow between measurement times
in animals receiving either enalaprilat or enalaprilat plus diclofenac
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b = change between measurement
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Comparisons of changes in glomerular filtration rate between measure-
ment times in animals receiving either enalaprilat or enalaprilat plus
diclofenac
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Comparisons of changes in plasma renin concentrations between
measurement times in animals receiving either enalaprilat or enalaprilat
plus diclofenac
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o = enalaprilat animals
o = enalaprilat + diclofenac animals M1 = preclamp control
M2 = postclamp
M3 = pre-unclamp
M4 = 30 min. post-unclamp
Values are given as absolute means, :!: 1 SEM
at the individual measurement periods
No significant differences in changes
between measurement times between the two
groups of animals
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Table 3.77 Electronmicroscopic ultrastructural change: severity grading in animals
which received enalaprilat (ACEI) and animals which received enalaprilat
and diclofenac (ACEI +NSAID)
Group & Total No. abnormal
Villi gER Mitochondria Chromatin Severityanimal No.
Score
parameters
ACEI
1 0 0 0 0 0 0
2 2 0 0 0 2 1
3 0 0 2 0 2 1
4 2 1 2 0 5 3
5 0 0 0 0 0 0
6 0 0 0 0 0 0
7 3 0 0 0 3 1
8 0 0 0 0 0 0
9 2 0 0 0 2 1
10 2 1 1 0 4 3
11 3 0 0 0 3 1
12 0 2 1 0 3 2
ACEI + NSAID
1 1 2 1 0 4 3
2 1 2 3 0 6 3
3 3 0 0 0 3 1
4 1 2 2 0 5 3
5 2 0 0 0 2 1
6 2 1 1 0 4 3
7 0 0 1 0 1 1
Severity grading per parameter: 0 - 3
Total severity score: Sum of parameter severity gradings (maximum = 12)
No. abnormal parameters: Number of parameters with grading> 0 (maximum = 4)
Table 3.78 Comparison of electronmicroscopic structural abnormalities between
animals which received enalaprilat (ACEI) and those which received
enalaprilat and diclofenac (ACEI + NSAID)
Severity Score Number of abnormal parameters ClearlyMinimal change - abnormal
25 75 25 75 normal animals animalsMean Median Mean MedianPerc Perc Perc Perc
ACEI
(n = 12) 2.0 2.0 0.25 3.0 1.0 1.0 0.25 1.5 8 4
NS
ACEI + NSAID 3.6 4.0 2.25 4.75 2.1 3.0 1.0 3.0 2 5
(n = 7)
No significant differences between groups
Mann-Whitney: Severity Score and number of abnormal parameters
Fisher exact: Minimal change - normal/clearly abnormal comparisons
Clearly abnormal: Severity score = 3 for at least one parameter and/or ~ 2 parameters with any
degree of abnormality
Stellenbosch University http://scholar.sun.ac.za
Photograph 3.14 Proximal straight tubule (ACEI plus NSAID group) showing
brush border irregularity with loss of microvilli (arrows). Scale
bar, 1cm = 1,8iJm.
eno
Photograph 3.15 Proximal straight tubule (ACEI plus NSAID group)
showing brush border irregularity with loss of microvilli
(arrows). Scale bar, 1cm = 1,3iJm.
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4.1 The patient model
The preoperative demographic profile of the patients included in the study (Table 3.15)
is similar to other recent reports where renal hemodynamics and function were studied
during infrarenal aortic surgery (Gamulin et al. 1984 and 1986; Colson et al. 1992a;
Licker et al. 1996). The preoperative creatinine clearance (Table 3.16) was within the
normal range in both groups of patients studied.
Preoperative insertion of a renal venous catheter made it possible to use isotopes to
determine control RBF measurements while patients were still awake and also to
continue measurements into the postoperative period. In previous studies where
isotope-labelled hippuran was used for the determination of RBF (Gamulin et al. 1984
and 1986; Colson et al. 1992a and 1992b), renal blood samples were taken by the
surgeon directly from the renal vein with the abdomen open in the intraoperative
period. This method not only precluded assessment of the influence of anaesthesia on
the renal hemodynamics, but also of the process of recovery of RBF, which was still
compromised after aortic unclamping (Gamulin et al. 1984 and 1986). This study is
therefore the first to report on renal hemodynamics from the preoperative into
the postoperative phase, with the concomitant changes in glomerular and renal
tubular function in patients subjected to infrarenal aortic aneurysm repair.
Unfortunately the renal venous catheter had to be removed 4 hours after surgery
because of concerns about the possibility of catheter-induced renal venous thrombosis
(in the absence of evidence to the contrary in the literature) if the catheter remained in
situ overnight. We were thus unable to follow progress of recovery of the renal
hemodynamics after the 4 hours post-unclamp measurements.
It is clear from the results that RBF and GFR were not influenced by anaesthesia and
surgical manipulation prior to aortic cross clamping. The fact that halothane at or
below I MAC apparently did not compromise RBF or GFR is supported by some
studies in different populations (RBF: Gelmann et al. 1984b; Bastron et al. 1979)
(GFR: Mazze et al. 1984). It is in contrast with indirect evidence to the contrary in a
study by Colson et al. (1992b) that demonstrated higher intra-operative RBF and GFR
values in patients anaesthetized with isoflurane than those who received halothane,
both before and after cross clamping of the aorta. However, after unclamping of the
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aorta, no differences in renal hemodynamics or function could be demonstrated
between Colson's rather small experimental groups (no group bigger than 10 patients).
The same group reported similar findings in another study where the differences could,
at least in part, be explained by the fact that firstly the two agents were not
administered in equipotent concentrations (halothane in higher concentrations than
isoflurane relative to their respective MAC values) and that secondly the isoflurane
patients received approximately 30% more intravenous fluid than the halothane group
(Colson et al. 1992c). In higher concentrations (> 0.9%) halothane does appear to
consistently decrease RBF and GFR (Deutsch et al. 1966; Hili et al. 1977;
Tranquilli et al. 1982).
Autoregulation of renal blood is maintained with halothane concentrations from 0.9% to
1.5% in experimental animals (Bastron et al. 1977; Priano 1983). This is confirmed in
both control and mannitol plus dopamine patients in our study where a 10 - 15%
decrease in MAP (between awake control and intraoperative preelamp measurements)
was accompanied by a similar reduction in RVR with maintenance of RBF.
A nitroglycerin infusion was used after induction, primarily to reduce afterload during
the perclamp period (Peterson et al. 1978) and to allow intravenous volume loading
before releasing the aortic cross clamp. At the latter period, a reduction in nitroglycerin
infusion rate was synchronised with release of the aorta cross clamp. It is also
considered to be the vasodilator of choice in this population group because of the
prevalence of ischemic heart disease and the frequency of myocardial ischemic events
in the perioperative period of aortic reconstruction surgery (Attia et al. 1976; McPail et
al. 1988). In addition, it has been proven to be beneficial on mycardial oxygen balance
during cross clamping of the aorta (Hummel et al. 1982).
No reference could be found which elucidates the effects of nitroglycerin on the renal
vasculature, renal hemodynamics or renal function. It is, however, possible that the
administration of intravenous nitroglycerin, which was initiated just after induction of
anaesthesia, could have played a role in the maintenance of RBF at pre-induction
levels prior to aortic cross clamping. If this had been the case, it would imply that
nitroglycerin exerted an equivalent vasodilatory effect on the afferent and efferent
arterioles to prevent significant change in intraglomerular capillary hydrostatic
pressure, given the maintenance of GFR at awake control values (Table 3.2).
Alternatively, if the vasodilatory effect of nitroglycerin had been more extensive on the
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efferent arterioles, the drop in intracapillary hydrostatic pressure would have had to be
compensated for by nitroglycerin-induced mesangial cell relaxation with resultant
increased glomerular permeability, to prevent a decrease in GFR. However, if
nitroglycerin played a role in the maintenance of RBF and GFR after induction of
anaesthesia, it was unable to prevent the increase in RVR and decrease in RBF during
the perclamp and initial unclamp periods despite similar dosages during those
measurement periods (Table 3.6).
The method used for the measurement of RBF (and GFR) is considered to be
acceptably accurate to the extent that it has been used in the majority of recent human
studies where RBF was measured during surgery of the abdominal aorta
(Gamulin et al. 1984 and 1986; Colson et al. 1992a and 1992b; Myers et al. 1984;
Licker et al. 1996 - in the latter two studies clearance of PAH were used). Our period
of equilibration of plasma isotope concentrations before the first measurements were
done, was similar to the above studies. The fact that there were no differences in the
concentration variation between the two samples during the six measurement periods
(Tables 3.7 and 3.14) indicate that adequate equilibration took place before the first
measurement period. Some degree of variation in isotope count, even over the 20 or
30 minutes of one measurement period, is unavoidable due to variations in isotope
loss from the body through the urine and surgical blood loss, and dilution from the
administration of intravenous fluid. We consider our method of determination of mean
plasma isotope concentration per measurement period (calculating the mean isotope
count from two samples taken at the middle and at the end of the measurement period,
each taken over a five minute period) a more accurate reflection of the true mean
value for the full duration of the measurement as opposed to the method employed by
Gamulin et al. (1984 and 1986) where only one blood sample was taken per
measurement period.
The aims of intravenous fluid administration, namely to maintain PAWP at 10 mmHg or
above and Hct at 30% or above, was achieved throughout the perioperative period in
both groups of patients. It is therefore probably safe to suggest that changes in
vascular filling pressures (Tables 3.3 and 3.10) and hematocrit (Tables 3.6 and 3.13)
did not compromise renal hemodynamics. If anything, RBF might have benefited most
from the reduced viscosity conferred by the lowest hematocrit (Crystal et al. 1988; Von
Restart et al. 1975) just after cross clamping of the aorta, which was at the time when
the lowest RBF's were in fact recorded. Paul et al. (1986) argued that their approach
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of intravenous volume expansion was probably responsible for the fact that GFR was
maintained during aortic cross clamping and only decreased significantly after
unclamping (they did not measure RBF), in contrast to Gamulin et al. (1984) where
GFR decreased immediately after infrarenal clamping of the aorta. The volumes
infused intraoperatively in our patients (Table 3.16) corresponds closely with the
experimental groups in the study by Paul et al. (crystalloids between 5813 ml and 6833
ml mean; blood between 1.8 and 2.2 units mean). The left ventricular filling pressures
in both patient groups in our study (Tables 3.3 and 3.10) resembled the PAWP
measurements recorded by Paul et al. with mean values which varied from 11.6 mmHg
to 17.1 mmHg. Despite these similarities between our patients and the study by Paul
et al. in terms of intravascular (and, presumably, extracellular) fluid volumes, our
patients responded to aorta cross clamping with a significant decrease in GFR
(Tables 3.2 and 3.9). These changes in GFR emulated those reported by Gamulin et
al. (1984 and 1986) and raises doubts about the explanation suggested by Paul et al.
(1986) for the difference between their results and those of Gamulin et al. (1984).
4.2 Control patients
The awake control measurements of RBF and RBF/CO are consistent with values which
have been described as normal for humans (Thurau, 1964). Maintenance of RBF after
induction of anaesthesia and in the preelamp surgical phase is in conflict with some
evidence that comparable concentrations of halothane decreased RBF at the same
stage of surgery in a similar population (Colson et al. 1992b). The MAP of the patients
in the Colson study were perilously close to the lowest acceptable level for
autoregulation of RBF even for young, healthy adults (76.9 mmHg ± 2.5 (SEM)). The
fact that these patients were elderly and at least some of them were probably
hypertensive (5/9 received ACE inhibitors preoperatively and 6/9 calcium antagonists),
suggests that the blood pressure was probably below the autoregulatory range in at
least some of their patients. The increase in RBF after release of the aortic cross
clamp (relative to the preclamp measurement) may, at least in part, be due to a higher
MAP (83.9 mmHg) ± 2.6 (SEM)). The effective renal plasma flow (ERPF) in the
preclamp period was also much lower in all anaesthetic subgroups of the Colson
(1992b) study than those reported in a comparable study (Licker et al. 1996) where
higher MAP's were maintained. Unfortunately, ERPF (rather than RBF) was reported
in the studies by Licker et al. (1996) and Colson (1992a and 1992b) without providing
hematocrit values (which would make it possible to calculate RBF) so that comparisons
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of absolute values of RBF between the above studies and those of Gamulin et al.
(1984 and 1986) and our own, are not possible. Myers et al. (1984) reported preclamp
RBF measurements (using a PAH clearance technique in a patient subgroup
subsequently subjected to infrarenal aorta clamping) of 676 ml.mln' (391 ± 80 (SEM)
rnl.rnin' per 1.73m2 BSA) which suggests that RBF in those patients was significantly
impaired by anaesthesia and initial surgical exploration. Although awake control RBF
measurements could not be done in the studies by Gamulin et al. (1984 and 1986), the
RBF: CO ratios of 0.215 (Gamulin et al. 1984) and 0.283 (Gamulin et al. 1986) before
aorta cross clamping suggest that anaesthesia and exploratory surgery did probably
not compromise RBF significantly since these ratios resemble the value of 0.25
considered to be normal in awake humans (Dworkin and Brenner 1996).
The 48% decrease in RBF after infrarenal cross clamping in our patients relative to
both awake control and preelamp values (Table 3.1) is similar to changes reported by
Gamulin et al. (1984 and 1986). The persistence of the decreased RBF into the early
post-unclamp period also corresponds with the Gamulin (1984 and 1986) studies. The
fact that anaesthesia and early surgical exploration probably induced a decrease in
RBF in the studies by Myers (1984) and Colson (1992a and 1992b), may obscure the
influence of aortic clamping in those studies, since awake measurements were not
available as controls. Nevertheless, Colson et al. (1992a) reported a decreased
perclamp RBF relative to (a probably already compromised) preelamp RBF
measurement. Our study is the first to measure and report RBF 4 hours after
unclamping of the aorta which, although significantly improved on perelamp and the
first unclamp measurements, was still significantly less than awake control and
preelamp flows (Table 3.1). This occurred despite the fact that calculated RVR had
returned to awake values. It should, however, be pointed out that RVR is a calculated
parameter dependent on MAP to CVP gradient and the RBF. With a mean pressure
gradient that was 21.8% lower than the awake control value, RVR at the 4 hours post-
unclamp measurement should have been even lower than the calculated value in our
study to allow RBF to return to normal values. Potential causes for this apparent lack
of adequate vasodilatory ability could be the presence of renal vasoconstrictive
substances (Bengston et al. 1987; Frank et al. 1988) and/or compromised auto-
regulation after the preceding period of ischemia (Kelleher et al. 1984; Conger and
Robinette 1979).
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The progressive decrease in EH,P which eventually became statistically significant 4
hours after unclamping of the aorta (relative to awake control and preclamp
measurements; Table 3.1) is suggestive of redistribution of renal blood flow away from
the cortex since hippuran clearance corresponds to the cortical or effective renal
plasma flow (Ram et al. 1967; Maher and Elveback 1970). This redistribution is
consistent with redistribution of flow found in acute renal failure in man (Hollenberg et
al. 1968) and was also demonstrated in studies in experimental animals after infrarenal
aortic cross clamping (Gelman et al. 1984a, Abbott et al. 1973 and 1974). The
changes in our study are, however, in conflict with the studies by Gamulin et al. (1984
and 1986). They suggested, on the grounds of a statistically significant increase in EH,P
from 0.67 to 0.74, that RBF was redistributed towards the cortex. Gelman and Navar
(1985) expressed reservations about this conclusion and suggested that increased
extraction could have been the result of prolonged exposure of hippuran to the
secretory mechanisms due to the reduction in total blood flow. Even if there had been
a redistribution of blood flow to the renal cortex in the studies by Gamulin, it might have
been caused by mannitol (Abbott et al. 1974) which they used as a constant infusion
(20 q.hour") "in order to maintain an adequate urine output" (Gamulin et al. 1984).
Absolute values and changes in GFR as measured by clearance of 0_51 EDTA were
very similar to calculated Cereal' The decreased GFR in the perclamp (steps 3 and 4,
Table 3.2) and immediately post-unclamp (step 5) periods corresponds with the
findings of most human studies in which both GFR and RBF were measured (Gamulin
et al. 1986; Colson et al. 1992a; Licker et al. 1996), although infrarenal aortic clamping
did not decrease GFR significantly in other studies (Colson et al. 1992b). Persistence
of the decreased GFR in the early postoperative period (step 6) was also
demonstrated by Licker et al. (1996) 12 hours postoperatively while Myers et al. (1984)
reported no significant change between GFR measured preoperatively and again 24
hours postoperatively.
There are a number of potential reasons for the reduction in glomerular ultrafiltration
induced by aorta cross clamping in our patients. A decrease in glomerular capillary
hydrostatic pressure (Pgc) could have been responsible through either a decrease in
MAP or an imbalance in vascular tone between the afferent and efferent glomerular
arterioles with greater prominence of vascular tone in the afferent (relative to efferent)
arterioles. It is unlikely that the significant decrease in MAP demonstrated in our
patients was responsible because this decrease had already occurred in the preclamp
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intraoperative phase without any influence on GFR. Vital organ perfusion is not
compromised in elderly patients during mild hypotension provided that MAP's are
maintained within 20-30% normal resting pressure, which was relevant in our patient
population (Standgaard 1976). The release of vasoconstrictive substances after aortic
cross clamping could have mediated a decrease in Pegprovided that such (an) agent(s)
induced a more significant increase in vascular tone in the afferent than the efferent
arterioles. Individually, however, potential endogenous vasoactive substances usually
induce greater increases in resistance in the efferent than in the afferent arterioles
(Maddox and Brenner 1996). A decrease in the glomerular ultrafiltration coefficient (Kr)
could have played a role in the decreased GFR. Endogenous mediators such as
angiotensin II (Blantz et al. 1976), ADH (Schor et al. 1981), noradrenaline (Kon et al.
1983), endothelin (Badr et al. 1989), leukotrienes (Badr et al. 1987) and adenosine
(Olivera et al. 1989) have all been demonstrated to induce mesangial cell contraction
and decrease Kr through mechanisms which involve the influx of Ca2+ (Maddox and
Brenner 1996). Finally, the decrease in RBF might also have contributed, because a
reduction in renal plasma flow has been demonstrated to decrease GFR in the
absence of significant changes in the other determinants of GFR (Deen et al. 1972).
During conditions of reduced RBF, the rate of increase in plasma protein concentration
(and therefore the oncotic pressure) rises more rapidly along the glomerular capillary
so that filtration pressure equilibrium (balance between hydrostatic and oncotic
pressures) is reached closer to the afferent side of the capillaries. It is possible that, in
our patients, the predominance of the decrease in RBF together with a speculative
mediator-induced reduction in Kr, over a mediator-induced increase in Pge, was
responsible for the decrease in GFR. However, even Pgemight have been decreased
through the combined effect of more than one vasoactive substance (Maddox and
Brenner 1996). Predominance of efferent arteriolar vasoconstriction with increased Pge
should have been responsible for an increase in FF, while our patients responded with
a small decrease in FF (Table 3.2), albeit not statistically significant.
The baseline FENa in excess of 0.01 in our patients (0.04 ± 0.019 SO; Table 3.4) is
higher than one would expect in a normal, resting adult (Oken 1981). A number of
factors could have been instrumental in mean preoperative FENa values being greater
than those reported for normal, resting adults. One contributing factor could have
been the fact that the patients had already been volume-loaded with intravenous fluid
(Ringers lactate) at the time of measurement, constituting a high sodium load (Steiner
1984). The renal changes associated with ageing are also documented to produce
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similar findings (Epstein et al. 1976; Sporn et al. 1962). With the decrease in GFR and
particularly with the increase in aldosterone concentrations in the measurement steps
subsequent to aortic cross clamping (Table 3.5), one would expect a decrease in FENa,
which did not occur. FENa in excess of 0.01 under such circumstances would be
suggestive of renal tubular injury (Steiner 1984; Miller TR et al. 1978) although only
when FENa exceeds 0.06 is it considered to be diagnostic (Oken 1981). Such an
unequivocal conclusion is compromised by the high initial FENa values. Both Licker et
al. (1996) and Colson et al. (1992a) reported increased FENa during the perclamp and
post-unelamp periods (relative to preelamp control), but failed to comment on these
changes in the discussion of their results. In the latter study, the increase in FENa
predictably occurred earlier in a patient subgroup who received enalapril (which would
decrease aldosterone secretion) than in a control group.
CH20 is a sensitive indicator of renal tubular concentrating function (Smith 1956) and a
valuable early predictor of the development of acute renal insufficiency (Landes et al.
1976, Baek et al. 1973 and 1975). It becomes increasingly positive in states of renal
tubular dysfunction. A progression towards positive values occurred in our patients in
the perelamp period failed to reach statistical significance (Table 3.4), which is similar
to results reported by Gamulin et al. (1984) while Licker et al. (1996) demonstrated
significant changes in CH20 suggesting tubular dysfunction.
An increase in urinary r12-microglobulin concentration indicative of proximal tubular
damage only became apparent in our patients after release of the aortic cross clamp
with progressively increasing mean concentrations until 24 hours after surgery. 112-
microglobulin is a nonpolymorphic protein component of the two-chain structure of the
HLA class I molecule (Schwartz 1996) which is filtered by the glomerulus and almost
completely (99.9%) reabsorbed and metabolized by the cells of the proximal tubules,
even in conditions with increased production and plasma concentrations (Hall et al.
1981). Increased urinary concentrations of 112-microglobulin have been demonstrated
in a wide range of renal diseases and renal failure where proximal tubular damage with
associated dysfunction of tubular cells is a feature (Schardijn and Van Eps 1987). In
ischemic injury of the kidney, the proximal tubule has been demonstrated to be
particularly susceptible to such damage (Shanley et al. 1986a; Donohoe et al. 1978;
Venkatachalam et al. 1978). Lysozymuria, another indicator of proximal tubular injury,
had been demonstrated in more than 70% of patients after both elective and
emergency repair of abdominal aorta aneurysms by Powis (1975), in contrast to the
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studies by Gamulin et al. (1984 and 1986) where Iysozymuria was absent during and
immediately after clamping of the aorta. It is possible that the last urine sample tested
for Iysozymuria in the Gamulin studies Gust after release of the aortic cross clamp)
preceded the biochemically overt manifestation of proximal tubular injury. In our study,
a relatively small (statistically significant) quantitative increase in 112-microblobulin was
evident 30 minutes after unclamping of the aorta, with much more substantial
increases in mean values recorded 4 hours and 24 hours after unclamping.
In summary, the changes in 112-microglubulin strongly suggest proximal tubular injury,
while the other parameters of tubular function, although suggestive, do not conclusively
prove proximal and/or distal tubular damage.
The decrease in urine volumes at all measurement steps after cross clamping of the
aorta, corresponded closely with the reductions in GFR during the same steps in our
control patients. Previous studies have demonstrated urine volume to be a poor
predictor of postoperative renal function in patients undergoing abdominal aortic
revascularization (Alpert et al. 1984).
The initial increase in serum ADH concentration, before application of the aorta cross
clamp (Table 3.5), was probably due to surgical stimulation (Knight et al. 1986;
Ishihara et al. 1978) rather than the effect of anaesthetic drugs, hemodynamic
impairment or changes in serum osmolality. Intravascular filling pressures did not
change in our patients (Table 3.3) and although MAP decreased significantly after
induction of anaesthesia, the extent of this reduction was not sufficient to expect a
significant increase in ADH concentration in response (Schrier et al. 1979; Woods et al.
1983). Serum osmolality (not shown in result tables) did not change at any stage in
the course of our study. The anaesthetic drugs used in our patients do not increase
ADH secretion in the absence of hemodynamic changes (Woods et al. 1983; Ishihara
et al. 1978). Increases in angiotensin II concentration might have contributed in
maintaining high levels of ADH (Stella and ZancheUi 1987; Schrier and Berl 1975) after
aorta clamping, but did not playa role in the initial rise as plasma renin concentration
was not influenced by anaesthesia and surgical stimulation prior to cross clamping of
the aorta (Table 3.5). The increases in ADH concentrations at the various
measurement steps correspond with the only other published study where ADH was
also measured perioperatively in patients subjected to infrarenal aorta aneurysm repair
(Kataja et al. 1989). They reported an increase in ADH levels prior to cross clamping
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of the aorta, reaching a peak in the early postoperative period with increased levels still
present on the first postoperative day. Changes in RBF and renal function were not
reported in their study.
ADH was clearly not the primary pathogenic or pathophysiological factor which induced
the changes in renal hemodynamics and glomerular function, as these parameters
were not influenced by the preelamp increase in ADH. In addition, ADH concentration
did not escalate further in the perelamp periods when the renal parameters did change.
It is possible that the increased ADH might have contributed to the raised RVR at the
times of decreased RBF and GFR by enhancing the vasoactive effects of other
(primary) vasoconstrictor agent(s). ADH has been demonstrated to potentiate the
vasoconstrictor response of angiotensin (Hostetter and Brenner 1988) and
catecholamines (Medina et al. 1997; Ishikawa et al. 1984). These potentiating effects
occur at ADH concentrations substantially lower than those required to produce a
direct contractile response by ADH on its own. This indirect (potentiating) effect of
ADH is suggested to involve increased Ca2+ entry into the vascular smooth muscle
cells through voltage-dependent Ca2+ channels (Medina et al. 1997).
The increase in ADH concentrations would, at least partially, have been responsible for
the maintenance of high FENa values, which persisted even when aldosterone was also
increased during the later stages. This fact, due to the predominant effect of ADH on
the distal tubule and collecting duct, which leads to a greater degree of water than
sodium reabsorption, indirectly influences FENa and renders this parameter a less
accurate predictor of acute renal failure (Zaloga et al. 1990). The perpetuation of
sodium loss might also have been contributed to by high levels of atrial natriuretic
hormone (ANH) (not measured in our study) due to stimulation of its secretion by ADH
(Manoogian et al. 1988) and to the increased right atrial filling pressures in the latter
part of our study (Table 3.3). The fact that the CH20 was significantly more positive
during the two perclamp measurement steps despite the high ADH concentrations
which classically produce a negative CH20 (Berry 1990; Fieldman et al. 1985), adds
significance to the changes in this predictor of renal tubular injury and dysfunction.
The increase in arterial (Pren)and renal venous (RVren) plasma concentrations of renin
and therefore presumably also angiotensin II, coincided with cross clamping of the
aorta and remained elevated into the postoperative period. Some of the mechanisms
controlling renin release were observed in our study. A lack of change in MAP
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between preclamp and postclamp measurements as well as maintenance of MAP
above levels of 70 to 75 mmHg (Robertson and Michelakis 1972) makes renin release
induced by pressure (reduction) unlikely. Catecholamine-induced renin release
(Michelakis et al. 1969) is also unlikely since catecholamine concentrations did not
change significantly subsequent to aortic cross clamping (Table 3.17). In addition,
there was no correlation between the changes in renin and noradrenaline
concentrations induced by aortic clamping (R=O.029; p=O.923). Although it is possible
that placement of the aorta cross clamp could have produced stimulation of the renal
nerve which would have induced renin release (Vander 1965), this is again an unlikely
scenario. Infrarenal para-aortic dissection in preparation for aortic clamping had
already been performed during the preclamp period without apparent renin release. In
addition, subsequent perpetuation of increased renin levels occurred in the absence of
surgical stimulation in the proximity of the renal neurovascular structures, particularly
during the two measurement periods after release of the aortic clamp. Increased
levels of ADH, a known stimulus for renin release (Stella and Zanchetti 1987) had no
influence on Prenof RVrenbefore aortic clamping. The increased concentrations of both
ADH and renin after application of the cross clamp were therefore probably largely
coincidental. Salt depletion and a decreased extracellular fluid volume (Davis and
Freeman 1976) was clearly not responsible for the increase in renin concentrations,
considering the volumes of isotonic intravenous fluid with high sodium concentration
adminstered and the maintenance of intravascular pressures in the capacitance
vessels (Table 3.3). None of the known physiological and pathophysiological
stimulants for renin release can therefore be considered as clearly responsible for the
aortic clamp-induced increase and the sustained elevation in Prenand RVrenrelative to
the control and preelamp concentrations.
In concurrence with our study, the majority of publications which report on
perioperative changes in Pren in humans subjected to infrarenal aorta surgery,
demonstrated increased renin and/or angiotensin concentrations induced by aorta
clamping (Kataja et al. 1989; Salem et al. 1988; Grant and Jenkins 1983; Grind-
linger et al. 1981). The increased renin levels progressed into the postoperative
period, with the exception of the study by Salem et al. where renin was not measured
postoperatively. In only one published study (Gal et al. 1974) did an increase in Pren
(relative to awake control measurements) precede application of the aorta cross
clamp. None of the above studies reports on concomitant measurement of RBF or
nephron function although the potential role of angiotensin in the etiology of renal
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hemodynamic changes during infrarenal aorta surgery was alluded to (Kataja et al.
1989; Salem et al. 1988; Grant and Jenkins 1983).
Experimental studies (in dogs) where Pren was measured with infrarenal aortic
clamping, also measured RBF (Cronenwett and Lindenauer 1977; Berkowitz and
Shetty 1974). They produced conflicting results with Berkowitz reporting clamp-
induced raised Pren and redistribution of RBF away from the renal cortex and
Cronenwett no change in either Pren or RBF.
In our study the decreases in RBF and GFR clearly coincided with the increased Pren
and RVren. It is therefore possible that the increased renin release, through activation
of angiotensin, could have been responsible for the changes in renal hemodynamics
and nephron function. If angiotensin had been exclusively or predominantly
responsible for the changes, one would perhaps have expected a less extensive effect
on GFR than on RBF due to the greater effect of angiotensin lion the efferent arteriole
with maintenance (and even increase) of Pgc. This would also have increased FF
(Tucker et al. 1986). None of these changes predicted by an exclusive influence of
angiotensin occurred in our patients (RBF vs GFR, Table 3.1 and 3.2; FF, Table 3.2).
The changes demonstrated in our patients does not, however, exclude a primary role
for angiotensin as similar angiotensin-mediated changes in RBF, GFR and FF have
been demonstrated in a number of clinical and experimental circumstances (Ichikawa
and Brenner 1984; Kon et al. 1985; Navar et al. 1982). In addition, the renal effects of
angiotensin could have been modified by the nitroglycerin administered to our patients
after induction of anaesthesia for the duration of the study. The elevated levels of ADH
demonstrated in our patients would have potentiated the (renal) vasoconstrictive
effects of angiotensin (Hostetter and Brenner 1988). Angiotensin enhancement of
prejunctional noradrenaline release (Zimmerman 1978) from the renal nerves might
also have contributed to the renovascular and functional changes, despite the fact that
circulating levels of the catecholamines did not change significantly in our patients
(Table 3.17). The increased levels of angiotensin probably also exerted some of its
renovascular effects through stimulation of endothelin synthesis and release (Kohno et
al. 1991) and by increasing vascular responsiveness to endothelin (Dohi et al. 1992).
The increase in endothelin plasma levels after infrarenal cross clamping of the aorta
described by Antonucci et al. (1990) might in fact have been in response to increased
levels of renin and angiotensin, a possibility not suggested by the authors.
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Our human study does not prove conclusively that renin-mediated increases in
angiotensin concentration played a primary pathogenic role in the renal changes
induced by infrarenal aortic cross clamping. It is possible that the renin-angiotensin
mechanism, although certainly contributing to the measured changes and therefore to
the global pathophysiological process, were only activated after (and because of) initial
functional and vascular changes similar to the role suggested in ischemic and other
forms of acute renal failure (Myers and Moran 1986). Complete abolition of the renal
response to infrarenal aorta clamping by either inhibition of renin release or prevention
of angiotensin effects (through ACE-inhibition or angiotensin receptor blockade), would
provide evidence for a significant, if not exclusive, pathogenic and pathophysiologic
role for angiotensin. Unfortunately, evidence in this regard is inconclusive. Colson et
al. (1992a) were unable to prevent clamp-induced reduction in RBF by preoperative
administration of an ACE-inhibitor. This lack of success can possibly be attributed to
inadequate ACE-inhibitor dosage which, even if it had been sufficient to prevent
systemic activation of angiotensin, might not have been enough to block intrarenal
angiotensin activation which. requires higher dosages (Gunning et al. 1996).
Successful prevention of renal hemodynamic changes in another human study by
Licker et al. (1996) might be confounded by the fact that 5 of their 11 patients also
received calcium channel blockers preoperatively, despite their suggestion that more
appropriate ACE-inhibitor dosage was responsible for the difference between their
study and that of Colson et al. (1992a). The ambiguity of the two relevant animal
studies (Cronenwett and Lindenauer 1977; Berkowitz and Shetty 1974) has already
been alluded to.
The increase in serum aldosterone concentrations was predictable due to the renin-
induced increase in angiotensin II production. The raised aldosterone levels lagged
behind the initial increase in Pren to become statistically significantly increased only
later in the perelamp period. The changes in aldosterone concentrations in our study
are in accordance with results of other similar studies (Cochrane 1978). Changes in
aldosterone concentrations do not correlate with altered ACTH concentrations
(Table 3.5), which concur with the normal physiological control of aldosterone secretion
as well as the mechanisms which pertain peri operatively (Le Quesne et al. 1985). The
extent of urinary sodium loss (FENa and total urinary sodium) is again surprizing if one
considers the increased aldosterone concentration and may reflect some degree of
functional impairment of the proximal and/or distal tubules. The patients in our study
demonstrated an almost 4-fold increase in aldosterone levels while the increase is
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usually limited to double the preoperative concentration if sodium intake and
intravascular volume status are adequate (Cochrane 1978). This was probably due to
the extent of Prenincrease after aortic cross clamping.
4.3 Mannitol plus dopamine patients and comparison with control patients
The significantly greater volumes of crystalloids infused in mannitol plus dopamine
patients relative to the control group (Table 3.16), can at least partially be ascribed to
the larger volumes of urine produced in the former group. The larger volumes of
intravenous crystalloids in mannitol plus dopamine patients should also be interpreted
in the context of the consistently lower PAWP in this group (relative to controls),
reaching statistical significance after aortic cross clamping (Figure 3.14). Infusion of
intravenous fluids to equivalent left ventricular filling pressures would have resulted in
an even greater difference in fluid volumes administered. The difference in
intravenous fluid volumes in our study contrasts with two studies where peri operative
fluid volumes were similar between control and mannitol plus dopamine patients
subjected to infrarenal aortic surgery (Paul et al. 1986; Mazer et al. 1984).
Mannitol and dopamine failed to protect the kidney against a reduction in Cerealwhen
comparing preoperative values with (24 hour urine sample) measurements one week
postoperatively. This result in our study is contrary to the findings of both Paul et al.
(1986) and Mazer et al. (1984) where initial intraoperative decreases in Cerealreturned
to preoperative control values within 24 hours postoperatively in patients who received
mannitol and dopamine. Other studies where mannitol and dopamine were not
administered perioperatively in aortic surgery, showed variable results with regard to
changes in Cereal. Myers et al. (1984) and Cohn et al. (1970) demonstrated complete
recovery of Cerealto preoperative values within 24 hours and 7 days after surgery
respectively. Licker et al. (1996) reported lack of Cereal recovery 12 hours
postoperatively, while Pollock and Johnson (1973), when retrospectively dividing
patients in high and low intravenous fluid volume groups, demonstrated recovery of
Cerealin the former and reduced Cerealin the latter group postoperatively. Powis (1975)
did not publish statistical analysis on postoperative Cerealmeasurements, but reported
postoperative recovery of Cerealin 3 patients, improved values in 9 patients and
reduced measurements in 21 patients relative to their individual preoperative controls.
It is possible that the majority of studies demonstrating no significant difference
between preoperative and postoperative Cereal!were unable to do so because of a
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small sample size. When reported, they almost invariably indicated either a mean
postoperative Cereal less than the preoperative mean (statistically not significant), or
some individual patients with considerably reduced values postoperatively.
The aortic cross clamp-induced decrease in RBF was clearly not prevented by the
administration of mannitol and dopamine (Figure 3.1). Ours is the first study to report
on the influence of the combination of these two agents on RBF during infrarenal aortic
surgery. In a study of patients subjected to suprarenal aortic cross clamping of the
aorta, Pass et al. (1988) were unable to establish any benefit from the use of mannitol
and dopamine (both individually and as a combination) in the continued reduction of
RBF (for the first 150 minutes) subsequent to release of the suprarenal cross clamp.
Mannitol had been demonstrated to correct the reversal of RBF away from the renal
cortex induced by infrarenal aortic cross clamping (Abbott and Austen 1974) in
experimental animals. The clinical relevance of this study is compromised by the fact
that the mannitol was administered directly into the renal artery. Barry et al. (1961)
reported an increase in urine flow effected by a high dose of mannitol (a minimum of
237 gram per patient) during infrarenal aortic surgery with a small population
(5 mannitol and 5 control patients). They interpreted the increased urine volume as an
indication of increased RBF and GFR based on a previous study, which demonstrated
a correlation between urine volume and RBF (Barry et al. 1960). This relationship has
subsequently been shown not to exist universally (Alpert et al. 1984). In addition,
another experimental study in dogs could not demonstrate that mannitol prevented a
decrease in RBF with infrarenal aortic cross clamping, despite a significant
improvement in urine volume (Stein et al. 1972).
The lack of clear evidence of maintenance or improvement of RBF by mannitol in aortic
surgery contrasts with other experimental models where benefit has been
demonstrated. Such improvement in RBF has been shown in both cortical and
medullary blood flow in normal dogs (Velasques et al. 1973; Wendling et al. 1969), in
the post-ischemic kidney (Zager et al. 1985) and during partial occlusion of the renal
artery (Behnia et al. 1996). Mechanisms proposed for the beneficial effect of mannitol
on the renal circulation had been the release of intrarenal vasodilatory prostaglandins
(Johnston et al. 1981), the release of atrial natriuretic hormone (ANH) (Kurnik et al.
1990), and a decrease in renin release (Lang 1987). Although ANH concentrations
were not measured in our study, there is no reason to suspect a higher concentration
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of ANH in the mannitol plus dopamine patients relative to the control group, particularly
with atrial filling pressures being comparable or even lower in the former group of
patients. Mannitol clearly did not suppress renin secretion in our patients
(Figures 3.16, 3.17), an effect which should not have been influenced by the
concurrent administration of a low dose of dopamine (Levinson et al. 1985). Urinary
concentrations of prostaglandins were not measured in our study.
Low dose dopamine (2 f.lg.kg-1.min-1), in a very small sample (n = 5) of patients after
abdominal aorta surgery was shown to increase RBF (Schwartz et al. 1988). However,
this study suffers from the same methodological problem as many other studies where
PAH clearance had been used to calculate RBF. Dopamine alters PAH extraction, so
that PAH clearance becomes invalid as method of RBF calculation unless PAH
extraction is measured through arterial and renal venous blood sampling (Duke and
Bersten 1992).
Although there are numerous animal (Kapusta and Robie 1988; Hollenberg et al. 1973)
and human (Stevens et al. 1989; McDonald et al. 1964) studies which report increased
RBF with low dose continuous infusion of dopamine, the majority of these studies
suffer from the failure to adequately control for the other direct and indirect effects of
dopamine such as an increase in CO, raised renal perfusion pressure and its effect on
tubular function, which may also influence RBF. The methodological caveat alluded to
above and the fact that plasma dopamine levels correlate poorly with the infused dose,
particularly in critically ill patients (Zaritsky et al. 1988), are also frequently ignored.
Some studies failed to show an increase in RBF (Wassermann et al. 1980; Hilberman
et al. 1984), or suggested the increase in RBF to be a secondary phenomenon to an
increase in CO, even with low dose dopamine infusion (Gordon et al. 1995;
Shoemaker et al. 1989). Cardiac output was not influenced by dopamine in our
patients, as significant differences did not exist at any measurement period between
control and mannitol plus dopamine patients (Figure 3.15). It is possible that the
renovascular effects of increasing age (nephrosclerosis) in our patients could have
limited the renovascular effects of dopamine (Hollenberg et al. 1973). On the other
hand, the fact that some of our patients had been hypertensive should have enhanced
the renal vasodilatory effect of dopamine (Breckenridge et al. 1971) due to
upregulation of dopamine receptors in these patients (Andrejak and Hary 1986).
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The pattern of changes in RVR (given the changes in RBF without prominent
fluctuations in MAP and venous pressures) is predictable in the mannitol plus
dopamine patients. Where both dopamine (Hollenberg et al. 1973) and mannitol
(Velasques et al. 1973) have been demonstrated to decrease RVR in conditions not
involving aortic manipulation, these drugs were clearly unable to induce such a
beneficial effect in our vascular surgery population.
Similar to control patients, mannitol plus dopamine patients responded to aortic cross
clamping with a substantial decrease in GFR. GFR improved progressively after
release of the cross clamp, but was still almost 30% below awake control values 4
hours after unclamping. This lack of positive influence of mannitol plus dopamine on
GFR in aortic surgery has been demonstrated previously (Paul et al. 1986; Mazer et al.
1984). Where mannitol or dopamine has been reported to enhance GFR, it has almost
invariably been associated with a coincidental improvement in RBF when both
parameters were measured (Andrejak and Harry 1986; Blantz 1974). Mannitol and
dopamine clearly did not enhance RBF in the patients in our study.
Only Cohn et al. (1970) measured Cerealin the later postoperative phase and were
unable to show significant differences with preoperative control values. Our study is
therefore the first to demonstrate persistence of decreased GFR (as measured with
Cereal)as late as 1 week postoperatively (Table 3.16). Adequacy of urine collection is
suggested by the total urine creatinine values reported in chapter 2 (section 2.1) of this
thesis (Gonin and Molitoris 1997). A reduction of 8.58 or 9.7 rnl.rnin." (the mean
decreases found in our control and mannitol plus dopamine groups respectively) will be
of no immediate significance in patients with normal preoperative renal function.
However, such a decrease in GFR may induce an increase in plasma creatinine and
other sequelae of renal failure in patients who preoperatively have significant
compromise of renal glomerular reserve with loss of functional glomeruli in excess of
50% of normal, while still maintaining a normal serum creatinine concentration
(McLachlan 1978). Such a scenario would not be uncommon in our surgical population
of elderly patients with diseases such as hypertension and diabetes, which
compromise renal ultrastructure and function (McLachlan 1978). A specific subgroup of
patients at risk of progressing towards renal failure with postoperative serum creatinine
concentrations in excess of 120)lmol.l-1 7 days after surgery, were identified in our
study. Statistical analysis of our data suggest that 95% of such a population at risk
would present with a preoperative Cerealof less than 68ml.min-1• Preoperative serum
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creatinine concentrations are not helpful to identify this subgroup of patients. Despite
the possibility that Cerealmay still improve in the period subsequent to 7 days post-
surgery, our data suggests that the determination of creatinine clearance should be a
component of the preoperative work-up of patients scheduled for abdominal aorta
aneurysm repair, rather than serum creatinine measurement which is a poor indicator
of renal function until its serum concentration starts to increase appreciably, which only
occurs when approximately 50% of renal function is lost (Rowe 1977). In the presence
of a preoperative Cerealbelow 68ml.min·1 a conservative (rather than surgical) approach
with regular follow up to monitor change in aneurysm size could be considered,
particularly in patients with other risk factors for the development of perioperative ARF.
More than one factor could have been responsible for the mannitol plus dopamine
intragroup decrease in FF during the perclamp period (Table 3.9), and relative to the
control patients in both the perelamp period and prior to aortic clamping (Figure 3.7).
Vascular dopamine-1 receptor stimulation results in a predominantly postglomerular
response by direct vasodilation of the efferent arterioles (Girbes et al. 1990, Wee et al.
1986). Such an effect would decrease intraglomerular capillary hydrostatic pressure in
the mannitol plus dopamine patients and therefore reduce FF. The difference between
the mannitol plus dopamine group and control patients can also be accounted for by a
tubuloglomerular feedback-induced lower FF (Maddox and Brenner 1996) in the former
group. The intragroup decrease in FF is difficult to ascribe to a tubuloglomerular
feedback mechanism in the presence of a decrease in urine volume and TUNa at the
measurement times, which coincided with the reduced FF. It is possible that the TNT
infusion could, through a predominant effect on the efferent arteriole, have contributed
to the decrease in FF. The highest TNT infusion rates coincided with the lowest FF
values.
Mannitol and dopamine prevented the aortic cross clamp-induced decrease in volume
of urine produced and was responsible for significantly higher volumes at all
measurement times subsequent to aortic clamping relative to control patients. In the
study by Paul et al. (1986) mannitol and dopamine induced the production of urine
during and after aortic clamping which was significantly more than the mean post-
induction volume. It is a consistent feature of published trials that dopamine increases
urine output during (Salem et al. 1988, Schwartz et al. 1988) and after (Girbes et al.
1996; Schwartz et al. 1988) infrarenal aortic surgery. Mannitol has also been
demonstrated to induce increased volumes of urine production perioperatively in
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. patients subjected to aortic reconstructive surgery (Abbott and Austen 1974, Luck and
Irvine 1965; Barry et al. 1961). The maintenance of urine output induced by the
combination of mannitol and dopamine may, when more specific parameters of renal
function are not available, lead to a false sense of security. Three of the patients in the
mannitol plus dopamine group became anurie during the night after surgery with
adequate urine volumes produced until sudden cessation of urine flow. In all three
cases, assessment revealed that intravascular volume status became progressively
compromised with PAWP decreasing to zero over a period of 2-4 hours without the
attending staff taking cognisance of this fact. Intravenous fluid resuscitation led to
prompt stabilization of hemodynamic status and resumption of urine production in all
three patients.
The fact that there were no differences in urinary sodium concentrations between
control and mannitol plus dopamine patients (results not shown) and the higher urine
volumes in the latter group, predicts the higher TUNain the mannitol plus dopamine
patients at all measurement times subsequent to starting administration of the drugs
(relative to control patients; Figure 3.9). Dopamine had previously been shown to
increase total urinary sodium excretion both during (Salem et al. 1988) and after
(Schwartz et al. 1988) infrarenal aortic cross clamping. The natriuretic effect of
dopamine becomes more evident under states of extracellular fluid expansion (Agnoli
et al. 1987). This might have contributed to the sodium excretion in the mannitol plus
dopamine patients in our study with the maintenance of PAWP at mean values in
excess of 10 mmHg. The natriuretic effect of dopamine had also been demonstrated
to prevail in the absence of increases in RBF and GFR (Jose et al. 1987), a situation
which was pertinent in our study. The maintenance of urinary sodium concentrations,
despite an initial decrease in urine volume in the mannitol plus dopamine patients
(Table 3.11), might have been due to inhibition of tubular reabsorption of sodium
(Krishna et al. 1985) or impairment of the tubuloglomerular feedback mechanism by
dopamine (Schnermann et al. 1990). Mannitol also increases total urinary sodium in
aortic surgery despite a decrease in urinary sodium concentration (Abbott and Austen
1974). The mechanism of mannitol-induced natriuresis is the result of osmotic
inhibition of water (more than sodium) transport in the proximal tubule (Warren and
Blantz 1981) which diminishes the gradient for passive sodium absorption in the thin
ascending limb of Henle (Seely and Dirks 1969).
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While FENa decreased in control patients after the awake control measurement,
mannitol and dopamine maintained this parameter at mean values which were higher
than the pre-induction values, although this did not reach statistical significance. The
FENa in the mannitol plus dopamine group was, however, significantly higher than in
control patients at al measurement times after commencement of the drugs in the
former group (Figure 3.10). This was predictable as both mannitol (Warren and Blantz
1981) and low-dose dopamine (Andrejak and Hary 1986) have been demonstrated to
increase FENa• The dopamine-induced enhancement of FENa was probably augmented
by the fact that some of our patients were hypertensive, a condition which enhances
the natriuretic effect of dopamine (Andrejak and Hary 1986). The use of mannitol and
dopamine renders the FENa an unreliable predictor of renal tubular injury, despite the
fact that FENa values were consistently higher than 0.06, which is considered to be
diagnostic of tubular damage (Oken 1981).
Despite the fact that mannitol induces an even bigger water than sodium loss (Gennari
and Kassirer 1974), thus obligating a more positive CH20(Gann et al. 1964), there was
no difference in CH20values between control and mannitol plus dopamine patients at
any measurement time. CH20values in mannitol plus dopamine patients gave no
indication of the development of acute renal insufficiency (Landes et al. 1976).
The progression and extent of ~2-microglobulinuria was similar in control and mannitol
plus dopamine patients. Mannitol and dopamine were therefore unable to protect the
kidney from proximal tubular injury (Schardijn and Van Eps 1987).
Pren and RVren in mannitol plus dopamine patients increased at the same measurement
times as in control patients. Neither Pren or RVren was different in the mannitol plus
dopamine group from the measurements in control patients at any measurement time,
despite higher plasma noradrenaline concentrations in the former group. Higher doses
of dopamine have been demonstrated to increase renin levels through fs-receptor
stimulation (Lopez et al. 1979) and by stimulating dopaminergic receptors (Williams et
al. 1983). However, at a dose of 3Ilg.kg-1.min·1 no increase in plasma renin concen-
tration has been recorded despite an increase in plasma noradrenaline concentration
(Levinson et al. 1985).
Although mean serum aldosterone concentrations were consistently lower in mannitol
plus dopamine patients than in the control group (after starting the drugs in the former
group), these differences never reached statistical significance. Dopamine had been
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shown to inhibit zona glomerulosa function which decreased aldosterone release
(Carey et al. 1979) and also specifically to inhibit both angiotensin-stimulated
biosynthesis and release of aldosterone (McKenna et al. 1979). This effect may
contribute to the natriuretic and diuretic effect of dopamine.
Although dopamine, via dopamine-2 receptor stimulation, can inhibit the release of
ADH from the posterior pituitary gland (Pittman et al. 1983), this was not evident in the
mannitol plus dopamine patients in our study. ADH release, induced by surgical
stress, was similar in control and in mannitol plus dopamine patients.
In summary, mannitol and dopamine was unsuccessful in preventing the aortic cross
clamp-induced decrease in RBF and nephron dysfunction. Although both mannitol
(Cronin et al. 1978) and law dose dopamine (Davis et al. 1982) have been suggested
to modify the course of ischemic acute renal failure (ARF), there are no properly
controlled studies showing a decrease in the incidence of ARF with the use of these
potentially protective agents in populations at risk. Indeed, there is growing concern
that the increased sodium load presented to the thick ascending limb of the loop of
Henle and to the distal tubules with the use of these agents, may increase the tubular
oxygen demand and therefore compromise tubular survival (Duke and Bersten 1992,
Cottee 1995). In our study, the combination of mannitol and dopamine also had no
significant influence on the hormonal changes potentially involved with the
pathogenesis or pathophysiology of altered renal hemodynamics and nephron function
with infrarenal aortic cross clamping.
4.4 Potential benefit of ACE inhibition and B-adrenergic blockade
Appropriate methods to investigate the pathophysiological role of angiotensin II in the
renal hemodynamic and functional changes associated with infrarenal aortic cross
clamping, would be to block angiotensin receptors or to prevent activation of
angiotensin with ACE inhibitors, or to prevent release of renin with a ïs-blocker. We
chose the latter two methods as these drugs are more readily available and are more
likely to be used in the relevant clinical situation if demonstrated to be beneficial.
To assess the influence of drugs on the renal parameters, the ideal would be to take
control measurements intraoperatively, then administer the drugs and allow adequate
time for the agents to take full effect before another set of preelamp control
measurements are taken. Such an approach would add substantially to the experi-
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mental time, as adding another measurement period would extend the experiment by
more than 30 minutes (20 minutes sampling period plus taking measurements and
samples at the end). In addition, at least 60 minutes would have to be allowed for
maximum (renal) biophase effect to be achieved after drug administration before the
(post-drug) preclamp measurements could be taken. This would have been
necessary, even with the short half life, rapid acting drugs esmolol and enalaprilat as
the former drug has been demonstrated to require 32.1 (± 15 (SO)) minutes to achieve
90% of maximum effect on plasma renin activity (Ornstein et al. 1995). The onset time
for enalaprilat is in excess of 60 minutes (Waeber et al. 1989; Mirenda et al. 1991).
The total time added would have compelled the radioisotope counts to be done on the
following day and the relatively short half-lives of the isotopes would have rendered
these measurements inaccurate. The "control" (preclamp) measurements are
therefore not truly comparable between the three animal groups (esmolol, enalaprilat
and control groups), as parameters in the experimental drug groups might already
have been influenced by those agents. Although there were no statistically significant
differences between the groups in any of the important parameters at the "control"
(preclamp) measurement time, mean values between groups did demonstrate some
variation in some parameters such as RBF (Tables 3.19, 3.23 and 3.28). To
accommodate the above, statistics were performed to measure the differences in
changes between groups induced by interventions (clamping = change from
measurement time 1 to 2; duration of Clamping = change from measurement time 2 to
3; unclamping = change from measurement time 3 to 4; whole procedure = change
from measurement time 1 to 4). For comparison of sequential measurements within a
specific animal group (intragroup differences), however, conventional parametric/ non-
parametric statistical methods remain valid.
It is conspicuous that RBF decreased significantly in control animals upon application
of the aortic cross clamp (Table 3.19) while cross clamping did not induce such a
change in the enalaprilat (Table 3.28) group. Although RBF did decrease in the
esmolol group upon application of the aortic clamp, this reduction was much less than
in control animals in absolute (71 vs 291 rnl.rnin') and relative (13.5% vs 52.8% lower
than preelamp values) terms. The protective effects of esmolol and enalaprilat are
confirmed by the fact that the comparison of intergroup changes from measurement 1
to 2 also demonstrates differences between control and the esmolol as well as the
control and enalaprilat groups (Figure 3.24). The beneficial effect of ACE inhibition in
our study concurs with the findings in the clinical study of Licker et al. (1996), but is in
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conflict with the results of Colson et al. (1992a) who failed to demonstrate significant
advantage with ACE inhibition. However, the adequacy of the preoperative oral
dosages of enalapril in the latter study may be questioned. The higher doses of ACE
inhibitors used in our study and the Licker et al. (1996) report, are likely to have been
more successful in maintaining renal hemodynamics through more effective blockade
of intrarenal angiotensin activation (Dzau 1987). Prevention of renin release with 11-
blockade (and therefore, presumably, activation of angiotensin) with infrarenal aortic
clamping were demonstrated to prevent redistribution of RBF to the deeper cortex and
medulla in a study on dogs (Berkowitz and Shetty 1974). Unfortunately, RBF was not
measured in any of the human studies which reported on the influence of ïs-blockade
on renin release during abdominal aortic surgery (Grind linger et al. 1981; Grant and
Jenkins 1983).
It therefore appears that angiotensin plays an important role in the decrease in RBF
induced by infrarenal aortic cross clamping. Although angiotensin might have played a
primary role in this context, it is also possible that renal vasoconstriction was mediated
through the permissive effect of angiotensin on the influence of other vasoactive
substances. Such a role for angiotensin has been described with endothelin
(Miller et al. 1989) and adenosine (Dietrich et al. 1990). The presence of angiotensin
is essential for the renal vasoconstrictive effects of both these substances. Endothelin
release could also have been the instigating event, since it could theoretically induce a
decrease in RBF through enhancing the activity of ACE (Kawaguchi et al. 1990) which
could explain the beneficial effect of ACE inhibition. A significant role for the latter
mechanism is unlikely, however, since that would have resulted in a much more
beneficial effect of ACE-inhibition on RBF than that achieved with ïs-blockade which
reduces angiotensin through inhibition of renin release without any direct influence on
the ACE. A somewhat better protective effect on RBF by ACE inhibition is suggested
by the fact that RBF did decrease significantly in the esmolol group upon application of
the aortic clamp without any significant change in enalaprilat animals (intragroup
differences), although the changes between measurements 1 and 2 were no different
between the groups. This could be explained by some degree of primary release of
endothelin and its effect on ACE activity described above (Kawaguchi et al. 1990), or
possibly by the renal vasodilatory effects of bradykinin. The ACE is responsible for the
degradation of the latter substance; ACE inhibition would consequently increase
bradykinin concentration (Williams 1988). Bradykinin induces renal vasodilation on its
own, as well as possibly through stimulating the synthesis of various prostaglandins
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(Rotmensch et al. 1988; Williams 1988). Increased bradykinin concentration through
the influence of ACE inhibition also produces renal vasodilatation indirectly (particularly
under pathophysiological circumstances) by inhibiting endothelin (a potent renal
vasoconstrictor) synthesis (Momose et al. 1993).
Considering the clamp induced increase in noradrenaline concentration in one patient
group in our human study which has also been reported previously (Kataja et al. 1989),
both ïs-blockade and ACE inhibition is likely to have been of benefit through modulating
the interaction between the sympathetic and renin-angiotensin systems. By
decreasing angiotensin II concentrations, both enalaprilat and esmolol would have
decreased presynaptic noradrenaline release (Zimmerman 1978). fs-receptor blockade
byesmolol would also have decreased vascular production of angiotensin II and the
consequent effect of the latter substance on the renal vascular tone (Kawasaki et al.
1984). ~-blocker inhibition of vascular angiotensin production would also be of indirect
benefit since the latter substance enhances presynaptic noradrenaline release which
promotes additional vasoconstriction (Kawasaki et al. 1984, Nakamaru et al. 1986).
In both the enalaprilat and esmolol animals, RBF decreased significantly upon release
of the aortic clamp (relative to its mean preclamp value in enalaprilat animals and
relative to all three previous measurements in esmolol pigs), while no further significant
decrease in control animals occurred. This clearly suggests the release of (a)
vasoactive substance(s) or (a) hemodynamic event(s) in which the two experimental
drugs proved ineffective protective agents. Changes in hemodynamic variables as
causative events are unlikely. Decreases in cardiac filling pressures (which might have
induced decreases in atrial natriuretic peptide, with indirect reduction of RBF
(Weidmann et al. 1986)) did not occur after aortic unclamping in any of the groups.
Both CO and MAP were also maintained relative to preelamp measurements in all
groups, the latter parameter being consistently within autoregulatory range.
Since the plasma renin levels did not increase in the ïs-blocked animals, it is probably
safe to assume that circulating angiotensin II levels did not increase in that group.
Consistently high renin concentrations in the enalaprilat group suggest adequate
blockade of systemic ACE, with low angiotensin II concentrations abolishing the
negative feedback on renin secretion. Although it is possible that intrarenal (rather
than systemic) activation of angiotensin II could have been primarily responsible for the
decrease in RBF after aortic unclamping in the two experimental drug groups, it is
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unlikely. The dose of enalaprilat used, and its duration of action, should have been
adequate even to inhibit intrarenal angiotensin activation (Dzau 1987). Unlike other
similar studies, renin (and presumably also angiotensin) concentration did not increase
further after release of the aortic clamp relative to postclamp values in our control
group (Gal et al. 1974; Grindlinger et al. 1981; Grant and Jenkins 1983), providing
further evidence for the involvement of other vasoactive substances in the curtailment
of RBF after clamp release in the two drug groups.
It is quite possible that vasoactive substances can be released into the systemic
circulation from (at least partially) ischemic tissues distal to the aortic cross clamp
when the aorta is unclamped. Plasma purine degradation products, and adenosine in
particular, could play such a role. Plasma adenosine concentrations have been
reported in only one experimental study where an infra renal aortic cross clamp was
applied in a dog model (Frank et al. 1988). Although mean plasma adenosine levels
after release of the clamp peaked at 92% above pre-unclamp controls, the difference
was not significantly different due to data scatter. In addition, the mean difference
dropped off to 34% after 10 minutes while RBF decreased significantly after clamp
removal (relative to pre-unclamp measurements) and was still significantly reduced
beyond the 10 minutes post-unelamp measurements. Clearly, although adenosine
release could contribute to the initial decrease in RBF after aortic unclamping, it could
not be responsible for the prolonged post-unelamp compromise evident in both our
human and animal studies and reported in numerous other studies (Gamulin 1984,
1986; Colson 1992a, 1992b). While our own human study was restricted to patients
scheduled for abdominal aortic aneurysm repair, the other four studies quoted above
also included patients with aorto-iliac occlusive disease. Due to the development of
collateral circulation in such individuals, clamp-induced distal ischemia with significant
adenosine release upon unclamping is unlikely. Unfortunately a statistical analysis
comparing the changes in aortic aneurysm patients with those with aorto-iliac disease
was not performed in any of these studies, neither was there any reference to a
possible difference between such patients.
Postischemie systemic release of endothelin (Battistini et al. 1993) might also have
played a role in the post-unclamp decrease in RBF in the esmolol and enalaprilat
animal groups. Plasma endothelin concentration has been reported to be raised even
before aortic unclamping (Antonucci et al. 1990) and could quite possibly increase
even more after aortic unclamping due to synthesis and release from ischemic tissue
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distal to the clamp although this was not measured/reported in the Antonucci study.
The duration of endothelin-induced renal vasoconstriction is also more likely to
correspond with our reported post-unelamp renal ischemia as the contractile response
of endothelin is sustained and more difficult to wash out than that effected by other
vasoconstrictors (De Nucci et al. 1988). However, the inability of enalaprilat to prevent
the aortic unclamp-induced decrease in RBF in that animal group, suggests a
complementary role at most for endothelin in this phase as ACE-inhibition significantly
reduces the renal vasoconstrictive effects of endothelin (Chan et al. 1994). If
endothelin had played a significant role in post-unelamp renal ischemia, the
administration of dihidropiridine Ca2+ channel blockers would have attenuated this
response (Madeddu et al. 1990; Loutzenhiser et al. 1990). By contrast, verapamil
should have been ineffective in blunting the renal vasoconstriction (Cao and Banks
1990) (see again in next section).
The role of other vasoactive substances in this unclamp-induced renal ischemia can
only be speculated about. Inhibition of synthesis of both prostaglandins and nitric oxide
(NO) have been demonstrated to greatly aggravate the unclamp-induced decrease in
RBF in rats (Myers et al. 1996). The authors do not claim inhibition of these
substances to be responsible for the renal ischemia induced by aortic unclamping, but
rather suggest their presence to be important in the (partial) maintenance of
autoregulation of RBF. However, it is conceivable that reactive oxygen intermediates
released from ischemic tissues distal to the aortic clamp at the time of unclamping and
reperfusion, can inactivate NO and also influence the synthesis of protective
prostaglandins as have been previously demonstrated in other models (Marsden et al.
1996, Ardaillou and Baud 1992).
It is unlikely that reperfusion-induced changes in the vasculature of the kidney itself
could be responsible for the decrease in RBF after unclamping in the two experimental
groups. Firstly there was no decrease in total RBF during the aortic clamping period in
these groups which could have induced the production of reactive oxygen
intermediates. Secondly, regional ischemia in the kidney due to substantial
redistribution of RBF (even with an unchanged total RBF), could theoretically render
some areas sufficiently ischemic to effect the generation of reactive oxygen
intermediates in such areas. Based on the fact that EH,P were not influenced by aortic
clamping in any of the groups, it can be assumed that redistribution of RBF between
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the cortical and medullary/deeper cortical areas of the kidneys did not occur (Gamulin
1984).
The extent and time periods of changes in GFR in the three animal groups closely
resembled the changes in RBF. GFR was preserved during aortic clamping in the two
experimental groups while it decreased substantially (by 52.8%) upon aortic clamping
in control animals (Figure 3.25). Nevertheless, the extent of the change was only
significantly different between the control and enalaprilat groups, again suggesting a
somewhat better protective effect of ACE inhibition (relative to ïs-blockade). Aortic
unclamping induced significant decreases in GFR in both enalaprilat (33.2% decrease)
and esmolol (37% decrease) animals while it remained essentially unchanged relative
to pre-unclamp measurements in control pigs. The extent of change in GFR induced
by aortic unclamping was also significantly different between the two drug groups and
control animals. The fact that the FF did not increase in association with the decrease
in GFR upon aortic clamping in control animals suggests that factors other than
angiotensin II also had an influence on glomerular dynamics. In the presence of
angiotensin alone, predominant vasoconstriction of the efferent arterioles would occur,
increasing hydrostatic pressure in glomerular capillaries and increasing nett filtration
(prevailing over the angiotensin-induced mesangial cell contraction which would
decrease the filtration coefficient and tend to have the opposite effect) (Edwards 1983;
Ichikawa et al. 1991). The unchanged FF associated with the decreased GFR after
aortic unclamping in the enalaprilat and esmolol groups also suggests the influence of
vasoconstrictor agent(s) with a balanced effect on the afferent and efferent arterioles.
Although urine output is suggested to be a poor indicator of the status of RBF under
surgical conditions (Alpert et al. 1984), changes in RBF were very similar to
percentage changes in urine volumes at the various measurement times in the control
and esmolol groups. The post-unelamp decrease in RBF in the enalaprilat group,
however, was not associated with a significant reduction in urine output. The
administration of an ACE inhibitor has previously been demonstrated to be
accompanied by the maintenance or even increase of urine volumes in abdominal
aortic surgery although RBF was not measured in this study (Kataja et al. 1989). This
could possibly be mediated by increased intrarenal concentrations of bradykinin due to
inhibition of its metabolism by ACE inhibitors (Williams 1988). The localization of the
kallikrein-kininogen system in the collecting duct suggests that kinins may playa role in
transport processes in that part of the nephron (Gunning et al. 1996). Inhibition of
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endogenous bradykinin has been demonstrated to result in decreased sodium and
water excretion (Marin-Grez 1974). Kinins have also been shown to inhibit ADH-
stimulated water (Schuster et al. 1984) and sodium (Tomita et al. 1984) permeability in
the collecting duct and thus restricting the antidiuretic effect of the hormone.
CH20 and FENa calculations did not provide evidence of ischemic (distal) tubular
dysfunction in any animal group except for the CH20 becoming significantly more
positive just after aortic clamping in the control group, but recovering subsequently.
While increased FENa is regarded as an indicator of renal tubular dysfunction in the
development of acute renal failure (Oken 1981), decreased angiotensin concentration
(due to the influence of ACE inhibition or ts-btockade) could also increase FENa (Steiner
1984), particularly in the presence of raised levels of ADH such as during intense
surgical stress (Field man et al. 1985; our own human study). The fact that FENa did
not increase in the esmolol and enalaprilat animal groups could therefore be regarded
as an indicator of the absence of significant tubular injury.
Although the severity scores and number of abnormal subcellular structures were
better in esmolol and enalaprilat animals than in the control group, these differences
did not reach statistical significance (Table 3.58). The same applies to the comparison
of numbers of animals per group which were classified as clearly abnormal versus
normal or only minimal change to the renal ultrastructure (Table 3.59). Since the renal
biopsies were taken approximately 60 minutes after aortic unclamping, this constitutes
periods of decreased RBF (relative to preclamp RBF values in the respective groups)
of 60 minutes in the enalaprilat and esmolol groups and 120 minutes in control
animals. Histological changes similar to those found in our animal groups, have
previously been described after periods of 60 to 110 minutes of partial renal ischemia
(Kreisberg et al. 1976, Dobyan et al. 1977). None of the ultrastructural changes found
in our animal groups can be considered to be irreversible (Reimer et al. 1972,
Glaumann et al. 1977). However, RBF was still decreased relative to preelamp values
at the time of biopsy in all three animal groups. It is therefore likely that the extent of
ischemic injury would have been worse if the biopsies had been taken at a later stage,
depending on the duration of eventual ischemia (Glaumann et al. 1975a, 1975b).
While some studies claim a selective susceptibility of the medullary thick ascending
limb (mTAL) for renal ischemic injury (Brezis et al. 1984a, 1984b, 1984c), the changes
in all three animal groups in our study were restricted to the proximal tubule,
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particularly the S3 segment in the inner cortex and outer medulla. This corresponds
with the sensitivity for ischemic injury described for this part of the nephron
(Venkatachalam et al. 1978, Endre et al. 1989).
In summary, ACE inhibition and r.,-blockade prevented the aortic cross clamp induced
decrease in RBF and GFR. However, aortic unclamping induced a significant
decrease in both these parameters in animals "protected" by either enalaprilat or
esmolol. A vasoconstrictive mechanism(s) other than angiotensin is therefore
responsible for the pathophysiological changes induced by aortic unclamping. The fact
that prevention of angiotensin II production inhibited the changes in renal
hemodynamics and glomerular function induced by aortic clamping, does not establish
a primary pathogenic role for the hormone in that time period. Both ACE inhibitors and
r.,-blockers have other renal protective effects unrelated to (preventing) the direct
effects of angiotensin II.
4.5 The potential benefit of calcium channel blockers
As the renal changes in control and ACE-inhibited animals and differences between
those groups have been discussed previously, this section will concentrate on the
influence of calcium channel blockade and its comparison with the two other groups.
The dose of verapamil and the decision to use a continuous infusion is consistent with
its relatively short duration of effect on renal hemodynamics and based on dosages
previously demonstrated to be protective in models of experimental acute ischemic
renal failure (Alvarez et al. 1994, Fisher and Grotta 1993, Wait et al. 1983).
Similar to the ACE-inhibitor group, RBF did not decrease in the verapamil group upon
aortic cross clamping (Table 3.28, 3.39 Figure 3.27). This is consistent with the
postclamp maintenance of RBF demonstrated during infrarenal aortic aneurysm repair
by Colson et al. (1992a) in patients who received nicardepine preoperatively. In
addition, the post-unelamp decrease in RBF which occurred in ACE-inhibited animals,
was not evident in the verapamil group. The superior protective effect of Ca2+ -channel
blockade after cross clamp release is confirmed by the difference in changes of RBF
from measurement times 3 to 4 between the verapamil and enalaprilat groups. Post-
unclamp maintenance of RBF despite a significant increase in renin concentration at
that measurement time, is in keeping with calcium blocker inhibition of renal
vasoconstriction induced by angiotensin (Ichikawa et al. 1979, Goldberg and Schrier
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1984). However, calcium influx has also been demonstrated to be instrumental in the
renal vasoconstrive effects of other potential causative agents such as noradrenaline
(Steele and Challoner-Hue 1984), endothelin (Migas et al. 1993), thromboxane
(Loutzenhiser et al. 1986) and ADH (Goldberg and Schrier 1984). Calcium channel
blockers have been reported to successfully reverse the renal hemodynamic effects of
these vasoconstrictors (Loutzenhiser and Epstein 1985, Loutzenhiser et al. 1986,
Kiowsky et al. 1991).
If the beneficial renal hemodynamic effect of verapamil had been due to
prevention/reversal of angiotensin induced renal vasoconstriction, one would have
expected the FF to increase at the time (which did not occur) as the efferent arteriole is
less responsive to calcium channel blockers under the influence of angiotensin than
the afferent arteriole (Ichikawa 1979). This is possibly due to the fact that efferent
arteriole vasoconstriction is mediated largely through mobilization of intracellular
calcium in response to angiotensin II, rather than influx of extracellular calcium through
voltage regulated channels (Smith et al. 1984). This is substantiated by the fact that
the renal vasodilatation obtained with ACE-inhibition during coincident verapamil
infusion could be partly reversed by angiotensin II administration, indicating partial
transmembrane calcium flux independence of the renovascular effects of angiotensin
(Navar et al. 1986). However, while dihidropyridine calcium channel blockers appear
to preferentially decrease afferent arteriolar constriction (Loutzenhiser and Epstein
1985), verapamil has both afferent and efferent effects (Fisher and Grotta 1993) which
would prevent major changes in intraglomerular capillary hydrostatic pressure and thus
maintain FF relatively unchanged. It is also possible that FF did not increase because
verapamil did not completely block the effect of angiotensin lion the glomerular
filtration coefficient (angiotensin induced mesangial cell contraction which decreases
the coefficient) (Ichikawa et al. 1974). However, it is perhaps most likely that the
beneficial effect of calcium channel blockade after aortic unclamping had been due to
inhibition of transmembrane calcium flux induced by other vasoconstrictors, since
ACE-inhibition had been unsuccessful in preventing a post-unelamp decrease in RBF
in that experimental group.
The maintenance of RBF in both perclamp and the post-unelamp periods with the
administration of verapamil is not necessarily (only) due to the role of calcium in the
final common pathway of vascular smooth muscle contraction induced by
vasoconstrictors. Calcium channel blockers also interfere with the activation of some
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cell types, which result in decreased synthesis and secretion of vasoactive substances.
Calcium channel blockade has been demonstrated to decrease the synthesis and
release of the potent vasoconstrictive prostanoid, thromboxane (Rostagno et al. 1991)
and modulates the release of endothelin during infrarenal aortic surgery (Antonucci et
al. 1996). It also suppresses the activation of macrophages (Wright et al. 1985),
neutrophils (Jouvin-Marché et al. 1983) and platelets (DeCree et al. 1979), all of which
are important sources of vasoactive substances.
One concern about the universal use of calcium channel blockers in infrarenal aortic
surgery, is the fact that these agents have been demonstrated to block renal
autoregulatory capability in vitro (Cohen and Fray 1982) and in vivo (Nava et al. 1986).
The flow : pressure relationship below autoregulatory pressure range is however no
worse with Ca2+ -blockade than without it (Navar et al. 1986). Other vasodilators
including acetylcholine, dopamine and prostaglandin E2 induce additional (beneficial)
vasodilatation at arterial pressures below the autoregulatory range (Baer and
Navar 1973; Gross et al. 1976). This leftward shift of the flow: pressure relationship at
perfusion pressures below normal autoregulatory range, would effect improved renal
perfusion under such detrimental clinical conditions which Ca2+ -blockade would not
emulate. Conversely, verapamil prevents ischemia induced loss of autoregulation of
RBF (Robinette et al. 1987), which would be beneficial in the event of an ischemic
insult to the kidneys. Despite the beneficial effect of calcium channel blockade on RBF
demonstrated in one human study (Colson et al. 1992a) and our own animal study, this
matter needs further investigation in an appropriate model since unstable systemic
hemodynamics with episodes of hypotension is the norm rather than the exception
under these surgical circumstances.
Factors other than vasoconstrictive mediators, such as turbulence of blood flow
proximal to the aortic cross clamp (close to the origin of the renal arteries) have been
suggested as etiology for the decrease in RBF. Since pressure and flow lose their
linear relationship with tubulence, renal blood flow would decrease for a given
perfusion pressure at the origin of the renal arteries (Parbrook et al. 1990). These
detrimental circumstances would be aggravated in patients with atheromatous lesions
in their renal arteries. This scenario is unlikely for two reasons. It would firstly not
explain the decreased RBF after aortic unclamping. Secondly, if calcium channel
blockers compromise autoregulation of RBF (Cohen and Fray 1982, Navar et al. 1986),
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these drugs should not protect RBF to the extent demonstrated in our own study and
others (Colson et al. 1992a).
Maintenance of GFR during the preelamp and post-unelamp periods is a feature in the
verapamil animals in contrast to the control group where GFR was decreased for the
full duration of the experiment after clamping, as well as the enalaprilat animals where
unclamping induced a significant decrease in this parameter. These intragroup
changes are confirmed by the comparisons of changes between the experimental
groups (Figure 3.28). Calcium channel blockers improved GFR in 14 of 19 studies
where these agents were administered to anaesthetized animals (Loutzenhiser and
Epstein 1985). All 5 studies in which an improvement in GFR did not occur, were
performed in the absence of exogenous vasoconstrictors. Such a beneficial effect for
calcium blockers during abdominal aortic surgery was also evident in two clinical
studies (Colson et al. 1992a, Antonucci et al. 1996). The validity of the suggestion that
endothelin (alone) is responsible for the decrease in GFR (Antonucci et al. 1990, 1996)
is questionable since verapamil which was beneficial in our study, was reported to be
unsuccessful in blunting the glomerular effects of endothelin-1 (Cao and Banks 1990)
although other studies have shown a beneficial effect for calcium channel blockade
(Luscher et al. 1992). This caveat, together with the fact that ACE inhibition (which
had been demonstrated to significantly reduce the renal effects of endothelin (Chan et
al. 1994)) was unsuccessful in influencing the decrease in GFR after unclamping (ACE
inhibition animal group), suggest a supplementary rather than a comprehensive role for
endothelin.
A more significant enhancement of calcium channel blockers on GFR than on RBF is
suggested under the influence of renal vasoconstrictive agents (Loutzenhiser et al.
1984, 1985). This is considered to be due to a predominantly preglomerular
vasodilatory effect of these drugs, which would increase glomerular capillary
hydrostatic pressure. Verapamil has also been demonstrated to inhibit the
tubuloglomerular feedback mechanism, thus preventing both afferent arteriolar
vasoconstriction and the resultant decrease in GFR when an increased solute load is
delivered to the renal tubules (Muller-Suur et al. 1976). Such preferential
augmentation of GFR could not be assessed in our study as verapamil was given
prophylactically rather than to reverse the established renal effects of vasoactive
substance(s). A predominant preglomerular effect is unlikely, however, since there
was no difference in FF between the verapamil animals and the other two groups.
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Calcium channel blockers usually exert a stimulatory, rather than an inhibitory effect on
renin release (Dietz et al. 1983, Amana et al. 1995). The fact that renin concentration
did not increase in verapamil animals after aortic cross clamping suggests that the
increase in renin levels in the control group (and the difference in change from pre- to
postclamp values between the two groups: Figure 3.29) had been due to stimulation of
its release secondary to the reduction in RBF and GFR rather than it being a primary
cause of the changes in those parameters. If increased renin and angiotensin had
been a primary cause, renin values would also have increased in the verapamil group,
with verapamil then responsible for attenuation of the angiotensin induced renal
changes. The fact that enalaprilat was successful in maintaining RBF and GFR at the
two perelamp measurement periods, may nevertheless indicate an important
supplementary role for angiotensin. This influence could manifest through direct renal
effects of angiotensin or indirectly due to its stimulatory role in the release of other
mediators such as endothelin (Chan et al. 1994) and noradrenaline (Zimmerman
1978). Conversely, at least part of the benefit of ACE inhibition could have been
gained through increased bradykinin levels (Williams 1988).
The increase in renin concentration in verapamil animals after release of the aortic
clamp could have been in response to the systemic release of other vasoactive
substances from ischemic tissues distal to the clamp as described in the previous
section. The renal effects of verapamil were clearly sufficient to counteract the
deleterious influences of those agent(s) without causing detrimental effects of its own.
The verapamil animals were the only group where urine output increased after aortic
clamping. Calcium channel blockers have previously been demonstrated to be
natriuretic (leonetti et al. 1982, Maclaughlin et al. 1985) and diuretic (leonetti et al.
1982, Wait et al. 1983). The fact that renin concentration, and presumably therefore
also angiotensin and aldosterone, did not increase in the two perelamp measurement
periods in verapamil animals, would have assisted in the prevention of antinatriuresis
and oliguria. Although FENa did not increase during aortic clamping in the verapamil
group, the total sodium load excreted was significantly raised. The natriuretic effect of
calcium channel blockers is suggested to be due to direct action of these agents on the
proximal (McCarty and O'Neil 1991, Rose et al. 1994), as well as distal tubules and
collecting ducts (Dibona and Sawin 1984). Inhibition of tubular sodium reabsorption
would decrease renal oxygen consumption and thus be protective in the ischemically
compromised kidney (Van Zwieten 1993, lopez-Neblina et al. 1996). Inhibition of
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ADH-mediated water reabsorption might also have played a role in the increased urine
output, since ADH-stimulated water transport across the toad bladder has been
demonstrated to be inhibited by verapamil (Humes et al. 1980.)
Mitochondrial swelling was the only ultrastructural change which was apparent in
(some) verapamil animals, while changes in the gER and the brush border microvilli
also occurred in the other two animal groups (Table 3.64). Although both the
(mean/median) severity scores and numbers of abnormal parameters suggest a
protective influence of verapamil, statistical significance is not achieved (p = 0.06,
Table 3.65). The inability to achieve statistical significance can be attributed to the
presence of mitochondrial changes in verapamil animals since, when only the other
ultrastructural changes are considered in all three animal groups, verapamil animals
demonstrate better total severity scores (p < 0.05 vs control and enalaprilat) and less
numbers of abnormal parameters (p < 0.01 vs control, p < 0.05 vs enalaprilat). The
possibility that mitochondrial swelling constitutes the earliest ultrastructural change, is
contradicted by the fact that gER and/or microvillous changes occurred in a number of
animals in the control and enalaprilat groups without mitochondrial swelling
(Table 3.64). No potential explanation for this phenomenon could be found in the
literature.
Comparing the numbers of animals per group classified as demonstrating clearly
abnormal versus normal or minimally changed histology, do suggest a protective effect
for verapamil relative to control and enalaprilat animals (Table 3.66).
At a cellular level, calcium influx into ischemically injured renal tubular cells is
considered to be a fundamental component of damage and eventual necrosis (Young
and Humes 1991, Rose et al. 1994). L-type Ca2+ channel blockers have been shown
to reduce Ca2+ uptake of proximal tubular cells exposed to hypoxia (Almeida et al.
1992). Verapamil has also been demonstrated to preserve the ultrastructural integrity
of renal tubules in animals exposed to ischemia (Alvarez et al. 1994). The protective
effect of verapamil on the brush border microvilli was particularly impressive in the
Alvarez study. At least part of the protective effect of Ca2+ channel blockade in vivo is
due to a direct tubular effect of these drugs which, through inhibition of sodium
reabsorption, decreases cellular oxygen consumption (Van Zwieten 1993).
The protective effect of calcium blockers on cellular integrity in our experimental study
could therefore be established firstly through its demonstrated beneficial effect on
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. RBF, and secondly (even if ischemia does occur) by direct influence on the
pathophysiological process induced by ischemia at cellular level.
In summary, the administration of verapamil was instrumental in the maintenance of
RBF throughout the perclamp and post-unelamp periods, while ACE inhibition
prevented a decrease in RBF only during aortic clamping, with a significant decrease
occurring after release of the clamp. These results confirm a calcium-mediated
vasoconstrictive response associated with the decreased RBF both during aortic
clamping and after unclamping. It also suggests that different vasoactive mediators
are responsible for the perclamp and post-unelamp reduction in RBF respectively.
Preservation of perelamp RBF under the influence of ACE inhibition does not confirm a
primary pathogenic role for angiotensin II in the renal hemodynamic changes during
aortic clamping. ACE inhibitors have other effects such as the inhibition of bradykinin
metabolism, which may also influence RBF. In addition, angiotensin also plays a
permissive role in the vasoconstrictive effects of other vasoactive substances such as
noradrenaline and endothelin, which may possibly be more important. Verapamil
appears to inhibit the (ischemic) renal ultrastructural changes induced by infrarenal
aortic cross clamping.
4.6 The role of prostaglandins
The dose of diclofenac used in our experimental animals had previously been
demonstrated to block renal and systemic prostaglandin synthesis (Wanecek et al.
1997; Bayliss et al. 1978). A maximal reduction in urinary prostaglandin excretion of
between 60 and 80% had been described with nonsteroidal anti-inflammatory drugs
(Patrono and Dunn 1987).
As in the other experimental groups where drugs had been administered, the
diclofenac was injected immediately after securing intravenous access. This implies
that potential changes in prostaglandin homeostasis would have been influenced at all
measurement times. The inhibition of prostaglandin synthesis most probably accounts
for the fact that RBF prior to aortic cross clamping was already 27% lower in diclofenac
animals than in the control group (Table 3.19, 3.44; Figure 3.30). Although renal
prostaglandins do not appear to be important in the maintenance of renal homeostasis
in normal man (Patrono and Dunn 1987) or experimental animals (Swan et al. 1975),
prostanoids do influence renal hemodynamics and function during laparotomy under
general anaesthesia similar to our experimental conditions (Terragno et al. 1977). In
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the latter study, indomethasin induced a 40% reduction in RBF intraoperatively, with
urinary prostaglandin E (PgE) concentrations significantly lower than in control
animals. A similar pattern was demonstrated in the only published study which
examined the influence of non-steroidal anti-inflammatory drugs (NSAID) in the course
of infrarenal cross clamping of the aorta in rats (Myers et al. 1996). It appears that
PgE2 and PGI2 are the most important prostaglandins in the regulation of RBF under
pathophysiological circumstances with both prostanoids inducing renal vasodilatation
(Harris 1992, Schlondorff et al. 1985, Stahl et al. 1984).
While our study demonstrated a further decrease in RBF immediately after infrarenal
aortic clamping which deteriorated further during the 60 minute clamping period, Myers
et al. (1996) could only show a significant clamp-induced reduction in RBF towards the
end of a 60 minute clamping period in rats where prostaglandin synthesis was inhibited
with a NSAID. Assessment of the validity and comparability of the results of the Myers
study is compromised by the fact that they reported data as a percentage change in
RBF, as a percentage of total aortic blood flow, without providing the absolute values
of these parameters. The most significant decrease in RBF in the Myers (1996) study
occurred in the 60 minutes subsequent to the release of the aortic cross clamp in the
NSAID group, suggesting the release of vasoconstrictive agent(s) by unclamping,
without the protective counterbalance of the vasodilatory prostaglandins. Our
experimental animals did not demonstrate a further drop in RBF after aortic
unclamping, but RBF values remained depressed relative to preclamp measurements
and were also significantly lower than post-unelamp RBF in the control animals
(Figure 3.30), again indicating the importance of the protective vasodilatory influence of
the prostaglandins into the post-unclamp/postoperative period. Although an aortic
clamp-induced increase in systemic (plasma) PgE concentration was shown to
increase even further after release of the clamp (Rittenhouse et al. 1976), this is not
necessarily a reflection of intrarenal prostaglandin status (Breyer and Bads 1996). The
lung appears to be the predominant source of systemic prostaglandin release during
surgery, at least partially induced by increased plasma levels of other vasoactive
substances such as angiotensin II (Krausz et al. 1983, Mullane and Monaca 1980).
It is possible that the lower preelamp RBF in the diclofenac animals in comparison with
control pigs could, at least partially, have been due to the threefold higher mean renin
(and concomitant angiotensin II) levels in the former group, although this difference did
not reach statistical significance due to scatter of data (Figure 3.32). The effect of
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prostaglandin inhibition on the renal circulation has previously been shown to be
related to the degree of activation of the renin-angiotensin system in anaesthetised
dogs (Satoh and Simmerman 1975). Increased concentrations of other vasoactive
substances not measured in our study which had previously been shown to be
counterbalanced by the effect of prostaglandin release in the renal vasculature such as
catecholamines (Dunn and Zambraski 1980), ADH (Edwards et al. 1989) and
endothelin (Bugge 1995), could also have contributed to the low preelamp RBF in the
diclofenac animals.
If a decrease in EH1P is accepted as a valid indication of redistribution of RBF away from
the outer cortex towards the inner cortex and medulla (Gamulin et al. 1984), our
control animals did not demonstrate such redistribution statistically relative to
diclofenac animals, although mean EH1P was consistently lower in the former group.
Changes in EH1P are, however, not universally accepted as a valid parameter of altered
distribution of RBF, particularly when total RBF is decreased (Gelman et al. 1985).
Redistribution of RBF to the inner cortex and medulla is a universal finding under
conditions of renal ischemia (Abbott et al. 1973, 1974, Hollenberg et al. 1968).
Prostaglandins have been demonstrated to be responsible for this shift in distribution of
RBF under a number of experimental conditions (Mark et al. 1977, Kirschenbaum et al.
1974, Itskovitz et al. 1973). Blockade of this prostaglandin-mediated response would
therefore have predicted a higher EH1P in the diclofenac group than in the control
animals.
The maintenance of GFR in diclofenac animals to values similar to control animals at
the preelamp measurement (Figure 3.31), despite the lower RBF in the former group
(Figure3.30), is clearly attributable to the increased FF in that group. It is possible that
the higher mean renin concentration (accompanied by raised angiotensin II levels) in
the diclofenac animals could have been responsible for this increase in FF (despite the
fact that the mean renin concentration which was more than 100% higher in diclofenac
than in control animals, did not reach statistical significance due to scatter of data in
the former group). The predominant effect of angiotension lion the efferent arteriole
would increase glomerular intracapillary hydrostatic pressure and increase FF in the
absence of significant changes in glomerular ultrafiltration coefficient (Kastner et al.
1984, Edwards 1983). The persistence of the increased FF throughout the
experimental period is rather difficult to explain. Pg12'the predominant prostaglandin in
both human (Stahl et al. 1984) and pig (Livio et al. 1988) glomeruli, dilates both
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afferent and efferent arterioles (Edwards 1985). Blocking Pgl2 synthesis with
diclofenac might have accentuated the predominant effect of angiotensin lion the
efferent arteriole which in turn would have assisted in the maintenance of glomerular
capillary hydrostatic pressure relative to glomerular plasma flow and thus increased
FF. Although the GFR in both control and diclofenac animals decreased significantly
with aortic clamping relative to their respective preclamp values, this reduction was
much more significant in the diclofenac group in the later clamping and post-unclamp
periods (Figure 3.31). The consequences of the abolition of the (partial) protective
effect of the prostaglandins on GFR under these experimental conditions is similar to
other states of increased endogenous levels of angiotensin II and other
vasoconstrictors, such as a reduction in cardiac output (Oliver et al. 1981) and
haemorrhage-induced hypotension (Henrich et al. 1978b).
The fact that urine volume should not be considered as an indication of RBF or
nephron function (Alpert et al. 1984), is demonstrated by the significantly higher urine
volume in the diclofenac group at the preclamp measurement time when compared
with the control animals (Tables 3.20 and 3.45; p < 0.05). The lower urine volumes in
control animals (relative to the diclofenac group) at the other measurement times were
not statistically significant. The higher urine volumes in diclofenac animals relative to
the control group, are in sharp contrast with RBF measurements which were
consistently higher, as well as the GFR which were higher in control than diclofenac
animals in the later measurement periods. The higher FF in the diclofenac group
(Figure 3.31a) should have been responsible for an increase in the oncotic pressure
and a decrease in the hydrostatic pressure in the peritubular capillaries. This change
in the Starling forces across the walls of the peritubular capillaries should increase
proximal tubular fluid reabsorption substantially (Ichikawa and Brenner 1979) and
should also have contributed to lower urine volumes in the diclofenac animals
(Ichikawa and Brenner 1980). Although the urine volumes decreased at all postclamp
measurement periods relative to the preelamp value in diclofenac animals, the
antidiuretic effect of prostaglandin inhibition (Walker 1983) was not apparent in
comparison to control pigs.
Although FENa did not increase significantly during the experimental period in the
diclofenac group due to scatter of data, this parameter was significantly increased
(p< 0.05) relative to the values in control animals in all three postclamp measurement
periods. Higher sodium excretion in diclofenac animals may be partly explained by the
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fact that PgE2 antagonises the effect of ADH (Lum et al. 1977), or conversely, NSAIDs
potentiate ADH influence on the distal tubules and collecting ducts which mediates a
greater reabsorption of water than sodium (Carmichael and Shankel 1984). However,
the higher calculated FENa was largely due to a lower urinary creatinine in the
diclofenac animals which, in the presence of reduced urine volume, is suggestive of
intrinsic renal injury (Steiner 1984).
Due to the NSAID potentiation of the effect of ADH (Schlondorff 1986), a more
negative CH20 would be predicted in diclofenac animals (Power et al. 1992). This was
not evident in our data. In fact, CH20 mean values were consistently more negative in
control animals than in the diclofenac group although data variability prevented these
differences from reaching statistical significance. Significantly more positive (less
negative) CH20 would have provided further evidence of ischemic tubular injury (Landes
et al. 1976, Baek et al. 1973) in the diclofenac group.
Other than the statistically nonsignificant threefold higher preclamp plasma renin
concentration in the diclofenac group relative to control animals, plasma and renal
venous renin concentrations were almost identical between the two animal groups at
the various measurement times. Increased renal prostaglandin synthesis and release
has been demonstrated to induce renin release and increase angiotensin II
concentration subsequent to a decrease in renal perfusion pressure (Bugge and
Stokke 1994) or due to a change in sodium chloride delivery to the macula densa
(Bugge et al. 1988). Inhibition of prostaglandin synthesis decreases renin release
related to these stimuli (Frólich et al. 1979, Frolich et al. 1976). The fact that renin
release in response to renal nerve stimulation (Kopp et al. 1981) and l1-adrenergic
stimulation due to circulating catecholamines (Franco-Saenz et al. 1980) is
independent of prostaglandin influence, may explain the fact that renin concentration
was not higher in control than in diclofenac animals, as both these mechanisms were
probably involved in the increased renin levels in both diclofenac and control animals.
The ultrastructural damage observed in the NSAID group clearly demonstrated a
greater degree of ischemic injury than the changes which occurred in the control
animals. These changes were consistent with ultrastructural injury previously
described in animals subjected to total (Shanley et al. 1986b, Glaumann et al. 1977,
Reimer et al. 1972) or partial renal ischemia (Dobyan et al. 1977, Kreisberg et al.
1976). In all these studies, biopsies were taken after variable periods of recovery/
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reperfusion. The segments of the nephron previously demonstrated to be most
vulnerable to ischemic injury (medullary proximal (S3) tubule) were most affected in
both our animal groups (Endre et al. 1989, Venkatachalam et al. 1978). The NSAID
animals were the only group to exhibit significant ultrastructural changes in the
medullary thick ascending limb (mTAL), which has been described to be selectively
susceptible to ischemic cell damage (Brezis et al. 1984 a, 1984 b, 1984 c). The
diclofenac animals were also the only group where nuclear chromatin clumping, which
is considered to be an early demonstration of irreversible cell damage (Reimer et al.
1972), was evident electron microscopically. The extent of cellular injury in diclofenac
animals clearly demonstrates the importance of the protective homeostatic role of
intrarenal prostaglandins under these pathophysiological conditions.
In summary, blocking prostaglandin synthesis was clearly detrimental to the renal
hemodynamics and glomerular function under these experimental conditions. This
demonstrates the essential protective role of renal prostaglandins in the presence of
vasoconstrictive influence(s) during and after infrarenal aortic cross clamping. The
importance of the protective influence of prostaglandins under these
pathophysiological circumstances is confirmed by the (ischemic) renal tubular
dysfunction and the severity of the ultrastructural injury induced by the administration
of a NSAID.
4.7 The relationship between angiotensin and prostaglandins
An important interactive relationship exists between angiotensin II and renal
prostaglandins in both the control of renal hemodynamics under some
pathophysiological circumstances (Satoh and Zimmerman 1975) and mutual influence
on the release or activation of each other (Frëlich et al. 1976, 1979, Bugge and Stokke
1994). This part of the study was designed to explore the importance of this
relationship under these specific experimental/clinical conditions, and to shed
additional light on the importance of angiotensin II in the pathogenesis and
pathophysiology of the changed renal hemodynamics induced by infrarenal aortic
clamping.
If the lower RBF discussed in section 4.6 in diclofenac animals (relative to control
animals) at the preclamp measurement time had been due to the (statistically non-
significant) raised renin (Figure 3.32) (and angiotensin) concentrations, it should have
been possible to prevent that decrease in RBF with the administration of an ACE
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inhibitor (Satoh and Zimmerman 1975, Levenson et al. 1982). Such a scenario seems
possible considering the fact that RBF measurements in enalaprilat and enalaprilat
plus diclofenac animals were not statistically different at the preelamp measurement
period (Figure 3.33).
By the same token, if angiotensin had been primarily responsible for the decrease in
RBF after clamping of the aorta, prostaglandin synthesis inhibition by diclofenac should
not produce a decrease of RBF in the presence of ACE inhibition (Satoh and
Zimmerman 1975). The fact that RBF decreased significantly in diclofenac plus
enalaprilat animals relative to enalaprilat pigs after aortic clamping (Table 3.74,
Figure 3.33), therefore provides further, and perhaps conclusive, evidence that
angiotensin does not play a primary pathogenic role in the changed renal
hemodynamics induced by infrarenal aortic clamping. The beneficial effect of
ACE inhibition at the time of aortic cross clamping should therefore be considered to
be due to the prevention of the permissive effect of angiotensin on the influence of
other vasoconstrictors such as noradrenaline (Zimmerman 1978), endothelin (Miller et
al. 1989) and adenosine (Dietrich et al. 1991); and/or other beneficial effects of ACE
inhibitors such as the prevention of the breakdown of bradykinin which would also
evoke renal vasodilatation (Williams 1988). Despite initial evidence to the contrary,
current data suggest that the vasodilatory action of bradykinin in the kidney is
minimally dependent on prostaglandins (Blasingham and Nasjletti 1979). It therefore
appears that renal prostaglandins are essential renal vasodilators to maintain RBF
after aortic clamping in the presence of renal vasoconstrictive agent(s) other than
angiotensin, a role which has been described for the eicosanoids under other
pathophysiological circumstances (Patrono and Dunn 1987). The vasoconstrictive
substances other than angiotensin which have been demonstrated to induce renal
synthesis and release of PgE and/or Pgl include ADH (Zipser et al. 1981, Ardaillou et
al. 1985), endethefin (Rae et al. 1989), noradrenaline (Walshe and Venuto 1979) and
adenosine (Gunning et al. 1996).
The changes in RBF between further consecutive measurement times did not
demonstrate any differences between the two animal groups (Figure 3.33). The
(intragroup) decrease in RBF in the enalaprilat group after aortic unclamping
(Table 3.33) was probably responsible for the fact that the changes from preelamp to
post-unclamp (x1-4; Table 3.74) were not statistically significant between the two
groups. The post-unelamp RBF measurement in the enalaprilat group, which was very
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similar to the diclofenac plus enalaprilat value, suggest a very potent vasoconstrictive
influence at that time; to the extent that an intact prostaglandin protective influence (in
the enalaprilat animals) could not effect more favourable renal hemodynamics than
conditions where this beneficial mediator was absent (in enalaprilat plus diclofenac
animals).
Considering the redistribution of RBF towards the inner cortex and medulla induced by
renal prostaglandins under a number of experimental circumstances (Itskovitz et al.
1973, Kirschenbaum et al. 1974), a decrease in EH1P suggesting such redistribution
(Gamulin et al. 1984) in enalaprilat animals relative to the diclofenac plus enalaprilat
could be predicted. Maximal redistribution of RBF should occur at the time of
maximum vasoconstrictor influence (Levenson et al. 1982), which in our experimental
model was presumably after release of the aorta cross clamp. EH1P values were,
however, almost identical between the two animai groups and no decrease was
recorded after unclamping in enalaprilat animals (Tables 3.33 and 3.49). Other than
the contested value of EH1P as acceptable indicator of distribution of RBF (Gelman and
Navar 1985), no pathophysiological explanation can be offered for these results.
The decrease in GFR in enalaprilat plus diclofenac pigs relative to the enalaprilat
animals after aortic clamping (Table 3.74, Figure 3.34), coincided with the change in
RBF of a similar magnitude. This decrease in GFR is consistent with reported changes
under the influence of renal vasoconstrictors during blockade of prostaglandin
synthesis (Bugge and Stokke 1994). The presence of the potential protective effect of
prostaglandins were ineffective in preventing a decrease of GFR at aortic unclamping
(again similar to RBF change) in the enalaprilat animals. Under (probably lesser)
vasoconstrictive influences, PgE2 synthesis has been shown to be effective in
offsetting decrements in GFR (Scharschmidt et al. 1983).
The inability of prostaglandin protection to preserve GFR after aortic unclamping in
enalaprilat animals was responsible for the fact that the decrease in GFR over the
course of the experimental period was similar between the two animal groups
(Figure 3.34).
Renal prostaglandins are involved in the stimulation of renin release in the majority of
stimulatory mechanisms, to the extent that renin release is described to be
"prostaglandin-dependent" (Bugge 1995). Renin release due to fs-aorenerqic
stimulation, however, is independent of renal prostaglandins (Vikse et al. 1985). Under
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conditions of stress (such as was present in our experimental model), the
administration of NSAID should reduce renin release (and hence the production of
angiotensin II) (Bugge 1995). Quantitatively this effect is small, since ~-adrenergic
activity plays a substantial role under such circumstances (Holdaas et al. 1985). The
angiotensin-renin feedback loop also requires an intact prostaglandin system
(Campbell et al. 1979). This loop controls renin in inverse proportion to angiotensin II
concentration under the influence of renal prostaglandins, so that prostaglandin
synthesis inhibition blocks the increase in renin secretion associated with ACE
inhibition (Abe et al. 1980). Although mean plasma renin concentrations in diclofenac
plus enalaprilat pigs were slightly lower at the first three measurement periods than in
animals which received only the ACE inhibitor (Figure 3.35), these differences were
minimal considering the response one would predict in the context of the interaction
described by Abe et al. (1980). The most likely explanation for this similarity in plasma
renin concentrations, is the presence of significant ïs-receptor stimulated renin release
which is independent of the presence of renal prostaglandins (Vikse et al. 1985).
Changes in urine volumes and FENa between measurement times were not different
between the two animal groups (Table 3.75). Although statistics were not done on the
differences between the two groups at the 4 measurement periods (for reasons
discussed in section 4.4), the mean values for both urine volume and FENa were at
least 130% and 70% higher respectively than in the diclofenac plus enalaprilat group at
the two postclamp and the post-unelamp measurement periods (Tables 3.35 and
3.50). Considering the results of our animal studies discussed in sections 4.4 to 4.6, it
can be suggested that renal prostaglandin synthesis was stimulated at all
measurement periods after aortic clamping, due to the presence of renal
vasoconstrictor influences. Prostaglandin E2 inhibits sodium chloride reabsorption in
the thick ascending limb of the loop of Henle and in the collecting tubule (Schlondorff
1986). Prostaglandin E2 also antagonizes the antidiuretic effect of ADH in the
collecting tubules (Berl et al. 1977), an influence which may be important in our
experimental model considering the increased ADH levels recorded in our human
study. Inhibition of the above renal tubular effects of prostaglandins are probably
responsible for the relatively low urine volume and FENa values in the diclofenac plus
enalaprilat animals (particularly in view of the similarity in GFR values between the two
animal groups). Prevention of the inhibitory effect of prostaglandins on tubular
reabsorption (by the NSAID in the enalaprilat plus diclofenac group) would also
compromise the oxygen balance in ischemic kidneys due to the oxygen consumptive
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nature of the reabsorption process (Jabs et al. 1989) and may therefore aggravate
ischemic injury.
Although the mean total severity score, mean number of abnormal parameters, as well
as percentage of biopsies considered to be clearly abnormal in the enalaprilat plus
diclofenac animals were all approximately double that of the enalaprilat group, these
differences were not statistically significant (Table 3.78). More severe ischemic injury
in the diclofenac plus enalaprilat animals would not have been surprizing since
blocking synthesis of the protective prostaglandins should prevent redistribution of RBF
to the most vulnerable deeper cortical layer and the medulla (Itskovitz et al. 1973).
Even if this protective redistribution of RBF had not been compromised, the more
extensive tubular sodium chloride reabsorption (due to prostaglandin inhibition) with
the associated oxygen consumption in an ischemically threatened kidney, would
aggravate ischemic injury (Jabs et al. 1989).
In summary, the inability of ACE inhibition to prevent a decrease in RBF in the
presence of prostaglandin synthesis inhibition at the time of aortic cross clamping,
confirms a supplementary role at most for angiotensin II in renal hemodynamic and
glomerular changes induced by that surgical intervention. The more substantial energy
and oxygen dependent tubular reabsorption of sodium chloride and possibly also the
absence of redistribution of RBF to the potentially compromised corticomedullary
region effected by prostaglandin inhibition, are responsible for the tendency towards
greater ultrastructural injury in diclofenac plus enalaprilat animals, although this
comparative difference with the enalaprilat group was not statistically significant.
4.8 Conclusions and recommendations
Our patient study demonstrated no significant influence of the anaesthetic technique
employed, on renal hemodynamics and nephron function. The decrease in both RBF
and GFR induced by infrarenal aortic cross clamping correspond with results
previously published (Gamulin et al. 1984, 1986, Colson et al. 1992a, Licker et al.
1996). We have demonstrated persistence of the compromise in these parameters as
long as 4 hours into the postoperative phase, which has previously only been reported
for the period immediately after aortic unclamping with the abdomen still open.
Unfortunately we have been unable to follow the course of full restoration of RBF and
its relationship with the GFR recovery. The persistence of a depressed GFR until just
before discharge of the patients, is cause for concern, particularly in patients with
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compromised glomerular function prior to surgery. This information establishes the
need for the determination of creatinine clearance as part of the preoperative
assessment of patients presenting for infrarenal aortic surgery.
Of the measured hormones with a potential influence on RBF and nephron function,
renin was the only mediator where changes in plasma concentrations coincided with
the decreases in RBF and GFR at the time of aortic cross clamping. The design of our
study did not allow us to conclude whether the concomitant increase in angiotensin II
was primarily responsible for the change in renal hemodynamics, or whether the raised
renin (and angiotensin) levels were stimulated by the decrease in RBF induced by
another mechanism(s).
The combination of mannitol plus dopamine was clearly of no benefit in preventing the
deleterious renal effects of aortic clamping. In fact, the high volumes of urine produced
under the influence of these two agents, which did not correlate with RBF at the
corresponding time periods, is likely to prompt a false sense of security (and lack of the
necessary vigilant attention to other parameters which are important for optimal renal
perfusion and function and/or provide evidence of the renal status). Mannitol and
dopamine also render some parameters of renal functional status, such as FENa,
unreliable. The use of these agents in these clinical circumstances should therefore be
discouraged. The lack of a favourable influence on the kidney by mannitol and
dopamine may be partly due to an increase in circulating noradrenaline induced by the
latter drug, which may cause renal vasoconstriction directly via a-adrenergic
stimulation, or indirectly through stimulating the activation of other vasoactive
substances such as angiotensin (subsequent to ~-adrenergically mediated renin
release).
The animal studies were aimed at elucidation of the exact role of angiotensin in the
pathogenesis and pathophysiology of the renal changes associated with infrarenal
aortic clamping, as well as the interaction of angiotensin with other modulators for
which an interactive relationship had been described previously under other
experimental and/or clinical circumstances.
The first study showed that, although renin (and thus angiotensin) concentrations were
high after aortic unclamping, the hormone had no pathogenic or pathophysiological
role of substance in the observed renal changes during this period (since blocking
angiotensin II activation by the prevention of renin release, or by inhibiting the
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conversion enzyme, did not prevent a substantial decrease in RBF or GFR during that
period). Preventing angiotensin II activation did, however, prevent renal changes
during aortic clamping. This beneficial effect did not establish a primary role for
angiotensin during that period, since the favourable influence could also (at least
partially) be explained by prevention of the permissive influence of angiotensin on
other vasoconstrictors and/or other vasodilatory influences of ACE inhibition and 11-
blockade which are unrelated to angiotensin. This study did indicate that (at least
partially) different mechanisms are responsible for the renal changes seen during
aortic clamping, and after aortic unclamping.
The second study explored the role of calcium in the renal pathophysiological changes
during aortic clamping and after unclamping. The protective influence effected by
the administration of a Ca2+ -blocker suggest the dependence of the renal
vasoconstrictive and glomerular pathophysiological process(es) on the cellular influx of
Ca2+ through voltage-gated channels. It unfortunately provides no definitive insight
into the primary instigators of these processes. However, it does offer a clinically
useful method of preventing these changes and protecting the kidney against ischemic
injury during abdominal aortic surgery.
The third component of the animal studies demonstrates the importance of the
protective effect of renal prostaglandins during the specific experimental (and probably
also the clinical) circumstances. Again, it does not provide definitive information on the
mediators responsible for the renal changes, since the deleterious effects of numerous
endogenous substances have previously been shown to be counterbalanced by
intrarenal synthesis of prostaglandins under various experimental and clinical
circumstances. The extent of the pathophysiological and ultrastructural changes which
occurred under the influence of a NSAID does, however, suggest that these drugs
should not be used under these clinical circumstances.
The last component of the study provides evidence that angiotensin only plays a
secondary/supplementary role in the renal pathophysiological process even during
aortic clamping. This may explain the contradictory evidence regarding the potential
beneficial effect of ACE inhibition (on renal hemodynamics and glomerular function)
during abdominal aortic surgery (Licker et al. 1996, Colson et al. 1992a). Based on
our studies, ACE inhibition can not be supported for this purpose.
Stellenbosch University http://scholar.sun.ac.za
197
Unanswered questions which should be explored with future studies, are the following:
1. The question of which vasa-active substances are responsible for the renal
changes during aortic cross clamping and after unclamping remains unresolved.
This should be investigated experimentally (and clinically), preferably by the direct
measurement of concentrations of potential mediators and/or indirectly by the
administration of specific antagonists or antibodies to these substances.
2. The renal hemodynamic and functional course after aortic surgery in humans
should be investigated to determine the full extent and duration of RBF and GFR
recovery. Improved doppler technology should enable accurate non-invasive blood
flow measurement.
3. The difference in changes in RBF and renal function in aortic surgery between
patients with aortic aneurysms and those with aorta-iliac occlusive disease should
be explored. It is possible that collateral blood flow to tissues distal to the aortic
clamp in the latter group, may be responsible for a lesser degree of compromise
after unclamping.
Stellenbosch University http://scholar.sun.ac.za
198
Abbott WM, Abel RM, Fischer JE
Treatment of acute renal insufficiency after aortoiliac surgery
Archives of Surgery 1971; 103: 590-594
Abbott WM, Abel RM, Fischer JE
The effect of aortic clamping and declamping on renal blood flow distribution
Journal of Surgical Research 1973; 14: 385-392
Abbott WM, Austen WG
The reversal of renal cortical ischaemia during aortic occlusion by mannitol
Journal of Surgical Research 1974; 16: 482-489
Abbott WM, Abel RM, Beck CH, Fisher JE
Renal failure after ruptured aneurysm
Archives of Surgery 1975; 110: 1110-1112
Abe K, Itoh T, Satoh M, Haruyama T, Imai Y, Goto T, et al.
Indomethacin (INO) inhibits an enhanced renin release following the captopril, sa
14225, administration
Life Sciences 1980; 26: 561-565
Adams PL, Adams FF, Bell PO, Navar LG
Impaired renal blood flow autoregulation in ischemic acute renal failure
Kidney International 1980; 18: 68-76
Agnoli GC, Cacciari M, Garutti C, Ikonomu E, Lenzi P, Marchetti G
Effects of extracellular fluid volume changes on renal response to low-dose dopamine
infusion in normal women
Clinical Physiology 1987; 7: 465-479
Almeida ARP, Bunnachak 0, Burnier M, Wetzels JFM, Burke TJ, Schrier RW
Time dependent protective effects of calcium channel blockers on anoxia- and
hypoxia-induced proximal tubule injury
Journal of Pharmacology and Experimental Therapeutics 1992; 260: 526-532
Alpert RA, Roizen MF, Hamilton WK, Stoney RJ, Ehrenfeld WK, Poler SM, et al.
Intraoperative urinary output does not predict postoperative renal function in patients
undergoing abdominal aortic revascularization
Surgery 1984; 95: 707-711
Alvarez A, Martul E, Veiga F, Forteza J
Functional, histologic and ultrastructural study of the protective effects of verapamil in
experimental ischemic acute renal failure in the rabbit
Renal Failure 1994; 16: 193-207
Amano J, Suzuki A, Sunamori M, Tofukuji M
Effects of calcium antagonist diltiazem on renal function in open heart surgery
Chest 1995; 107: 1260-1265
Stellenbosch University http://scholar.sun.ac.za
199
Amiel C, Bailley C, Friedlander G
Multiple hormonal control of the thick ascending limb functions
Advances in Nephrology from the Necker Hospital 1987; 16: 125-136
Anderson RJ, Taher MS, Cronin RE, McDonald KM, Schrier RW
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins
on renal autoregulation
American Journal of Physiology 1975; 229: 731-736
Anderson WP, Korner PI, Selig SE
Mechanisms involved in the renal responses to intravenous and renal artery infusions
of noradrenaline in conscious dogs
Journal of Physiology (London) 1981; 321: 21-30
Andrejak M, Hary L
Enhanced dopamine renal responsiveness in patients with hypertension
Clinical Pharmacology and Therapeutics 1986; 40: 610-614
Antonucci F, Bertolissi M, Calo L
Plasma endothelin and renal function during infrarenal aortic crossclamping and
nifedipine infusion
Lancet 1990; 336: 1449
Antonucci F, Calo L, Rizzolo M, Cantaro S, Bertolissi M, Travaglini M, et al.
Nifedipine can preserve renal function in patients undergoing aortic surgery with
infra renal crossclamping
Nephron 1996; 74: 668-673
Ardaillou N, Hagege J, Nivez MP, Ardaillou R, Schlondorff 0
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells
American Journal of Physiology 1985; 248: F240-F247
Ardaillou R, Sraer J, Chansel 0, Ardaillou N, Sraer JD
The effects of angiotensin II on isolated glomeruli and cultured glomerular cells
Kidney International 1987; 31, Suppl20, S74-80
Ardaillou R, Baud L
Mediation of glomerular injury. Interactions between glomerular autocoids
Seminars in Nephrology 1991; 11: 340-345
Arendhorst WJ, Finn WF, Gottschalk CW
Micropuncture study of acute renal failure following temporary renal ischemia in the rat
Kidney International 1976; Suppl 10: S100-103
Arnold PE, Van Putten VJ, Lumlertgul 0, Burke TJ, Schrier RW
Adenine nucleotide metabolism and mitochondrial Ca2+ transport following renal
ischemia
American Journal of Physiology 1986; 250: F357-363
Attia RR, Murphy JD, Snider M, Lappas DG, Darling RC, Lowenstein E
Myocardial ischemia due to infrarenal aortic cross-clamping during aortic surgery in
patients with severe coronary artery disease
Circulation 1976; 53: 961-965
Stellenbosch University http://scholar.sun.ac.za
200
Badr KF, Brenner BM, Ichikawa I
Effects of leukotriene 04 on glomerular dynamics in the rat
American Journal of Physiology 1987; 253: F239-F243
Badr KF, Ichikawa I
Prerenal failure: a deleterious shift from renal compensation to decompensation
The New England Journal Medicine (Boston MA) 1988; 319: 623-629
Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney
Journal of Clinical Investigation 1989; 83: 336-342
Baek SM, Brown RS, Shoemaker WC
Early prediction of acute renal failure and recovery: I. Sequential measurement of free
water clearance
Annals of Surgery (Philadelphia PA) 1973; 177: 253-258
Baek SM, Makabali GG, Brown RS, Shoemaker WC
Free-water clearance patterns as predictors and therapeutic guides in acute renal
failure
Surgery 1975; 77: 632-640
Baer PG, Navar lG
Renal vasodilatation and uncoupling of blood flow and filtration rate autoregulation
Kidney International 1973; 4: 12-21
Baird RJ, Gurry JF, Kellam JF, Wilson DR
Abdominal aortic aneurysms: recent experience with 210 patients
Canadian Medical Association Journal 1978; 118: 1229-1235
Barros EJ, Boim MA, Ajzen H, Ramos Ol, Schor N
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity
Kidney International 1987; 32: 19-25
Barry KG, Cohen A, Knochel JP et al.
Prevention of oliguria attending crossclamping of abdominal aorta below renal arteries
in humans by mannitolization
Clinical Research 1960; 8: 364-370
Barry KG, Cohen A, Knochel JP, Whelan TJ, Beisel WR, Vargas CA, et al.
Mannitol infusion. II. The prevention of acute functional renal failure during resection of
an aneurysm of the abdominal aorta
New England Journal of Medicine 1961; 264: 967-971
Bastron RD, Perkins RM, Pyne Jl
Autoregulation of renal blood flow during halothane anesthesia
Anesthesiology 1977; 46: 142-144
Bastron RD, Pyne Jl, Inagaki M
Halothane induced renal vasodilation
Anesthesiology 1979; 50: 126-131
Stellenbosch University http://scholar.sun.ac.za
201
Battistini B, D'Orleans-Juste P, Sirois P
Endothelins: Circulating plasma levels and presence in other biologic fluids
Laboratory Investigation 1993; 68: 600-628
Baylis C, Brenner BM
Modulation by prostaglandin synthesis inhibitors of the actions of exogenous
angiotensin lion glomerular ultrafiltration in the rat
Circulation Research 1978; 43: 889-898
Beall AC, Holman MR, Morris GC, DeBakey ME
Mannitol-induced osmotic diuresis during vascular surgery
Archives of Surgery 1963; 86: 34-42
Behnia R, Koushanpour E, Brunner EA
Effects of hyperosmotic mannitol infusion on hemodynamics of dog kidney
Anesthesia and Analgesia 1996; 82: 902-908
Bell AJ, Lindner A
Effects of verapamil and nifedipine on renal function and hemodynamics in the dog
Renal Physiology 1984; 7: 329-343
Bengston A, Lannsjë W, Heideman M
Complement and anaphylatoxin responses to cross-clamping of the aorta. Studies
during general anaesthesia with or without extradural blockade
British Journal Anaesthesia 1987; 59: 1093-1097
Bergqvist D, Olsson PO, TakolanderR, Almen T, Cederholm C, Jonsson K
Renal failure as a complication to aortoiliac and iliac reconstructive surgery
Acta Chirurgica Scandinavica 1983; 149: 37-41
Berkowitz HD, Shetty S
Renin release and renal cortical ischemia following aortic cross clamping
Archives of Surgery 1974; 109: 612-617
Berl T, Raz A, Wald H
Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat
American Journal of Physiology 1977; 232: 529-537
Berry AJ
Excess ADH and oliguria in patients with normal renal function
Anesthesiology 1990; 73: 583-585
Berry CA, Ives HE, Rector FC
Renal transport of glucose, amino acids, sodium, chloride and water
In: The Kidney
Brenner BM (Ed) 1996. WB Saunders Company, Philadelphia
Bidani A, Churchill P, Fleischmann L
Sodium chloride induced protection in nephrotoxic acute renal failure: independence
from renin
Kidney International 1979; 16: 481-490
Stellenbosch University http://scholar.sun.ac.za
202
Biron P, Koiw W, Nowaczynski W, Brouillet J, Genest J
The effects of intravenous infusion of valine-5-angiotensin II and other pressor agents
on urinary electrolyte and corticosteroids including aldosterone
Journal of Clinical Investigation 1961; 40: 338-347
Blantz RC
Effect of mannitol on glomerular ultrafiltration in the hydropenic rat
Journal Clinical Investigations 1974; 54: 1135-1143
Blantz RC, Konnen KS, Tucker BJ
Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient
of the rat
Journal of Clinical Investigation 1976; 57: 419-434
Blantz RC, Gabbai FB
Effect of angiotensin II on glomerular hemodynamics and ultrafiltration coefficient
Kidney International 1987; Suppl 20, S108-S111
Blasingham MC, Nasjletti A
Contribution of renal prostaglandins to the natriuretic action of bradykinin in the dog
American Journal of Physiology 1979; 237: F182-F187
Bonventre JV, Skorecki KL, Kreisberg Jl, Cheung JY
Vasopressin increases cytosolic free calcium concentration in glomerular mesangial
cells
American Journal of Physiology 1986; 251: F94-102
Boulanger C, Luscher TF
Release of endothelin from the intact porcine aorta. Inhibition by endothelium-derived
nitric oxide
Journal of Clinical Investigation 1990; 85: 587-590
Boyle W, Valiquette G, Grodin WK, Sawyer WH, Zimmerman EA
Vasopressin is an important determinant of systemic vascular resistance
Anesthesiology 1983; 59: A55
Brady HR, Brenner BM, Lieberthal W
Acute renal failure
In: The Kidney
Brenner BM (Ed) 1996. WB Saunders Company, Philadelphia
Breckenridge A, Orme M, Dollery CT
The effect of dopamine on renal blood flow in man
European Journal of Clinical Pharmacology 1971; 3: 131-136
Breckwoldt WL, Mackey WC, Belkin M, O'Donnell TF
The effect of suprarenal cross-clamping on abdominal aortic aneurysm repair
Archives of of Surgery 1992; 127: 520-524
Breyer MD, Badr KF
Arachidonic acid metabolites and the kidney
In: The Kidney
Brenner BM (Ed) 1996. WB Saunders Company, Philadelphia
Stellenbosch University http://scholar.sun.ac.za
203
Brezis M, Rosen S, Silva P, Epstein FH
Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated
perfused rat kidney
Journal of Clinical Investigation 1984a; 73: 182-190
Brezis M, Rosen S, Silva P, Epstein FH
Transport activity modifies thick ascending limb damage in the isolated perfused
kidney
Kidney International 1984b; 25: 65-72
Brezis M, Rosen S, Silva P, Epstein FH
Renal ischemia: A new perspective
Kidney International 1984c; 26: 375-383
Brezis M, Rosen SN, Epstein FH
The pathophysiological implications of medullary hypoxia
American Journal of Kidney Disease 1989; 13: 253-258
Brown JJ, Gleadle RI, Lawson DH, Lever AF, Linton AL, Macadam RF, et al.
Renin and acute renal failure: studies in man
British Medical Journal 1970; 1: 253-258
Brunner HR, Waeber B, Nussberger J
Angiotensin converting enzyme inhibition and the normal kidney
Kidney International 1987; Suppl20: S104-S107
Bugge JF, Stokke ES, Kiil F
Properties of the macula densa mechanism for renin release in the dog
Acta Physiologica Scandinavica 1988; 132: 401-412
Bugge JF, Stokke ES
Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling
renal blood flow and glomerular filtration rate
Acta Physiologica Scandinavica 1994; 150: 431-440
Bugge JF
Renal effects and complications of NSAIDs for routine postoperative pain relief:
increased awareness of a real problem is needed
Bailliére's Clinical Anaesthesiology 1995; 9: 483-492
Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW
Ischemia and tubular obstruction during acute renal failure in dogs: Mannitol in
protection
American Journal of Physiology 1980; 238: F305-F314
Bush HL, Huse JB, Johnson WC, O'Hara ET, Nabseth DC
Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal
volume loading
Archives of Surgery 1981; 116: 1517-1524
Stellenbosch University http://scholar.sun.ac.za
204
Bush HL
Renal failure following abdominal aortic reconstruction
Surgery 1983; 93: 107-109
Campbell WB, Jackson EK, Graham RM
Saralisin-induced renin release: its blockade by prostaglandin synthesis inhibitors in
the conscious rat
Hypertension 1979; 1: 637-642
Cao L, Banks RO
Cardiovascular and renal actions of endothelin: Effects of calcium-channel blockers
American Journal of Physiology 1990; 258: F254-F258
Carey RM, Thorner MO, Ortt EM
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone
system in man: dopaminergic control of aldosterone
Journal of Clinical Investigation 1979; 63: 727-733
Carmichael J, Shankel SW
Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
The American Journal of Medicine 1985; 78: 992-1000
Chan OP, CIaveIl A, Keiser J, Burnett JC Jr
Effects of renin angiotensin system in mediating endothelin-induced renal
vasoconstriction: therapeutic implications
Journal of Hypertension 1994; 12 (Sup pi 4): S43-S49
Chansel 0, Ardaillou N, Nivez MP, Ardaillou R
Angiotensin II receptors in human isolated renal glomeruli
Journal of Clinical Endocrinology and Metabolism 1982; 55: 961-966
Chasson AL, Grady HJ, Stanley MA
Determination of creatinine by means of automatic chemical analysis
American Journal of Clinical Pathology 1961; 35: 83-88
Chawla SK, Najafi H, Ing TS, Dye WS, Javid H, Hunter JA, et al.
Acute renal failure complicating ruptured abdominal aortic aneurysm
Archives of Surgery 1975; 110: 521-526
Chou SY, Dahhan A, Porush JG
Renal actions of endothelin: Interaction with prostacyclin
American Journal of Physiology 1990; 259: F645-F652
Christenson J, Eklof B, Gustafson I
Abdominal aortic aneurysms: should they all be resected?
British Journal of Surgery 1977; 64: 767-772
Clappison BH, Anderson WP, Johnston Cl
Renal hemodynamics and renal kinins after angiotensin converting enzyme inhibition
Kidney International 1981; 20: 615-620
Stellenbosch University http://scholar.sun.ac.za
205
Cochrane JP
The aldosterone response to surgery and the relationship of this response to
postoperative sodium retention
British Journal of Surgery 1978; 65: 744-747
Cohen AJ, Fray JC
Calcium ion dependance of myogenic renal plasma flow autoregulation: Evidence from
the isolated perfused rat kidney
Journal of Physiology (London) 1982; 330: 449-460
Cohen JR, Mannick JA, Couch NP, Whittemore AD
Abdominal aortic aneurysm repair in patients with preoperative renal failure
Journal of Vascular Surgery 1986; 3: 867-870
Cohn LH, Powell MR, Seidlitz L, Hamilton WK, Wylie EJ
Fluid requirements and shifts after reconstruction of the aorta
American Journal of Surgery 1970; 120: 182-186
Colson P, Ribstein J, Mimran A, Grolleau 0, Chaptal PA, Roquefeuil B
Effect of angiotensin converting enzyme inhibition on blood pressure and renal function
during open heart surgery
Anesthesiology 1990; 72: 23-27
Colson P, Ribstein J, Seguin JR, Marty-Ane C, Roquefeuil B
Mechanisms of renal hemodynamic impairment during infrarenal aortic cross-clamping
Anesthesia and Analgesia 1992a; 75: 18-23
Colson P, Capdevilla X, Cuchet 0, Saussine M, Seguin JR, Marty-Ane C, et al.
Does choice of the anesthetic influence renal function during infrarenal aortic surgery?
Anesthesia and Analgesia 1992b; 74: 481-485
Colson P, Capdevilla X, Bariet H, Seguin JR, Marty-Ane C, Roquefeuil B
Effects of halothane and isoflurane on transient renal dysfunction associated with
infrarenal aortic crossclamping
Journal of Cardiothoracic and Vascular Anesthesia 1992c; 6: 295-298
Conger JD, Robinette JB
Loss of blood flow autoregulation in acute renal failure
Kidney International 1979; 16: 850
Cottee DBF
Con: Dopamine does not preserve renal function
Journal of Cardiothoracic and Vascular Anesthesia 1995; 9: 335-337
Couch NP, Lane FC, Crane C
Management and mortality in resection of abdominal aortic aneurysms. A study of 114
cases
American Journal of Surgery 1970; 119: 408-416
Crawford ES, Saleh SA, Babb JW, Glaeser DH, Vaccaro PS, Silvers A
Infrarenal abdominal aortic aneurysm:
Factors influencing survival after operation performed over a 25 year period
Annals of Surgery 1981; 193: 699-709
Stellenbosch University http://scholar.sun.ac.za
206
Cronenwett JL, Lindenauer SM
Distribution of intrarenal blood flow following aortic clamping and declamping
Journal of Surgical Research 1977; 22: 469-482
Cronin RE, De Torrente A, Miller PO, Bulger RE, Burke TJ, Schrier RW
Pathogenic mechanisms in early norepinephrine-induced acute renal failure: functional
and histological correlates of protection
Kidney International 1978a; 14: 115-125
Cronin RE, Erickson AM, De Torrente A, McDonald KM, Schrier RW
Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal
failure
Kidney International 1978b; 14: 187-190
Crystal GJ, Ruiz JR, Rooney MW, et al.
Regional hemodynamics and oxcygen supply during isovolemic hemodilution in the
absence and presence of beta-adrenergic blockade
Journal of Cardiothoracic Anesthesia 1988; 2: 772-779
Davis JO, Freeman RH
Mechanisms regulating renin release
Physiology Review 1976; 56: 1-56
Davis RF, Lappas DG, Kirklin JK, Buckley MJ, Lowenstein E
Acute oliguria after cardiopulmonary bypass: renal functional improvement with low-
dose dopamine infusion
Critical Care Medicine 1982; 10: 852-856
De Cree J, De Cock W, Geukens H, De Clerck F, Beerens M, Verhaegen H
The rheological effects of cinnarizine and flunarizine in normal and pathologic
conditions
Angiology 1979; 30: 505-515
De Nucci G, Thomas R, D'Orleans Juste P, Antunes E, Walder C, Warner TO, et al.
Pressor effects of circulating endothelin are limited by its removal in the pulmonary
circulation and by the release of prostacyclin and endothelium-derived relaxing factor
Proceedings of the National Acadamy of Science of the USA 1988; 85: 9797-9800
De Torrente A
Acute renal failure
International Anesthesiology Clinics 1984; 22: 83-100
Deen WM, Robertson CR, Brenner BM
A model of glomerular ultrafiltration in the rat
American Journal of Physiology 1972; 223: 1178-1183
Deray G, Carayon A, Le Hoang P
Increased endothelin level after cyclosporin therapy
Annals of Internal Medicine 1991; 114: 809
Stellenbosch University http://scholar.sun.ac.za
207
Deutsch S, Goldberg M, Stephen GF, Wu WH
Effects of halothane anesthesia on renal function in normal man
Anesthesiology 1966; 27: 793-804
Dibona GF, Sawin LL
Renal tubular site of action of felodipine
Journal of Pharmacology and Experimental Therapeutics 1984; 228: 420-424
Diehl JT, Cali RF, Hertzer NR, Beven EG
Complications of abdominal aortic reconstruction. An analysis of peri operative risk
factors in 557 patients
Annals of Surgery 1983; 197: 49-56
Dietrich MS, Endlich K, Parekh N, Steinhausen M
Interaction between adenosine and angiotensin II in renal microcirculation
Microvascular Research 1991; 41: 275-288
Dietz JR, Davis JO, Freeman RH, Villarreal D, Echtenkamp SF
Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs
Hypertension 1983; 5: 482-488
Dobyan DC, Nagle RB, Bulger RE
Acute tubular necrosis in the rat kidney following sustained hypotension.
Physiological and morphological observations
Laboratory Investigation 1977; 37: 411-422
Dohi Y, Hahn AW, Boulanger CM, Buhler FR, Luscher TF
Endothelin stimulated by angiotensin II augments contractility of spontaneously
hypertensive rat resistance arteries
Hypertension 1992; 19: 131-137
Donker AJ, Arisz L, Brentjens JR, Van der Hem GK, Hollemans HJ
The effect of indomethacin on kidney function and plasma renin activity in man
Nephron 1976; 17: 288-296
Donohoe JF, Venkatachalam MA, Bernard DB, Levinsky NG
Tubular leakage and obstruction after renal ischemia: structural-functional correlations
Kidney International 1978; 13: 208-222
Douglas JG, Brown G, White C
Influence of cations on kinetics and angiotensin II binding to adrenal, renal and smooth
muscle receptors
Hypertension 1982; 4: (Suppl. III); 11179-11184
DuBost C, Allary M, Oeconomos N
Resection of an aneurysm of the abdominal aorta: Reestablishment of the continuity by
a preserved human arterial graft, with result after five months
Archives of Surgery 1952; 64: 405-408
Duke GJ, Bersten AD
Dopamine and renal salvage in the critically ill patient
Anaesthesia and Intensive Care 1992; 20: 277-287
Stellenbosch University http://scholar.sun.ac.za
208
Dunn MJ, Zambraski EJ
Renal effects of drugs that inhibit prostaglandin synthesis
Kidney International 1980; 18: 609-622
Dworkin LO, Brenner BM
The renal circulations
In: The Kidney
Brenner BM (Ed) 1996. WB Saunders Company, Philadelphia
Dzau VJ
Implications of local angiotensin production in cardiovascular physiology and
pharmacology
American Journal of Cardiology 1987; 59: 59A-65A
Edwards RM
Segmental effects of norepinephrine and angiotensin" on isolated renal microvessels.
American Journal of Physiology 1983; 244: F526-F534
Edwards RM
Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles
American Journal of Physiology 1985; 248: F779-F784
Edwards RM, Trizna W, Kinter LB
Renal microvascular effects of vasopressin and vasopressin antagonists
American Journal of Physiology 1989; 256: F274-F278
Endre ZH, Ratcliffe PJ, Tange JD, Ferguson DJ, Radda GK, Ledingham JG
Erythrocytes alter the pattern of renal hypoxic injury: Predominance of proximal tubular
injury with moderate hypoxia
Clinical Science 1989; 76: 19-29
Epstein M, Hollenberg NK
Age as a determinant of renal sodium conservation in normal man
Journal of Laboratory and Clinical Medicine 1976; 87: 411-417
Falk SA, Conger JD, Guggenheim S
Protective effect of (1-SAR, 5-ILE, 8-GLY) angiotensin" (AI) in the renal failure of
generalized Schwartzman reaction
Proceedings of the American Society of Nephrology 1980; 13: 92A
Fielding JL, Black J, Ashton F and Slaney G
Ruptured aortic aneurysms: postoperative complications and their aetiology
British Journal of Surgery 1984; 71: 487-491
Fieldman NR, Forsling ML, Le Quesne LP
The effect of vasopressin on solute and water excretion during and after surgical
operations
Annals of Surgery 1985; 201: 383-390
Firth JD, Ratcliffe PJ, Raine AE, Ledingham JG
Endothelin: An important factor in acute renal failure?
The Lancet 1988; 2: 1179-1182
Stellenbosch University http://scholar.sun.ac.za
209
Fisher M, Grotta J
New uses for calcium channel blockers: therapeutic implications
Drugs 1993; 46: 961-975
Flemming JT, Parekh N, Steinhausen M
Calcium antagonist preferentially dilate preglomerular vessels of hydronephrotic kidney
American Journal of Physiology 1987; 253: F1157 -F1163
Franco-Saenz R, Suzuki S, Tan SY, Mulrow PJ
Prostaglandin stimulation of renin release: Independence of beta-adrenergic receptor
activity and mechanism of action
Endocrinology 1980; 106: 1400-1407
Frank RS, Moursi MM, Podrazik RM, Zelenock GB, D'Alecy LG
Renal vasoconstriction and transient declamp hypotension after infrarenal aortic
occlusion: Role of plasma purine degradation products
Journal of Vascular Surgery 1988; 7: 515-523
Frëlich JC, Hollifield JW, Dormois JC, Frolich BL, Seyberth H, Michelakis AM, et al.
Suppression of plasma renin activity by indomethacin in man
Circulation Research 1976; 39: 447-452
Frólich JC, Hollifield JW, Michelakis AM, Vesper BS, Wilson JP, Shand DG, et al.
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in
human subjects: independence of sodium retention
Circulation Research 1979; 44: 781-787
Gagnon JA, Bolt DA, Clarke RW, Geever EF
The effects of lower aortic occlusion on renal function in the dog
Surgery 1960; 47: 240-246
Gal TJ, Cooperman LH, Berkowitz HO
Plasma renin activity in patients undergoing surgery of the abdominal aorta
Annals of Surgery 1974; 179: 65-69
Gamulin Z, Forster A, MorelD, Simonet F, Aymon E, Favre H
Effects of infrarenal aortic cross-clamping on renal hymodynamics in humans
Anesthesiology 1984; 61: 394-399
Gamulin Z, Forster A, Simonet F, Aymon E, Favre H
Effects of renal sympathetic blockade on renal hemodynamics in patients undergoing
major aortic abdominal surgery
Anesthesiology 1986; 65: 688-692
Gelman S, Patel K, Bishop SP, Fowler KL, Smith LR
Renal and splanchnic circulation during infrarenal aortic cross-clamping
Archives of Surgery 1984a; 119: 1394-1399
Gelman S, Fowler KC, Smith LR
Regional blood flow during isoflurane and halothane anesthesia
Anesthesia and Analgesia 1984b; 63: 557-565
Stellenbosch University http://scholar.sun.ac.za
210
Gelman S, Navar LG
Infrarenal aortic cross-clamping and renal hemodynamics
Anesthesiology 1985; 63: 223-224
Gelman S
The pathophysiology of aortic cross-clamping and unclamping
Anesthesiology 1995; 82: 1026-1060
Gennari FJ, Kassirer JP
Osmotic diuresis
New England Journal of Medicine 1974; 291: 714-720
Gillies A, Morgan T
Activity of renin in the juxtaglomerular apparatus
Kidney International 1982; 22 (Suppl 12): S67-S72
Girbes AR, Smit AJ, Meijer S, Reitsma WD
Renal and endocrine effects of fenoldopam and metoclopramide in normal man
Nephron 1990; 56: 179-185
Girbes AR, Lieverse AG, Smit AJ, van Veldhuisen DJ, Zwaveling JH, Meijer S, et al.
Lack of specific renal hemodynamic effects of different doses of dopamine after
infrarenal aortic surgery
British Journal of Anaesthesia 1996; 77: 753-757
Glaumann B, Glaumann H, Berezesky IK, Trump BF
Studies on the pathogenesis of ischemic cell injury: II. Morphological changes of the
pars convaluta (P1 and P2) of the proximal tubule of the rat kidney made ischemic in
vivo
Virchows Archives B Cell Pathology 1975a; 19: 281-302
Glaumann B, Trump BF
Studies on the pathogenesis of ischemic cell injury. III. Morphological changes of the
proximal pars recta tubules (P3) of the rat kidney made ischemic in vivo
Virchows Archives B Cell Pathology 1975b; 19: 303-323
Glaumann B, Glaumann H, Berezesky IK, Trump BF
Studies on cellular recovery from injury: II. Ultrastructural studies on the recovery of
the pars convaluta of the proximal tubule of the rat kidney from temporary ischemia
Virchows Archives B Cell Pathology 1977; 24: 1-18
Goetz K, Wang BC, Leadly R, Zhu JL, Madwed J, Bie P
Endothelin and sarafotoxin produce dissimilar effects on renal blood flow, but both
block the antidiuretic effects of vasopressin
Proceedings of the Society for Experimental Biology and Medicine 1989; 191: 425-427
Goldberg JP, Schrier RW
Effect of calcium membrane blockers on in vivo vasoconstrictor properties of
norepinephrine, angiotensin II and vasopressin
Mineral and Electrolyte Metabolism 1984; 10: 178-183
Stellenbosch University http://scholar.sun.ac.za
211
Gonin J, Molitoris BA
Diagnostic and therapeutic modalities in renal and electrolyte diseases
In: Textbook of Internal Medicine (3rd Edition)
Kelly WN (Ed). Lippencott Raven 1997
Gordon IL, Wesley R, Wong DH, Ingegno MD, Spivak B, Wilson SE
Effect of dopamine on renal blood flow and cardiac output
Archives of Surgery 1995; 130: 864-868
Graham AL, Najafi H, Dye WS, Javid H, Huter JA, Julian DC
Ruptured abdominal aortic aneurysm: Surgical management
Archives of Surgery 1968; 97: 1024-1031
Grant RP, Jenkins LC
Modification by preoperative beta-blockade of the renin response to infrarenal aortic
cross-clamping
Canadian Anaesthetic Society Journal 1983; 30: 480-486
Grez M
The influence of antibodies against bradykinin on isotonic saline diuresis in the rat.
Evidence for kinin involvement in renal function
Pfluqers Archives 1974; 350: 231-239
Grindlinger GA, Vegas AM, Williams GH, Mannick JA, Hechtman HB
Independence of renin production and hypertension in abdominal aortic
aneurysmectory
American Journal of Surgery 1981; 141: 472-477
Gross R, Kirchheim H, Brandstetter K
Basal vascular tone in the kidney
Circulation Research 1976; 38: 525-531
Gunning ME, Ingelfinger JR, King AJ, Brenner BM
Vasoactive peptides and the kidney
In: The Kidney. Brenner BM (Ed.) 1996
WB Saunders Company, Philadelphia
Gurwitz JH, Avorn J, Ross-Degnan 0, Lipsitz LA
Nonsteroidal anti-inflammatory drug-associated azotemia in the very old
Journal of the American Medical Association 1990; 264: 471-475
Haas M, Glick SM
Radioimmunoesayable plasma vasopressin associated with surgery
Archives of Surgery 1978; 113: 597-600
Haber E
The role of renin in normal and pathological cardiovascular homeostasis
Circulation 1976; 54: 849-861
Hakim RM, Wingard R, Parker RA
Effect of the dialysis membrane in the treatment of patients with acute renal failure
New England Journal of Medicine 1994; 331: 1338-1342
Stellenbosch University http://scholar.sun.ac.za
212
Hall JE, Guyton AC, Trippodo NC, Lohmeier TE, McCaa RE, Cowley AW
Intrarenal control of electrolyte excretion by angiotensin II
American Journal of Physiology 1977; 232: F538-F544
Hall JE, Guyton AC, Smith MJ, Coleman TG
Chronic blockade of angiotensin II formation during sodium deprivation
American Journal of Physiology 1979; 237: F424-F432
Hall JE, Granger JP, Hester RL
Interactions between adenosine and angiotensin II in controlling glomerular filtration
American Journal of Physiology 1985; 248: F340-346
Hall PW, Ricanati ES
Renal handling of ~2-microglobulin in renal disorders with special refrence to hepa-
torenal syndrome
Nephron 1981; 27: 62-66
Hardin CA
Survival and complications after 121 surgically treated abdominal aneurysms
Surgery, Gynecology and Obstetrics 1964; 118: 541-544
Harris K
The role of prostaglandins in the control of renal function
British Journal of Anaesthesia 1992; 69: 233-235
Hashimoto K, Kokobun H
Adenosine-catecholamine interaction in the renal vascular response
Proceedings of the Society for Experimental Biology and Medicine 1971; 136: 1125-
1128
Henrich WL, Anderson RJ, Berns AS, McDonald KM, Paulsen PJ, Berl T et al.
The role of renal nerves and prostaglandins in control of renal hemodynamics and
plasma renin activity during hypotensive hemorrhage in the dog
Journal of Clinical Investigation 1978a; 61: 744-750
Henrich WL, Berl T, McDonald KM, Anderson RJ, Schrier RW
Angiotensin II, renal nerves and prostaglandins in renal hemodynamics during
hemorrhage
American Journal of Physiology 1978b; 235: F46-F51
Hermansson K, Larson M, Kallskog 0, Wolgast M
Influence of renal nerve activity on arteriolar resistance, ultrafiltration dynamics and
fluid reabsorbtion
Pfluqers Archiv. European Journal of Physiology 1981; 389: 85-90
Hester RL, Granger JP, Williams J, Hall JE
Acute and chronic servo-control of renal perfusion pressure
American Journal of Physiology 1983; 244: F455-F460
Hicks GL, Eastland MW, DeWeese JA, May AG, Rob CG
Survival improvement following aortic aneurysms resection
Annals of Surgery 1975; 181: 863-869
Stellenbosch University http://scholar.sun.ac.za
213
Hilberman M, Maseda J, Stinson EB, Derby GC, Spencer RJ, Miller DC, et al.
The diuretic properties of dopamine in patients after open-heart operation
Anesthesiology 1984; 61: 489-494
Hili GE, Lunn JK, Hodges MR, Stanley TH, Sentker CR, Johansen R, et al.
N20 modification of halothane - altered renal function in the dog
Anesthesia and Analgesia 1977; 56: 690-695
Holdaas H, Langard 0, Eide I, Kiil F
Conditions for enhancement of renin release by isoproterinol, dopamine and glucagon
American Journal of Physiology 1985; 242: F267 -F273
Hollenberg NK, Epstein M, Rosen SM, Basch RI, Oken DE, Merrill JP
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia
Medicine (Baltimore) 1968; 47: 455-474
Hollenberg NK, Adams OF, Mendell P, Abrams HL, Merrill JP
Renal vascular responses to dopamine: haemodynamic and angiographic observations
in normal man
Clinical Science and Molecular Medicine 1973; 45: 733-742
Holz FG, Steinhausen M
Renovascular effects of adenosine receptor agonists
Renal Physiology 1987; 10: 272-282
Hong SA, Gelman S, Henderson T
Angiotensin and adrenoceptors in the hemodynamic response to aortic cross-clamping
Archives of Surgery 1992; 127: 438-441
Hostetter TH, Brenner BM
Renal circulatory and nephron function in experimental acute renal failure
In: Acute Renal Failure. Brenner BM, Lazarus JM, Eds. Second Edition 1988.
Churchill Livingstone, New York
Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ
Captopril-induced functional renal insufficiency in patients with bilateral renal-artery
stenoses or renal-artery stenosis in a solitary kidney
New England Journal of Medicine 1983; 308: 373-376
Humes HO, Simmons CF Jr, Brenner BM
Effect of verapamil on the hydroosmotic response to antidiuretic hormone in toad
urinary bladder
American Journal of Physiology 1980; 239: F250-F257
Hummel BW, Raess DH, Gewertz BL, Wheeler HT, Fry WJ
Effect of nitroglycerin and aortic occlusion on myocardial blood flow
Surgery 1982; 92: 159-166
Ichikawa I, Miele JF, Brenner BM
Reversal of renal cortical actions of angiotensin II by verapamil and manganese
Kidney International 1979; 16: 137-147
Stellenbosch University http://scholar.sun.ac.za
214
Ichikawa I, Brenner BM
Mechanism of inhibition of proximal tubule fluid reabsorption after exposure of the rat
kidney to the physical effects of expansion of extracellular fluid volume
Journal of Clinical Investigation 1979; 64: 1466-1474
Ichikawa I, Brenner BM
The importance of efferent arteriolar vascular tone in the regulation of proximal tubule
fluid reabsorption and glomerular balance in the rat
Journal of Clinical Investigation 1980; 65: 1192-1201
Ichikawa I, Brenner BM
Glomerular actions of angiotensin II
American Journal of Medicine 1984; 76: 43-49
Ichikawa I, Harris RC
Angiotensin actions in the kidney: Renewed insight into the old hormone
Kidney International 1991; 40: 583-596
Ishihara H, Ishida K, Oyama T, Kudo T, Kudo M
Effects of general anaesthesia and surgery on renal function and plasma ADH levels
Canadian Anaesthetists Society Journal 1978; 25: 312-318
Ishikawa S, Goldberg JP, Schrier DM, Aisenbrey GA, Schrier RW
Interrelationship between subpressor effects of vasopressin and other vasoactive
hormones in the rat
Mineral and Electrolyte Metabolism 1984; 10: 184-189
Itskovitz HO, Stemper J, Pacholczyk 0, McGiff JC
Renal prostaglandins: determinants of intrarenal distribution of blood flow in the dog
Clinical Science and Molecular Medicine 1973; 45 (Suppl, I): 321 S-324S
Jabs K, Zeidel ML, Silva P
Prostaglandin E2 inhibits Na+-K+-ATPase activity in the inner medullary collecting duct
American Journal of Physiology 1989; 257: F424-F430
Johnston JP, Bernard DB, Perrin NS, Levinsky NG
Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat
kidney
Journal of Clinical Investigation 1981; 68: 127-133
Johnston KW, Scobie TK
Multicenter prospective study of nonruptured abdominal aortic aneurysm. I.
Population and operative management
Journal of Vascular Surgery 1988; 7: 69-81
Joob AW, Harman PK, Kaiser DL, Kron IL
The effect of renin-angiotensin system blockade on visceral blood flow during and after
thoracic aortic cross-clamping
Journal of Thoracic and Cardiovascular Surgery 1986; 91: 411-418
Jose PA. Eisner GM, Robillard JE
Renal hemodynamics and natriuresis induced by the dopamine-1 agonist, SKF 82526.
American Journal of Medical Sciences 1987: 294: 181-186
Stellenbosch University http://scholar.sun.ac.za
215
Jouvin-Marché E, Cerrina J, Coeffier E, Duroux P, Benveniste J
Effect of the Ca2+ -antagonist nifedipine on the release of platelet-activating factor
(acether), slow-reacting substance and beta-glucoronidase from human neutrophils
European Journal of Pharmacology 1983; 89: 19-26
Kaplan C, Pasternack B, Shah H, Gallo G
Age-related incidence of sclerotic glomeruli in human kidneys
American Journal of Pathology 1975; 80: 227-234
Kapusta DR, Robie NW
Plasma dopamine in the regulation of canine renal blood flow
American Journal of Physiology 1988; 255: R379-R387
Kasinath BS, Fried TA, Davalath S, Marsden PA
Glomerular epithelial cells synthesize endothelin peptides
American Journal of Pathology 1992; 141: 279-283
Kastner PR, Hall JE, Guyton AC
Control of glomerular filtration rate: Role of intrarenally formed angiotensin II
American Journal of Physiology 1984; 246: F897 -F906
Kataja JH, Kaukinen S, Viinamaki OV, Metsa-Ketela TJ, Vapaatolo H
Hemodynamic and hormonal changes in patients pretreated with captopril for surgery
of the abdominal aorta
Journal of Cardiothoracic Anesthesia 1989; 3: 425-432
Kawaguchi H, Sawa H, Yasuda H
Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary
artery endothelial cells
Journal of Molecular and Cellular Cardiology 1990; 22: 839-842
Kawasaki H, Cline WH, Su C
Involvement of the vascular renin-angiotensin system in beta-adrenergic receptor-
mediated facilitation of vascular transmission in spontaneously hypertensive rats
Journal of Pharmacology and Experimental Therapeutics 1984; 231: 23-32
Kelleher SP, Robinette JB, Conger JD
Sympathetic nervous system in the loss of autoregulation in acute renal failure
American Journal of Physiology 1984; 246: F379-F386
Kim KE, Onseti G, Ramirez 0
Creatinine clearance in renal disease
British Medical Journal 1969; 4: 11-14
Kiowsky W, Luscher TF, Linder L, Buhler FR
Endothelin-1 induced vasoconstriction in humans: Reversal by calcium channel
blockade but not by nitrovasodilators or endothelin-derived relaxing factor
Circulation 1991; 83: 469-475
Kirschenbaum MA, White N, Stein JH, Ferris TF
Redistribution of renal cortical blood flow during inhibition of prostaglandin synthesis
American Journal of Physiology 1974; 227: 801-805
Stellenbosch University http://scholar.sun.ac.za
216
Knight A, Forsling M, Treasure T, Aveling W, Loh L, Sturridge MF
Changes in plasma vasopressin concentration in association with coronary artery
surgery or thymectomy
British Journal of Anaesthesia 1986; 58: 1273-1277
Kohno M, Yasunari K, Yokikawa K, Murakawa K, Horio T, Takeda T
Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after
stimulation with angiotensin II and thrombin of cultured human endothelial cells
Journal of Clinical Investigation 1991; 87: 1999-2004
Kon V, Ichikawa I
Effector loci for renal nerve control of cortical microcirculation
American Journal of Physiology 1983; 245: F545-F553
Kon V, Yared A, Ichikawa I
The role of renal sympathetic nerves in mediating hypoperfusion of renal cortical
microcirculation in experimental congestive heart failure and acute ECF volume
depletion
Journal of Clinical Investigation 1985; 76: 1913-1920
Kon V, Yoshioka T, Fogo A, Ichikawa I
Glomerular actions of endothelin in vivo
Journal of Clinical Investigation 1989; 83: 1762-1767
Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL
Role of endothelin in cyclosporine-induced glomerular dysfunction
Kidney International 1990; 37: 1487-1491
Kopp U, Aurell M, Sjolander M, Ablad B
The role of prostaglandins in alpha- and beta-adrenoceptor mediated renin release
response to graded renal nerve stimulation
PfiOgers Archives 1981; 391: 1-8
Krausz MM, Utsunomiya T, Mclrvine AJ, Allen PO, Levine L, Mannick JA, et al.
Modulation of cardiovascular function and platelet survival by endogenous prostacyclin
released during surgery
Surgery 1983; 93: 554-559
Kreisberg Jl, Bulger RE, Trump BF, Nagle RB
Effects of transient hypotension on the structure and function of rat kidney
Virchows Archives B Cell Pathology 1976; 22: 121-133
Krishna GG, Danovitch GM, Beck FW, Sowers JR
Dopaminergic mediation of the natriuretic response to volume expansion
Journal of laboratory and clinical medicine1985; 105: 214-218
Kurnik BR, Weisberg LS, Cuttler 1M, Kurnik PB
Effects of atrial natriuretic peptide versus mannitol on renal blood flow during
radiocontrast infusion in chronic renal failure
Journal of Laboratory and Clinical Medicine 1990; 116: 27-36
Stellenbosch University http://scholar.sun.ac.za
217
Lakhani M, Lewis RV
Enalapril-induced renal impairment in bilateral renal artery stenosis
British Medical Journal 1985; 291: 824-825
Landes RG, Lillehei RC, Lindsay WG, Nocoloff OM
Free-water clearance and the early recognition of acute renal insufficiency after cardio-
pulmonary bypass
Annals of Thoracic Surgery 1976; 22: 41-43
Lang F
Osmotic diuresis
Renal Physiology 1987; 10: 160-173
Lawrie GM, Morris GC, Crawford ES, Howell JF, Whisennand HH, Badami JP, et al.
Improved results of operation for ruptured abdominal aortic aneurysms
Surgery 1979; 85: 483-488
Lazarus JM
Acute renal failure
Intensive Care Medicine 1986; 12: 61-63
Leonetti G, Cuspidi C, Sampieri L, Terzoli L, ZancheUi A
Comparison of cardiovascular, renal and humoral effects of acute administration of two
calcium channel blockers in normotensive and hypertensive subjects
Journal of Cardiovascular Pharmacology 1982; 4 (Suppl. 3): S319-S324
Le Quesne LP, Cochrane JPS, Fieldman NR
Fluid and electrolyte disturbances after trauma: the role of adrenocortical and pituitary
hormones
British Medical Bulletin 1985: 41: 212-217
Lerman A, Sand ok EA, Hildebrand FL, Burnett JC
Inhibition of endothelium-derived-relaxing-factor enhances endothelin-mediated
vasoconstriction
Circulation 1992; 85: 1894-1898
Levenson OJ, Simmons CE, Brenner BM
Arachidonic acid metabolism, prostaglandins and the kidney
American Journal of Medicine 1982; 72: 354-367
Levinson PO, Goldstein OS, Munson PJ, Gill JR, Keiser HR
Endocrine, renal, and hemodynamic responses to graded dopamine infusions in
normal men
Journal of Clinical Endocrinology and Metabolism 1985; 60: 821-826
Licker M, Bednarkiewicz M, Neidhart P, Pretre R, Montessuit M, Favre H et al.
Preoperative inhibition of angiotensin-converting enzyme improves systemic and renal
haemodynamic changes during aortic abdominal surgery
British Journal of Anaesthesia 1996; 76: 632-639
Lightman SL, Forsling ML
Evidence for endogenous opioid control of vasopressin release in man
Journal of Clinical Endocrinology and Metabolism 1980; 50: 569-571
Stellenbosch University http://scholar.sun.ac.za
218
Livia M, Chiabrando C, Macconi D, Benigni A, Zimei M, De Pietro MT, et al.
Metabolism of arachidonic acid in isolated glomeruli from pig kidney
Biochimica et Biophysica Acta 1988; 961: 110-121
Ljungqvist A, Wagermark J
The adrenergic innervation of intrarenal glomerular and extra-glomerular circulatory
routes
Nephron 1970; 7: 218-229
Lopez-Neblina F, Páes-Rollys AJ, Toledo-Pereyra LH
Mechanism of protection of verapamil by preventing neutrophil infiltration in the
ischemic rat kidney
Journal of Surgical Research 1996; 61: 469-472
Loutzenhiser R, Epstein C, Horton C, Sonke P
Reversal by calcium antagonist nisoldipine of norepinephrine-induced reduction of
GFR: evidence for preferential antagonism of preglomerular vasoconstriction
Journal of Pharmacology and Experimental Therapeutics 1984; 232: 382-387
Loutzenhiser R, Epstein M
Effects of calcium antagonists on renal hemodynamics
American Journal of Physiology 1985; 249: F619-F629
Loutzenhiser R, Epstein M, Horton C, Sonke P
Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by
diltiazem
American Journal of Physiology 1986; 250: R619-626
Loutzenhiser R, Epstein M
Modification of the renal hemodynamic response to vasoconstrictors by calcium
antagonists
American Journal of Nephrology 1987; 7 (Suppl 1): 7-16
Loutzenhiser R, Epstein M, Hayashi K, Horton C
Direct visualization of effects of endothelin on the renal microvasculature
American Journal of Physiology 1990; 258: F61-F68
Luck RJ, Irvine WT
Mannitol in the surgery of aortic aneyrysm
Lancet 1965; 28:409-499
Lum GM, Aisenbrey GA, Dunn MJ, Berl T, Schrier RW, McDonald KM
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to
vasopressin
Journal of Clinical Investigation 1977; 59: 8-13
Luscher TF, Bock HA, Yang ZH, Diederich D
Endothelium-derived relaxing and contracting factors: Perspectives in nephrology
Kidney International 1991; 39: 575-590
Stellenbosch University http://scholar.sun.ac.za
219
Luscher TF, Boulanger CM, Dohi Y, Yang Z
Endothelium derived contracting factors
Hypertension 1992; 19: 117-130
Maclaughlin M, De Mello Aires M, Malnic G
Verapamil effect on renal function of normotensive and hypertensive rats
Renal Physiology 1985; 8: 112-119
Maddox DA, Brenner BM
Glomerular ultrafiltration
In: The Kidney. Brenner BM (Ed.) 1996
WB Saunders Company, Philadelphia
Madeddu P, Yang XP, Anania V, Troffa C, Pazzola A, Soro A, et al.
Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of
endothelin
American Journal of Physiology 1990; 259: F304-F311
Maher FT, Elveback lR
Simultaneous renal clearances of 1251 and 1311 labelled orthoiods hippurate and
paraaminohippurate in the estimation of effective and renal plasma flow in man
Mayo Clinical Proceedings 1970; 45: 657-661
Malis 0, Cheung JY, leaf A, Bonventre JV
Effects of verapamil in models of ischemic acute renal failure in the rat
American Journal of Physiology 1983; 245: F735-741
Manoogian C, Pandian M, Ehrlich l, Fisher 0; Horton R
Plasma atrial natriuretic hormone levels in patients with the syndrome of inappropriate
antidiuretic hormone secretion
Journal of Clinical Endocrinology and Metabolism 1988; 67: 571-575
Margolis Bl, Stein JH
The renal circulation
International Anesthesiology Clinics 1984; 22: 35-63
Marsden PA, Dorfman DM, Collins T, Brenner BM, Orkin SH, Ballermann BJ
Regulated expression of endothelin-1 in glomerular cappilary endothelial cells
American Journal of Phisiology 1991; 261: F117 -F125
Marsden PA, Hall AV, Brenner BM
Reactive nitrogen and oxygen intermediates and the kidney
In: The Kidney
Brenner BM (Ed) 1996. WB Saunders Company, Philadelphia
Maslowski AH, Ikram H, Nicholls MG, Espiner EA
Hemodynamic, hormonal and electrolyte responses to captopril in resistant heart
failure
Lancet 1981; 1: 71-74
Stellenbosch University http://scholar.sun.ac.za
220
Mason J, Kain H, Shiigai T, Welsch J
The early phase of experimental acute renal failure. V. The influence of suppressing
the renin-angiotensin system
PfiOgers Archives 1979; 380: 233-243
Mauk RH, Patak RV, Fadem SZ, Lifschitz MD Stein JH
Effect of prostaglandin E administration in a neprotoxic and a vasocontrictor model of
acute renal failure
Kidney International 1977; 12: 122-130
Mazer CD, Rose OK, Goldstein M, Paul M, Byrick RJ
Renal function in man during infra-renal aortic clamping: Influence of mannitol and
dopamine
Anesthesiology 1984; 61: A65
Mazze RI, Sievenpiper TS, Stevenson J
Renal effects of enflurance and halothane in patients with abnormal renal function
Anesthesiology 1984; 60: 161-163
McCarty NA, O'Neil RG
Calcium-dependent control of volume regulation in renal proximal tubule cells. II.
Swelling-activated Ca2+ entry and release
Journal of Membrane Biology 1991; 123: 149-160
McCombs PR, Roberts B
Acute renal failure following resection of abdominal aortic aneurysm
Surgery, Gynecology and Obstetrics 1979; 148: 175-178
McDonald RH, Godberg LI, McNay JL, Tuttle EP
Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration
rate, and renal plasma flow
Journal of Clinical Investigation 1964; 43: 1116-1124
McKenna TJ, Island OP, Nicholson WE, Liddle GW
Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal
cells
Journal of Clinical Investigation 1979; 64: 287-291
McLachlan MS
The ageing kidney
Lancet 1978; 2: 143-145
McNeill JR, Stark RD, Greenway CV
Intestinal vasoconstriction after hemorrhage: Roles of vasopressin and angiotensin
American Journal of Physiology 1970; 219: 1342-1347
McPhail N, Calvin JE, Shariatmadar A, Barber GG, Scobie TK
The use of preoperative exercise testing to predict cardiac complications after arterial
reconstruction
Journal of Vascular Surgery 1988; 7: 60-68
Stellenbosch University http://scholar.sun.ac.za
221
Medina P, Noguera I, Aldasoro M, Vila JM, Flor B, Lluch S
Enhancement by vasopressin of adrenergic responses in human mesenteric arteries
American Journal of Physiology 1997; 272: H1087-H1093
Mendelsohn FA
Angiotensin II: Evidence for its role as an intrarenal hormone
Kidney International 1982; 22 (Suppl 12): S78-S81
Michelakis AM, Caudle J, Liddle GW
In vitro stimulation of renin production by epinephrine, noropinephrine and cyclic AMP
Proceedings of the Society for Experimental Biology and Medicine 1969; 130: 748-753
Migas I, Backer A, Meyer-Lehnert H, Michel H, Wulfhekel U, Kramer HJ
Characteristics of endothelin receptors and intracellular signalling in porcine inner
medullary collecting duct cells
American Journal of Hypertension 1993; 6: 611-618
Miller TR, Anderson RJ, Linas SL, Henrich WL, Berns AS, Gabow PA, et al.
Urinary diagnostic indices in acute renal failure
Annals of Internal Medicine 1978; 89: 47-50
Miller WA, Thomas RA, Berne RM, Rubio R
Adenosine production in the ischemic kidney
Circulation Research 1978; 43: 390-397
Miller WL, Redfield MM, Burnett JC
Integrated cardiac, renal and endocrine actions of endothelin
Journal of Clinical Investigation 1989; 83: 317-320
Mirenda JV, Grissom TE
Anesthetic implications of the renin-angiotensin system and angiotensin-converting
enzyme inhibitors
Anesthesia and Analgesia 1991; 72: 667-683
Mitchell KO, Navar LG
Superficial nephron responses to peritubular capillary infusions of angiotensins I and II
American Journal of Physiology 1987; 252: F818-F824
Momose N, Fukuo K, Morimoto S, Ogihara T
Captopril inhibits endothelin-1 secretion from endothelium cells through bradykinin
Hypertension 1993; 21: 921-924
Moran SM, Myers BO
Pathophysiology of protracted acute renal failure in man
Journal of Clinical Investigation 1985; 76: 1440-1448
Mowlem A, McClintock JT, Campbell GS
Effect on renal function of occlusion of aorta inferior to renal vessels
Surgery, Gynecology and Obstetrics 1960; 111: 423-428
Mullane KM, Moncada S
Prostacyclin release and the modulation of some vasoactive hormones
Prostaglandins 1980; 20: 25-49
Stellenbosch University http://scholar.sun.ac.za
222
Muller-Suur R, Gutsche HU, Schurek HJ
Acute and reversible inhibition of tubulo-glomerular feedback mediated afferent
vasoconstriction by the calcium-antagonist verapamil
Current Problems in Clinical Biochemistry 1976; 6: 291-298
Myers BO, Miller DC, Mehigan JT, Olcott CO 4th, Golbetz H; Robertson CR et al.
Nature of the renal injury following total renal ischemia in man
Journal of Clinical Investigation 1984; 73: 329-341
Myers BO, Moran SM
Hemodynamically mediated acute renal failure
The New England Journal of Medicine 1986; 314: 97-105
Myers SI, Turnage RH, Hernandez R, Castenada A, Valentine RJ
Autoregulation of renal and splanchnic blood flow following infra-renal aortic clamping
is mediated by nitric oxide and vasodilator prostanoids
Journal of Cardiovascular Surgery (Torino) 1996; 37: 97-103
Nachbur B, Gut A, Sigrist S
Prognostic factors in the surgical treatment of aorto-iliac aneurysmal disease. Factors
affecting survival and long-term results.
Journal of Cardiovascular Surgery (Torino)1987; 28: 469-478
Nakamaru M, Jackson EK, Inagami T
Beta-adrenoreceptor mediated release of angiotensin II from mesenteric arteries
American Journal of Physiology 1986; 250: H144-H148
Nanson EM, Noble JG
The effect on the kidneys of cross-clamping the abdominal aorta distal to the renal
arteries
Surgery 1959; 46: 388-395
Navar LG, Jirakulsomchok 0, Bell PO, Thomas CE, Huang WC
Influence of converting enzyme inhibition on renal hemodynamics and glomerular
dynamics in sodium-restricted dogs
Hypertension 1982; 4: 58-68
Navar LG, Champion WJ, Thomas CE
Effects of calcium channel blockade on renal vascular resistance responses to
changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs
Circulation Research 1986; 58: 874-881
Novick AC, Banowsky LH, Stewart BH, Straffon RA
Renal revascularization in patients with severe atherosclerosis of the abdominal aorta
or a previous operation on the abdominal aorta
Surgery, Gynecology and Obstetrics 1977; 144: 211-218
Novis BK, Roizen MF, Aronson S, Thisted RA
Association of preoperative risk factors with postoperative acute renal failure
Anesthesia and Analgesia 1994; 78: 143-149
Stellenbosch University http://scholar.sun.ac.za
223
Ofstad J, Aukland K
Renal Circulation
In: The Kidney: Physiology and Pathophysiology. Seldin OW, Giebisch, Eds
Raven Press, New York. 1985: 471-496
Oken DE
On the differential diagnosis of acute renal failure
American Journal of Medicine 1981; 71: 916-920
Oliver JA, Sciacca RR, Pinto JJ, Cannon PJ
Participation of the prostaglandins in the control of renal blood flow during acute
reduction of cardiac output in the dog
Journal of Clinical Investigation 1981; 67: 229-237
Olivera A, Lamas S, Rodriguez-Puyol 0, Lopez-Novoa JM
Adenosine induces mesangial cell contraction by an A1-type receptor
Kidney International 1989; 35: 1300-1305
Ornstein E, Young WL, Ostapkovich N, Matteo RS, Diaz J
Are all effects of esmolol equally rapid in onset?
Anesthesia and Analgesia 1995; 81: 297-300
Osborn JL, BiBona GF, Thames MD
Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve
stimulation
Journal of Pharmacology and Experimental Therapeutics 1981; 216: 265-269
Osswald H, Nabakowski G, Hermes H
Adenosine as a possible mediator of metabolic control of glomerular filtration rate
International Journal of Biochemistry 1980; 12: 263-267
Ostri P, Mouritsen L, Jorgensen B, Frimodt-Moller C
Renal function following aneurysmectomy of the abdominal aorta
Journal of Cardiovascular Surgery (Torino) 1986; 27: 714-718
Padfield PL, Brown JJ, Lever AF, Morton JJ, Robertson Jl
Blood pressure in acute and chronic vasopressin excess: studies of malignant
hypertension and the syndrome of inappropriate antidiuretic hormone secretion
New England Journal of Medicine 1981; 304: 1067-1070
Parbrook GO, Davis PO, Parbrook EO
Fluid flow
In: Basic Physics and Measurement in Anaesthesia
Parbrook GO, Davis PO, Parbrook EO (Eds). Third Edition 1990.
Butterworth-Heinemann, Oxford
Parekh N, Veith U
Renal hemodynamics and oxygen consumption during postichemic acute renal failure
in the rat
Kidney International 1981; 19: 306-316
Stellenbosch University http://scholar.sun.ac.za
224
Pass LJ, Eberhart RC, Brown JC, Rohn GN, Estrera AS
The effect of mannitol and dopamine of the renal response to thoracic aortic cross-
clamping
Journal of Thoracic and Cariovascular Surgery 1988; 95: 608-612
Patrono C, Dunn MJ
The clinical significance of inhibition of renal prostaglandin synthesis
Kidney International 1987; 32: 1-12
Paul MD, Mazer CD, Byrick RJ, Rose OK, Goldstein MB
Influence of mannitol and dopamine on renal function during elective infrarenal aortic
clamping in man
American Journal of Nephrology 1986; 6: 427-434
Pelayo JC, Ziegler MG, Blantz RC
Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics
American Journal of Physiology 1984; 247: F799-F807
Peterson A, Brant D, Kirsh MM
Nitroglycerin infusion during infrarenal aortic cross-clamping in dogs: an experimental
study
Surgery 1978; 84: 216-223
Pittman OJ, Lawrence 0, Lederio K
Presynaptic interactions in the neurophypophysis: endogenous modulators of release
In: The Neurophypophysis: Structure, function and control
Cross BA, Leng G Eds. Amsterdam: Elsevier 1983: 319-332
Pollock H, Johnson G
Effect of acute occlusion of the infrarenal aorta on renal function
Surgery, Gynecology and Obstetrics 1973; 137: 805-809
Porter JM, McGregor F Jr, Acinapura AJ, Silver 0
Renal function following abdominal aortic aneurysmectomy
Surgery, Gynnecology and Obstetrics 1966; 123: 819-825
Power I, Cumming AD, Pugh GC
Effect of diclofenac on renal function and prostacyclin generation after surgery
British Journal of Anaesthesia 1992; 69: 451-456
Power RF, Wharton J, Zhao Y, Bloom SR, Polak JM
Autoradiographic localization of endothelin - 1 binding sites in the cardiovascular and
respiratory systems
Journal of Cardiovascular Pharmacology 1989; 13 (Suppl. 5): S50-S56
Powers SR, Baba A, Stein A
The mechanism and prevention of distal tubular necrosis following aneurysmectomy
Surgery 1957; 42: 156-162
Powers SR
Renal failure after ruptured aneurysm
Archives of Surgery 1975; 110: 1069
Stellenbosch University http://scholar.sun.ac.za
225
Powis SJ
Renal function following aortic surgery
Journal of Cardiovascular Surgery (Torino) 1975; 16: 565-571
Priano LL
Effect of halothane on renal hemodynamics during normovolemia and acute
hemorrhagic hypovolemia
Anesthesiology 1985; 63: 357-363
Rae GA, Trybulec M, De Nucci G, Vane JR
Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen
Journal of Cardiovascular Pharmacology 1989; 13 (Suppl. 5): S89-S92
Ram MD, Evans K, Chisholm GD
Measurement of effective renal plasma-flow by the clearance of 1251-Hippuran
Lancet: 1967: 645-646
Reams GP, Bauer JH
Acute and chronic effects of calcium antagonists on the essential hypertensive kidney
In: Epstein M, Loutzenhiser R, Eds. Calcium Antagonists and the Kidney. Hanley &
Belfus, Philadelphia 1990; 247-256
Rector JB, Stein JH, Bay WH, Osgood RW, Ferris TF
Effect of hemorrhage and vasopressor agents on distribution of renal blood flow
American Journal of Physiology 1972; 222: 1125-1131
Reimer KA, Ganote CE, Jennings RB
Alterations in renal cortex following ischemic injury: III. Ultrastructure of proximal
tubules after ischemia or autolysis
Laboratory Investigation 1972; 26: 347-363
Reubi F
The pathogenesis of anuria following shock
Kidney International 1974; 5: 106-110
Rittenhouse EA, Maixner W, Knott HW, Barnes RW, Jaffe BM
The role of prostaglandin E in the hemodynamic response to aortic clamping and
declamping
Surgery 1976; 80: 137-144
Roberts AJ, Niarchos AP, Subramanian VA, Abel RM, Hoover EL, McCabe JC, et al.
Hypertension following coronary artery bypass graft surgery. Comparison of hemo-
dynamic responses to nitroprusside, phentolamine and converting enzyme inhibitor
Circulation 1978; 58 (Suppl 1): 1-43 - 1-49
Robertson 0, Michelakis AM
Effect of anesthesia and surgery on plasma renin activity in man
Journal of Clinical Endocrinology and Metabolism 1972; 34: 831-836
Robertson GL, Klein LA, Roth J, Gorden P
Immunoassay of plasma vasopressin in man
Proceedings of National Acadamy of Science (USA) 1970; 66: 1298-1305
Stellenbosch University http://scholar.sun.ac.za
226
Robertson GL, Mahr EA, Athar P, Sinha T
Development and clinical application of a new method for radio-immunoassay of
arginine vasopressin in human plasma
Journal of Clinical Investigations 1973; 52: 2340-2350
Robinette JR, Conger JD, Schrier RW
The roles of cell calcium and endothelium-derived relaxing factor in the loss of renal
blood flow autoregulation in ischemic acute renal failure
Kidney International 1987; 31: 374
Rose UM, Bindels RJ, Jansen JW, Van Os CH
Effects of Ca2+ channel blockers, low Ca2+ medium and glycine on cell Ca2+ and injury
in anoxic rabbit proximal tubules
Kidney International 1994; 46: 223-229
Rostagno C, Abbate R, Gensini GF, Coppo M, Prisco 0, Boddi M, et al.
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on
intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation.
Comparison with diltiazem, nifedipine and verapamil
Thrombosis Research 1991; 63: 457-462
Rotmensch HH, Vlasses PH, Ferguson RK
Angiotensin converting enzyme inhibitors
Medical Clinics of North America 1988; 72: 399-425
Rowe, JW
Clinical research on aging: strategies and directions
New England Journal of Medicine 1977; 297: 1332-1336
Roy MW, Guthrie GP, Holladay FP, Kotchen TA
Effects of varapamil on renin and aldosterone in the dog and rat
American Journal of Physiology 1983; 245: E410-E416
Russell VA, Lamm MC, De Villiers AS, Taljaard JJF, Chalton DO
Effects of combined administration of L-tryptophan and tricyclic antidepressants on a2-
and 112-adrenoceptors and monoamine levels in rat brain
Neurochemical Research 1985: 10: 1661-1671
Rutledge J, Ayers C, Davidson R, DiPette 0, Guthrie G, Fisher M, et al.
Effect of intravenous enalaprilat in moderate and severe systemic hypertension
American Journal of Cardiology 1988; 62: 1062-1067
Salem MG, Crooke JW, McLoughlin GA, Middle JG, Taylor WH
The effect of dopamine on renal function during aortic crossclamping
Annals of the Royal College of Surgeons of England 1988; 70: 9-12
Satoh S, Zimmerman BG
Influence of the renin-angiotensin system on the effect of prostaglandin synthesis
inhibitors in the renal vasculature
Circulation Research 1975; 36 (Suppl I): 89-96
Stellenbosch University http://scholar.sun.ac.za
227
Sawyer WH, Acosta M, Manning M
Structural changes in the argine vasopressin molecule that prolongs its antidiuretic
action
Endocrinology 1974; 95: 140-149
Schardijn GH, Van Eps LW
r12-microglobulin: Its significance in the evaluation of renal function
Kidney International 1987; 32: 635-641
Scharschmidt LA, Lianos E, Dunn MJ
Arachidonate metabolites and the control of glomerular function
Federation Proceedings 1983; 42: 3058-3063
Schlondorff D, Perez J, Satriano JA
Differential stimulation of PgE2 synthesis in mesangial cells by angiotensin and A23187
American Journal of Physiology 1985; 248: C119-C126
Schlondorff D
Renal prostaglandin synthesis: Sites of production and specific actions of
prostaglandins
American Journal of Medicine 1986; 81 (2B): 1-11
Schnermann J, Briggs JP, Weber PC
Tubuloglomerular feedback, prostaglandins and angiotensin in the autoregulation of
glomerular filtration rate
Kidney International 1984; 25: 53-64
Schnermann J, Todd KM, Briggs JP
Effect of dopamine on the tubuloglomerular feedback mechanism
American Journal of Physiology 1990; 258: F790-798
Schor N, Ichikawa I, Brenner BM
Mechanisms of actions of various hormones and vasoactive substances on glomerular
ultrafiltration in the rat
Kidney International 1981; 20: 442-451
Schrier RW
Effects of the adrenergic nervous system and catecholamines on systemic and renal
hemodynamics, sodium and water excretion and renin secretion
Kidney International 1974; 6: 291-306
Schrier RW, Berl T
Nonosmolar factors affecting renal water excretion
New England Journal of Medicine 1975; 292: 81-88
Schrier RW, Berl T, Anderson RJ
Osmotic and nonosmotic control of vasopressin release
American Journal of Physiology 1979; 236: F321-F332
Schrier RW, Arnold PE, Van Putten VJ, Burke TJ
Cellular calcium in ischemic acute renal failure: role of calcium entry blockers.
Kidney International 1987; 32: 313-321
Stellenbosch University http://scholar.sun.ac.za
228
Schuster VL, Kokko JP, Jacobson HR
Interaction of Iysyl-bradykinin and antidiuretic hormone in the rabbit cortical collecting
tubule
Journal of Clinical Investigation 1984; 73: 1659-1667
Schwartz BO
The HLA major histocompatibility complex
In: Clinical Immunology. Principles and Practice
Rich RR (Ed) 1996. Mosby-Year Book, Inc., Missouri
Schwartz LB, Bissell MG, Murphy M, Gewertz BL
Renal effects of dopamine in vascular surgical patients
Journal of Vascular Surgery 1988; 8: 367-374
Scobie K, McPhail N, Hubbard C
Early and late results of resection of abdominal aortic aneurysms
Canadian Medical Association Journal 1977; 117: 147-150
Seely JF, Dirks JH
Micropuncture study of hypertonic mannitol diuresis in the proximal and distal tubule of
the dog kidney
Journal of Clinical Investigations 1969; 48: 2330-2340
Serrano-Hernando FJ, Martin-Paredero V, Del-Rio A, Lopez-Parra JJ, Solis JV,
Tovar A, et al.
Abdominal aorta aneurysms. Results of surgical treatment
Journal of Vascular Surgery 1985; 26: 539-546
Shanley PF, Brezis M, Spokes K, Silva P, Epstein FH, Rosen S
Hypoxic injury in the proximal tubule of the isolated perfused rat kidney
Kidney International 1986a; 29: 1021-1032
Shanley PF, Rosen MD, Brezis M, Silva P, Epstein FH, Rosen S
Topography of focal proximal tubular necrosis after ischemia with reflow in the rat
kidney
American Journal of Pathology 1986b; 122: 462-468
Shibouta Y, Suzuki N, Shino A, Matsumoto H, Terashita Z, Kondo K, Nishikawa K
Pathophysiologic role of endothelin in acute renal failure
Life Sciences 1990; 46: 1611-1618
Shoemaker WC, Apple PL, Kram HB, Duarte 0, Harrier HO, Ocampo HA
Comparison of hemodynamic and oxygen transport effects of dopamine and
dobutamine in critically ill surgical patients
Che~1989; 96: 120-126
Shultz PJ, Schorer AE, Raij L
Effects of endothelium derived relaxing factor (EDRF) and nitric oxide (NO) on rat
mesangial cells
American Journal of Physiology 1990; 258: F162-F167
Stellenbosch University http://scholar.sun.ac.za
229
Siegel S
The Kruskal-Wallace one-way analysis of variance by ranks
In: Nonparametric statistics for the behavioral sciences
Ed. Siegel S. McGraw Hill, London; 1953a: 184-196
Siegel S
The Wilcoxon matched pairs, signed rank test
In: Nonparametric statistics for the behavioral sciences
Ed. Siegel S. McGraw Hill, London; 1953b: 75-83
Siegel S
The Fisher exact probability test
In: Nonparametric statistics for the behavioral sciences
Ed. Siegel S. McGraw Hill, London; 1953c: 96
Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, et al.
Endothelin stimulates phospholipase C, Na+/W exchange, c-fos expression and
mitogenesis in rat mesangial cells
Journal of Clinical Investigation 1989; 83: 708-712
Sinnatamby C, Edwards CR, Kitau M, Irving MH
Antidiuretic hormone response to high and conservative fluid regimes in patients
undergoing operation
Surgery, Gynecology and Obstetrics 1974; 139: 715-719
Smith HW
Principles of renal physiology
Oxford University Press, New York, 1956
Smith JB, Smith L, Brown ER, Barnes D, Sabir MA, Davis JS, Farese RV
Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis,
phosphoinositide hydrolysis and calcium mobilization in cultured arterial muscle cells
Proceedings of the National Academy of Science of the USA 1984; 81: 7812-7816
Spielman WS, Thompson Cl
A proposed role for adenosine in the regulation of renal hemodynamics and renin
release
American Journal of Physiology 1982; 242: F423-F435
Sporn IN, Lancestremere RG, Papper S
Differential diagnosis of oliguria in aged patients
New England Journal of Medicine 1962; 267: 130-134
Stahl RA, Paravicini M, Schollmeyer P
Angiotensin II stimulation of prostaglandin E2 and 6-keto-F 1a formation by isolated
human glomeruli
Kidney International 1984; 26: 30-34
Standgaard S
Autoregulation of cerebral blood flow in hypertensive patients
Circulation 1976; 53: 720-727
Stellenbosch University http://scholar.sun.ac.za
230
Steele TH, Challoner Hue L
Renal interactions between norepinephrine and calcium antagonists
Kidney International 1984; 26: 719-24
Stein M, James PM, Kelly J, Brown 0, Shircliffe AC, Patterson WE
Renal protection during aortic cross-clamping
American Surgeon 1972; 38: 681-689
Steiner RW
Interpreting the fractional excretion of sodium
The American Journal of Medicine 1984; 77: 699-703
Stella A, Zanchetti A
Control of renal renin release
Kidney International 1987; 31: Suppl20, S89-S94
Stevens PE, Bolsin S, Gwyther SJ, Hanson ME, Boultbee JE, Kox W
Practical use of duplex doppler analysis of the renal vasculature in critically ill patients
Lancet 1989; 1:240-242
Sturm JT, Billiar TR, Luxemberg MG, Perry JF
Risk factors for the development of renal failure following the surgical treatment of
traumatic aortic rupture.
Annals of Thoracic Surgery 1987; 43: 425-427
Sullivan CA, Rohrer MJ, Cutler BS
Clinical management of the symptomatic but unruptured abdominal aortic aneurysm
Journal of Vascular Surgery 1990; 11: 799-803
Svensson LG, Coselli JS, Safi HJ, Hess KR, Crawford ES
Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or
thoracoabdominal aorta
Journal of Vascular Surgery 1989; 10: 230-239
Symbas PN, Pfaender LM, Drucker MH, Lester JL, Gravanis MB, Zacharopoulos L
Crossclamping of the descending aorta: hemodynamic and neurohumoral effects
Journal of Thoracic and Cardiovascular Surgery 1983; 85: 330-335
Szilagyi DE, Elliott JP Jr, Smith RF, Reddy DJ, McPharlin M
A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive
disease
Journal of Vascular Surgery 1986; 3: 421-436
Tagawa H, Vander AJ
Effects of adenosine compounds on renal function and renin secretion in dogs
Circulation Research 1970; 26: 327-338
Takeda K, Torikai S, Asano Y, Imai M
Modulation by verapamil of hormonal action on the Henle's loop of mice
Kidney International 1986; 29: 863-869
Stellenbosch University http://scholar.sun.ac.za
231
Takeda K, Meyer-Lehnert H, Kim JK, Schrier RW
AVP-induced Ca fluxes and contraction of rat glomerular mesangial cells
American Journal of Physiology 1988; 255: F142-150
Taylor KM, Morton JJ, Brown JJ, Bain WH, Caves PK
Hypertension and the renin-angiotensin system following open heart surgery
Journal of Thoracic and Cardiovascular Surgery 1977; 74: 840-845
Terragno NA, Terragno DA, McGifff JC
Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and
laparotomized dogs
Circulation Research 1977; 40: 590-595
Ter Wee PM, Rosman JB, Van der Geest S, Sluiter WJ, Donker AJ
Renal hemodynamics during seperate and combined infusion of amino acids and
dopamine
Kidney International 1986; 29: 870-874
Thompson JE, Hollier LH, Patman RD, Persson AV
Surgical management of abdominal aortic aneurysms: Factors influencing mortality
and morbidity - a 20 year experience
Annals of Surgery 1975; 181: 654-661
Thurau K
Renal hemodynamics
American Journal of Medicine 1964; 36: 698-719
Thurlbeck WM, Castleman B
Atheromatous emboli to the kidneys after aortic surgery
The New England Journal of Medicine 1957; 257: 442-447
Tobias GJ, McLaughlin RF, Hopper J
Endogenous creatinine clearance. A valuable clinical test of glomerular filtration and a
prognostic guide in chronic renal failure
New England Journal of Medicine 1962; 266: 317-323
Tolins JP, Palmer RM, Moncada S, Raij L
Role of endothelium-derived relaxing factor in regulation of renal hemodynamic
responses
American Journal of Physiology 1990; 258: H655-H662
Tomita K, Pisano JJ, Knepper MA
Control of sodium and potassium transport in the cortical collecting duct of the rat.
Effects of bradykinin, vasopressin, and deoxycorticosterone
Journal of Clinical Investigation 1985; 76: 132-136
Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda 0, Ando K, et al.
Plasma endothelin levels in patients with acute renal failure
New England Journal of Medicine 1989; 321: 1127
Stellenbosch University http://scholar.sun.ac.za
232
Tranquilli WJ, Manohar M, Parks CM, Thurmon JC, Theodorakis MC, Benson GJ
Systemic and regional blood flow distribution in anesthetized swine and swine
anesthetized with halothane and nitrous oxicle, halothane or enflurance
Anesthesiology 1982; 56: 369-379
Tucker BJ, Mundy CA, Maciejewski AR, Printz MP, Ziegler MG, Pelayo JC, et al.
Changes in glomerular hemodynamic response to angiotensin II after subacute renal
denervation in rats
Journal of Clinical Investigation 1986; 78: 680-688
Vander AJ
Effects of cateholamines and the renal nerves on renin secretion in anesthetized dogs
American Journal of Physiology 1965; 209: 659-662
Van Heeckeren OW
Ruptured abdominal aortic aneurysms
The American Journal of Surgery 1970; 119: 402-407
Van Zwieten PA
Protective effects of calcium antagonists in different organs and tissues
American Heart Journal 1993; 125: 566-571
Velasquez MT, Notargiacomo AV, Cohn JN
Comparative effects of saline and mannitol on renal cortical blood flow and volume in
the dog
American Journal of Physiology 1973; 224: 322-327
Venkatachalam MA, Bernard DB, Donohoe JF, Levinsky NG
Ischemic damage and repair in the rat proximal tubule: Differences among the S1' S2
and S3 segments
Kidney International 1978; 14: 31-49
Vikse A, Holdaas H, Sejersteed OM, Kiil F
Hemodynamic conditions for renal PgE2 and renin release during a, and l1-adrenergic
stimulation in dogs
Acta Physiologica Scandinavica 1985; 124: 163-172
Von Restorff W, Hofling B, Holtz J, Bassenge E
Effect of increased blood fluidity through hemodilution on general circulation at rest and
during exercise in dogs
PflOgers Archives 1975; 357: 25-34
Waeber B, Nussberger J, Juillerat L, Brunner HR
Angiotensin converting enzyme inhibition: Discrepancy between antihypertensive effect
and suppression of enzyme activity
Journal of Cardiovascular Pharmocology 1989; 14 (Sup pi 4): S53-S59
Wakefield TW, Whitehouse WM Jr, Wu SC, Zelenock GB, Cronenwett JL, Erlandson
EE, et al.
Abdominal aortic aneurysm rupture: Statistical analysis of factors affecting outcome of
surgical treatment
Surgery 1982; 91: 586-596
Stellenbosch University http://scholar.sun.ac.za
233
Wait RB, White G, Davis JH
Beneficial effects of verapamil on postischemic renal failure
Surgery 1983; 94: 276-282
Walker BR
Antidiuresis and decreased sodium excretion during cyclo-oxygenase inhibition in the
conscious dog
Renal Physiology 1983; 6: 53-62
Wallia R, Greenberg A, Puschett JB
Renal hemodynamic and tubular transport effect of nifedipine
Journal of Clinical and Laboratory Medicine 1985; 105: 498-503
Walshe JJ, Venuto RC
Acute oliguric renal failure induced by indomethacin: possible mechanism
Annals of Internal Medicine 1979; 91: 47-49
Wanecek M, Rudehill A, Hemsen A, Lundberg JM, Weitzberg E
The endothelin antagonist, bosentan, in combination with the cyclooxygenase inhibitor,
diclofenac, counteracts pulmonary hypertension in porcine endotoxic shock
Critical Care Medicine 1997; 25: 848-857
Wantz GE, Guida PM, Moore SW
Immediate complications following abdominal aortic surgery
Surgical Clinics of North America 1964; 44: 469-481
Warren SE, Blantz RC
Mannitol
Archives of Internal Medicine 1981; 141: 493-497
Wassermann J, Huss R, Kullmann R
Dopamine induced diuresis in the cat without changes in renal hemodynamics
Naunyn-Schmiedebergs Archives of Pharmacology 1980; 312: 77-83
Waugh WH, Shanks RG
Cause of genuine autoregulation of the renal circulation
Circulation Research 1960; 8: 871-888
Weidmann P, Hasler L, Gnadinger MP, Lang RE, Uehlinger DE, Shaw S, et al.
Blood levels and renal effects of atrial natriuretic peptide in normal man
Journal of Clinical Investigation 1986; 77: 734-742
Weinberg JM
The cell biology of ischemic renal injury
Kidney International 1991; 39: 476-500
Wendling MG, Eckstein JW, Abboud FM
Effects of mannitol on the renal circulation
Journal of Laboratory and Clinical Medicine 1969; 74: 541-547
Whitley JE, Witcofski RL, Felts JH, Meschan I
The investigation of renal complications of aortic clamping
Surgery 1961; 50: 673-675
Stellenbosch University http://scholar.sun.ac.za
234
Whittemore AD, Clowes AW, Hechtman HB, Mannick JA
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of
optimal cardiac performance
Annals of Surgery 1980; 192: 414-421
Wilkes BM, Mailloux LU
Acute renal failure. Pathogenesis and prevention
Americal Journal of Medicine 1986; 80: 1129-1136
Williams GH
Converting-enzyme inhibitors in the treatment of hypertension
New England Journal of Medicine 1988; 319: 1517-1525
Wilson DR, Arnold PE, Burke TJ, Schrier RW
Mitochondrial calcium accumulation and respiration in ischemic acute renal failure in
the rat
Kidney International 1984; 25: 519-526
Woods WGA, Forsling ML, Sturridge MF, Bennett PJ, Le Quesne LP
Vasopressin release and arterial pressure during cardiac surgery
British Journal of Surgery 1983; 70: 302
Woolley JL, Barker GR, Jacobsen WK, Gingrich GA, Stewart SC, Briggs BA, et al.
Effect of the calcium entry blocker verapamil on renal ischemia
Critical Care Medicine 1988; 16: 48-51
Wright B, Zeidman I, Greig R, Poste G
Inhibition of macrophage activation by calcium channel blockers and calmodulin
antagonist
Cellular Immunology 1985; 95: 46-53
Yamashita M, Oyama T, Kudo T
Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and
renal perfusion in haemorrhagic shock
Canadian Anaesthetists' Society Journal 1977; 24: 695-701
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Nature 1988; 332: 411-415
Yang Z, Von Zegesser L, Bauer E, Stulz P, Turina M, Luscher TF
Threshold concentrations of endothelin-1 potentiates contractions to norepinephrine
and serotonin in human arteries: A new mechanism of vasospasm?
Circulation 1990; 82: 188-195
Yared A, Kon V, Ichikawa I
Mechanism of preservation of glomerular perfusion and filtration during acute
extracellular fluid volume depletion. Importance of intrarenal vasopressin-
prostaglandin interaction for protecting kidneys from constrictor action of vasopressin
Journal of Clinical Investigation 1985; 75: 1477-1487
Stellenbosch University http://scholar.sun.ac.za
235
Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I
Role of angiotensin II in an overt functional proteinuria
Kidney International 1986; 30: 538-545
Young AE, Sandberg GW, Couch NP
The reduction of mortality of abdominal aortic aneurysm resection
American Journal of Surgery 1977; 134: 585-590
Young EW, Humes HO
Calcium and acute renal failure
Mineral and Electrolyte Metabolism 1991; 17: 106-111
Zager RA, Mahan J, Merola AJ
Effects of mannitol on the postischemic kidney. Biochemical, functional and
morphologic assessments
Laboratory Investigation 1985; 53: 433-442
Zaloga GP, Hughes SS
Oliguria in patients with normal renal function
Anesthesiology 1990; 72: 598-602
Zaritsky A, Lotze A, Stull R, Goldstein OS
Steady state dopamine clearance in critically ill infants and children
Critical Care Medicine 1988; 16: 217-220
Zerbe RL, Feurstein G, Kopin IJ
Effect of captopril on cardiovascular, sympathetic and vasopressin responses to
hemorrhage
European Journal of Pharmacology 1981; 72: 391-395
Zimmerman BG
Actions of angiotensin on adrenergic nerve endings
Federation Proceedings 1978; 37: 199-202
Zipser RO, Myers SI, Needleman P
Stimulation of renal prostaglandin synthesis by the pressor activity of vasopressin
Endocrinology 1981; 108: 495-499
Zoja C, Orisio S, Perico N, Benigni A, Morigi M, Benatti L, et al.
Constitutive expression of endothelin gene in cultured human mesangial cells and its
modulation by transforming growth factor 11,thrombin and thromboxane A2 analogue
Laboratory Investigation 1991; 64: 16-20
Zusman RM, Keiser HR
Prostaglandin synthesis by rabbit renomedullary interstitial cells in culture. Stimulation
by angiotensin II, bradykinin and arginine vasopressin
Journal of Clinical Investigation 1977; 60: 215-222
Stellenbosch University http://scholar.sun.ac.za
